1 |
Metformin FDA Label
|
2 |
Simvastatin FDA Label
|
3 |
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy.J Natl Cancer Inst. 2020 Feb 1;112(2):179-190. doi: 10.1093/jnci/djz075.
|
4 |
Identification of potential diagnostic and prognostic biomarkers for prostate cancer.Oncol Lett. 2019 Oct;18(4):4237-4245. doi: 10.3892/ol.2019.10765. Epub 2019 Aug 16.
|
5 |
PAC1-R null isoform expression in human prostate cancer tissue.Prostate. 2006 Apr 1;66(5):514-21. doi: 10.1002/pros.20356.
|
6 |
MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance.Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3734-3741. doi: 10.26355/eurrev_201806_15253.
|
7 |
Cross-talk between alpha1D-adrenoceptors and transient receptor potential vanilloid type 1 triggers prostate cancer cell proliferation.BMC Cancer. 2014 Dec 7;14:921. doi: 10.1186/1471-2407-14-921.
|
8 |
Expression of autotaxin and acylglycerol kinase in prostate cancer: association with cancer development and progression.Cancer Sci. 2009 Sep;100(9):1631-8. doi: 10.1111/j.1349-7006.2009.01234.x. Epub 2009 May 31.
|
9 |
Prohibitin-2 negatively regulates AKT2 expression to promote prostate cancer cell migration.Int J Mol Med. 2018 Feb;41(2):1147-1155. doi: 10.3892/ijmm.2017.3307. Epub 2017 Dec 4.
|
10 |
Angiogenin mediates androgen-stimulated prostate cancer growth and enables castration resistance.Mol Cancer Res. 2013 Oct;11(10):1203-14. doi: 10.1158/1541-7786.MCR-13-0072. Epub 2013 Jul 12.
|
11 |
Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF- signaling.Cell Death Dis. 2018 Jun 13;9(6):703. doi: 10.1038/s41419-018-0735-2.
|
12 |
Design, synthesis and biological evaluation of new -carboline-bisindole compounds as DNA binding, photocleavage agents and topoisomerase I inhibitors.Eur J Med Chem. 2018 Jan 1;143:1563-1577. doi: 10.1016/j.ejmech.2017.10.054. Epub 2017 Oct 23.
|
13 |
Validation of HB-EGF and amphiregulin as targets for human cancer therapy.Biochem Biophys Res Commun. 2008 Jan 18;365(3):555-61. doi: 10.1016/j.bbrc.2007.11.015. Epub 2007 Nov 20.
|
14 |
Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human prostate cancer. PLoS One. 2010 Aug 11;5(8):e12107.
|
15 |
Loss of ATF3 promotes hormone-induced prostate carcinogenesis and the emergence of CK5(+)CK8(+) epithelial cells.Oncogene. 2016 Jul 7;35(27):3555-64. doi: 10.1038/onc.2015.417. Epub 2015 Nov 2.
|
16 |
Purification and Functional Characterization of the C-Terminal Domain of the -Actin-Binding Protein AIM1 In Vitro.Molecules. 2018 Dec 11;23(12):3281. doi: 10.3390/molecules23123281.
|
17 |
AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.J Cell Physiol. 2019 Aug;234(10):17444-17458. doi: 10.1002/jcp.28366. Epub 2019 Feb 28.
|
18 |
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis.Oncotarget. 2014 Aug 30;5(16):6896-908. doi: 10.18632/oncotarget.2229.
|
19 |
CACNA2D2 promotes tumorigenesis by stimulating cell proliferation and angiogenesis.Oncogene. 2015 Oct 16;34(42):5383-94. doi: 10.1038/onc.2014.467. Epub 2015 Jan 26.
|
20 |
Improvement of prostate cancer detection combining a computer-aided diagnostic system with TRUS-MRI targeted biopsy.Abdom Radiol (NY). 2019 Jan;44(1):264-271. doi: 10.1007/s00261-018-1712-z.
|
21 |
Design, Synthesis and Biological Evaluation of 4-Aryl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one Derivatives as a PI3K Inhibitor.Biol Pharm Bull. 2019;42(6):1013-1018. doi: 10.1248/bpb.b19-00080.
|
22 |
The gastrin/cholecystokinin-B receptor on prostate cells--a novel target for bifunctional prostate cancer imaging.Eur J Pharm Sci. 2014 Feb 14;52:69-76. doi: 10.1016/j.ejps.2013.10.013. Epub 2013 Nov 6.
|
23 |
Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.Prostate. 2019 Jun;79(9):1018-1031. doi: 10.1002/pros.23810. Epub 2019 Apr 24.
|
24 |
Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.Oncotarget. 2015 May 10;6(13):10712-27. doi: 10.18632/oncotarget.3544.
|
25 |
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells.J Clin Med. 2019 Mar 13;8(3):354. doi: 10.3390/jcm8030354.
|
26 |
Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size.Gene. 2017 Dec 15;636:96-102. doi: 10.1016/j.gene.2017.09.016. Epub 2017 Sep 10.
|
27 |
Tumor necrosis factor- induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation.Cancer Sci. 2018 May;109(5):1524-1531. doi: 10.1111/cas.13586. Epub 2018 Apr 29.
|
28 |
TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.Clin Cancer Res. 2015 Aug 15;21(16):3771-82. doi: 10.1158/1078-0432.CCR-14-3145. Epub 2015 May 12.
|
29 |
iTRAQ-based Comparative Serum Proteomic Analysis of Prostate Cancer Patients with or without Bone Metastasis.J Cancer. 2019 Jul 10;10(18):4165-4177. doi: 10.7150/jca.33497. eCollection 2019.
|
30 |
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy.Cancer Med. 2019 Jun;8(6):2777-2783. doi: 10.1002/cam4.2163. Epub 2019 Apr 16.
|
31 |
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications.Int J Mol Sci. 2019 Aug 9;20(16):3881. doi: 10.3390/ijms20163881.
|
32 |
Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.Int J Cancer. 2020 Jan 15;146(2):577-588. doi: 10.1002/ijc.32551. Epub 2019 Jul 19.
|
33 |
CCAAT enhancer binding protein promotes tumor growth and inhibits apoptosis in prostate cancer by methylating estrogen receptor .Neoplasma. 2018;65(1):34-41. doi: 10.4149/neo_2018_161205N620.
|
34 |
Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.Prostate. 2015 Aug 1;75(11):1197-205. doi: 10.1002/pros.23002. Epub 2015 Apr 15.
|
35 |
Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus.Radiother Oncol. 2019 Nov;140:131-142. doi: 10.1016/j.radonc.2019.06.023. Epub 2019 Jul 2.
|
36 |
CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors.Eur Urol. 2002 Mar;41(3):335-41. doi: 10.1016/s0302-2838(02)00020-9.
|
37 |
Targeting IB Kinase /NF-B Signaling in Human Prostate Cancer by a Novel IB Kinase Inhibitor CmpdA.Mol Cancer Ther. 2016 Jul;15(7):1504-14. doi: 10.1158/1535-7163.MCT-15-0999. Epub 2016 Apr 8.
|
38 |
Identification of Novel Epigenetic Markers of Prostate Cancer by NotI-Microarray Analysis.Dis Markers. 2015;2015:241301. doi: 10.1155/2015/241301. Epub 2015 Sep 28.
|
39 |
Chloride intracellular channel 1 regulates prostate cancer cell proliferation and migration through the MAPK/ERK pathway.Cancer Biother Radiopharm. 2014 Oct;29(8):339-44. doi: 10.1089/cbr.2014.1666.
|
40 |
Neural Cell Adhesion Protein CNTN1 Promotes the Metastatic Progression of Prostate Cancer.Cancer Res. 2016 Mar 15;76(6):1603-14. doi: 10.1158/0008-5472.CAN-15-1898. Epub 2016 Jan 21.
|
41 |
Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach.Biomolecules. 2019 Oct 9;9(10):591. doi: 10.3390/biom9100591.
|
42 |
Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study.Cancer Res. 2009 Dec 15;69(24):9315-22. doi: 10.1158/0008-5472.CAN-09-0648.
|
43 |
NAD(P)H:quinone oxidoreductase 1 (NQO1) P187S polymorphism and prostate cancer risk in Caucasians.Int J Mol Sci. 2012;13(9):10959-10969. doi: 10.3390/ijms130910959. Epub 2012 Jul 26.
|
44 |
Targeting CK2 for cancer therapy.Anticancer Drugs. 2005 Nov;16(10):1037-43. doi: 10.1097/00001813-200511000-00001.
|
45 |
CXXC5 expression in prostate cancer: implications for cancer progression.Int J Exp Pathol. 2017 Aug;98(4):234-243. doi: 10.1111/iep.12241.
|
46 |
Dietary lipids and environmental xenobiotics as risk factors for prostate cancer: The role of cytochrome P450.Pharmacol Rep. 2019 Oct;71(5):826-832. doi: 10.1016/j.pharep.2019.04.011. Epub 2019 Apr 15.
|
47 |
Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer.Cancer Lett. 2016 Jul 28;377(2):134-9. doi: 10.1016/j.canlet.2016.04.028. Epub 2016 Apr 25.
|
48 |
Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein.Biochim Biophys Acta. 2014 Sep;1842(9):1350-63. doi: 10.1016/j.bbadis.2014.04.018. Epub 2014 Apr 27.
|
49 |
DKK1 and Kremen Expression Predicts the Osteoblastic Response to Bone Metastasis.Transl Oncol. 2018 Aug;11(4):873-882. doi: 10.1016/j.tranon.2018.04.013. Epub 2018 May 15.
|
50 |
The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.Mol Cancer Res. 2015 May;13(5):913-22. doi: 10.1158/1541-7786.MCR-14-0680. Epub 2015 Mar 16.
|
51 |
Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.Biochim Biophys Acta. 2014 Sep;1839(9):858-65. doi: 10.1016/j.bbagrm.2014.07.001. Epub 2014 Jul 10.
|
52 |
p-mTOR, p-4EBP-1 and eIF4E expression in canine prostatic carcinoma.Res Vet Sci. 2019 Feb;122:86-92. doi: 10.1016/j.rvsc.2018.11.006. Epub 2018 Nov 16.
|
53 |
Low frequency of ESRRA-C11orf20 fusion gene in ovarian carcinomas.PLoS Biol. 2014 Feb 4;12(2):e1001784. doi: 10.1371/journal.pbio.1001784. eCollection 2014 Feb.
|
54 |
Increased expression of EphA1 protein in prostate cancers correlates with high Gleason score.Int J Clin Exp Pathol. 2013 Aug 15;6(9):1854-60. eCollection 2013.
|
55 |
Downregulation of EphA5 by promoter methylation in human prostate cancer.BMC Cancer. 2015 Jan 22;15:18. doi: 10.1186/s12885-015-1025-3.
|
56 |
EphA6 promotes angiogenesis and prostate cancer metastasis and is associated with human prostate cancer progression.Oncotarget. 2015 Sep 8;6(26):22587-97. doi: 10.18632/oncotarget.4088.
|
57 |
Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer.Asian J Androl. 2020 Jul-Aug;22(4):422-426. doi: 10.4103/aja.aja_80_19.
|
58 |
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.Oncogene. 2018 Jun;37(25):3340-3355. doi: 10.1038/s41388-018-0198-z. Epub 2018 Mar 20.
|
59 |
Withaferin A Inhibits Prostate Carcinogenesis in a PTEN-deficient Mouse Model of Prostate Cancer.Neoplasia. 2017 Jun;19(6):451-459. doi: 10.1016/j.neo.2017.04.005. Epub 2017 May 7.
|
60 |
Androgen receptor dampens tissue factor expression via nuclear factor-B and early growth response protein 1.J Thromb Haemost. 2018 Apr;16(4):749-758. doi: 10.1111/jth.13971. Epub 2018 Mar 13.
|
61 |
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.JAMA Oncol. 2015 Jul;1(4):466-74. doi: 10.1001/jamaoncol.2015.1313.
|
62 |
FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.Oncogene. 2019 Jun;38(26):5265-5280. doi: 10.1038/s41388-019-0791-9. Epub 2019 Mar 26.
|
63 |
Endocrine fibroblast growth factor FGF19 promotes prostate cancer progression.Cancer Res. 2013 Apr 15;73(8):2551-62. doi: 10.1158/0008-5472.CAN-12-4108. Epub 2013 Feb 25.
|
64 |
Delineation of human prostate cancer evolution identifies chromothripsis as a polyclonal event and FKBP4 as a potential driver of castration resistance.J Pathol. 2018 May;245(1):74-84. doi: 10.1002/path.5052. Epub 2018 Apr 2.
|
65 |
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.Oncologist. 2018 Dec;23(12):1413-e151. doi: 10.1634/theoncologist.2018-0652. Epub 2018 Nov 1.
|
66 |
Regulated expression of the TP isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3153-3169. doi: 10.1016/j.bbadis.2017.09.005. Epub 2017 Sep 8.
|
67 |
Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC.Cancer Res. 2019 Apr 1;79(7):1413-1425. doi: 10.1158/0008-5472.CAN-18-2049. Epub 2019 Feb 7.
|
68 |
Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.Am J Epidemiol. 2012 Dec 15;176(12):1121-9. doi: 10.1093/aje/kws191. Epub 2012 Nov 28.
|
69 |
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3.
|
70 |
The roles and mechanisms of G3BP1 in tumour promotion. J Drug Target. 2019 Mar;27(3):300-305.
|
71 |
The influence of PSA-RNA yield on the analysis of expressed prostatic secretions (EPS) for prostate cancer diagnosis.Can J Urol. 2013 Feb;20(1):6597-602.
|
72 |
Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.Mol Cancer Res. 2017 Dec;15(12):1644-1655. doi: 10.1158/1541-7786.MCR-17-0132. Epub 2017 Aug 16.
|
73 |
Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):291-299. doi: 10.1016/j.ijrobp.2019.10.014. Epub 2019 Oct 17.
|
74 |
A germ line mutation that delays prostate cancer progression and prolongs survival in a murine prostate cancer model.Oncogene. 2005 Jul 7;24(29):4736-40. doi: 10.1038/sj.onc.1208572.
|
75 |
Limited short-term effects on human prostate cancer xenograft growth and epidermal growth factor receptor gene expression by the ghrelin receptor antagonist [D-Lys(3)]-GHRP-6.Endocrine. 2019 May;64(2):393-405. doi: 10.1007/s12020-018-1796-9. Epub 2018 Nov 2.
|
76 |
GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer.Mol Cancer. 2016 Mar 18;15:25. doi: 10.1186/s12943-016-0508-4.
|
77 |
Preclinical evaluation of new GnRH-I receptor radionuclide therapy with (177) Lu-peptide tracer.J Labelled Comp Radiopharm. 2019 Jun 15;62(7):310-320. doi: 10.1002/jlcr.3742. Epub 2019 Jun 13.
|
78 |
G protein-coupled receptor kinase GRK5 phosphorylates moesin and regulates metastasis in prostate cancer.Cancer Res. 2014 Jul 1;74(13):3489-500. doi: 10.1158/0008-5472.CAN-13-2708. Epub 2014 Apr 22.
|
79 |
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.J Cancer Res Clin Oncol. 2014 Nov;140(11):1849-61. doi: 10.1007/s00432-014-1738-8. Epub 2014 Jun 18.
|
80 |
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.PLoS One. 2011;6(11):e27720. doi: 10.1371/journal.pone.0027720. Epub 2011 Nov 16.
|
81 |
The orexin type 1 receptor is overexpressed in advanced prostate cancer with a neuroendocrine differentiation, and mediates apoptosis.Eur J Cancer. 2014 Aug;50(12):2126-33. doi: 10.1016/j.ejca.2014.05.008. Epub 2014 Jun 5.
|
82 |
HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.J Steroid Biochem Mol Biol. 2017 Apr;168:91-101. doi: 10.1016/j.jsbmb.2017.02.008. Epub 2017 Feb 14.
|
83 |
Circulating Levels of Omentin, Leptin, VEGF, and HGF and Their Clinical Relevance with PSA Marker in Prostate Cancer.Dis Markers. 2018 Aug 16;2018:3852401. doi: 10.1155/2018/3852401. eCollection 2018.
|
84 |
The RNA-binding protein hnRNPA2 regulates -catenin protein expression and is overexpressed in prostate cancer.RNA Biol. 2014;11(6):755-65. doi: 10.4161/rna.28800. Epub 2014 Apr 24.
|
85 |
VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription.Epigenetics. 2015;10(1):40-9. doi: 10.4161/15592294.2014.989088. Epub 2015 Jan 29.
|
86 |
The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence.Reprod Biol Endocrinol. 2015 Aug 7;13:88. doi: 10.1186/s12958-015-0087-z.
|
87 |
17-Hydroxysteroid dehydrogenases (17-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.J Steroid Biochem Mol Biol. 2011 May;125(1-2):66-82. doi: 10.1016/j.jsbmb.2010.12.013. Epub 2010 Dec 28.
|
88 |
Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.Clin Genitourin Cancer. 2014 Apr;12(2):87-93. doi: 10.1016/j.clgc.2013.08.007. Epub 2013 Oct 12.
|
89 |
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.Prostate. 2019 Jun;79(9):969-979. doi: 10.1002/pros.23808. Epub 2019 Apr 18.
|
90 |
NAC1 promotes the migration of prostate cancer cells and participates in osteoclastogenesis by negatively regulating IFN.Oncol Lett. 2018 Mar;15(3):2921-2928. doi: 10.3892/ol.2017.7670. Epub 2017 Dec 20.
|
91 |
Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.Cancer Causes Control. 2017 Jun;28(6):497-528. doi: 10.1007/s10552-017-0883-1. Epub 2017 Mar 30.
|
92 |
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.Cancer Res. 2000 Jun 1;60(11):3058-64.
|
93 |
Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.PLoS One. 2007 Aug 22;2(8):e769. doi: 10.1371/journal.pone.0000769.
|
94 |
Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis.J Biol Chem. 2004 Jul 9;279(28):29302-7. doi: 10.1074/jbc.M403664200. Epub 2004 Apr 30.
|
95 |
Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells.BJU Int. 2020 Jan;125(1):89-102. doi: 10.1111/bju.14893. Epub 2019 Aug 7.
|
96 |
Vaccination with tumor cells expressing IL-15 and IL-15R inhibits murine breast and prostate cancer.Gene Ther. 2014 Apr;21(4):393-401. doi: 10.1038/gt.2014.10. Epub 2014 Feb 27.
|
97 |
Immune analysis of expression of IL-17 relative ligands and their receptors in bladder cancer: comparison with polyp and cystitis.BMC Immunol. 2016 Oct 3;17(1):36. doi: 10.1186/s12865-016-0174-8.
|
98 |
Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.Cancer Res. 2008 Nov 15;68(22):9311-7. doi: 10.1158/0008-5472.CAN-08-2810.
|
99 |
Differential expressions of integrin-linked kinase, -parvin and cofilin 1 in high-fat diet induced prostate cancer progression in a transgenic mouse model.Oncol Lett. 2018 Oct;16(4):4945-4952. doi: 10.3892/ol.2018.9276. Epub 2018 Aug 7.
|
100 |
Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.Int J Cancer. 2014 Oct 1;135(7):1596-604. doi: 10.1002/ijc.28808. Epub 2014 Mar 4.
|
101 |
A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers.Eur Urol. 2013 Dec;64(6):941-50. doi: 10.1016/j.eururo.2013.02.039. Epub 2013 Mar 7.
|
102 |
Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.Carcinogenesis. 2018 Dec 31;39(12):1431-1437. doi: 10.1093/carcin/bgy112.
|
103 |
IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.Oncotarget. 2018 Sep 21;9(74):33871-33883. doi: 10.18632/oncotarget.26049. eCollection 2018 Sep 21.
|
104 |
Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819886867. doi: 10.1177/1533033819886867.
|
105 |
Methylation of Integrin 4 and E-Cadherin Genes in Human Prostate Cancer.Pathol Oncol Res. 2015 Sep;21(4):921-7. doi: 10.1007/s12253-015-9917-8. Epub 2015 Mar 6.
|
106 |
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.EBioMedicine. 2016 Aug;10:150-63. doi: 10.1016/j.ebiom.2016.07.022. Epub 2016 Jul 20.
|
107 |
Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.Cancer Lett. 2020 Jan 1;468:88-101. doi: 10.1016/j.canlet.2019.10.006. Epub 2019 Oct 5.
|
108 |
Endoplasmic reticulum Ca(2+) content decrease by PKA-dependent hyperphosphorylation of type 1 IP3 receptor contributes to prostate cancer cell resistance to androgen deprivation.Cell Calcium. 2015 Apr;57(4):312-20. doi: 10.1016/j.ceca.2015.02.004. Epub 2015 Feb 18.
|
109 |
KAT5 and KAT6B are in positive regulation on cell proliferation of prostate cancer through PI3K-AKT signaling.Int J Clin Exp Pathol. 2013 Nov 15;6(12):2864-71. eCollection 2013.
|
110 |
A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity.Radiother Oncol. 2014 May;111(2):178-85. doi: 10.1016/j.radonc.2014.02.012. Epub 2014 Apr 28.
|
111 |
A Rhodium(III)-Based Inhibitor of Lysine-Specific Histone Demethylase 1 as an Epigenetic Modulator in Prostate Cancer Cells.J Med Chem. 2017 Mar 23;60(6):2597-2603. doi: 10.1021/acs.jmedchem.7b00133. Epub 2017 Mar 1.
|
112 |
MiR-10a functions as a tumor suppressor in prostate cancer via targeting KDM4A.J Cell Biochem. 2019 Apr;120(4):4987-4997. doi: 10.1002/jcb.27774. Epub 2018 Oct 9.
|
113 |
Potential Prognostic Role for SPOP, DAXX, RARRES1, and LAMP2 as an Autophagy Related Genes in Prostate Cancer.Urol J. 2020 Mar 16;17(2):156-163. doi: 10.22037/uj.v0i0.4935.
|
114 |
miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression.Oncotarget. 2015 Mar 20;6(8):6092-104. doi: 10.18632/oncotarget.3341.
|
115 |
MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer.Int J Oncol. 2015 Aug;47(2):710-8. doi: 10.3892/ijo.2015.3043. Epub 2015 Jun 10.
|
116 |
Targeting Galectin-1 Impairs Castration-Resistant Prostate Cancer Progression and Invasion.Clin Cancer Res. 2018 Sep 1;24(17):4319-4331. doi: 10.1158/1078-0432.CCR-18-0157. Epub 2018 Apr 17.
|
117 |
Effects of luteinizing hormone receptor signaling in prostate cancer cells.Prostate. 2015 Feb;75(2):141-50. doi: 10.1002/pros.22899. Epub 2014 Nov 12.
|
118 |
Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway.Cancer Lett. 2019 Jun 1;451:110-121. doi: 10.1016/j.canlet.2019.02.042. Epub 2019 Mar 6.
|
119 |
Downregulation of microRNA-23a suppresses prostate cancer metastasis by targeting the PAK6-LIMK1 signaling pathway.Oncotarget. 2015 Feb 28;6(6):3904-17. doi: 10.18632/oncotarget.2880.
|
120 |
Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer.Mol Cancer Ther. 2014 Jul;13(7):1952-63. doi: 10.1158/1535-7163.MCT-14-0017. Epub 2014 May 9.
|
121 |
Mannose-6-phosphate receptor: a target for theranostics of prostate cancer.Angew Chem Int Ed Engl. 2015 May 11;54(20):5952-6. doi: 10.1002/anie.201500286. Epub 2015 Mar 20.
|
122 |
Total anatomical reconstruction during robot-assisted radical prostatectomy: focus on urinary continence recovery and related complications after 1000 procedures.BJU Int. 2019 Sep;124(3):477-486. doi: 10.1111/bju.14716. Epub 2019 Mar 15.
|
123 |
Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.J Cancer Res Clin Oncol. 2018 Sep;144(9):1685-1699. doi: 10.1007/s00432-018-2696-3. Epub 2018 Jun 29.
|
124 |
Mixed lineage kinase 3 modulates -catenin signaling in cancer cells.J Biol Chem. 2011 Oct 28;286(43):37470-82. doi: 10.1074/jbc.M111.298943. Epub 2011 Aug 31.
|
125 |
MicroRNA-188 inhibits proliferation migration and invasion of prostate carcinoma by targeting at MARCKS.Am J Transl Res. 2019 Aug 15;11(8):5019-5028. eCollection 2019.
|
126 |
Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.Prostate. 2009 May 15;69(7):727-36. doi: 10.1002/pros.20920.
|
127 |
MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.J Exp Clin Cancer Res. 2019 Sep 5;38(1):391. doi: 10.1186/s13046-019-1374-x.
|
128 |
Ultraviolet radiation: effects on risks of prostate cancer and other internal cancers.Mutat Res. 2005 Apr 1;571(1-2):207-19. doi: 10.1016/j.mrfmmm.2004.09.015. Epub 2005 Jan 28.
|
129 |
Metastatic Prostate Cancer: Effects of Genetic Testing on Care.Clin J Oncol Nurs. 2019 Feb 1;23(1):32-35. doi: 10.1188/19.CJON.32-35.
|
130 |
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival.J Pathol. 2015 Mar;235(4):581-92. doi: 10.1002/path.4485. Epub 2014 Dec 24.
|
131 |
MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.Nutrients. 2019 Sep 4;11(9):2096. doi: 10.3390/nu11092096.
|
132 |
The targeting of MTDH by miR?45?p or miR?45?p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells.Int J Oncol. 2019 Jun;54(6):1955-1968. doi: 10.3892/ijo.2019.4782. Epub 2019 Apr 12.
|
133 |
Melatonin MT1 receptor-induced transcriptional up-regulation of p27(Kip1) in prostate cancer antiproliferation is mediated via inhibition of constitutively active nuclear factor kappa B (NF-B): potential implications on prostate cancer chemoprevention and therapy.J Pineal Res. 2013 Jan;54(1):69-79. doi: 10.1111/j.1600-079X.2012.01026.x. Epub 2012 Aug 1.
|
134 |
A single-nucleotide polymorphism (rs1805087) in the methionine synthase (METH) gene increases the risk of prostate cancer.Aging (Albany NY). 2018 Oct 18;10(10):2741-2754. doi: 10.18632/aging.101584.
|
135 |
CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo.Oncol Rep. 2014 Jan;31(1):241-7. doi: 10.3892/or.2013.2823. Epub 2013 Oct 29.
|
136 |
Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.Mol Cell Proteomics. 2014 Jul;13(7):1753-68. doi: 10.1074/mcp.M114.038273. Epub 2014 Apr 16.
|
137 |
Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.Int J Biochem Cell Biol. 2018 Jan;94:125-132. doi: 10.1016/j.biocel.2017.12.005. Epub 2017 Dec 7.
|
138 |
Upregulation of GRIM-19 augments the sensitivity of prostate cancer cells to docetaxel by targeting Rad23b.Clin Exp Pharmacol Physiol. 2020 Jan;47(1):76-84. doi: 10.1111/1440-1681.13179. Epub 2019 Oct 22.
|
139 |
Nerve Growth Factor Induces Proliferation and Aggressiveness In Prostate Cancer Cells.Cancers (Basel). 2019 Jun 6;11(6):784. doi: 10.3390/cancers11060784.
|
140 |
C-type natriuretic peptide and its precursor: potential markers in human prostate cancer.Biomark Med. 2015;9(4):319-26. doi: 10.2217/bmm.14.74.
|
141 |
Expression of neuregulin 4 splice variants in normal human tissues and prostate cancer and their effects on cell motility.Endocr Relat Cancer. 2010 Dec 13;18(1):39-49. doi: 10.1677/ERC-10-0112. Print 2011 Feb.
|
142 |
Peptide-targeted, stimuli-responsive polymersomes for delivering a cancer stemness inhibitor to cancer stem cell microtumors.Colloids Surf B Biointerfaces. 2018 Mar 1;163:225-235. doi: 10.1016/j.colsurfb.2017.12.036. Epub 2017 Dec 24.
|
143 |
Neurotensin and its receptors mediate neuroendocrine transdifferentiation in prostate cancer.Oncogene. 2019 Jun;38(24):4875-4884. doi: 10.1038/s41388-019-0750-5. Epub 2019 Feb 15.
|
144 |
Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.Int J Cancer. 2020 Mar 1;146(5):1346-1358. doi: 10.1002/ijc.32535. Epub 2019 Jul 9.
|
145 |
Oligophrenin-1 is associated with cell adhesion and migration in prostate cancer.Pathobiology. 2014;81(4):190-8. doi: 10.1159/000363345. Epub 2014 Aug 27.
|
146 |
P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells.Br J Cancer. 2013 Sep 17;109(6):1666-75. doi: 10.1038/bjc.2013.484. Epub 2013 Aug 22.
|
147 |
A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.Cancer Res. 2009 Oct 1;69(19):7689-95. doi: 10.1158/0008-5472.CAN-08-2472. Epub 2009 Sep 22.
|
148 |
Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells.Onco Targets Ther. 2017 Apr 12;10:2139-2146. doi: 10.2147/OTT.S129413. eCollection 2017.
|
149 |
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells.Br J Cancer. 2014 Mar 4;110(5):1278-87. doi: 10.1038/bjc.2014.22. Epub 2014 Feb 11.
|
150 |
Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.Am J Pathol. 2014 Oct;184(10):2671-86. doi: 10.1016/j.ajpath.2014.06.030. Epub 2014 Aug 14.
|
151 |
Meta-Analysis of steroid-converting enzymes and related receptors in prostate cancer suggesting novel combined therapies.J Steroid Biochem Mol Biol. 2020 Apr;198:105559. doi: 10.1016/j.jsbmb.2019.105559. Epub 2019 Nov 26.
|
152 |
Multifunctional Envelope-Type siRNA Delivery Nanoparticle Platform for Prostate Cancer Therapy.ACS Nano. 2017 Mar 28;11(3):2618-2627. doi: 10.1021/acsnano.6b07195. Epub 2017 Mar 3.
|
153 |
A novel cross-talk between CXCR4 and PI4KIII in prostate cancer cells.Oncogene. 2019 Jan;38(3):332-344. doi: 10.1038/s41388-018-0448-0. Epub 2018 Aug 15.
|
154 |
KDM8/JMJD5 as a dual coactivator of AR and PKM2 integrates AR/EZH2 network and tumor metabolism in CRPC.Oncogene. 2019 Jan;38(1):17-32. doi: 10.1038/s41388-018-0414-x. Epub 2018 Aug 2.
|
155 |
Phospholipase A2-Responsive Phosphate Micelle-Loaded UCNPs for Bioimaging of Prostate Cancer Cells.Sci Rep. 2017 Nov 22;7(1):16073. doi: 10.1038/s41598-017-16136-4.
|
156 |
Increased expression of p21Waf1/Cip1 and JNK with costimulation of prostate cancer cell activation by an siRNA Egr-1 inhibitor.Oncol Rep. 2013 Aug;30(2):911-6. doi: 10.3892/or.2013.2503. Epub 2013 May 28.
|
157 |
Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.Cancer Biol Ther. 2009 Dec;8(23):2286-96. doi: 10.4161/cbt.8.23.10138. Epub 2009 Dec 19.
|
158 |
The malignancy index in plasma samples as a prostate cancer biomarker.Discov Med. 2018 May;25(139):235-242.
|
159 |
Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery.Pharmaceutics. 2019 Nov 12;11(11):600. doi: 10.3390/pharmaceutics11110600.
|
160 |
CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer.Neoplasia. 2012 Sep;14(9):799-806. doi: 10.1593/neo.12580.
|
161 |
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.Nat Genet. 2018 Feb;50(2):206-218. doi: 10.1038/s41588-017-0027-2. Epub 2018 Jan 15.
|
162 |
Pre-diagnostic metabolite concentrations and prostate cancer risk in 1077 cases and 1077 matched controls in the European Prospective Investigation into Cancer and Nutrition.BMC Med. 2017 Jul 5;15(1):122. doi: 10.1186/s12916-017-0885-6.
|
163 |
Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death.Cancer Res. 2007 Apr 15;67(8):3654-62. doi: 10.1158/0008-5472.CAN-06-1759.
|
164 |
PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation.Onco Targets Ther. 2018 Sep 12;11:5797-5809. doi: 10.2147/OTT.S161280. eCollection 2018.
|
165 |
Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro.J Proteome Res. 2012 Apr 6;11(4):2452-66. doi: 10.1021/pr201172n. Epub 2012 Mar 28.
|
166 |
The role of PKC and PKD in CXCL12 directed prostate cancer migration.Biochem Biophys Res Commun. 2019 Oct 29;519(1):86-92. doi: 10.1016/j.bbrc.2019.08.134. Epub 2019 Aug 30.
|
167 |
Activation of nuclear factor B (NF-B) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).J Biol Chem. 2012 Oct 26;287(44):37570-82. doi: 10.1074/jbc.M112.398925. Epub 2012 Sep 6.
|
168 |
Pleiotropic Impact of DNA-PK in Cancer and Implications for Therapeutic Strategies.Clin Cancer Res. 2019 Sep 15;25(18):5623-5637. doi: 10.1158/1078-0432.CCR-18-2207. Epub 2019 Jul 2.
|
169 |
High Glucose Induces VEGF-C Expression via the LPA1/3-Akt-ROS-LEDGF Signaling Axis in Human Prostate Cancer PC-3 Cells.Cell Physiol Biochem. 2018;50(2):597-611. doi: 10.1159/000494177. Epub 2018 Oct 12.
|
170 |
COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins.Prostate. 2014 Jul;74(10):999-1011. doi: 10.1002/pros.22815. Epub 2014 May 7.
|
171 |
Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation.J Pharmacol Exp Ther. 2013 Feb;344(2):360-7. doi: 10.1124/jpet.112.200444. Epub 2012 Nov 28.
|
172 |
Significance of divergent expression of prostaglandin EP4 and EP3 receptors in human prostate cancer.Mol Cancer Res. 2013 Apr;11(4):427-39. doi: 10.1158/1541-7786.MCR-12-0464. Epub 2013 Jan 30.
|
173 |
Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer.Int J Mol Sci. 2014 Jul 1;15(7):11665-77. doi: 10.3390/ijms150711665.
|
174 |
Expression of pleiotrophin in the prostate is androgen regulated and it functions as an autocrine regulator of mesenchyme and cancer associated fibroblasts and as a paracrine regulator of epithelia.Prostate. 2011 Feb 15;71(3):305-17. doi: 10.1002/pros.21244. Epub 2010 Sep 1.
|
175 |
Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.Urol Oncol. 2014 Aug;32(6):769-78. doi: 10.1016/j.urolonc.2014.03.007. Epub 2014 Jun 23.
|
176 |
Resveratrol promotes apoptosis through the induction of dual specificity phosphatase 1 and sensitizes prostate cancer cells to cisplatin.Food Chem Toxicol. 2019 Feb;124:273-279. doi: 10.1016/j.fct.2018.12.014. Epub 2018 Dec 12.
|
177 |
Prostatic carcinoma with neuroendocrine differentiation harboring the EWSR1-FEV fusion transcript in a man with the WRN G327X germline mutation: A new variant of prostatic carcinoma or a member of the Ewing sarcoma family of tumors?.Pathol Res Pract. 2020 Feb;216(2):152758. doi: 10.1016/j.prp.2019.152758. Epub 2019 Nov 22.
|
178 |
Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer.Biol Pharm Bull. 2019;42(3):448-452. doi: 10.1248/bpb.b18-00782.
|
179 |
The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.BMC Cancer. 2014 Dec 23;14:994. doi: 10.1186/1471-2407-14-994.
|
180 |
Ring finger protein 6 promotes breast cancer cell proliferation by stabilizing estrogen receptor alpha.Oncotarget. 2017 Mar 21;8(12):20103-20112. doi: 10.18632/oncotarget.15384.
|
181 |
Rho-Associated Protein Kinase (ROCK) Promotes Proliferation and Migration of PC-3 and DU145 Prostate Cancer Cells by Targeting LIM Kinase 1 (LIMK1) and Matrix Metalloproteinase-2 (MMP-2).Med Sci Monit. 2019 Apr 26;25:3090-3099. doi: 10.12659/MSM.912098.
|
182 |
A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.J Nanobiotechnology. 2019 Aug 26;17(1):91. doi: 10.1186/s12951-019-0521-z.
|
183 |
Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer.Prostate. 2014 Jun;74(9):959-69. doi: 10.1002/pros.22813. Epub 2014 Apr 17.
|
184 |
A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).Clin Cancer Res. 2019 Jul 15;25(14):4480-4492. doi: 10.1158/1078-0432.CCR-18-4046. Epub 2019 Apr 17.
|
185 |
Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms.Cancers (Basel). 2018 Jul 23;10(7):239. doi: 10.3390/cancers10070239.
|
186 |
Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy.Neoplasia. 2019 Sep;21(9):872-881. doi: 10.1016/j.neo.2019.07.003. Epub 2019 Aug 2.
|
187 |
Extrinsic sphingosine 1-phosphate activates S1P5 and induces autophagy through generating endoplasmic reticulum stress in human prostate cancer PC-3 cells.Cell Signal. 2014 Mar;26(3):611-8. doi: 10.1016/j.cellsig.2013.11.024. Epub 2013 Dec 11.
|
188 |
Development and Preliminary Clinical Application of Circulating Tumor Cell Detection System for Prostate Cancer.J Biomed Nanotechnol. 2019 Mar 1;15(3):612-620. doi: 10.1166/jbn.2019.2706.
|
189 |
Uteroglobin: a potential novel tumor suppressor and molecular therapeutic for prostate cancer.Clin Prostate Cancer. 2002 Sep;1(2):118-24. doi: 10.3816/cgc.2002.n.014.
|
190 |
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer.Urol Oncol. 2018 Jun;36(6):312.e9-312.e15. doi: 10.1016/j.urolonc.2018.03.010. Epub 2018 Apr 5.
|
191 |
SENP1 Interacts with HIF1 to Regulate Glycolysis of Prostatic Carcinoma Cells.Int J Biol Sci. 2019 Jan 1;15(2):395-403. doi: 10.7150/ijbs.27256. eCollection 2019.
|
192 |
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer.Sci Rep. 2014 Dec 18;4:7546. doi: 10.1038/srep07546.
|
193 |
Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/-catenin signaling.J Mol Med (Berl). 2019 Aug;97(8):1169-1182. doi: 10.1007/s00109-019-01807-8. Epub 2019 Jun 11.
|
194 |
Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.Mol Cancer Res. 2015 Apr;13(4):620-635. doi: 10.1158/1541-7786.MCR-13-0182-T. Epub 2014 Dec 29.
|
195 |
Sphingosine Kinase-1 Involves the Inhibitory Action of HIF-1 by Chlorogenic Acid in Hypoxic DU145 Cells.Int J Mol Sci. 2017 Feb 4;18(2):325. doi: 10.3390/ijms18020325.
|
196 |
The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.Mol Cancer Ther. 2015 Dec;14(12):2744-52. doi: 10.1158/1535-7163.MCT-15-0279. Epub 2015 Oct 22.
|
197 |
Delineation of TMPRSS2-ERG splice variants in prostate cancer.Clin Cancer Res. 2008 Aug 1;14(15):4719-25. doi: 10.1158/1078-0432.CCR-08-0531.
|
198 |
Adipocyte p62/SQSTM1 Suppresses Tumorigenesis through Opposite Regulations of Metabolism in Adipose Tissue and Tumor.Cancer Cell. 2018 Apr 9;33(4):770-784.e6. doi: 10.1016/j.ccell.2018.03.001.
|
199 |
Lipid pathway deregulation in advanced prostate cancer.Pharmacol Res. 2018 May;131:177-184. doi: 10.1016/j.phrs.2018.02.022. Epub 2018 Feb 18.
|
200 |
Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.Biomed Pharmacother. 2018 Jun;102:531-538. doi: 10.1016/j.biopha.2018.03.079. Epub 2018 Mar 26.
|
201 |
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth.Mol Cell Endocrinol. 2014 Feb 15;382(2):860-70. doi: 10.1016/j.mce.2013.10.027. Epub 2013 Nov 5.
|
202 |
IGF2 increases de novo steroidogenesis in prostate cancer cells.Endocr Relat Cancer. 2013 Mar 22;20(2):173-86. doi: 10.1530/ERC-12-0250. Print 2013 Apr.
|
203 |
Stanniocalcin-1 protein expression profile and mechanisms in proliferation and cell death pathways in prostate cancer.Mol Cell Endocrinol. 2020 Feb 15;502:110659. doi: 10.1016/j.mce.2019.110659. Epub 2019 Dec 7.
|
204 |
miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.Mol Cancer Res. 2018 Jul;16(7):1125-1137. doi: 10.1158/1541-7786.MCR-17-0230. Epub 2017 Oct 12.
|
205 |
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts.Oncotarget. 2015 Jun 10;6(16):14318-28. doi: 10.18632/oncotarget.3960.
|
206 |
Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.Cell Tissue Res. 2010 Feb;339(2):337-47. doi: 10.1007/s00441-009-0902-y. Epub 2009 Dec 11.
|
207 |
TBK1 regulates prostate cancer dormancy through mTOR inhibition.Neoplasia. 2013 Sep;15(9):1064-74. doi: 10.1593/neo.13402.
|
208 |
Erratum: CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.Oncotarget. 2019 Jun 25;10(41):4247-4248. doi: 10.18632/oncotarget.27038. eCollection 2019 Jun 25.
|
209 |
Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway.Int J Mol Sci. 2019 Mar 7;20(5):1164. doi: 10.3390/ijms20051164.
|
210 |
Therapeutic efficacy of intravenously administered transferrin-conjugated dendriplexes on prostate carcinomas.Nanomedicine (Lond). 2014 Apr;9(4):421-34. doi: 10.2217/NNM.13.25.
|
211 |
PPAR Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.Cancer Res. 2018 Jan 15;78(2):399-409. doi: 10.1158/0008-5472.CAN-17-0908. Epub 2017 Nov 29.
|
212 |
MicroRNA-124 regulates TGF--induced epithelial-mesenchymal transition in human prostate cancer cells.Int J Oncol. 2014 Sep;45(3):1225-31. doi: 10.3892/ijo.2014.2506. Epub 2014 Jun 19.
|
213 |
Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFRIII-p38MAPK-pS249/T252RB Pathway.Cancer Res. 2018 Jun 1;78(11):2911-2924. doi: 10.1158/0008-5472.CAN-17-1051. Epub 2018 Mar 7.
|
214 |
Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.Int J Exp Pathol. 2019 Apr;100(2):123-132. doi: 10.1111/iep.12314. Epub 2019 May 14.
|
215 |
The influence of matriptase-2 on prostate cancer in vitro: a possible role for -catenin.Oncol Rep. 2012 Oct;28(4):1491-7. doi: 10.3892/or.2012.1945. Epub 2012 Aug 2.
|
216 |
Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis.Mol Cancer Ther. 2018 Jun;17(6):1217-1228. doi: 10.1158/1535-7163.MCT-17-1157. Epub 2018 Mar 16.
|
217 |
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.Cancer Res. 2001 Mar 1;61(5):1964-9.
|
218 |
UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction.Cancer Lett. 2011 Mar 28;302(2):128-35. doi: 10.1016/j.canlet.2011.01.006.
|
219 |
Expression of the Bcl-2 family genes and complexes involved in the mitochondrial transport in prostate cancer cells.Int J Oncol. 2014 Oct;45(4):1489-96. doi: 10.3892/ijo.2014.2576.
|
220 |
Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study.J Hematol Oncol. 2017 Mar 23;10(1):74. doi: 10.1186/s13045-017-0440-0.
|
221 |
Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer.Biochim Biophys Acta. 2013 Dec;1832(12):2127-35. doi: 10.1016/j.bbadis.2013.08.001. Epub 2013 Aug 9.
|
222 |
Relation between Ku80 and microRNA-99a expression and late rectal bleeding after radiotherapy for prostate cancer.Radiother Oncol. 2015 May;115(2):235-9. doi: 10.1016/j.radonc.2015.04.008. Epub 2015 Apr 30.
|
223 |
MicroRNA-200c-3p/ZEB2 loop plays a crucial role in the tumor progression of prostate carcinoma.Ann Transl Med. 2019 Apr;7(7):141. doi: 10.21037/atm.2019.02.40.
|
224 |
Integrated Bioinformatics Analysis of Potential Biomarkers for Prostate Cancer.Pathol Oncol Res. 2019 Apr;25(2):455-460. doi: 10.1007/s12253-017-0346-8. Epub 2017 Dec 19.
|
225 |
Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex.Prostate. 2013 Apr;73(5):455-66. doi: 10.1002/pros.22587. Epub 2012 Oct 4.
|
226 |
The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer.Clinics (Sao Paulo). 2013 May;68(5):652-7. doi: 10.6061/clinics/2013(05)12.
|
227 |
Characterization of hydrogen sulfide and its synthases, cystathionine -synthase and cystathionine -lyase, in human prostatic tissue and cells.Urology. 2012 Feb;79(2):483.e1-5. doi: 10.1016/j.urology.2011.10.013.
|
228 |
Expressional profiling of prostate cancer risk SNPs at 11q13.5 identifies DGAT2 as a new target gene.Genes Chromosomes Cancer. 2016 Aug;55(8):661-73. doi: 10.1002/gcc.22368. Epub 2016 May 24.
|
229 |
The prognosis value of EphA3 and the androgen receptor in prostate cancer treated with radical prostatectomy.J Clin Lab Anal. 2019 Jun;33(5):e22871. doi: 10.1002/jcla.22871. Epub 2019 Apr 8.
|
230 |
Ezrin mediates c-Myc actions in prostate cancer cell invasion.Oncogene. 2010 Mar 11;29(10):1531-42. doi: 10.1038/onc.2009.442. Epub 2009 Dec 14.
|
231 |
Fatty acid binding protein 4 enhances prostate cancer progression by upregulating matrix metalloproteinases and stromal cell cytokine production.Oncotarget. 2017 Dec 4;8(67):111780-111794. doi: 10.18632/oncotarget.22908. eCollection 2017 Dec 19.
|
232 |
Docetaxel/cabazitaxel and fatty acid binding protein 5 inhibitors produce synergistic inhibition of prostate cancer growth.Prostate. 2020 Jan;80(1):88-98. doi: 10.1002/pros.23921. Epub 2019 Oct 29.
|
233 |
A genetic variant of FcRIIIa is strongly associatedwith humoral immunity to cyclin B1 in African American patients with prostate cancer.Immunogenetics. 2013 Feb;65(2):91-6. doi: 10.1007/s00251-012-0660-y. Epub 2012 Nov 1.
|
234 |
Androgen receptor reverses the oncometabolite R-2-hydroxyglutarate-induced prostate cancer cell invasion via suppressing the circRNA-51217/miRNA-646/TGF1/p-Smad2/3 signaling.Cancer Lett. 2020 Mar 1;472:151-164. doi: 10.1016/j.canlet.2019.12.014. Epub 2019 Dec 14.
|
235 |
Activation of PSGR with -ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocation.Cancer Lett. 2019 Jul 1;453:193-205. doi: 10.1016/j.canlet.2019.03.044. Epub 2019 Mar 27.
|
236 |
Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells.J Biol Chem. 2013 Oct 18;288(42):30054-30063. doi: 10.1074/jbc.M113.481283. Epub 2013 Aug 28.
|
237 |
Suppression of miR-4735-3p in androgen receptor-expressing prostate cancer cells increases cell death during chemotherapy.Am J Transl Res. 2017 Aug 15;9(8):3714-3722. eCollection 2017.
|
238 |
Impact of Genetic and Epigenetic Variations Within the FADS Cluster on the Composition and Metabolism of Polyunsaturated Fatty Acids in Prostate Cancer.Prostate. 2016 Sep;76(13):1182-91. doi: 10.1002/pros.23205. Epub 2016 May 16.
|
239 |
ANP-NPRA signaling pathway--a potential therapeutic target for the treatment of malignancy.Crit Rev Eukaryot Gene Expr. 2013;23(2):93-101. doi: 10.1615/critreveukargeneexpr.2013006641.
|
240 |
Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.Oncogene. 2019 Jun;38(23):4496-4511. doi: 10.1038/s41388-019-0732-7. Epub 2019 Feb 11.
|
241 |
Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.Prostate. 2020 Feb;80(2):162-172. doi: 10.1002/pros.23928. Epub 2019 Nov 26.
|
242 |
Association between methylation of SHP-1 isoform I and SSTR2A promoter regions with breast and prostate carcinoma development.Cancer Invest. 2015 Mar;33(3):61-9. doi: 10.3109/07357907.2014.1001892. Epub 2015 Jan 30.
|
243 |
In vivo targeting of ADAM9 gene expression using lentivirus-delivered shRNA suppresses prostate cancer growth by regulating REG4 dependent cell cycle progression.PLoS One. 2013;8(1):e53795. doi: 10.1371/journal.pone.0053795. Epub 2013 Jan 16.
|
244 |
Inhibition of Gli1-mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway.Oncol Lett. 2017 Dec;14(6):7970-7976. doi: 10.3892/ol.2017.7254. Epub 2017 Oct 23.
|
245 |
Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.Oncogene. 2016 Dec 8;35(49):6350-6358. doi: 10.1038/onc.2016.171. Epub 2016 Jun 6.
|
246 |
Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.Mol Cancer Res. 2012 Jun;10(6):821-33. doi: 10.1158/1541-7786.MCR-11-0615. Epub 2012 Mar 27.
|
247 |
Frequent down-regulation of ABC transporter genes in prostate cancer. BMC Cancer. 2015 Oct 12;15:683.
|
248 |
Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.Biochimie. 2017 Sep;140:66-72. doi: 10.1016/j.biochi.2017.06.007. Epub 2017 Jun 15.
|
249 |
Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.Prostate. 2014 May;74(6):637-46. doi: 10.1002/pros.22781. Epub 2014 Feb 5.
|
250 |
Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination.Oncotarget. 2019 Oct 29;10(59):6362-6377. doi: 10.18632/oncotarget.27279. eCollection 2019 Oct 29.
|
251 |
Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients.PLoS One. 2017 Oct 5;12(10):e0183122. doi: 10.1371/journal.pone.0183122. eCollection 2017.
|
252 |
AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.Mol Cancer Res. 2019 Feb;17(2):356-369. doi: 10.1158/1541-7786.MCR-18-0718. Epub 2018 Oct 5.
|
253 |
Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains.ChemMedChem. 2018 Jul 18;13(14):1479-1487. doi: 10.1002/cmdc.201800234. Epub 2018 Jun 21.
|
254 |
Nonconserved miR-608 suppresses prostate cancer progression through RAC2/PAK4/LIMK1 and BCL2L1/caspase-3 pathways by targeting the 3'-UTRs of RAC2/BCL2L1 and the coding region of PAK4.Cancer Med. 2019 Sep;8(12):5716-5734. doi: 10.1002/cam4.2455. Epub 2019 Aug 7.
|
255 |
Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis.Chem Commun (Camb). 2019 Oct 31;55(88):13267-13270. doi: 10.1039/c9cc07009e.
|
256 |
Rare germline mutations in African American men diagnosed with early-onset prostate cancer.Prostate. 2018 Apr;78(5):321-326. doi: 10.1002/pros.23464. Epub 2018 Jan 21.
|
257 |
BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.Cancer Res. 2018 Sep 15;78(18):5203-5215. doi: 10.1158/0008-5472.CAN-17-3615. Epub 2018 Jul 16.
|
258 |
Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):273-286. doi: 10.21873/cgp.20132.
|
259 |
Association of caspases with an increased prostate cancer risk in north Indian population.DNA Cell Biol. 2012 Jan;31(1):67-73. doi: 10.1089/dna.2011.1285. Epub 2011 Jun 13.
|
260 |
Definition of a FoxA1 Cistrome that is crucial for G1 to S-phase cell-cycle transit in castration-resistant prostate cancer.Cancer Res. 2011 Nov 1;71(21):6738-6748. doi: 10.1158/0008-5472.CAN-11-1882. Epub 2011 Sep 7.
|
261 |
CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling.Cytokine. 2013 Oct;64(1):251-7. doi: 10.1016/j.cyto.2013.06.313. Epub 2013 Jul 19.
|
262 |
Eotaxin-1 promotes prostate cancer cell invasion via activation of the CCR3-ERK pathway and upregulation of MMP-3 expression.Oncol Rep. 2014 May;31(5):2049-54. doi: 10.3892/or.2014.3060. Epub 2014 Mar 5.
|
263 |
Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer.Oncotarget. 2018 Jan 5;9(5):6550-6561. doi: 10.18632/oncotarget.23973. eCollection 2018 Jan 19.
|
264 |
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens.Mol Cancer Ther. 2012 Dec;11(12):2664-73. doi: 10.1158/1535-7163.MCT-12-0042. Epub 2012 Oct 5.
|
265 |
MZF1 and SCAND1 Reciprocally Regulate CDC37 Gene Expression in Prostate Cancer.Cancers (Basel). 2019 Jun 8;11(6):792. doi: 10.3390/cancers11060792.
|
266 |
Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213.Cell Commun Signal. 2019 Aug 20;17(1):100. doi: 10.1186/s12964-019-0404-9.
|
267 |
Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1.Cancer Discov. 2019 Nov;9(11):1490-1492. doi: 10.1158/2159-8290.CD-19-1028.
|
268 |
Novel identification of the ETS-1 splice variants p42 and p27 in prostate cancer cell lines.Oncol Rep. 2012 May;27(5):1321-4. doi: 10.3892/or.2012.1667. Epub 2012 Feb 1.
|
269 |
Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.J Mol Med (Berl). 2012 Oct;90(10):1121-32. doi: 10.1007/s00109-012-0885-0. Epub 2012 Mar 16.
|
270 |
CX3CL1/fractalkine enhances prostate cancer spinal metastasis by activating the Src/FAK pathway.Int J Oncol. 2018 Oct;53(4):1544-1556. doi: 10.3892/ijo.2018.4487. Epub 2018 Jul 18.
|
271 |
Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment.Sci Rep. 2019 Oct 18;9(1):14963. doi: 10.1038/s41598-019-46491-3.
|
272 |
Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics.Genome Res. 2012 Jun;22(6):1015-25. doi: 10.1101/gr.133280.111. Epub 2012 Apr 16.
|
273 |
Development and validation of a prediction model for identifying men with intermediate- or high-risk prostate cancer for whom bone imaging is unnecessary: a nation-wide population-based study.Scand J Urol. 2019 Dec;53(6):378-384. doi: 10.1080/21681805.2019.1697358. Epub 2019 Dec 5.
|
274 |
Downregulation of Dipeptidyl Peptidase 4 Accelerates Progression to Castration-Resistant Prostate Cancer.Cancer Res. 2018 Nov 15;78(22):6354-6362. doi: 10.1158/0008-5472.CAN-18-0687. Epub 2018 Sep 21.
|
275 |
Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.Cancer Res. 2006 Apr 15;66(8):4516-24. doi: 10.1158/0008-5472.CAN-05-3796.
|
276 |
Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.J Biol Chem. 2012 Oct 12;287(42):35251-35259. doi: 10.1074/jbc.M112.374686. Epub 2012 Aug 20.
|
277 |
Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.Anticancer Res. 2018 Mar;38(3):1391-1399. doi: 10.21873/anticanres.12362.
|
278 |
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.Am J Pathol. 2011 Feb;178(2):525-36. doi: 10.1016/j.ajpath.2010.10.002.
|
279 |
Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression.Prostate. 2018 Jan;78(1):2-10. doi: 10.1002/pros.23446. Epub 2017 Nov 2.
|
280 |
MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer.Biomed Pharmacother. 2017 Dec;96:634-641. doi: 10.1016/j.biopha.2017.10.037. Epub 2017 Nov 6.
|
281 |
Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.J Exp Clin Cancer Res. 2017 Oct 10;36(1):139. doi: 10.1186/s13046-017-0609-y.
|
282 |
Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer.Prostate Cancer Prostatic Dis. 2012 Dec;15(4):339-45. doi: 10.1038/pcan.2012.14. Epub 2012 May 1.
|
283 |
Insulin Enhances Migration and Invasion in Prostate Cancer Cells by Up-Regulation of FOXC2.Front Endocrinol (Lausanne). 2019 Jul 17;10:481. doi: 10.3389/fendo.2019.00481. eCollection 2019.
|
284 |
Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.Biomed Pharmacother. 2017 Nov;95:1112-1118. doi: 10.1016/j.biopha.2017.09.019. Epub 2017 Oct 6.
|
285 |
Hypermethylation of the GABRE~miR-452~miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy.Clin Cancer Res. 2014 Apr 15;20(8):2169-81. doi: 10.1158/1078-0432.CCR-13-2642.
|
286 |
ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models.Front Cell Dev Biol. 2017 Dec 5;5:104. doi: 10.3389/fcell.2017.00104. eCollection 2017.
|
287 |
Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells.Prostate. 2012 Sep 15;72(13):1431-42. doi: 10.1002/pros.22494. Epub 2012 Jan 30.
|
288 |
Distinct expression and activity of GSK-3 and GSK-3 in prostate cancer.Int J Cancer. 2012 Sep 15;131(6):E872-83. doi: 10.1002/ijc.27620. Epub 2012 May 22.
|
289 |
Effect of survivin downregulation by simvastatin on the growth and invasion of salivary adenoid cystic carcinoma.Mol Med Rep. 2018 Aug;18(2):1939-1946. doi: 10.3892/mmr.2018.9204. Epub 2018 Jun 22.
|
290 |
Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclinD1 and MMP-7.Oncol Rep. 2017 Feb;37(2):1045-1051. doi: 10.3892/or.2016.5288. Epub 2016 Dec 2.
|
291 |
A Prostate Cancer Risk Element Functions as a Repressive Loop that Regulates HOXA13.Cell Rep. 2017 Nov 7;21(6):1411-1417. doi: 10.1016/j.celrep.2017.10.048.
|
292 |
Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy.Oncotarget. 2018 Jul 27;9(58):31200-31213. doi: 10.18632/oncotarget.25756. eCollection 2018 Jul 27.
|
293 |
Prostate cancer in elderly Croatian men: 5-HT genetic polymorphisms and the influence of androgen deprivation therapy on osteopenia--a pilot study.Genet Test Mol Biomarkers. 2012 Jun;16(6):598-604. doi: 10.1089/gtmb.2011.0279. Epub 2012 Mar 15.
|
294 |
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C- inhibitor as a potential prostate carcinoma therapeutic.Anticancer Drugs. 2019 Jan;30(1):65-71. doi: 10.1097/CAD.0000000000000694.
|
295 |
Efficient Photodynamic Therapy of Prostate Cancer Cells through an Improved Targeting of the Cation-Independent Mannose 6-Phosphate Receptor.Int J Mol Sci. 2019 Jun 8;20(11):2809. doi: 10.3390/ijms20112809.
|
296 |
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.J Exp Clin Cancer Res. 2019 Jul 18;38(1):317. doi: 10.1186/s13046-019-1317-6.
|
297 |
Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.J Cell Biochem. 2017 May;118(5):1038-1049. doi: 10.1002/jcb.25673. Epub 2017 Jan 5.
|
298 |
Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc.Cancers (Basel). 2019 Nov 13;11(11):1785. doi: 10.3390/cancers11111785.
|
299 |
Long noncoding RNA LUCAT1 promotes migration and invasion of prostate cancer cells by inhibiting KISS1 expression.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3277-3283. doi: 10.26355/eurrev_201904_17689.
|
300 |
The molecular function of kallikrein-related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer.Mol Oncol. 2020 Jan;14(1):105-128. doi: 10.1002/1878-0261.12587. Epub 2019 Nov 28.
|
301 |
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw258.
|
302 |
Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.Gene. 2017 Aug 30;626:354-357. doi: 10.1016/j.gene.2017.05.060. Epub 2017 Jun 1.
|
303 |
Detection of CK19 mRNA Using One-step Nucleic Acid Amplification (OSNA) in Prostate Cancer: Preliminary Results.J Cancer. 2018 Nov 24;9(24):4611-4617. doi: 10.7150/jca.26794. eCollection 2018.
|
304 |
LanCL1 protects prostate cancer cells from oxidative stress via suppression of JNK pathway.Cell Death Dis. 2018 Feb 7;9(2):197. doi: 10.1038/s41419-017-0207-0.
|
305 |
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression.Prostate. 2017 Feb;77(3):309-320. doi: 10.1002/pros.23269. Epub 2016 Oct 24.
|
306 |
Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.Basic Clin Pharmacol Toxicol. 2017 Mar;120(3):256-263. doi: 10.1111/bcpt.12687. Epub 2016 Dec 28.
|
307 |
Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing.Am J Cancer Res. 2018 Feb 1;8(2):226-244. eCollection 2018.
|
308 |
The impact of TRAIL on proliferation of secretory prostate cancer PC-3 cell and LMO2 gene expression.Eur Rev Med Pharmacol Sci. 2018 Nov;22(21):7172-7177. doi: 10.26355/eurrev_201811_16249.
|
309 |
Oxidised low-density lipoprotein, a possible distinguishing lipid profile biomolecule between prostate cancer and benign prostatic hyperplasia.Andrologia. 2019 Sep;51(8):e13321. doi: 10.1111/and.13321. Epub 2019 May 30.
|
310 |
Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk.Prostate. 2011 Sep 15;71(13):1382-9. doi: 10.1002/pros.21354. Epub 2011 Feb 9.
|
311 |
HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion.Prostate. 2011 May 15;71(7):690-9. doi: 10.1002/pros.21285. Epub 2010 Oct 26.
|
312 |
Breviscapine (BVP) inhibits prostate cancer progression through damaging DNA by minichromosome maintenance protein-7 (MCM-7) modulation.Biomed Pharmacother. 2017 Sep;93:103-116. doi: 10.1016/j.biopha.2017.06.024. Epub 2017 Jun 17.
|
313 |
Suppression of cancer progression by MGAT1 shRNA knockdown.PLoS One. 2012;7(9):e43721. doi: 10.1371/journal.pone.0043721. Epub 2012 Sep 5.
|
314 |
Elevated Ki-67 (MIB-1) expression as an independent predictor for unfavorable pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with localized prostate cancer: A propensity score matched study.PLoS One. 2019 Nov 7;14(11):e0224671. doi: 10.1371/journal.pone.0224671. eCollection 2019.
|
315 |
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.Mol Cancer Ther. 2012 Mar;11(3):775-83. doi: 10.1158/1535-7163.MCT-11-0826. Epub 2012 Jan 17.
|
316 |
Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.Antioxid Redox Signal. 2013 Dec 1;19(16):1863-76. doi: 10.1089/ars.2012.4820. Epub 2013 Jul 5.
|
317 |
Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.Cell Cycle. 2011 Oct 15;10(20):3571-97. doi: 10.4161/cc.10.20.17842.
|
318 |
Correlation of SOX9 and NM23 genes with the incidence and prognosis of prostate cancer.Oncol Lett. 2019 Feb;17(2):2296-2302. doi: 10.3892/ol.2018.9828. Epub 2018 Dec 12.
|
319 |
Nur77 suppression facilitates androgen deprivation-induced cell invasion of prostate cancer cells mediated by TGF- signaling.Clin Transl Oncol. 2018 Oct;20(10):1302-1313. doi: 10.1007/s12094-018-1862-z. Epub 2018 Mar 28.
|
320 |
pH low insertion peptide mediated cell division cycle-associated protein 1 -siRNA transportation for prostatic cancer therapy targeted to the tumor microenvironment.Biochem Biophys Res Commun. 2018 Sep 10;503(3):1761-1767. doi: 10.1016/j.bbrc.2018.07.110. Epub 2018 Aug 18.
|
321 |
LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells.Cancer Lett. 2018 Feb 1;414:34-43. doi: 10.1016/j.canlet.2017.10.035. Epub 2017 Nov 14.
|
322 |
miR-181b/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation.J Cell Biochem. 2020 Feb;121(2):1664-1674. doi: 10.1002/jcb.29401. Epub 2019 Nov 3.
|
323 |
Membrane Androgen Receptors Unrelated to Nuclear Steroid Receptors.Endocrinology. 2019 Apr 1;160(4):772-781. doi: 10.1210/en.2018-00987.
|
324 |
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function.Proc Natl Acad Sci U S A. 2019 Jul 16;116(29):14573-14582. doi: 10.1073/pnas.1908547116. Epub 2019 Jul 2.
|
325 |
Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.Oncotarget. 2016 Oct 25;7(43):70669-70684. doi: 10.18632/oncotarget.12204.
|
326 |
PLAC1: biology and potential application in cancer immunotherapy.Cancer Immunol Immunother. 2019 Jul;68(7):1039-1058. doi: 10.1007/s00262-019-02350-8. Epub 2019 Jun 5.
|
327 |
Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer.PLoS One. 2012;7(11):e48709. doi: 10.1371/journal.pone.0048709. Epub 2012 Nov 1.
|
328 |
PRKAR2B promotes prostate cancer metastasis by activating Wnt/-catenin and inducing epithelial-mesenchymal transition.J Cell Biochem. 2018 Sep;119(9):7319-7327. doi: 10.1002/jcb.27030. Epub 2018 May 15.
|
329 |
Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.Prostate. 2015 Oct;75(14):1586-600. doi: 10.1002/pros.23034. Epub 2015 Jun 12.
|
330 |
A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice.Br J Cancer. 2012 Jun 26;107(1):53-62. doi: 10.1038/bjc.2012.243. Epub 2012 Jun 7.
|
331 |
PRL? increases the aggressive phenotype of prostate cancer cells invitro and its expression correlates with high-grade prostate tumors in patients.Int J Oncol. 2018 Feb;52(2):402-412. doi: 10.3892/ijo.2017.4208. Epub 2017 Nov 20.
|
332 |
PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers.Cancer Res. 2016 Jun 1;76(11):3130-5. doi: 10.1158/0008-5472.CAN-15-1501. Epub 2016 Mar 28.
|
333 |
Trop-2 inhibits prostate cancer cell adhesion to fibronectin through the 1 integrin-RACK1 axis.J Cell Physiol. 2012 Nov;227(11):3670-7. doi: 10.1002/jcp.24074.
|
334 |
Evidence for a pro-proliferative feedback loop in prostate cancer: the role of Epac1 and COX-2-dependent pathways.PLoS One. 2013 Apr 30;8(4):e63150. doi: 10.1371/journal.pone.0063150. Print 2013.
|
335 |
Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.Int J Cancer. 2019 Feb 1;144(3):440-447. doi: 10.1002/ijc.31802. Epub 2018 Nov 5.
|
336 |
In Search for risk predictors at the microscopic scenario of a negative biopsy. A systematic review.Actas Urol Esp (Engl Ed). 2019 Sep;43(7):337-347. doi: 10.1016/j.acuro.2019.01.010. Epub 2019 May 17.
|
337 |
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.Oncotarget. 2017 May 13;8(41):69508-69519. doi: 10.18632/oncotarget.17843. eCollection 2017 Sep 19.
|
338 |
Selective neutralization of IL-12 p40 monomer induces death in prostate cancer cells via IL-12-IFN-.Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11482-11487. doi: 10.1073/pnas.1705536114. Epub 2017 Oct 9.
|
339 |
Expression of LDL-A module of relaxin receptor in prostate cancer cells inhibits tumorigenesis.Int J Oncol. 2011 Dec;39(6):1559-65. doi: 10.3892/ijo.2011.1159. Epub 2011 Aug 12.
|
340 |
Large-scale evaluation of SLC18A2 in prostate cancer reveals diagnostic and prognostic biomarker potential at three molecular levels. Mol Oncol. 2016 Jun;10(6):825-37.
|
341 |
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for (18)F-FDG Imaging of PSMA-Suppressed Tumors.J Nucl Med. 2020 Jun;61(6):904-910. doi: 10.2967/jnumed.119.231068. Epub 2019 Dec 5.
|
342 |
Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy.Prostate Cancer Prostatic Dis. 2019 Dec;22(4):560-568. doi: 10.1038/s41391-019-0141-6. Epub 2019 Mar 19.
|
343 |
MiR-199a-3p suppresses proliferation and invasion of prostate cancer cells by targeting Smad1.Oncotarget. 2017 Apr 18;8(32):52465-52473. doi: 10.18632/oncotarget.17191. eCollection 2017 Aug 8.
|
344 |
Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-1/ Smad signaling pathway.Cancer Biomark. 2018 Feb 14;21(3):613-620. doi: 10.3233/CBM-170683.
|
345 |
High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer.Urol Oncol. 2018 Apr;36(4):161.e7-161.e17. doi: 10.1016/j.urolonc.2017.10.028. Epub 2017 Nov 22.
|
346 |
RNA splicing and splicing regulator changes in prostate cancer pathology.Hum Genet. 2017 Sep;136(9):1143-1154. doi: 10.1007/s00439-017-1792-9. Epub 2017 Apr 5.
|
347 |
IFN, a Double-Edged Sword in Cancer Immunity and Metastasis.Cancer Res. 2019 Mar 15;79(6):1032-1033. doi: 10.1158/0008-5472.CAN-19-0083.
|
348 |
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.Nat Genet. 2018 Jul;50(7):928-936. doi: 10.1038/s41588-018-0142-8. Epub 2018 Jun 11.
|
349 |
Expression of Telomere Repeat Binding Factor 1 and TRF2 in Prostate Cancer and Correlation with Clinical Parameters.Biomed Res Int. 2017;2017:9764752. doi: 10.1155/2017/9764752. Epub 2017 Jul 20.
|
350 |
Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.PLoS One. 2012;7(10):e45539. doi: 10.1371/journal.pone.0045539. Epub 2012 Oct 8.
|
351 |
Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.Biochem Biophys Res Commun. 2017 May 6;486(3):607-612. doi: 10.1016/j.bbrc.2017.03.021. Epub 2017 Mar 21.
|
352 |
LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth.Oncogene. 2011 Apr 21;30(16):1892-900. doi: 10.1038/onc.2010.575. Epub 2011 Jan 10.
|
353 |
Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer.Onco Targets Ther. 2017 Jul 17;10:3531-3543. doi: 10.2147/OTT.S136491. eCollection 2017.
|
354 |
Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer.Eur Rev Med Pharmacol Sci. 2016 Dec;20(23):4864-4873.
|
355 |
Optimizing TRPM4 inhibitors in the MHFP6 chemical space.Eur J Med Chem. 2019 Mar 15;166:167-177. doi: 10.1016/j.ejmech.2019.01.048. Epub 2019 Jan 24.
|
356 |
Isobavachalcone Induces ROS-Mediated Apoptosis via Targeting Thioredoxin Reductase 1 in Human Prostate Cancer PC-3 Cells.Oxid Med Cell Longev. 2018 Oct 16;2018:1915828. doi: 10.1155/2018/1915828. eCollection 2018.
|
357 |
Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.PLoS One. 2013 Jun 6;8(6):e60562. doi: 10.1371/journal.pone.0060562. Print 2013.
|
358 |
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.Mol Cancer. 2011 Oct 14;10:129. doi: 10.1186/1476-4598-10-129.
|
359 |
Development of a highly reliable assay for ubiquitin-specific protease 2 inhibitors.Bioorg Med Chem Lett. 2017 Sep 1;27(17):4015-4018. doi: 10.1016/j.bmcl.2017.07.059. Epub 2017 Jul 23.
|
360 |
VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen.World J Urol. 2018 May;36(5):719-726. doi: 10.1007/s00345-018-2263-1. Epub 2018 Mar 14.
|
361 |
Effect of high WDR5 expression on the hepatocellular carcinoma prognosis.Oncol Lett. 2018 May;15(5):7864-7870. doi: 10.3892/ol.2018.8298. Epub 2018 Mar 20.
|
362 |
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer.Br J Cancer. 2016 May 10;114(10):1135-44. doi: 10.1038/bjc.2016.95. Epub 2016 Apr 12.
|
363 |
Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.Oncotarget. 2016 Dec 20;7(51):84893-84906. doi: 10.18632/oncotarget.12753.
|
364 |
Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.Aging (Albany NY). 2019 Jul 15;11(13):4736-4756. doi: 10.18632/aging.102087.
|
365 |
Upregulation of fractalkine contributes to theproliferative response of prostate cancer cells to hypoxia via promoting the G1/S phase transition.Mol Med Rep. 2015 Dec;12(6):7907-14. doi: 10.3892/mmr.2015.4438. Epub 2015 Oct 13.
|
366 |
LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.IUBMB Life. 2019 Oct;71(10):1537-1551. doi: 10.1002/iub.2075. Epub 2019 Jun 12.
|
367 |
Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.Carcinogenesis. 2018 Jul 3;39(7):879-888. doi: 10.1093/carcin/bgy062.
|
368 |
The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines.Asian J Androl. 2019 Sep-Oct;21(5):460-467. doi: 10.4103/aja.aja_1_19.
|
369 |
Contrasting roles of the ABCG2 Q141K variant in prostate cancer.Exp Cell Res. 2017 May 1;354(1):40-47. doi: 10.1016/j.yexcr.2017.03.020. Epub 2017 Mar 11.
|
370 |
Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men. Epigenetics. 2015;10(4):319-28.
|
371 |
Lipopolysaccharide (LPS) enhances prostate cancer metastasis potentially through NF-B activation and recurrent dexamethasone administration fails to suppress it in vivo.Prostate. 2019 Feb;79(2):168-182. doi: 10.1002/pros.23722. Epub 2018 Sep 27.
|
372 |
Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue.ACS Omega. 2019 Jan 31;4(1):1470-1478. doi: 10.1021/acsomega.8b03293. Epub 2019 Jan 16.
|
373 |
Zinc cooperates with p53 to inhibit the activity of mitochondrial aconitase through reactive oxygen species accumulation.Cancer Med. 2019 May;8(5):2462-2473. doi: 10.1002/cam4.2130. Epub 2019 Apr 10.
|
374 |
ACR Appropriateness Criteria() Post-treatmentFollow-up Prostate Cancer.J Am Coll Radiol. 2018 May;15(5S):S132-S149. doi: 10.1016/j.jacr.2018.03.019.
|
375 |
Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.Cancer Genet Cytogenet. 2005 Dec;163(2):123-9. doi: 10.1016/j.cancergencyto.2005.05.007.
|
376 |
TMPRSS2:ERG gene fusion variants induce TGF- signaling and epithelial to mesenchymal transition in human prostate cancer cells.Oncotarget. 2017 Apr 11;8(15):25115-25130. doi: 10.18632/oncotarget.15931.
|
377 |
Nuclear translocation of ADAM-10 contributes to the pathogenesis and progression of human prostate cancer.Cancer Sci. 2007 Nov;98(11):1720-6. doi: 10.1111/j.1349-7006.2007.00601.x. Epub 2007 Aug 28.
|
378 |
CircHIPK3 overexpression accelerates the proliferation and invasion of prostate cancer cells through regulating miRNA-338-3p.Onco Targets Ther. 2019 May 2;12:3363-3372. doi: 10.2147/OTT.S196931. eCollection 2019.
|
379 |
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.Virchows Arch. 2006 Dec;449(6):628-36. doi: 10.1007/s00428-006-0315-1. Epub 2006 Nov 8.
|
380 |
Overexpression of ADAM9 in oral squamous cell carcinoma.Oncol Lett. 2018 Jan;15(1):495-502. doi: 10.3892/ol.2017.7284. Epub 2017 Oct 30.
|
381 |
Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis.Prostate Cancer Prostatic Dis. 2020 Mar;23(1):11-23. doi: 10.1038/s41391-019-0154-1. Epub 2019 May 30.
|
382 |
ADRB2-Targeting Therapies for Prostate Cancer.Cancers (Basel). 2019 Mar 13;11(3):358. doi: 10.3390/cancers11030358.
|
383 |
Pro-metastatic activity of AGR2 interrupts angiogenesis target bevacizumab efficiency via direct interaction with VEGFA and activation of NF-B pathway.Biochim Biophys Acta Mol Basis Dis. 2018 May;1864(5 Pt A):1622-1633. doi: 10.1016/j.bbadis.2018.01.021. Epub 2018 Feb 1.
|
384 |
Chemopreventive effects of angiotensin II receptor type 2 agonist on prostate carcinogenesis by the down-regulation of the androgen receptor.Oncotarget. 2018 Feb 14;9(17):13859-13869. doi: 10.18632/oncotarget.24492. eCollection 2018 Mar 2.
|
385 |
Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12.Arch Biochem Biophys. 2018 Sep 15;654:47-54. doi: 10.1016/j.abb.2018.07.010. Epub 2018 Jul 18.
|
386 |
Knockdown of COPS3 inhibits the progress of prostate cancer through reducing phosphorylated p38 MAPK expression and impairs the epithelial-mesenchymal transition process.Prostate. 2019 Dec;79(16):1823-1831. doi: 10.1002/pros.23907. Epub 2019 Sep 11.
|
387 |
Consecutive Prostate Cancer Specimens Revealed Increased AldoKeto Reductase Family 1 Member C3 Expression with Progression to Castration-Resistant Prostate Cancer.J Clin Med. 2019 May 1;8(5):601. doi: 10.3390/jcm8050601.
|
388 |
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?.J Mol Med (Berl). 2005 Dec;83(12):1014-24. doi: 10.1007/s00109-005-0703-z. Epub 2005 Oct 7.
|
389 |
Epigenome-Wide Tumor DNA Methylation Profiling Identifies Novel Prognostic Biomarkers of Metastatic-Lethal Progression in Men Diagnosed with Clinically Localized Prostate Cancer.Clin Cancer Res. 2017 Jan 1;23(1):311-319. doi: 10.1158/1078-0432.CCR-16-0549. Epub 2016 Jun 29.
|
390 |
Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-B.Int J Cancer. 2013 Oct 15;133(8):1784-91. doi: 10.1002/ijc.28165. Epub 2013 Jul 13.
|
391 |
7-Farnesyloxycoumarin Exerts Anti-cancer Effects on a Prostate Cancer Cell Line by 15-LOX-1 Inhibition.Arch Iran Med. 2018 Jun 1;21(6):251-259.
|
392 |
Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase.Oncotarget. 2019 Jan 11;10(4):424-436. doi: 10.18632/oncotarget.13422. eCollection 2019 Jan 11.
|
393 |
Tumour-derived alkaline phosphatase regulates tumour growth, epithelial plasticity and disease-free survival in metastatic prostate cancer.Br J Cancer. 2017 Jan 17;116(2):227-236. doi: 10.1038/bjc.2016.402. Epub 2016 Dec 22.
|
394 |
Corrigendum: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.Nature. 2018 Feb 22;554(7693):554. doi: 10.1038/nature25470. Epub 2018 Jan 17.
|
395 |
Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.Oncotarget. 2017 Feb 7;8(6):10145-10160. doi: 10.18632/oncotarget.14358.
|
396 |
Effects of testosterone and 17estradiol on angiotensininduced changes in tyrosine kinase activity in the androgenindependent human prostate cancer cell line, DU145.Int J Mol Med. 2017 Nov;40(5):1573-1581. doi: 10.3892/ijmm.2017.3149. Epub 2017 Sep 25.
|
397 |
Expression and function of ATIP/MTUS1 in human prostate cancer cell lines.Prostate. 2010 Oct 1;70(14):1563-74. doi: 10.1002/pros.21192.
|
398 |
Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.Oncol Rep. 2017 Jul;38(1):120-128. doi: 10.3892/or.2017.5669. Epub 2017 May 24.
|
399 |
Autoantibody against new gene expressed in prostate protein is traceable in prostate cancer patients.Biomark Med. 2018 Oct;12(10):1125-1138. doi: 10.2217/bmm-2018-0069. Epub 2018 Sep 7.
|
400 |
Increased Soluble CMG2 Serum Protein Concentration is Associated with the Progression of Prostate Carcinoma.Cancers (Basel). 2019 Jul 26;11(8):1059. doi: 10.3390/cancers11081059.
|
401 |
Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.Cell Adh Migr. 2017 May 4;11(3):247-260. doi: 10.1080/19336918.2016.1259056. Epub 2016 Nov 11.
|
402 |
Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.Prostate. 2017 Mar;77(4):337-349. doi: 10.1002/pros.23273. Epub 2016 Nov 8.
|
403 |
MicroRNA-206 regulates the epithelial-mesenchymal transition and inhibits the invasion and metastasis of prostate cancer cells by targeting Annexin A2.Oncol Lett. 2018 Jun;15(6):8295-8302. doi: 10.3892/ol.2018.8395. Epub 2018 Mar 30.
|
404 |
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.Eur Urol. 2018 Dec;74(6):710-719. doi: 10.1016/j.eururo.2018.06.021. Epub 2018 Jul 7.
|
405 |
Relationship between XPD, RAD51, and APEX1 DNA repair genotypes and prostate cancer risk in the male population of Rio de Janeiro, Brazil.Genet Mol Biol. 2017 Oct-Dec;40(4):751-758. doi: 10.1590/1678-4685-GMB-2017-0039. Epub 2017 Nov 6.
|
406 |
Overexpression of Aquaporin-1 is a Prognostic Factor for Biochemical Recurrence in Prostate Adenocarcinoma.Pathol Oncol Res. 2017 Jan;23(1):189-196. doi: 10.1007/s12253-016-0145-7. Epub 2016 Nov 5.
|
407 |
Subcellular localization of aquaporin 3 in prostate cancer is regulated by RalA.Oncol Rep. 2018 May;39(5):2171-2177. doi: 10.3892/or.2018.6308. Epub 2018 Mar 9.
|
408 |
Expression, localisation and potential significance of aquaporins in benign and malignant human prostate tissue.BMC Urol. 2018 Sep 3;18(1):75. doi: 10.1186/s12894-018-0391-y.
|
409 |
Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.J Exp Clin Cancer Res. 2017 Aug 23;36(1):112. doi: 10.1186/s13046-017-0583-4.
|
410 |
Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.Mol Cancer Res. 2012 Feb;10(2):218-29. doi: 10.1158/1541-7786.MCR-11-0451. Epub 2011 Dec 5.
|
411 |
Arylsulfatase B is reduced in prostate cancer recurrences.Cancer Biomark. 2017 Dec 12;21(1):229-234. doi: 10.3233/CBM-170680.
|
412 |
Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b.Acta Pharmacol Sin. 2019 Sep;40(9):1228-1236. doi: 10.1038/s41401-019-0234-8. Epub 2019 Apr 26.
|
413 |
Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer.Oncogene. 2019 Aug;38(35):6301-6318. doi: 10.1038/s41388-019-0879-2. Epub 2019 Jul 16.
|
414 |
Reciprocal Network between Cancer Stem-Like Cells and Macrophages Facilitates the Progression and Androgen Deprivation Therapy Resistance of Prostate Cancer.Clin Cancer Res. 2018 Sep 15;24(18):4612-4626. doi: 10.1158/1078-0432.CCR-18-0461. Epub 2018 Apr 24.
|
415 |
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 2000 Mar 1;60(5):1312-6.
|
416 |
Characterization of CD133(+)/CD44(+) human prostate cancer stem cells with ATR-FTIR spectroscopy.Analyst. 2019 Mar 21;144(6):2138-2149. doi: 10.1039/c9an00093c. Epub 2019 Feb 11.
|
417 |
Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10.1158/0008-5472.CAN-15-2980. Epub 2016 Apr 20.
|
418 |
End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom.Radiother Oncol. 2019 Dec;141:200-207. doi: 10.1016/j.radonc.2019.09.014. Epub 2019 Oct 1.
|
419 |
Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.Mol Cell Proteomics. 2015 Mar;14(3):471-83. doi: 10.1074/mcp.M114.039909. Epub 2014 Dec 19.
|
420 |
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1495-1504. doi: 10.1080/21691401.2017.1374284. Epub 2017 Sep 11.
|
421 |
PUMA decreases the growth of prostate cancer PC-3 cells independent of p53.Oncol Lett. 2017 Mar;13(3):1885-1890. doi: 10.3892/ol.2017.5657. Epub 2017 Jan 27.
|
422 |
MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.Mol Carcinog. 2017 Jun;56(6):1570-1577. doi: 10.1002/mc.22612. Epub 2017 Jan 18.
|
423 |
C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.Prostate. 2009 Sep 15;69(13):1435-47. doi: 10.1002/pros.20993.
|
424 |
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.Neoplasia. 2017 Sep;19(9):707-715. doi: 10.1016/j.neo.2017.06.003. Epub 2017 Aug 19.
|
425 |
Effects of cIAP-1, cIAP-2 and XIAP triple knockdown on prostate cancer cell susceptibility to apoptosis, cell survival and proliferation.Mol Cancer. 2009 Jun 23;8:39. doi: 10.1186/1476-4598-8-39.
|
426 |
High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818809694. doi: 10.1177/1533033818809694.
|
427 |
BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer.Oncogene. 2020 Jan;39(1):17-29. doi: 10.1038/s41388-019-0966-4. Epub 2019 Aug 28.
|
428 |
Bone morphogenetic protein-10 (BMP-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer.Cancer Sci. 2010 Oct;101(10):2137-44. doi: 10.1111/j.1349-7006.2010.01648.x. Epub 2010 Jul 1.
|
429 |
Decreased expression of bone morphogenetic protein-2 is correlated with biochemical recurrence in prostate cancer: Immunohistochemical analysis.Sci Rep. 2018 Jul 16;8(1):10748. doi: 10.1038/s41598-018-28566-9.
|
430 |
Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis.Int J Oncol. 2018 Sep;53(3):1354-1362. doi: 10.3892/ijo.2018.4469. Epub 2018 Jul 4.
|
431 |
Opposing roles of TGF and BMP signaling in prostate cancer development.Genes Dev. 2017 Dec 1;31(23-24):2337-2342. doi: 10.1101/gad.307116.117.
|
432 |
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.Sci Rep. 2019 Mar 7;9(1):3823. doi: 10.1038/s41598-019-40518-5.
|
433 |
Clinical significance of bromodomain-containing protein 7 and its association with tumor progression in prostate cancer.Oncol Lett. 2019 Jan;17(1):849-856. doi: 10.3892/ol.2018.9665. Epub 2018 Nov 5.
|
434 |
Identification of ADAM12 as a Novel Basigin Sheddase.Int J Mol Sci. 2019 Apr 22;20(8):1957. doi: 10.3390/ijms20081957.
|
435 |
Change of the cell cycle after flutamide treatment in prostate cancer cells and its molecular mechanism.Asian J Androl. 2005 Dec;7(4):375-80. doi: 10.1111/j.1745-7262.2005.00031.x.
|
436 |
Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles.Onco Targets Ther. 2017 Jun 29;10:3225-3232. doi: 10.2147/OTT.S135764. eCollection 2017.
|
437 |
Calcitonin induces stem cell-like phenotype in prostate cancer cells.Endocr Relat Cancer. 2019 Nov;26(11):815-828. doi: 10.1530/ERC-19-0333.
|
438 |
CAMKK2 Promotes Prostate Cancer Independently of AMPK via Increased Lipogenesis.Cancer Res. 2018 Dec 15;78(24):6747-6761. doi: 10.1158/0008-5472.CAN-18-0585. Epub 2018 Sep 21.
|
439 |
Inhibition of androgen receptor and -catenin activity in prostate cancer.Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):15710-5. doi: 10.1073/pnas.1218168110. Epub 2013 Sep 9.
|
440 |
Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation.Oncotarget. 2018 Sep 25;9(75):34190. doi: 10.18632/oncotarget.26197. eCollection 2018 Sep 25.
|
441 |
TSA-induced cell death in prostate cancer cell lines is caspase-2 dependent and involves the PIDDosome.Cancer Biol Ther. 2006 Sep;5(9):1199-205. doi: 10.4161/cbt.5.9.3168. Epub 2006 Sep 9.
|
442 |
Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.Cancer Res. 2001 Jun 15;61(12):4693-700.
|
443 |
MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.Oncogene. 2013 Aug 29;32(35):4139-47. doi: 10.1038/onc.2012.424. Epub 2012 Sep 17.
|
444 |
A Single Nucleotide Polymorphism in HPGD Gene Is Associated with Prostate Cancer Risk.J Cancer. 2017 Oct 24;8(19):4083-4086. doi: 10.7150/jca.22025. eCollection 2017.
|
445 |
Circulating inflammation markers and prostate cancer.Prostate. 2019 Aug;79(11):1338-1346. doi: 10.1002/pros.23842. Epub 2019 Jun 18.
|
446 |
Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer.J Cancer Res Clin Oncol. 2008 Nov;134(11):1181-9. doi: 10.1007/s00432-008-0403-5. Epub 2008 May 9.
|
447 |
Visual electrochemiluminescence ratiometry on bipolar electrode for bioanalysis.Biosens Bioelectron. 2018 Apr 15;102:624-630. doi: 10.1016/j.bios.2017.12.008. Epub 2017 Dec 6.
|
448 |
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer.Mod Pathol. 2020 May;33(5):905-915. doi: 10.1038/s41379-019-0418-2. Epub 2019 Dec 4.
|
449 |
SPOP suppresses prostate cancer through regulation of CYCLIN E1 stability.Cell Death Differ. 2019 Jun;26(6):1156-1168. doi: 10.1038/s41418-018-0198-0. Epub 2018 Sep 20.
|
450 |
TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.Cell Signal. 2019 Jul;59:152-162. doi: 10.1016/j.cellsig.2019.03.017. Epub 2019 Mar 26.
|
451 |
Mutant Kras-induced upregulation of CD24 enhances prostate cancer stemness and bone metastasis.Oncogene. 2019 Mar;38(12):2005-2019. doi: 10.1038/s41388-018-0575-7. Epub 2018 Nov 22.
|
452 |
Identification of targets for prostate cancer immunotherapy.Prostate. 2019 Apr;79(5):498-505. doi: 10.1002/pros.23756. Epub 2019 Jan 6.
|
453 |
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer.Cancer Immunol Immunother. 2017 Oct;66(10):1345-1357. doi: 10.1007/s00262-017-2027-6. Epub 2017 Jun 12.
|
454 |
Clinical Implications of Peripheral CD3+CD69+ T-Cell And CD8+CD28+ T-Cell Proportions in Patients Prior to Radical Prostatectomy.Urol J. 2020 May 16;17(3):257-261. doi: 10.22037/uj.v0i0.5103.
|
455 |
miR-518f-5p decreases tetraspanin CD9 protein levels and differentially affects non-tumourigenic prostate and prostate cancer cell migration and adhesion.Oncotarget. 2017 Dec 7;9(2):1980-1991. doi: 10.18632/oncotarget.23118. eCollection 2018 Jan 5.
|
456 |
Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of -catenin in cancer stem-like cells.EBioMedicine. 2019 Apr;42:397-407. doi: 10.1016/j.ebiom.2019.03.032. Epub 2019 Mar 21.
|
457 |
CDC25A functions as a novel Ar corepressor in prostate cancer cells.J Mol Biol. 2009 Jan 16;385(2):446-56. doi: 10.1016/j.jmb.2008.10.070. Epub 2008 Nov 3.
|
458 |
Overexpression of Cdc25B, an androgen receptor coactivator, in prostate cancer.Oncogene. 2003 Feb 6;22(5):734-9. doi: 10.1038/sj.onc.1206121.
|
459 |
Results, questions, perspectives of a study on human Polyomavirus BK and molecular actors in prostate cancer development.Cancer Genomics Proteomics. 2015 Mar-Apr;12(2):57-65.
|
460 |
The Identification of Potential Biomarkers and Biological Pathways in Prostate Cancer.J Cancer. 2019 Feb 23;10(6):1398-1408. doi: 10.7150/jca.29571. eCollection 2019.
|
461 |
Angiomotin is a novel component of cadherin-11/-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.FASEB J. 2015 Mar;29(3):1080-91. doi: 10.1096/fj.14-261594. Epub 2014 Dec 2.
|
462 |
Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced Prostate Cancer.Eur Urol. 2020 Mar;77(3):333-341. doi: 10.1016/j.eururo.2019.09.036. Epub 2019 Oct 20.
|
463 |
The co-chaperone p23 promotes prostate cancer motility and metastasis.Mol Oncol. 2015 Jan;9(1):295-308. doi: 10.1016/j.molonc.2014.08.014. Epub 2014 Sep 6.
|
464 |
Phase I trial of TAK-385 in hormone treatment-nave Japanese patients with nonmetastatic prostate cancer.Cancer Med. 2019 Oct;8(13):5891-5902. doi: 10.1002/cam4.2442. Epub 2019 Aug 19.
|
465 |
Flavokawain B targets protein neddylation for enhancing the anti-prostate cancer effect of Bortezomib via Skp2 degradation.Cell Commun Signal. 2019 Mar 18;17(1):25. doi: 10.1186/s12964-019-0338-2.
|
466 |
Engineered measles virus as a novel oncolytic therapy against prostate cancer.Prostate. 2009 Jan 1;69(1):82-91. doi: 10.1002/pros.20857.
|
467 |
Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.BMC Cancer. 2007 Jan 3;7:2. doi: 10.1186/1471-2407-7-2.
|
468 |
Loss of CCAAT-enhancer-binding protein alpha (CEBPA) is linked to poor prognosis in PTEN deleted and TMPRSS2:ERG fusion type prostate cancers.Prostate. 2019 Feb;79(3):302-311. doi: 10.1002/pros.23736. Epub 2018 Nov 14.
|
469 |
LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer Progression.Cancer Res. 2017 Oct 15;77(20):5479-5490. doi: 10.1158/0008-5472.CAN-17-0496. Epub 2017 Sep 15.
|
470 |
Expression of luteinizing hormone/human chorionic gonadotropin receptor gene in benign prostatic hyperplasia and in prostate carcinoma in humans.Biol Reprod. 1997 Jan;56(1):67-72. doi: 10.1095/biolreprod56.1.67.
|
471 |
Bringing Prostate Cancer Germline Genetics into Clinical Practice.J Urol. 2019 Aug;202(2):223-230. doi: 10.1097/JU.0000000000000137. Epub 2019 Jul 8.
|
472 |
Preclinical Development of a Nontoxic Oral Formulation of Monoethanolamine, a Lipid Precursor, for Prostate Cancer Treatment.Clin Cancer Res. 2017 Jul 15;23(14):3781-3793. doi: 10.1158/1078-0432.CCR-16-1716. Epub 2017 Feb 6.
|
473 |
Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling.Asian J Androl. 2018 Nov-Dec;20(6):608-614. doi: 10.4103/aja.aja_55_18.
|
474 |
MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.Int J Oncol. 2019 Feb;54(2):443-454. doi: 10.3892/ijo.2018.4647. Epub 2018 Nov 26.
|
475 |
Bcl-2-dependent modulation of swelling-activated Cl- current and ClC-3 expression in human prostate cancer epithelial cells.Cancer Res. 2004 Jul 15;64(14):4841-8. doi: 10.1158/0008-5472.CAN-03-3223.
|
476 |
Prognostic potential of ERG (ETS-related gene) expression in prostatic adenocarcinoma.Int Urol Nephrol. 2013 Jun;45(3):727-33. doi: 10.1007/s11255-013-0406-2. Epub 2013 May 18.
|
477 |
Structural and Dynamical Order of a Disordered Protein: Molecular Insights into Conformational Switching of PAGE4 at the Systems Level.Biomolecules. 2019 Feb 22;9(2):77. doi: 10.3390/biom9020077.
|
478 |
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study).Urol Int. 2019;103(1):8-18. doi: 10.1159/000496980. Epub 2019 Feb 7.
|
479 |
Store-operated Ca2+ current in prostate cancer epithelial cells. Role of endogenous Ca2+ transporter type 1.J Biol Chem. 2003 Apr 25;278(17):15381-9. doi: 10.1074/jbc.M212106200. Epub 2003 Feb 12.
|
480 |
The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.EMBO Mol Med. 2019 Nov 7;11(11):e10659. doi: 10.15252/emmm.201910659. Epub 2019 Sep 26.
|
481 |
Randomized phase II trial of neoadjuvant everolimus in patients with high-risk localized prostate cancer.Invest New Drugs. 2019 Jun;37(3):559-566. doi: 10.1007/s10637-019-00778-4. Epub 2019 Apr 30.
|
482 |
CRTC2 as a novel prognostic biomarker for worse pathologic outcomes and biochemical recurrence after radical prostatectomy in patients with prostate cancer.Investig Clin Urol. 2019 Mar;60(2):84-90. doi: 10.4111/icu.2019.60.2.84. Epub 2019 Feb 19.
|
483 |
Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells.PLoS One. 2018 Jan 11;13(1):e0191188. doi: 10.1371/journal.pone.0191188. eCollection 2018.
|
484 |
Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer.Oncoimmunology. 2019 Mar 28;8(6):e1581528. doi: 10.1080/2162402X.2019.1581528. eCollection 2019.
|
485 |
FENDRR reduces tumor invasiveness in prostate cancer PC-3 cells by targeting CSNK1E.Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7327-7337. doi: 10.26355/eurrev_201909_18838.
|
486 |
A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells.J Biol Chem. 2001 Feb 23;276(8):5992-9. doi: 10.1074/jbc.M004862200. Epub 2000 Nov 7.
|
487 |
Combination of Prostate Cancer Antigen 3 and Prostate-Specific Antigen Improves Diagnostic Accuracy in Men at Risk of Prostate Cancer.Arch Pathol Lab Med. 2018 Sep;142(9):1106-1112. doi: 10.5858/arpa.2017-0185-OA. Epub 2018 Mar 16.
|
488 |
Dysregulation of cystathionine -lyase promotes prostate cancer progression and metastasis.EMBO Rep. 2019 Oct 4;20(10):e45986. doi: 10.15252/embr.201845986. Epub 2019 Aug 29.
|
489 |
Targeting the lysosome by an aminomethylated Riccardin D triggers DNA damage through cathepsin B-mediated degradation of BRCA1.J Cell Mol Med. 2019 Mar;23(3):1798-1812. doi: 10.1111/jcmm.14077. Epub 2018 Dec 18.
|
490 |
Thrombospondin 1 and cathepsin D improve prostate cancer diagnosis by avoiding potentially unnecessary prostate biopsies.BJU Int. 2019 May;123(5):826-833. doi: 10.1111/bju.14540. Epub 2018 Oct 11.
|
491 |
Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.Biol Chem. 2010 Aug;391(8):947-58. doi: 10.1515/BC.2010.087.
|
492 |
Analysis of a truncated form of cathepsin H in human prostate tumor cells.J Biol Chem. 2002 Mar 29;277(13):11533-8. doi: 10.1074/jbc.M109557200. Epub 2002 Jan 16.
|
493 |
Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.J Cancer Res Clin Oncol. 2019 Aug;145(8):1999-2012. doi: 10.1007/s00432-019-02950-y. Epub 2019 Jun 6.
|
494 |
Snail transcription factor NLS and importin 1 regulate the subcellular localization of Cathepsin L and Cux1.Biochem Biophys Res Commun. 2017 Sep 9;491(1):59-64. doi: 10.1016/j.bbrc.2017.07.039. Epub 2017 Jul 8.
|
495 |
CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition.Cell Commun Signal. 2019 Sep 10;17(1):118. doi: 10.1186/s12964-019-0434-3.
|
496 |
MiR-206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11.Prostate. 2018 May;78(7):479-490. doi: 10.1002/pros.23468. Epub 2018 Mar 14.
|
497 |
CXCL9 promotes prostate cancer progression through inhibition of cytokines from Tcells.Mol Med Rep. 2018 Aug;18(2):1305-1310. doi: 10.3892/mmr.2018.9152. Epub 2018 Jun 11.
|
498 |
Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer.Cell Commun Signal. 2019 Dec 12;17(1):164. doi: 10.1186/s12964-019-0489-1.
|
499 |
Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.Cancer Sci. 2018 Apr;109(4):1230-1238. doi: 10.1111/cas.13517. Epub 2018 Feb 19.
|
500 |
Benzophenones as xanthone-open model CYP11B1 inhibitors potentially useful for promoting wound healing.Bioorg Chem. 2019 May;86:401-409. doi: 10.1016/j.bioorg.2019.01.066. Epub 2019 Jan 30.
|
501 |
Correction to: Association between NAT2, CYP1A1, and CYP1A2 genotypes, heterocyclic aromatic amines, and prostate cancer risk: a case control study in Japan.Environ Health Prev Med. 2018 Jul 4;23(1):30. doi: 10.1186/s12199-018-0718-z.
|
502 |
Polymorphisms of metabolic enzyme genes, living habits and prostate cancer susceptibility.Front Biosci. 2006 Sep 1;11:2052-60. doi: 10.2741/1947.
|
503 |
Missense mutations in -1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Hum Mol Genet. 2013 May 1;22(9):1746-54. doi: 10.1093/hmg/ddt021. Epub 2013 Jan 28.
|
504 |
Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.Cancer Res. 2001 Oct 1;61(19):7217-24.
|
505 |
Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer.Onco Targets Ther. 2018 Feb 28;11:1077-1086. doi: 10.2147/OTT.S157295. eCollection 2018.
|
506 |
Dual regulation of decorin by androgen and Hedgehog signaling during prostate morphogenesis.Dev Dyn. 2018 May;247(5):679-685. doi: 10.1002/dvdy.24619. Epub 2018 Feb 19.
|
507 |
Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer.Int J Biol Macromol. 2018 Oct 15;118(Pt A):599-609. doi: 10.1016/j.ijbiomac.2018.06.005. Epub 2018 Jun 3.
|
508 |
Molecular characteristic and physiological role of DOPA-decarboxylase.Postepy Hig Med Dosw (Online). 2016 Dec 31;70(0):1424-1440. doi: 10.5604/17322693.1227773.
|
509 |
REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase.Oncogene. 2005 Feb 10;24(7):1138-49. doi: 10.1038/sj.onc.1208236.
|
510 |
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer.Cancer Sci. 2008 Jan;99(1):39-45. doi: 10.1111/j.1349-7006.2007.00655.x. Epub 2007 Oct 29.
|
511 |
LncRNA CCAT1 Promotes Prostate Cancer Cell Proliferation by Interacting with DDX5 and MIR-28-5P.Mol Cancer Ther. 2019 Dec;18(12):2469-2479. doi: 10.1158/1535-7163.MCT-19-0095. Epub 2019 Aug 6.
|
512 |
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.Oncotarget. 2015 Jan 30;6(3):1806-20. doi: 10.18632/oncotarget.2809.
|
513 |
DEPDC1 promotes cell proliferation and tumor growth via activation of E2F signaling in prostate cancer.Biochem Biophys Res Commun. 2017 Aug 26;490(3):707-712. doi: 10.1016/j.bbrc.2017.06.105. Epub 2017 Jun 19.
|
514 |
DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals.Oncogene. 2020 Feb;39(7):1557-1571. doi: 10.1038/s41388-019-1085-y. Epub 2019 Nov 4.
|
515 |
DGAT1 Inhibitor Suppresses Prostate Tumor Growth and Migration by Regulating Intracellular Lipids and Non-Centrosomal MTOC Protein GM130.Sci Rep. 2019 Feb 28;9(1):3035. doi: 10.1038/s41598-019-39537-z.
|
516 |
Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors.Oncotarget. 2019 Mar 12;10(21):2113. doi: 10.18632/oncotarget.26802. eCollection 2019 Mar 12.
|
517 |
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.Sci Transl Med. 2019 Mar 20;11(484):eaav0891. doi: 10.1126/scitranslmed.aav0891.
|
518 |
Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.Cancer Res. 2007 Dec 1;67(23):11244-53. doi: 10.1158/0008-5472.CAN-07-0969.
|
519 |
Targeting the Hsp40/Hsp70 Chaperone Axis as a Novel Strategy to Treat Castration-Resistant Prostate Cancer.Cancer Res. 2018 Jul 15;78(14):4022-4035. doi: 10.1158/0008-5472.CAN-17-3728. Epub 2018 May 15.
|
520 |
Novel Insight into Differential Gene Expression and Clinical Significance of Dopamine Receptors, COMT, and IL6 in BPH and Prostate Cancer.Curr Mol Med. 2019;19(8):605-619. doi: 10.2174/1566524019666190709180146.
|
521 |
The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.Cancer Res. 2008 Nov 15;68(22):9255-64. doi: 10.1158/0008-5472.CAN-08-1224.
|
522 |
DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis.Sci Rep. 2018 Jan 29;8(1):1767. doi: 10.1038/s41598-018-20176-9.
|
523 |
MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2.PLoS One. 2010 Apr 14;5(4):e10147. doi: 10.1371/journal.pone.0010147.
|
524 |
Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration.Int J Cancer. 2011 Aug 1;129(3):586-98. doi: 10.1002/ijc.25719. Epub 2010 Dec 2.
|
525 |
Methylated genes as potential biomarkers in prostate cancer.BJU Int. 2010 May;105(10):1364-70. doi: 10.1111/j.1464-410X.2009.09167.x. Epub 2010 Jan 8.
|
526 |
Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells.Cancer Lett. 2017 Apr 1;390:11-20. doi: 10.1016/j.canlet.2017.01.003. Epub 2017 Jan 13.
|
527 |
Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.Oncogene. 2019 Jun;38(23):4540-4559. doi: 10.1038/s41388-019-0736-3. Epub 2019 Feb 12.
|
528 |
EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):7808-7815. doi: 10.26355/eurrev_201909_18990.
|
529 |
PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses.Oncotarget. 2017 Apr 11;8(15):24046-24062. doi: 10.18632/oncotarget.15733.
|
530 |
The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.Mol Cancer Res. 2018 Apr;16(4):682-695. doi: 10.1158/1541-7786.MCR-17-0696. Epub 2018 Feb 16.
|
531 |
Eukaryotic translation initiation factor 5A2 is highly expressed in prostate cancer and predicts poor prognosis.Exp Ther Med. 2019 May;17(5):3741-3747. doi: 10.3892/etm.2019.7331. Epub 2019 Mar 1.
|
532 |
Soluble CD105 is prognostic of disease recurrence in prostate cancer patients.Endocr Relat Cancer. 2020 Jan;27(1):1-9. doi: 10.1530/ERC-19-0370.
|
533 |
Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells.Prostate. 2008 Nov 1;68(15):1666-73. doi: 10.1002/pros.20835.
|
534 |
Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.J Cell Physiol. 2007 Jan;210(1):111-21. doi: 10.1002/jcp.20828.
|
535 |
Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer.Cells. 2019 Sep 11;8(9):1067. doi: 10.3390/cells8091067.
|
536 |
Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer.Anticancer Res. 2019 Nov;39(11):6249-6257. doi: 10.21873/anticanres.13834.
|
537 |
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.Cell Death Dis. 2017 Oct 12;8(10):e3122. doi: 10.1038/cddis.2017.507.
|
538 |
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer.Cancer Res. 2019 May 15;79(10):2580-2592. doi: 10.1158/0008-5472.CAN-18-2812. Epub 2019 Apr 5.
|
539 |
EPHB4 inhibition activates ER stress to promote immunogenic cell death of prostate cancer cells.Cell Death Dis. 2019 Oct 22;10(11):801. doi: 10.1038/s41419-019-2042-y.
|
540 |
Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression.Cancer Lett. 2017 Nov 1;408:155-163. doi: 10.1016/j.canlet.2017.08.014. Epub 2017 Aug 18.
|
541 |
Antibody-based detection of ERG rearrangement-positive prostate cancer.Neoplasia. 2010 Jul;12(7):590-8. doi: 10.1593/neo.10726.
|
542 |
IRE1-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.Nat Commun. 2019 Jan 24;10(1):323. doi: 10.1038/s41467-018-08152-3.
|
543 |
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine.Cancers (Basel). 2018 Jan 23;10(2):29. doi: 10.3390/cancers10020029.
|
544 |
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling.Biomed Res Int. 2019 Jun 16;2019:3808432. doi: 10.1155/2019/3808432. eCollection 2019.
|
545 |
Dual Inhibition of EZH2 and EZH1 Sensitizes PRC2-Dependent Tumors to Proteasome Inhibition.Clin Cancer Res. 2017 Aug 15;23(16):4817-4830. doi: 10.1158/1078-0432.CCR-16-2735. Epub 2017 May 10.
|
546 |
Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.Nat Commun. 2018 Jun 11;9(1):2256. doi: 10.1038/s41467-018-04109-8.
|
547 |
Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population.PLoS Genet. 2013 Mar;9(3):e1003419. doi: 10.1371/journal.pgen.1003419. Epub 2013 Mar 28.
|
548 |
Tissue specific and androgen-regulated expression of human prostate-specific transglutaminase.Biochem J. 1996 May 1;315 ( Pt 3)(Pt 3):901-8. doi: 10.1042/bj3150901.
|
549 |
Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1.Int J Cancer. 2010 Feb 1;126(3):599-610. doi: 10.1002/ijc.24904.
|
550 |
Expression of proteinase-activated receptor-2 (PAR2) is androgen-dependent in stromal cell line (hPCPs) from benign prostatic hyperplasia.Prostate. 2010 Sep 1;70(12):1350-8. doi: 10.1002/pros.21170.
|
551 |
Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.Int J Cancer. 2018 May 15;142(10):2056-2067. doi: 10.1002/ijc.31226. Epub 2018 Jan 4.
|
552 |
Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase.Prostate. 2019 Jun;79(8):864-871. doi: 10.1002/pros.23793. Epub 2019 Apr 7.
|
553 |
Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3 beta phosphorylation.Mol Cancer Ther. 2008 Oct;7(10):3203-11. doi: 10.1158/1535-7163.MCT-08-0494.
|
554 |
Single Cell Gene Co-Expression Network Reveals FECH/CROT Signature as a Prognostic Marker.Cells. 2019 Jul 10;8(7):698. doi: 10.3390/cells8070698.
|
555 |
MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology. 2017 Oct;153(4):1120-1132.e15. doi: 10.1053/j.gastro.2016.12.036. Epub 2017 Feb 27.
|
556 |
Oleic acid promotes prostate cancer malignant phenotype via the G protein-coupled receptor FFA1/GPR40.J Cell Physiol. 2018 Sep;233(9):7367-7378. doi: 10.1002/jcp.26572. Epub 2018 Apr 16.
|
557 |
Role of Host GPR120 in Mediating Dietary Omega-3 Fatty Acid Inhibition of Prostate Cancer.J Natl Cancer Inst. 2019 Jan 1;111(1):52-59. doi: 10.1093/jnci/djy125.
|
558 |
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.J Urol. 2013 Jun;189(6):2335-41. doi: 10.1016/j.juro.2012.11.074. Epub 2012 Nov 15.
|
559 |
Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer.Front Genet. 2019 Jan 30;10:12. doi: 10.3389/fgene.2019.00012. eCollection 2019.
|
560 |
Plant-based diets relatively low in bioavailable phosphate and calcium may aid prevention and control of prostate cancer by lessening production of fibroblast growth factor 23.Med Hypotheses. 2017 Feb;99:68-72. doi: 10.1016/j.mehy.2017.01.001. Epub 2017 Jan 3.
|
561 |
Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.Neoplasia. 2010 Nov;12(11):915-27. doi: 10.1593/neo.10776.
|
562 |
Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.Cancer Sci. 2008 Jul;99(7):1326-33. doi: 10.1111/j.1349-7006.2008.00816.x. Epub 2008 Apr 15.
|
563 |
The prognostic value of stromal FK506-binding protein 1 and androgen receptor in prostate cancer outcome.Prostate. 2017 Feb;77(2):185-195. doi: 10.1002/pros.23259. Epub 2016 Oct 8.
|
564 |
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.Clin Cancer Res. 2019 Jan 15;25(2):710-723. doi: 10.1158/1078-0432.CCR-18-0704. Epub 2018 Oct 15.
|
565 |
Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.Cancer Med. 2019 Mar;8(3):1110-1123. doi: 10.1002/cam4.1885. Epub 2019 Jan 8.
|
566 |
Intra-tumoral delivery of functional ID4 protein via PCL/maltodextrin nano-particle inhibits prostate cancer growth.Oncotarget. 2016 Oct 18;7(42):68072-68085. doi: 10.18632/oncotarget.10953.
|
567 |
A Bispecific Antibody Targeting the v and 51 Integrins Induces Integrin Degradation in Prostate Cancer Cells and Is Superior to Monospecific Antibodies.Mol Cancer Res. 2020 Jan;18(1):27-32. doi: 10.1158/1541-7786.MCR-19-0442. Epub 2019 Oct 21.
|
568 |
Folate-Decorated Amphiphilic Cyclodextrins as Cell-Targeted Nanophototherapeutics.Biomacromolecules. 2019 Jul 8;20(7):2530-2544. doi: 10.1021/acs.biomac.9b00306. Epub 2019 Jun 25.
|
569 |
Suppressor of activator protein-1 regulated by interferon expression in prostate cancer tissues and cells.Life Sci. 2019 Sep 1;232:116626. doi: 10.1016/j.lfs.2019.116626. Epub 2019 Jul 2.
|
570 |
FOSL1 enhances growth and metastasis of human prostate cancer cells through epithelial mesenchymal transition pathway.Eur Rev Med Pharmacol Sci. 2018 Dec;22(24):8609-8615. doi: 10.26355/eurrev_201812_16624.
|
571 |
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.BMC Cancer. 2011 Jan 25;11:31. doi: 10.1186/1471-2407-11-31.
|
572 |
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer.J Cancer. 2019 Jan 1;10(3):749-756. doi: 10.7150/jca.28099. eCollection 2019.
|
573 |
TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.Cell Biol Int. 2018 Mar;42(3):273-280. doi: 10.1002/cbin.10832. Epub 2017 Aug 21.
|
574 |
Screening, identification of prostate cancer urinary biomarkers and verification of important spots.Invest New Drugs. 2019 Oct;37(5):935-947. doi: 10.1007/s10637-018-0709-3. Epub 2019 Jan 4.
|
575 |
Knockdown of fucosyltransferase III disrupts the adhesion of circulating cancer cells to E-selectin without affecting hematopoietic cell adhesion.Carbohydr Res. 2010 Nov 2;345(16):2334-42. doi: 10.1016/j.carres.2010.07.028. Epub 2010 Jul 21.
|
576 |
SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer.Oncotarget. 2015 Dec 29;6(42):44072-83. doi: 10.18632/oncotarget.6398.
|
577 |
Prostate cancer-related anxiety in long-term survivors after radical prostatectomy.J Cancer Surviv. 2017 Dec;11(6):800-807. doi: 10.1007/s11764-017-0619-y. Epub 2017 May 21.
|
578 |
Matrine inhibits the progression of prostate cancer by promoting expression of GADD45B.Prostate. 2018 Apr;78(5):327-335. doi: 10.1002/pros.23469. Epub 2018 Jan 21.
|
579 |
An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.PLoS One. 2017 Aug 3;12(8):e0182305. doi: 10.1371/journal.pone.0182305. eCollection 2017.
|
580 |
Association of XPD polymorphisms with prostate cancer in Taiwanese patients.Anticancer Res. 2007 Jul-Aug;27(4C):2893-6.
|
581 |
Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.Cancer Res. 1992 Sep 15;52(18):5115-8.
|
582 |
Glyceryl trinitrateinduced cytotoxicity of docetaxelresistant prostatic cancer cells is associated with differential regulation of clusterin.Int J Oncol. 2019 Apr;54(4):1446-1456. doi: 10.3892/ijo.2019.4708. Epub 2019 Feb 1.
|
583 |
High-Level -Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.Int J Mol Sci. 2017 Jan 29;18(2):286. doi: 10.3390/ijms18020286.
|
584 |
Gamma-glutamyltransferase activity in exosomes as a potential marker for prostate cancer.BMC Cancer. 2017 May 5;17(1):316. doi: 10.1186/s12885-017-3301-x.
|
585 |
Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer.Clin Cancer Res. 2005 Dec 1;11(23):8295-303. doi: 10.1158/1078-0432.CCR-05-0443.
|
586 |
Impaired trafficking of connexins in androgen-independent human prostate cancer cell lines and its mitigation by alpha-catenin.J Biol Chem. 2002 Dec 20;277(51):50087-97. doi: 10.1074/jbc.M202652200. Epub 2002 Aug 29.
|
587 |
GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism.J Cell Biochem. 2018 Apr;119(4):3641-3652. doi: 10.1002/jcb.26572. Epub 2018 Jan 5.
|
588 |
Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control.J Cell Mol Med. 2018 May;22(5):2865-2883. doi: 10.1111/jcmm.13581. Epub 2018 Mar 5.
|
589 |
Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer.Anticancer Agents Med Chem. 2019;19(4):509-514. doi: 10.2174/1871520618666180801101730.
|
590 |
Glutamate Decarboxylase 65 Signals through the Androgen Receptor to Promote Castration Resistance in Prostate Cancer.Cancer Res. 2019 Sep 15;79(18):4638-4649. doi: 10.1158/0008-5472.CAN-19-0700. Epub 2019 Jun 10.
|
591 |
Oncological outcome of neoadjuvant low-dose estramustine plus LHRH agonist/antagonist followed by extended radical prostatectomy for Japanese patients with high-risk localized prostate cancer: a prospective single-arm study.Jpn J Clin Oncol. 2020 Jan 24;50(1):66-72. doi: 10.1093/jjco/hyz138.
|
592 |
Identification of a Glypican-3-Binding Peptide for In Vivo Non-Invasive Human Hepatocellular Carcinoma Detection.Macromol Biosci. 2017 Apr;17(4). doi: 10.1002/mabi.201600335. Epub 2016 Nov 15.
|
593 |
Raloxifene decreases cell viability and migratory potential in prostate cancer cells (LNCaP) with GPR30/GPER1 involvement.J Pharm Pharmacol. 2019 Jul;71(7):1065-1071. doi: 10.1111/jphp.13089. Epub 2019 Mar 28.
|
594 |
The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease.Int J Mol Sci. 2018 Feb 1;19(2):439. doi: 10.3390/ijms19020439.
|
595 |
DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers.Br J Cancer. 2005 Oct 31;93(9):1029-37. doi: 10.1038/sj.bjc.6602837.
|
596 |
Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate Cancer.Cancer Res. 2017 Jul 1;77(13):3417-3430. doi: 10.1158/0008-5472.CAN-16-1616. Epub 2017 May 4.
|
597 |
Anti-glutamate receptor 2 as a new potential diagnostic probe for prostatic adenocarcinoma: a pilot immunohistochemical study.Appl Immunohistochem Mol Morphol. 2012 Jul;20(4):344-9. doi: 10.1097/PAI.0b013e31824013ba.
|
598 |
Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth.J Biol Chem. 2003 Sep 26;278(39):37569-73. doi: 10.1074/jbc.M306276200. Epub 2003 Jul 17.
|
599 |
GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells.Oncotarget. 2016 Jul 19;7(29):45171-45185. doi: 10.18632/oncotarget.9359.
|
600 |
Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins.Anticancer Agents Med Chem. 2018;18(4):565-572. doi: 10.2174/1871520618666180228152713.
|
601 |
Comparison of biological properties of [(177) Lu]Lu-ProBOMB1 and [(177) Lu]Lu-NeoBOMB1 for GRPR targeting.J Labelled Comp Radiopharm. 2020 Feb;63(2):56-64. doi: 10.1002/jlcr.3815. Epub 2020 Jan 11.
|
602 |
Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/-Catenin Pathway and Epithelial-Mesenchymal Transition.Pharmacology. 2019;104(5-6):312-319. doi: 10.1159/000502400. Epub 2019 Sep 3.
|
603 |
Secreted gelsolin desensitizes and induces apoptosis of infiltrated lymphocytes in prostate cancer.Oncotarget. 2017 Aug 23;8(44):77152-77167. doi: 10.18632/oncotarget.20414. eCollection 2017 Sep 29.
|
604 |
Human glutathione S-transferase A2 polymorphisms: variant expression, distribution in prostate cancer cases/controls and a novel form. Pharmacogenetics. 2004 Jan;14(1):35-44.
|
605 |
Enterolactone glucuronide and -glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.AAPS PharmSciTech. 2017 Aug;18(6):2336-2345. doi: 10.1208/s12249-017-0721-5. Epub 2017 Jan 23.
|
606 |
YY1 negatively regulates the XAF1 gene expression in prostate cancer.Biochem Biophys Res Commun. 2019 Jan 15;508(3):973-979. doi: 10.1016/j.bbrc.2018.12.056. Epub 2018 Dec 11.
|
607 |
Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.Cancer Lett. 2020 Mar 31;473:118-129. doi: 10.1016/j.canlet.2019.12.018. Epub 2019 Dec 13.
|
608 |
Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.EMBO Mol Med. 2018 Apr;10(4):e8478. doi: 10.15252/emmm.201708478.
|
609 |
A New Histone Deacetylase Inhibitor, MHY4381, Induces Apoptosis via Generation of Reactive Oxygen Species in Human Prostate Cancer Cells.Biomol Ther (Seoul). 2020 Mar 1;28(2):184-194. doi: 10.4062/biomolther.2019.074.
|
610 |
Zinc and p53 disrupt mitochondrial binding of HK2 by phosphorylating VDAC1.Exp Cell Res. 2019 Jan 1;374(1):249-258. doi: 10.1016/j.yexcr.2018.12.002. Epub 2018 Dec 4.
|
611 |
Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.Oncol Rep. 2016 Jul;36(1):376-82. doi: 10.3892/or.2016.4797. Epub 2016 May 9.
|
612 |
Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.Biosci Rep. 2019 Sep 24;39(9):BSR20190635. doi: 10.1042/BSR20190635. Print 2019 Sep 30.
|
613 |
Glycyrrhizin Attenuates the Process of Epithelial-to-Mesenchymal Transition by Modulating HMGB1 Initiated Novel Signaling Pathway in Prostate Cancer Cells.J Agric Food Chem. 2019 Mar 27;67(12):3323-3332. doi: 10.1021/acs.jafc.9b00251. Epub 2019 Mar 13.
|
614 |
Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer.Curr Med Chem. 2020;27(20):3271-3289. doi: 10.2174/0929867326666190123120338.
|
615 |
Stromal regulation of prostate cancer cell growth by mevalonate pathway enzymes HMGCS1 and HMGCR.Oncol Lett. 2017 Dec;14(6):6533-6542. doi: 10.3892/ol.2017.7025. Epub 2017 Sep 22.
|
616 |
HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.Pathol Res Pract. 2019 Aug;215(8):152464. doi: 10.1016/j.prp.2019.152464. Epub 2019 May 22.
|
617 |
Design of Peptoid-peptide Macrocycles to Inhibit the -catenin TCF Interaction in Prostate Cancer.Nat Commun. 2018 Oct 23;9(1):4396. doi: 10.1038/s41467-018-06845-3.
|
618 |
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.Med Sci Monit. 2019 Jan 7;25:193-239. doi: 10.12659/MSM.912294.
|
619 |
Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells.Mol Cancer Ther. 2017 Dec;16(12):2770-2779. doi: 10.1158/1535-7163.MCT-17-0030. Epub 2017 Jul 20.
|
620 |
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.Br J Cancer. 2008 Feb 26;98(4):792-802. doi: 10.1038/sj.bjc.6604227. Epub 2008 Feb 5.
|
621 |
Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone.Clin Cancer Res. 2011 Sep 15;17(18):5844-9. doi: 10.1158/1078-0432.CCR-11-0644. Epub 2011 Jun 24.
|
622 |
Steroidogenic germline polymorphism predictors of prostate cancer progression in the estradiol pathway.Clin Cancer Res. 2014 Jun 1;20(11):2971-83. doi: 10.1158/1078-0432.CCR-13-2567. Epub 2014 Mar 28.
|
623 |
Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor.J Biol Chem. 2019 May 31;294(22):8699-8710. doi: 10.1074/jbc.RA119.007420. Epub 2019 Apr 16.
|
624 |
GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.BMC Cancer. 2018 Dec 18;18(1):1263. doi: 10.1186/s12885-018-5178-8.
|
625 |
Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells.Br J Cancer. 2007 Oct 8;97(7):941-8. doi: 10.1038/sj.bjc.6603964. Epub 2007 Sep 11.
|
626 |
Hsp-27 and NF-B pathway is associated with AR/AR-V7 expression in prostate cancer cells.Gene. 2019 May 20;697:138-143. doi: 10.1016/j.gene.2019.02.055. Epub 2019 Feb 23.
|
627 |
The Homeobox gene, HOXB13, Regulates a Mitotic Protein-Kinase Interaction Network in Metastatic Prostate Cancers.Sci Rep. 2019 Jul 4;9(1):9715. doi: 10.1038/s41598-019-46064-4.
|
628 |
Microarray-based data mining reveals key genes and potential therapeutic drugs for Cadmium-induced prostate cell malignant transformation.Environ Toxicol Pharmacol. 2019 May;68:141-147. doi: 10.1016/j.etap.2019.03.014. Epub 2019 Mar 15.
|
629 |
Transcriptional activation by NFB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.J Cell Biochem. 2014 Jul;115(7):1322-33. doi: 10.1002/jcb.24788.
|
630 |
TIP30 is associated with progression and metastasis of prostate cancer.Int J Cancer. 2008 Aug 15;123(4):810-6. doi: 10.1002/ijc.23638.
|
631 |
Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression.Clin Cancer Res. 2004 Mar 15;10(6):2044-51. doi: 10.1158/1078-0432.ccr-03-0933.
|
632 |
IFNL4-G Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer.Clin Cancer Res. 2018 Nov 1;24(21):5471-5481. doi: 10.1158/1078-0432.CCR-18-1060. Epub 2018 Jul 16.
|
633 |
Two prostate cancerassociated polymorphisms in the 3'UTR of IGF1R influences prostate cancer susceptibility by affecting miRNA binding.Oncol Rep. 2019 Jan;41(1):512-524. doi: 10.3892/or.2018.6810. Epub 2018 Oct 22.
|
634 |
Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. Br J Cancer. 2005 Apr 25;92(8):1538-44. doi: 10.1038/sj.bjc.6602520.
|
635 |
IGFBP7 promoter methylation and gene expression analysis in prostate cancer.J Urol. 2012 Oct;188(4):1354-60. doi: 10.1016/j.juro.2012.06.002. Epub 2012 Aug 17.
|
636 |
Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells.J Clin Invest. 2013 Apr;123(4):1615-29. doi: 10.1172/JCI59623. Epub 2013 Mar 15.
|
637 |
Circulating monocytes from prostate cancer patients promote invasion and motility of epithelial cells.Cancer Med. 2018 Sep;7(9):4639-4649. doi: 10.1002/cam4.1695. Epub 2018 Aug 9.
|
638 |
Poly(I:C)-Mediated Death of Human Prostate Cancer Cell Lines Is Induced by Interleukin-27 Treatment.J Interferon Cytokine Res. 2019 Aug;39(8):483-494. doi: 10.1089/jir.2018.0166. Epub 2019 Apr 22.
|
639 |
Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer.Transl Oncol. 2019 Mar;12(3):453-461. doi: 10.1016/j.tranon.2018.12.002. Epub 2018 Dec 20.
|
640 |
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.Int J Oncol. 2007 Jan;30(1):193-200.
|
641 |
Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition.Sci Rep. 2019 May 6;9(1):6917. doi: 10.1038/s41598-019-43294-4.
|
642 |
Enhanced expression of IMPDH2 promotes metastasis and advanced tumor progression in patients with prostate cancer.Clin Transl Oncol. 2014 Oct;16(10):906-13. doi: 10.1007/s12094-014-1167-9. Epub 2014 Mar 22.
|
643 |
High-Fat Diet-Induced Inflammation Accelerates Prostate Cancer Growth via IL6 Signaling.Clin Cancer Res. 2018 Sep 1;24(17):4309-4318. doi: 10.1158/1078-0432.CCR-18-0106. Epub 2018 May 18.
|
644 |
ITGB1-dependent upregulation of Caveolin-1 switches TGF signalling from tumour-suppressive to oncogenic in prostate cancer.Sci Rep. 2018 Feb 5;8(1):2338. doi: 10.1038/s41598-018-20161-2.
|
645 |
Tumor metastasis suppressor functions of Ets transcription factor through integrin 3-mediated signaling pathway.J Cell Physiol. 2019 Nov;234(11):20266-20274. doi: 10.1002/jcp.28627. Epub 2019 Apr 14.
|
646 |
PTEN counteracts FBXL2 to promote IP3R3- and Ca(2+)-mediated apoptosis limiting tumour growth.Nature. 2017 Jun 22;546(7659):554-558. doi: 10.1038/nature22965. Epub 2017 Jun 14.
|
647 |
Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.Cancer Genet Cytogenet. 2005 Sep;161(2):97-103. doi: 10.1016/j.cancergencyto.2005.02.006.
|
648 |
Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.Mol Cancer. 2019 Aug 6;18(1):122. doi: 10.1186/s12943-019-1051-x.
|
649 |
p300/CBP-associated factor promotes autophagic degradation of -catenin through acetylation and decreases prostate cancer tumorigenicity.Sci Rep. 2019 Mar 4;9(1):3351. doi: 10.1038/s41598-019-40238-w.
|
650 |
Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue.Cancer. 2001 Dec 15;92(12):2975-84. doi: 10.1002/1097-0142(20011215)92:12<2975::aid-cncr10113>3.0.co;2-k.
|
651 |
Prostate cancer tissues with positive TMPRSS2-ERG-gene-fusion status may display enhanced nerve density.Urol Oncol. 2020 Jan;38(1):3.e7-3.e15. doi: 10.1016/j.urolonc.2018.07.019. Epub 2018 Sep 18.
|
652 |
Role of KCNMA1 in breast cancer.PLoS One. 2012;7(8):e41664. doi: 10.1371/journal.pone.0041664. Epub 2012 Aug 10.
|
653 |
Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry.Oncogene. 2009 Apr 16;28(15):1792-806. doi: 10.1038/onc.2009.25. Epub 2009 Mar 9.
|
654 |
ZNFX1 anti-sense RNA 1 promotes the tumorigenesis of prostate cancer by regulating c-Myc expression via a regulatory network of competing endogenous RNAs.Cell Mol Life Sci. 2020 Mar;77(6):1135-1152. doi: 10.1007/s00018-019-03226-x. Epub 2019 Jul 18.
|
655 |
KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN.Biomed Pharmacother. 2019 Jun;114:108793. doi: 10.1016/j.biopha.2019.108793. Epub 2019 Mar 25.
|
656 |
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2.Oncotarget. 2018 May 4;9(34):23413-23425. doi: 10.18632/oncotarget.25182. eCollection 2018 May 4.
|
657 |
Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer.Int J Cancer. 2018 Dec 1;143(11):2849-2861. doi: 10.1002/ijc.31843. Epub 2018 Oct 9.
|
658 |
Osteopontin And Angiogenic Factors As New Biomarkers Of Prostate Cancer.Urol J. 2019 May 5;16(2):134-140. doi: 10.22037/uj.v0i0.4282.
|
659 |
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer.Nucleic Acids Res. 2019 Jul 9;47(12):6160-6171. doi: 10.1093/nar/gkz344.
|
660 |
Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness.Clin Genitourin Cancer. 2017 Aug;15(4):450-454. doi: 10.1016/j.clgc.2016.10.005. Epub 2016 Oct 19.
|
661 |
Klotho inhibits androgen/androgen receptorassociated epithelialmesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.Oncol Rep. 2018 Jul;40(1):217-225. doi: 10.3892/or.2018.6399. Epub 2018 Apr 25.
|
662 |
Downregulated Krppellike factor4 expression is associated with the aggressiveness of prostate cancer.Oncol Rep. 2019 Mar;41(3):1789-1796. doi: 10.3892/or.2019.6975. Epub 2019 Jan 22.
|
663 |
Identification of potential key genes and high-frequency mutant genes in prostate cancer by using RNA-Seq data.Oncol Lett. 2018 Apr;15(4):4550-4556. doi: 10.3892/ol.2018.7846. Epub 2018 Jan 24.
|
664 |
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men.Prostate. 2020 Jan;80(1):51-56. doi: 10.1002/pros.23916. Epub 2019 Oct 11.
|
665 |
KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone.Biol Chem. 2010 Apr;391(4):467-74. doi: 10.1515/BC.2010.026.
|
666 |
Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.Asian J Androl. 2015 Jan-Feb;17(1):106-10. doi: 10.4103/1008-682X.137613.
|
667 |
Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer.Nat Commun. 2017 Oct 31;8(1):1204. doi: 10.1038/s41467-017-01269-x.
|
668 |
Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.Oncogene. 2019 Jun;38(24):4700-4714. doi: 10.1038/s41388-019-0745-2. Epub 2019 Feb 11.
|
669 |
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.Cancer Discov. 2016 Sep;6(9):1052-67. doi: 10.1158/2159-8290.CD-15-1227. Epub 2016 Jul 17.
|
670 |
Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.J Cell Physiol. 2020 Mar;235(3):2776-2791. doi: 10.1002/jcp.29182. Epub 2019 Sep 23.
|
671 |
MRI-based prostate cancer detection with high-level representation and hierarchical classification.Med Phys. 2017 Mar;44(3):1028-1039. doi: 10.1002/mp.12116.
|
672 |
Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth.Mol Cancer. 2019 Jun 28;18(1):113. doi: 10.1186/s12943-019-1039-6.
|
673 |
Targeting lactate dehydrogenaseA promotes docetaxelinduced cytotoxicity predominantly in castrationresistant prostate cancer cells.Oncol Rep. 2019 Jul;42(1):224-230. doi: 10.3892/or.2019.7171. Epub 2019 May 24.
|
674 |
Interlink between cholesterol & cell cycle in prostate carcinoma.Indian J Med Res. 2017 Nov;146(Suppl):S38-S44. doi: 10.4103/ijmr.IJMR_1639_15.
|
675 |
Endogenous and exogenous galectin-3 promote the adhesion of tumor cells with low expression of MUC1 to HUVECs through upregulation of N-cadherin and CD44.Lab Invest. 2018 Dec;98(12):1642-1656. doi: 10.1038/s41374-018-0119-3. Epub 2018 Aug 31.
|
676 |
SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.Int J Mol Sci. 2017 Apr 12;18(4):808. doi: 10.3390/ijms18040808.
|
677 |
Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition.J Biol Chem. 2017 Sep 15;292(37):15525-15537. doi: 10.1074/jbc.M116.771931. Epub 2017 Aug 2.
|
678 |
Leukemia Inhibitory Factor Promotes Castration-resistant Prostate Cancer and Neuroendocrine Differentiation by Activated ZBTB46.Clin Cancer Res. 2019 Jul 1;25(13):4128-4140. doi: 10.1158/1078-0432.CCR-18-3239. Epub 2019 Apr 8.
|
679 |
Identification of LIMK2 as a therapeutic target in castration resistant prostate cancer.Cancer Lett. 2019 Apr 28;448:182-196. doi: 10.1016/j.canlet.2019.01.035. Epub 2019 Feb 1.
|
680 |
Lin28 induces resistance to anti-androgens via promotion of AR splice variant generation.Prostate. 2016 Apr;76(5):445-55. doi: 10.1002/pros.23134. Epub 2015 Dec 30.
|
681 |
Mice lacking lipid droplet-associated hydrolase, a gene linked to human prostate cancer, have normal cholesterol ester metabolism.J Lipid Res. 2017 Jan;58(1):226-235. doi: 10.1194/jlr.M072538. Epub 2016 Nov 11.
|
682 |
Urinary biomarkers in prostate cancer detection and monitoring progression.Crit Rev Oncol Hematol. 2017 Oct;118:15-26. doi: 10.1016/j.critrevonc.2017.08.002. Epub 2017 Aug 19.
|
683 |
Lysyl oxidase family members in urological tumorigenesis and fibrosis.Oncotarget. 2018 Apr 13;9(28):20156-20164. doi: 10.18632/oncotarget.24948. eCollection 2018 Apr 13.
|
684 |
Inhibition of LOXL2 Enhances the Radiosensitivity of Castration-Resistant Prostate Cancer Cells Associated with the Reversal of the EMT Process.Biomed Res Int. 2019 Jan 27;2019:4012590. doi: 10.1155/2019/4012590. eCollection 2019.
|
685 |
Genetic and epigenetic inactivation of LPL gene in human prostate cancer.Int J Cancer. 2009 Feb 1;124(3):734-8. doi: 10.1002/ijc.23972.
|
686 |
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.J Ovarian Res. 2016 May 14;9(1):27. doi: 10.1186/s13048-016-0239-6.
|
687 |
The Roles of Low-Density Lipoprotein Receptor-Related Proteins 5, 6, and 8 in Cancer: A Review.J Oncol. 2019 Mar 26;2019:4536302. doi: 10.1155/2019/4536302. eCollection 2019.
|
688 |
TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer.EBioMedicine. 2019 Jul;45:192-207. doi: 10.1016/j.ebiom.2019.06.046. Epub 2019 Jun 28.
|
689 |
Down-regulation of Lsm1 is involved in human prostate cancer progression.Br J Cancer. 2002 Mar 18;86(6):940-6. doi: 10.1038/sj.bjc.6600163.
|
690 |
The unexpected role of lymphotoxin beta receptor signaling in carcinogenesis: from lymphoid tissue formation to liver and prostate cancer development.Oncogene. 2010 Sep 9;29(36):5006-18. doi: 10.1038/onc.2010.260. Epub 2010 Jul 5.
|
691 |
Silencing of Lactotransferrin expression by methylation in prostate cancer progression.Cancer Biol Ther. 2007 Jul;6(7):1088-95. doi: 10.4161/cbt.6.7.4327.
|
692 |
Single-Cell Analysis Identifies LY6D as a Marker Linking Castration-Resistant Prostate Luminal Cells to Prostate Progenitors and Cancer.Cell Rep. 2018 Dec 18;25(12):3504-3518.e6. doi: 10.1016/j.celrep.2018.11.069.
|
693 |
Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.BMC Cancer. 2018 Jan 10;18(1):64. doi: 10.1186/s12885-017-3979-9.
|
694 |
Biopsy undergrading in men with Gleason score6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.Int J Urol. 2017 Apr;24(4):281-286. doi: 10.1111/iju.13294. Epub 2017 Feb 7.
|
695 |
Functional interaction between co-expressed MAGE-A proteins.PLoS One. 2017 May 24;12(5):e0178370. doi: 10.1371/journal.pone.0178370. eCollection 2017.
|
696 |
NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene.BMC Cancer. 2011 Aug 2;11:327. doi: 10.1186/1471-2407-11-327.
|
697 |
Expression of cancer/testis antigens in prostate cancer is associated with disease progression.Prostate. 2010 Dec 1;70(16):1778-87. doi: 10.1002/pros.21214.
|
698 |
Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.Prostate. 2019 May;79(6):667-677. doi: 10.1002/pros.23774. Epub 2019 Jan 28.
|
699 |
Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.Oncogene. 2008 May 8;27(21):2978-88. doi: 10.1038/sj.onc.1210963. Epub 2007 Dec 10.
|
700 |
MicroRNA? suppresses human prostate cancer cell viability, invasion and migration via modulation of mitogenactivated protein kinase kinase kinase 3 expression.Mol Med Rep. 2019 May;19(5):4407-4418. doi: 10.3892/mmr.2019.10065. Epub 2019 Mar 21.
|
701 |
Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion.Mod Pathol. 2009 Jul;22(7):866-71. doi: 10.1038/modpathol.2009.57. Epub 2009 Apr 24.
|
702 |
Parallel-Reaction-Monitoring-Based Proteome-Wide Profiling of Differential Kinase Protein Expression during Prostate Cancer Metastasis in Vitro.Anal Chem. 2019 Aug 6;91(15):9893-9900. doi: 10.1021/acs.analchem.9b01561. Epub 2019 Jul 10.
|
703 |
In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.Med Oncol. 2019 Apr 1;36(5):43. doi: 10.1007/s12032-019-1268-y.
|
704 |
Modulation of the response of prostate cancer cell lines to cisplatin treatment using small interfering RNA.Oncol Rep. 2013 Oct;30(4):1936-42. doi: 10.3892/or.2013.2637. Epub 2013 Jul 24.
|
705 |
MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.Oncogene. 2006 May 18;25(21):2987-98. doi: 10.1038/sj.onc.1209337.
|
706 |
Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer.J Clin Med. 2019 Nov 22;8(12):2056. doi: 10.3390/jcm8122056.
|
707 |
Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.Mol Cancer Res. 2019 May;17(5):1049-1062. doi: 10.1158/1541-7786.MCR-18-1220. Epub 2019 Feb 11.
|
708 |
Circular RNA circHIPK3 promotes cell proliferation and invasion of prostate cancer by sponging miR-193a-3p and regulating MCL1 expression.Cancer Manag Res. 2019 Feb 12;11:1415-1423. doi: 10.2147/CMAR.S190669. eCollection 2019.
|
709 |
MeCP2 overexpression inhibits proliferation, migration and invasion of C6 glioma by modulating ERK signaling and gene expression.Neurosci Lett. 2018 May 1;674:42-48. doi: 10.1016/j.neulet.2018.03.020. Epub 2018 Mar 11.
|
710 |
Identification of potential therapeutic targets in prostate cancer through a cross-species approach.EMBO Mol Med. 2018 Mar;10(3):e8274. doi: 10.15252/emmm.201708274.
|
711 |
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.J Cell Biochem. 2017 Apr;118(4):891-902. doi: 10.1002/jcb.25768. Epub 2016 Nov 10.
|
712 |
Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).Med Chem. 2020;16(6):735-749. doi: 10.2174/1573406415666190613162322.
|
713 |
FABP5 coordinates lipid signaling that promotes prostate cancer metastasis.Sci Rep. 2019 Dec 12;9(1):18944. doi: 10.1038/s41598-019-55418-x.
|
714 |
Upregulation of SPOCK2 inhibits the invasion and migration of prostate cancer cells by regulating the MT1-MMP/MMP2 pathway.PeerJ. 2019 Jul 12;7:e7163. doi: 10.7717/peerj.7163. eCollection 2019.
|
715 |
Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression.Carcinogenesis. 2019 Jul 4;40(5):633-642. doi: 10.1093/carcin/bgz058.
|
716 |
RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.Cancer Sci. 2020 Feb;111(2):369-382. doi: 10.1111/cas.14280. Epub 2020 Jan 4.
|
717 |
Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation.Neoplasia. 2018 Sep;20(9):917-929. doi: 10.1016/j.neo.2018.07.003. Epub 2018 Aug 15.
|
718 |
Reduced expression of the DNA glycosylase gene MUTYH is associated with an increased number of somatic mutations via a reduction in the DNA repair capacity in prostate adenocarcinoma.Mol Carcinog. 2017 Feb;56(2):781-788. doi: 10.1002/mc.22509. Epub 2016 Jun 10.
|
719 |
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.Mol Cancer. 2019 Jan 18;18(1):11. doi: 10.1186/s12943-019-0941-2.
|
720 |
Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression.Med Sci Monit. 2018 May 25;24:3462-3471. doi: 10.12659/MSM.908009.
|
721 |
Altered expression of lncRNA NCK1-AS1 distinguished patients with prostate cancer from those with benign prostatic hyperplasia.Oncol Lett. 2019 Dec;18(6):6379-6384. doi: 10.3892/ol.2019.11039. Epub 2019 Nov 1.
|
722 |
Aberrant expression of CITED2 promotes prostate cancer metastasis by activating the nucleolin-AKT pathway.Nat Commun. 2018 Oct 5;9(1):4113. doi: 10.1038/s41467-018-06606-2.
|
723 |
Investigation of the relationship between prostate cancer and MSMB and NCOA4 genetic variants and protein expression.Hum Mutat. 2013 Jan;34(1):149-56. doi: 10.1002/humu.22176. Epub 2012 Oct 4.
|
724 |
HIF-1 induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224.Biochem Biophys Res Commun. 2018 Sep 3;503(1):228-234. doi: 10.1016/j.bbrc.2018.06.007. Epub 2018 Jun 14.
|
725 |
Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN.Oncotarget. 2015 Jun 20;6(17):15137-49. doi: 10.18632/oncotarget.3526.
|
726 |
Gartanin is a novel NEDDylation inhibitor for induction of Skp2 degradation, FBXW2 expression, and autophagy.Mol Carcinog. 2020 Feb;59(2):193-201. doi: 10.1002/mc.23140. Epub 2019 Nov 29.
|
727 |
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.Int J Cancer. 2019 Aug 15;145(4):1055-1067. doi: 10.1002/ijc.32200. Epub 2019 Feb 25.
|
728 |
Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6.Cancer Res. 2017 Feb 1;77(3):753-765. doi: 10.1158/0008-5472.CAN-16-0455. Epub 2016 Nov 29.
|
729 |
p62 as a therapeutic target for inhibition of autophagy in prostate cancer.Prostate. 2018 Apr;78(5):390-400. doi: 10.1002/pros.23483. Epub 2018 Jan 25.
|
730 |
TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.J Clin Invest. 2018 Jul 2;128(7):3129-3143. doi: 10.1172/JCI96060. Epub 2018 Jun 18.
|
731 |
Utility of NKX3.1 Immunostaining in the Detection of Metastatic Prostatic Carcinoma on Fine-Needle Aspiration Smears.Am J Clin Pathol. 2019 Sep 9;152(4):495-501. doi: 10.1093/ajcp/aqz063.
|
732 |
Bloom Syndrome Protein Activates AKT and PRAS40 in Prostate Cancer Cells.Oxid Med Cell Longev. 2019 May 9;2019:3685817. doi: 10.1155/2019/3685817. eCollection 2019.
|
733 |
Notch-4 silencing inhibits prostate cancer growth and EMT via the NF-B pathway.Apoptosis. 2017 Jun;22(6):877-884. doi: 10.1007/s10495-017-1368-0.
|
734 |
Downregulated NOX4 underlies a novel inhibitory role of microRNA-137 in prostate cancer.J Cell Biochem. 2019 Jun;120(6):10215-10227. doi: 10.1002/jcb.28306. Epub 2019 Jan 13.
|
735 |
Identification of the key genes and pathways in prostate cancer.Oncol Lett. 2018 Nov;16(5):6663-6669. doi: 10.3892/ol.2018.9491. Epub 2018 Sep 24.
|
736 |
Aberrant expression of miR-141 and nuclear receptor small heterodimer partner in clinical samples of prostate cancer.Cancer Biomark. 2018;22(1):19-28. doi: 10.3233/CBM-170696.
|
737 |
Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.Oncotarget. 2017 Apr 11;8(15):24362-24371. doi: 10.18632/oncotarget.13848.
|
738 |
Liver X receptor activation inhibits PC-3 prostate cancer cells via the beta-catenin pathway.Pathol Res Pract. 2017 Mar;213(3):267-270. doi: 10.1016/j.prp.2016.04.013. Epub 2016 May 12.
|
739 |
Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer.J Urol. 2020 Apr;203(4):706-712. doi: 10.1097/JU.0000000000000617. Epub 2019 Oct 23.
|
740 |
The Role of Nuclear Receptors in Prostate Cancer.Cells. 2019 Jun 17;8(6):602. doi: 10.3390/cells8060602.
|
741 |
Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer.BMC Cancer. 2016 Mar 31;16:257. doi: 10.1186/s12885-016-2291-4.
|
742 |
Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.Cancer Res. 2018 May 1;78(9):2205-2218. doi: 10.1158/0008-5472.CAN-17-2341. Epub 2018 Feb 8.
|
743 |
Neuropilin-2 is an independent prognostic factor for shorter cancer-specific survival in patients with acinar adenocarcinoma of the prostate.Int J Cancer. 2020 May 1;146(9):2619-2627. doi: 10.1002/ijc.32679. Epub 2019 Oct 16.
|
744 |
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.Cancer Biother Radiopharm. 2018 Jun;33(5):203-211. doi: 10.1089/cbr.2018.2457.
|
745 |
Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity.Exp Cell Res. 2016 Dec 10;349(2):302-309. doi: 10.1016/j.yexcr.2016.10.023. Epub 2016 Nov 1.
|
746 |
Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.BMC Endocr Disord. 2019 Oct 16;19(1):103. doi: 10.1186/s12902-019-0435-7.
|
747 |
STIM1 accelerates cell senescence in a remodeled microenvironment but enhances the epithelial-to-mesenchymal transition in prostate cancer.Sci Rep. 2015 Aug 10;5:11754. doi: 10.1038/srep11754.
|
748 |
Genetic interaction of P2X7 receptor and VEGFR-2 polymorphisms identifies a favorable prognostic profile in prostate cancer patients.Oncotarget. 2015 Oct 6;6(30):28743-54. doi: 10.18632/oncotarget.4926.
|
749 |
Differing leukocyte gene expression profiles associated with fatigue in patients with prostate cancer versus chronic fatigue syndrome.Psychoneuroendocrinology. 2013 Dec;38(12):2983-95. doi: 10.1016/j.psyneuen.2013.08.008. Epub 2013 Sep 6.
|
750 |
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostate.Biochem Biophys Res Commun. 2004 Sep 10;322(1):239-49. doi: 10.1016/j.bbrc.2004.07.106.
|
751 |
Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.Pathol Res Pract. 2017 Nov;213(11):1365-1369. doi: 10.1016/j.prp.2017.09.017. Epub 2017 Sep 18.
|
752 |
Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.Oncotarget. 2017 Apr 4;8(14):22563-22580. doi: 10.18632/oncotarget.15124.
|
753 |
Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma.Mol Carcinog. 2003 Sep;38(1):14-24. doi: 10.1002/mc.10134.
|
754 |
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities.Nucleic Acids Res. 2019 Jun 20;47(11):5634-5647. doi: 10.1093/nar/gkz286.
|
755 |
PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy.Cell Death Dis. 2019 Sep 30;10(10):734. doi: 10.1038/s41419-019-1932-3.
|
756 |
A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer.Oncogene. 2019 Feb;38(7):1136-1150. doi: 10.1038/s41388-018-0501-z. Epub 2018 Sep 20.
|
757 |
New Insights into the Role of Polybromo-1 in Prostate Cancer.Int J Mol Sci. 2019 Jun 12;20(12):2852. doi: 10.3390/ijms20122852.
|
758 |
Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer.Cancers (Basel). 2019 Mar 14;11(3):364. doi: 10.3390/cancers11030364.
|
759 |
Identification and characterization of the novel human prostate cancer-specific PC-1 gene promoter.Biochem Biophys Res Commun. 2007 May 25;357(1):8-13. doi: 10.1016/j.bbrc.2007.02.153. Epub 2007 Mar 7.
|
760 |
Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.Sci Rep. 2019 Feb 14;9(1):2118. doi: 10.1038/s41598-018-37568-6.
|
761 |
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target.J Natl Cancer Inst. 2019 Mar 1;111(3):301-310. doi: 10.1093/jnci/djy141.
|
762 |
Identification of zinc finger protein of the cerebellum 5 as a survival factor of prostate and colorectal cancer cells.Cancer Sci. 2017 Dec;108(12):2405-2412. doi: 10.1111/cas.13419. Epub 2017 Oct 25.
|
763 |
Syndecan-1-dependent suppression of PDK1/Akt/bad signaling by docosahexaenoic acid induces apoptosis in prostate cancer.Neoplasia. 2010 Oct;12(10):826-36. doi: 10.1593/neo.10586.
|
764 |
Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.Neoplasma. 2018;65(2):228-233. doi: 10.4149/neo_2018_170203N72.
|
765 |
Inactivation of the Wnt/-catenin signaling pathway underlies inhibitory role of microRNA-129-5p in epithelial-mesenchymal transition and angiogenesis of prostate cancer by targeting ZIC2.Cancer Cell Int. 2019 Oct 21;19:271. doi: 10.1186/s12935-019-0977-9. eCollection 2019.
|
766 |
Automated 3D-printed unibody immunoarray for chemiluminescence detection of cancer biomarker proteins.Lab Chip. 2017 Jan 31;17(3):484-489. doi: 10.1039/c6lc01238h.
|
767 |
MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.FEBS Open Bio. 2019 Oct;9(10):1798-1807. doi: 10.1002/2211-5463.12718. Epub 2019 Aug 22.
|
768 |
Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts.Int J Mol Sci. 2013 Sep 3;14(9):17958-71. doi: 10.3390/ijms140917958.
|
769 |
c-MYC drives histone demethylase PHF8 during neuroendocrine differentiation and in castration-resistant prostate cancer.Oncotarget. 2016 Nov 15;7(46):75585-75602. doi: 10.18632/oncotarget.12310.
|
770 |
Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.Prostate. 2019 Mar;79(4):370-378. doi: 10.1002/pros.23743. Epub 2018 Nov 28.
|
771 |
Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate Cancer.Pathol Oncol Res. 2019 Jan;25(1):341-348. doi: 10.1007/s12253-017-0353-9. Epub 2017 Nov 9.
|
772 |
Small Molecule Pin1 Inhibitor Blocking NF-B Signaling in Prostate Cancer Cells.Chem Asian J. 2018 Feb 2;13(3):275-279. doi: 10.1002/asia.201701216. Epub 2018 Jan 15.
|
773 |
Mutational analysis of PINX1 in hereditary prostate cancer.Prostate. 2004 Sep 1;60(4):298-302. doi: 10.1002/pros.20075.
|
774 |
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1/pAKT in prostate cancer.Int J Cancer. 2020 Mar 15;146(6):1686-1699. doi: 10.1002/ijc.32607. Epub 2019 Aug 16.
|
775 |
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy.Endocrinology. 2006 Sep;147(9):4245-51. doi: 10.1210/en.2006-0614. Epub 2006 Jun 8.
|
776 |
The protein kinase C super-family member PKN is regulated by mTOR and influences differentiation during prostate cancer progression.Prostate. 2017 Nov;77(15):1452-1467. doi: 10.1002/pros.23400. Epub 2017 Sep 6.
|
777 |
Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.Prostate. 2012 Jul 1;72(10):1140-9. doi: 10.1002/pros.22463. Epub 2011 Nov 29.
|
778 |
AKT and cytosolic phospholipase A2 form a positive loop in prostate cancer cells.Curr Cancer Drug Targets. 2015;15(9):781-91. doi: 10.2174/1568009615666150706103234.
|
779 |
Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.PLoS One. 2016 May 19;11(5):e0155901. doi: 10.1371/journal.pone.0155901. eCollection 2016.
|
780 |
Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth in vitro and in vivo.Oncotarget. 2018 Nov 13;9(89):35983-35996. doi: 10.18632/oncotarget.26316. eCollection 2018 Nov 13.
|
781 |
Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy.J Control Release. 2011 Feb 10;149(3):314-22. doi: 10.1016/j.jconrel.2010.10.030. Epub 2010 Nov 1.
|
782 |
Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.Br J Cancer. 2018 Jan;118(2):189-199. doi: 10.1038/bjc.2017.391. Epub 2017 Nov 14.
|
783 |
Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.Br J Cancer. 2019 Dec;121(12):1016-1026. doi: 10.1038/s41416-019-0610-7. Epub 2019 Nov 1.
|
784 |
Phase 1/2 Dose-Escalation Study of the Use of Intensity Modulated Radiation Therapy to Treat the Prostate and Pelvic Nodes in Patients With Prostate Cancer.Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1234-1242. doi: 10.1016/j.ijrobp.2017.07.041. Epub 2017 Aug 2.
|
785 |
Implication of DNA repair genes in prostate tumourigenesis in Indian males.Indian J Med Res. 2012 Oct;136(4):622-32.
|
786 |
Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer. 2012 Jan 17;106(2):405-13.
|
787 |
Understanding the loss-of-function in a triple missense mutant of DNA polymerase found in prostate cancer.Int J Oncol. 2013 Oct;43(4):1131-40. doi: 10.3892/ijo.2013.2022. Epub 2013 Jul 19.
|
788 |
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome.Clin Genitourin Cancer. 2018 Dec;16(6):e1257-e1265. doi: 10.1016/j.clgc.2018.07.019. Epub 2018 Jul 29.
|
789 |
Induction of apoptosis in prostate cancer by ginsenoside Rh2.Oncotarget. 2018 Jan 27;9(13):11109-11118. doi: 10.18632/oncotarget.24326. eCollection 2018 Feb 16.
|
790 |
Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer?.Int J Mol Med. 2006 Dec;18(6):1169-75.
|
791 |
FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A.Oncogene. 2010 Mar 18;29(11):1691-701. doi: 10.1038/onc.2009.458. Epub 2009 Dec 21.
|
792 |
PPM1A is a RelA phosphatase with tumor suppressor-like activity.Oncogene. 2014 May 29;33(22):2918-27. doi: 10.1038/onc.2013.246. Epub 2013 Jul 1.
|
793 |
Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.Br J Cancer. 2014 Apr 15;110(8):2000-10. doi: 10.1038/bjc.2014.141. Epub 2014 Mar 18.
|
794 |
Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases.Med Sci Monit. 2018 Jul 12;24:4807-4822. doi: 10.12659/MSM.908057.
|
795 |
Antitumor effects of oncolytic adenovirus armed with PSA-IZ-CD40L fusion gene against prostate cancer.Gene Ther. 2014 Aug;21(8):723-31. doi: 10.1038/gt.2014.46. Epub 2014 May 22.
|
796 |
Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.Oncogene. 2009 Aug 13;28(32):2849-59. doi: 10.1038/onc.2009.144. Epub 2009 Jun 1.
|
797 |
Two novel PRKCI polymorphisms and prostate cancer risk in an Eastern Chinese Han population.Mol Carcinog. 2015 Aug;54(8):632-41. doi: 10.1002/mc.22130. Epub 2014 Feb 10.
|
798 |
PKC facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model.Oncogene. 2019 May;38(22):4215-4231. doi: 10.1038/s41388-019-0722-9. Epub 2019 Jan 31.
|
799 |
Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.J Exp Clin Cancer Res. 2019 Mar 6;38(1):114. doi: 10.1186/s13046-019-1118-y.
|
800 |
Low Preoperative Prolactin Levels Predict Non-Organ Confined Prostate Cancer in Clinically Localized Disease.Urol Int. 2019;103(4):391-399. doi: 10.1159/000496833. Epub 2019 Feb 14.
|
801 |
PRMT5 prognostic value in cancer.Oncotarget. 2019 May 7;10(34):3151-3153. doi: 10.18632/oncotarget.26883. eCollection 2019 May 7.
|
802 |
Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer.Clin Cancer Res. 2020 Mar 1;26(5):1054-1064. doi: 10.1158/1078-0432.CCR-19-1659. Epub 2019 Nov 15.
|
803 |
Regulation of prostasin expression and function in the prostate.Prostate. 2004 Apr 1;59(1):1-12. doi: 10.1002/pros.10346.
|
804 |
Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.Cancer Res. 2017 Jun 15;77(12):3144-3150. doi: 10.1158/0008-5472.CAN-16-0708. Epub 2017 Apr 20.
|
805 |
A PSCA/PGRN-NF-B-Integrin-4 Axis Promotes Prostate Cancer Cell Adhesion to Bone Marrow Endothelium and Enhances Metastatic Potential.Mol Cancer Res. 2020 Mar;18(3):501-513. doi: 10.1158/1541-7786.MCR-19-0278. Epub 2019 Nov 13.
|
806 |
Differential expression of the pS2 protein in the human prostate and prostate cancer: association with premalignant changes and neuroendocrine differentiation.Hum Pathol. 1995 Aug;26(8):824-8. doi: 10.1016/0046-8177(95)90002-0.
|
807 |
Transcriptional downregulation of miR-127-3p by CTCF promotes prostate cancer bone metastasis by targeting PSMB5.FEBS Lett. 2020 Feb;594(3):466-476. doi: 10.1002/1873-3468.13624. Epub 2019 Oct 7.
|
808 |
Correlation of Gankyrin oncoprotein overexpression with histopathological grade in prostate cancer.Neoplasma. 2017;64(5):732-737. doi: 10.4149/neo_2017_511.
|
809 |
PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells.Oncotarget. 2017 Feb 21;8(8):13846-13854. doi: 10.18632/oncotarget.14647.
|
810 |
The RNA-binding protein FXR1 modulates prostate cancer progression by regulating FBXO4.Funct Integr Genomics. 2019 May;19(3):487-496. doi: 10.1007/s10142-019-00661-8. Epub 2019 Feb 11.
|
811 |
Synthesis and evaluation of (18)F-labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography.Bioorg Med Chem Lett. 2017 May 15;27(10):2094-2098. doi: 10.1016/j.bmcl.2017.03.078. Epub 2017 Mar 27.
|
812 |
Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b(+)Gr1(+)MDSCs from bone marrow.Biomed Pharmacother. 2020 Jan;121:109581. doi: 10.1016/j.biopha.2019.109581. Epub 2019 Nov 10.
|
813 |
Androgen deprivation-induced ZBTB46-PTGS1 signaling promotes neuroendocrine differentiation of prostate cancer.Cancer Lett. 2019 Jan;440-441:35-46. doi: 10.1016/j.canlet.2018.10.004. Epub 2018 Oct 9.
|
814 |
Piperine depresses the migration progression via downregulating the Akt/mTOR/MMP? signaling pathway in DU145 cells.Mol Med Rep. 2018 May;17(5):6363-6370. doi: 10.3892/mmr.2018.8653. Epub 2018 Feb 28.
|
815 |
Vemurafenib Inhibits Active PTK6 in PTEN-null Prostate Tumor Cells.Mol Cancer Ther. 2019 May;18(5):937-946. doi: 10.1158/1535-7163.MCT-18-0862. Epub 2019 Mar 29.
|
816 |
Analysis of stromal-epithelial interactions in prostate cancer identifies PTPCAAX2 as a potential oncogene.Cancer Lett. 2002 Jan 10;175(1):63-9. doi: 10.1016/s0304-3835(01)00703-0.
|
817 |
Downregulation of protein tyrosine phosphatase PTPL1 alters cell cycle and upregulates invasion-related genes in prostate cancer cells.Clin Exp Metastasis. 2012 Apr;29(4):349-58. doi: 10.1007/s10585-012-9455-7. Epub 2012 Jan 25.
|
818 |
Mechanistic insights into Nav1.7-dependent regulation of rat prostate cancer cell invasiveness revealed by toxin probes and proteomic analysis.FEBS J. 2019 Jul;286(13):2549-2561. doi: 10.1111/febs.14823. Epub 2019 Apr 5.
|
819 |
Prognostic relevance of increased Rac GTPase expression in prostate carcinomas.Endocr Relat Cancer. 2007 Jun;14(2):245-56. doi: 10.1677/ERC-06-0036.
|
820 |
Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.Prostate. 2015 Jul 1;75(10):1051-62. doi: 10.1002/pros.22989. Epub 2015 Mar 23.
|
821 |
RalBP1 is necessary for metastasis of human cancer cell lines. Neoplasia. 2010 Dec;12(12):1003-12.
|
822 |
Gene promoter methylation and cancer: An umbrella review.Gene. 2019 Aug 20;710:333-340. doi: 10.1016/j.gene.2019.06.023. Epub 2019 Jun 13.
|
823 |
The miR-96 and RAR signaling axis governs androgen signaling and prostate cancer progression.Oncogene. 2019 Jan;38(3):421-444. doi: 10.1038/s41388-018-0450-6. Epub 2018 Aug 17.
|
824 |
Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes.Sci Rep. 2016 Apr 22;6:24922. doi: 10.1038/srep24922.
|
825 |
Hedgehog-interacting protein is highly expressed in endothelial cells but down-regulated during angiogenesis and in several human tumors.BMC Cancer. 2004 Aug 4;4:43. doi: 10.1186/1471-2407-4-43.
|
826 |
RGS12 Is a Novel Tumor-Suppressor Gene in African American Prostate Cancer That Represses AKT and MNX1 Expression. Cancer Res. 2017 Aug 15;77(16):4247-4257.
|
827 |
Analysis of regulator of G-protein signalling 2 (RGS2) expression and function during prostate cancer progression.Sci Rep. 2018 Nov 22;8(1):17259. doi: 10.1038/s41598-018-35332-4.
|
828 |
RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy.Oncotarget. 2017 Jan 24;8(4):5774-5788. doi: 10.18632/oncotarget.14391.
|
829 |
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer.Urol Oncol. 2005 Nov-Dec;23(6):407-12. doi: 10.1016/j.urolonc.2005.04.002.
|
830 |
RNF7 knockdown inhibits prostate cancer tumorigenesis by inactivation of ERK1/2 pathway.Sci Rep. 2017 Mar 2;7:43683. doi: 10.1038/srep43683.
|
831 |
ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.Int J Cancer. 2014 Dec 1;135(11):2493-506. doi: 10.1002/ijc.28919. Epub 2014 Apr 29.
|
832 |
Robo 4 - the double-edged sword in prostate cancer: impact on cancer cell aggressiveness and tumor vasculature.Int J Med Sci. 2019 Jan 1;16(1):115-124. doi: 10.7150/ijms.28735. eCollection 2019.
|
833 |
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase.Oncogene. 2010 Apr 8;29(14):2036-46. doi: 10.1038/onc.2009.496. Epub 2010 Jan 18.
|
834 |
Association study of Retinoic Acid Related Orphan Receptor A (RORA) gene and risk of prostate disorders.Urol J. 2019 May 5;16(2):141-144. doi: 10.22037/uj.v0i0.4373.
|
835 |
High RSF1 protein expression is an independent prognostic feature in prostate cancer.Acta Oncol. 2020 Mar;59(3):268-273. doi: 10.1080/0284186X.2019.1686537. Epub 2019 Nov 5.
|
836 |
RSPO3 is a prognostic biomarker and mediator of invasiveness in prostate cancer.J Transl Med. 2019 Apr 15;17(1):125. doi: 10.1186/s12967-019-1878-3.
|
837 |
Cell fate regulation by reticulon-4 in human prostate cancers.J Cell Physiol. 2019 Jul;234(7):10372-10385. doi: 10.1002/jcp.27704. Epub 2018 Nov 27.
|
838 |
Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):383-90.
|
839 |
Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.Prostate. 2005 Dec 1;65(4):322-30. doi: 10.1002/pros.20302.
|
840 |
Loss of Sun2 promotes the progression of prostate cancer by regulating fatty acid oxidation.Oncotarget. 2017 Jul 12;8(52):89620-89630. doi: 10.18632/oncotarget.19210. eCollection 2017 Oct 27.
|
841 |
Expression profiles of voltage-gated Na(+) channel alpha-subunit genes in rat and human prostate cancer cell lines.Prostate. 2001 Aug 1;48(3):165-78. doi: 10.1002/pros.1095.
|
842 |
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.Prostate Cancer Prostatic Dis. 2019 Dec;22(4):569-579. doi: 10.1038/s41391-019-0128-3. Epub 2019 Mar 20.
|
843 |
Aberrant presentation of HPA-reactive carbohydrates implies Selectin-independent metastasis formation in human prostate cancer.Clin Cancer Res. 2014 Apr 1;20(7):1791-802. doi: 10.1158/1078-0432.CCR-13-2308. Epub 2014 Feb 13.
|
844 |
Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma.Int J Mol Med. 2015 May;35(5):1374-80. doi: 10.3892/ijmm.2015.2142. Epub 2015 Mar 17.
|
845 |
Proteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.Electrophoresis. 2017 Oct;38(20):2638-2645. doi: 10.1002/elps.201700052. Epub 2017 Jul 10.
|
846 |
Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.Clin Cancer Res. 2002 May;8(5):1172-7.
|
847 |
Decreased expression of serine protease inhibitor family G1 (SERPING1) in prostate cancer can help distinguish high-risk prostate cancer and predicts malignant progression.Urol Oncol. 2018 Aug;36(8):366.e1-366.e9. doi: 10.1016/j.urolonc.2018.05.021. Epub 2018 Jun 19.
|
848 |
Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer Cells.Mol Nutr Food Res. 2018 Sep;62(18):e1700840. doi: 10.1002/mnfr.201700840. Epub 2018 Mar 6.
|
849 |
Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer.Transl Res. 2019 Oct;212:89-103. doi: 10.1016/j.trsl.2019.07.001. Epub 2019 Jul 9.
|
850 |
SFRP4 gene expression is increased in aggressive prostate cancer.Sci Rep. 2017 Oct 27;7(1):14276. doi: 10.1038/s41598-017-14622-3.
|
851 |
Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells.Front Oncol. 2019 Jul 11;9:565. doi: 10.3389/fonc.2019.00565. eCollection 2019.
|
852 |
Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.Onco Targets Ther. 2019 Feb 8;12:1111-1118. doi: 10.2147/OTT.S191157. eCollection 2019.
|
853 |
Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.Sci Rep. 2015 Nov 19;5:16974. doi: 10.1038/srep16974.
|
854 |
Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment.Carbohydr Polym. 2020 Feb 1;229:115498. doi: 10.1016/j.carbpol.2019.115498. Epub 2019 Oct 21.
|
855 |
SIRT1 Modulates the Sensitivity of Prostate Cancer Cells to Vesicular Stomatitis Virus Oncolysis.J Virol. 2019 Jul 17;93(15):e00626-19. doi: 10.1128/JVI.00626-19. Print 2019 Aug 1.
|
856 |
Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes.BMC Cancer. 2017 Dec 20;17(1):874. doi: 10.1186/s12885-017-3853-9.
|
857 |
SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/-catenin pathway.Exp Cell Res. 2018 Mar 15;364(2):143-151. doi: 10.1016/j.yexcr.2018.01.036. Epub 2018 Feb 6.
|
858 |
High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells.Sci Rep. 2019 Apr 5;9(1):5695. doi: 10.1038/s41598-019-42131-y.
|
859 |
MCT4 promotes cell proliferation and invasion of castration-resistant prostate cancer PC-3 cell line.EXCLI J. 2019 Mar 21;18:187-194. doi: 10.17179/excli2018-1879. eCollection 2019.
|
860 |
Circular RNA Expression Profiling Identifies Prostate Cancer- Specific circRNAs in Prostate Cancer.Cell Physiol Biochem. 2018;50(5):1903-1915. doi: 10.1159/000494870. Epub 2018 Nov 5.
|
861 |
Correlation between (18)F-1-amino-3-fluorocyclobutane-1-carboxylic acid ((18)F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer.EJNMMI Res. 2019 May 31;9(1):50. doi: 10.1186/s13550-019-0518-5.
|
862 |
Protein expression information of prostate infection based on data mining.J Infect Public Health. 2020 Oct;13(10):1533-1536. doi: 10.1016/j.jiph.2019.07.019. Epub 2019 Aug 14.
|
863 |
Pharmacology and new perspectives of angiotensin II receptor blocker in prostate cancer treatment.Int J Urol. 2008 Jan;15(1):19-26. doi: 10.1111/j.1442-2042.2007.01937.x.
|
864 |
Polymorphisms in XPC gene and risk for prostate cancer.Mol Biol Rep. 2019 Feb;46(1):1117-1125. doi: 10.1007/s11033-018-4572-2. Epub 2018 Dec 14.
|
865 |
Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.Prostate. 2005 Aug 1;64(3):246-52. doi: 10.1002/pros.20241.
|
866 |
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer.Mol Cancer Ther. 2016 Nov;15(11):2679-2687. doi: 10.1158/1535-7163.MCT-16-0225. Epub 2016 Aug 22.
|
867 |
Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.Gene Ther. 2016 Apr;23(4):357-68. doi: 10.1038/gt.2016.5. Epub 2016 Jan 27.
|
868 |
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.Int J Clin Oncol. 2017 Dec;22(6):1087-1093. doi: 10.1007/s10147-017-1160-8. Epub 2017 Jul 5.
|
869 |
Extracellular redox state shift: A novel approach to target prostate cancer invasion.Free Radic Biol Med. 2018 Mar;117:99-109. doi: 10.1016/j.freeradbiomed.2018.01.023. Epub 2018 Feb 2.
|
870 |
SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.Clin Epigenetics. 2019 Jul 9;11(1):99. doi: 10.1186/s13148-019-0693-2.
|
871 |
The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.Oncogene. 2010 Sep 30;29(39):5370-80. doi: 10.1038/onc.2010.269. Epub 2010 Jul 12.
|
872 |
BRG1 is a prognostic indicator and a potential therapeutic target for prostate cancer.J Cell Physiol. 2019 Sep;234(9):15194-15205. doi: 10.1002/jcp.28161. Epub 2019 Jan 22.
|
873 |
Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.BJU Int. 2018 Feb;121(2):194-202. doi: 10.1111/bju.14008. Epub 2017 Sep 22.
|
874 |
miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of SOCS1 in human prostate cancer.BMC Urol. 2018 Mar 5;18(1):14. doi: 10.1186/s12894-018-0325-8.
|
875 |
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior.Appl Immunohistochem Mol Morphol. 2018 May/Jun;26(5):324-329. doi: 10.1097/PAI.0000000000000438.
|
876 |
Sorbitol dehydrogenase expression is regulated by androgens in the human prostate.Oncol Rep. 2010 May;23(5):1233-9. doi: 10.3892/or_00000755.
|
877 |
SOX2 has dual functions as a regulator in the progression of neuroendocrine prostate cancer.Lab Invest. 2020 Apr;100(4):570-582. doi: 10.1038/s41374-019-0343-5. Epub 2019 Nov 26.
|
878 |
Secreted protein acidic and rich in cysteine (SPARC) induces epithelial-mesenchymal transition, enhancing migration and invasion, and is associated with high Gleason score in prostate cancer.Asian J Androl. 2019 Nov-Dec;21(6):557-564. doi: 10.4103/aja.aja_23_19.
|
879 |
Correlation of Sprouty1 and Jagged1 with aggressive prostate cancer cells with different sensitivities to androgen deprivation.J Cell Biochem. 2014 Sep;115(9):1505-15. doi: 10.1002/jcb.24805.
|
880 |
Inverse Regulation of DHT Synthesis Enzymes 5-Reductase Types 1 and 2 by the Androgen Receptor in Prostate Cancer.Endocrinology. 2017 Apr 1;158(4):1015-1021. doi: 10.1210/en.2016-1926.
|
881 |
Boosting Interleukin-12 Antitumor Activity and Synergism with Immunotherapy by Targeted Delivery with isoDGR-Tagged Nanogold.Small. 2019 Nov;15(45):e1903462. doi: 10.1002/smll.201903462. Epub 2019 Sep 16.
|
882 |
Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis.Int J Oncol. 2009 Feb;34(2):425-31.
|
883 |
Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells.Front Pharmacol. 2019 Feb 15;10:28. doi: 10.3389/fphar.2019.00028. eCollection 2019.
|
884 |
Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Prostate. 2017 Nov;77(15):1499-1511. doi: 10.1002/pros.23426. Epub 2017 Sep 14.
|
885 |
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression.Endocr Relat Cancer. 2018 Nov 23;26(2):131-146. doi: 10.1530/ERC-18-0226.
|
886 |
Activation of sphingosine kinase by lipopolysaccharide promotes prostate cancer cell invasion and metastasis via SphK1/S1PR4/matriptase.Oncogene. 2019 Jul;38(28):5580-5598. doi: 10.1038/s41388-019-0833-3. Epub 2019 May 31.
|
887 |
INSPstI polymorphism and prostate cancer in African-American men.Prostate. 2005 Sep 15;65(1):83-7. doi: 10.1002/pros.20271.
|
888 |
Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer.Cancer Sci. 2009 May;100(5):914-9. doi: 10.1111/j.1349-7006.2009.01117.x. Epub 2009 Feb 26.
|
889 |
Inhibition of mouse RM-1 prostate cancer and B16F10 melanoma by the fusion protein of HSP65 & STEAP1 (186-193).Biomed Pharmacother. 2019 Mar;111:1124-1131. doi: 10.1016/j.biopha.2019.01.012. Epub 2019 Jan 12.
|
890 |
STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.Cancer Biol Ther. 2020;21(3):278-291. doi: 10.1080/15384047.2019.1685290. Epub 2019 Nov 7.
|
891 |
Downregulation of NDR1 contributes to metastasis of prostate cancer cells via activating epithelial-mesenchymal transition.Cancer Med. 2018 Jul;7(7):3200-3212. doi: 10.1002/cam4.1532. Epub 2018 May 7.
|
892 |
Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells.Mol Cell Endocrinol. 2001 Sep;182(2):181-92. doi: 10.1016/s0303-7207(01)00560-3.
|
893 |
Mapping the STK4/Hippo signaling network in prostate cancer cell.PLoS One. 2017 Sep 7;12(9):e0184590. doi: 10.1371/journal.pone.0184590. eCollection 2017.
|
894 |
Overexpression of the potential kinase serine/ threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer.Cancer Sci. 2009 Nov;100(11):2109-14. doi: 10.1111/j.1349-7006.2009.01277.x. Epub 2009 Jul 7.
|
895 |
Metformin inhibits SUV39H1-mediated migration of prostate cancer cells.Oncogenesis. 2017 May 1;6(5):e324. doi: 10.1038/oncsis.2017.28.
|
896 |
Overexpression of TACC3 is correlated with tumor aggressiveness and poor prognosis in prostate cancer.Biochem Biophys Res Commun. 2017 May 13;486(4):872-878. doi: 10.1016/j.bbrc.2017.03.090. Epub 2017 Mar 20.
|
897 |
Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.Biochem Biophys Res Commun. 2012 May 25;422(1):146-51. doi: 10.1016/j.bbrc.2012.04.126. Epub 2012 Apr 30.
|
898 |
Emerging immunotherapeutic strategies targeting telomerases in genitourinary tumors.Crit Rev Oncol Hematol. 2018 Nov;131:1-6. doi: 10.1016/j.critrevonc.2018.07.008. Epub 2018 Aug 1.
|
899 |
Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells.Carcinogenesis. 2011 Dec;32(12):1773-81. doi: 10.1093/carcin/bgr212. Epub 2011 Sep 22.
|
900 |
Validation of SE-EPI-based T2 mapping for characterization of prostate cancer: a new method compared with the traditional CPMG method.Abdom Radiol (NY). 2019 Oct;44(10):3432-3440. doi: 10.1007/s00261-019-02105-0.
|
901 |
Ethnic differences in TGF-signaling pathway may contribute to prostate cancer health disparity.Carcinogenesis. 2018 Apr 5;39(4):546-555. doi: 10.1093/carcin/bgy020.
|
902 |
-Tocopherol inhibits human prostate cancer cell proliferation by up-regulation of transglutaminase 2 and down-regulation of cyclins.Amino Acids. 2013 Jan;44(1):45-51. doi: 10.1007/s00726-012-1278-y. Epub 2012 Mar 30.
|
903 |
Detection of Loss of Heterozygosity (LOH) Using Circulating Cell-free DNA (cfDNA) by Fluorescence-based Multiplex PCR for Identification of Patients With Prostate Cancer.Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):749-759. doi: 10.1097/PAI.0000000000000514.
|
904 |
The combination of AroCell TK 210 ELISA with Prostate Health Index or prostate-specific antigen density can improve the ability to differentiate prostate cancer from noncancerous conditions.Prostate. 2019 Jun;79(8):856-863. doi: 10.1002/pros.23791. Epub 2019 Mar 19.
|
905 |
Transketolase like 1 (TKTL1) expression alterations in prostate cancer tumorigenesis.Urol Oncol. 2018 Oct;36(10):472.e21-472.e27. doi: 10.1016/j.urolonc.2018.06.010. Epub 2018 Aug 16.
|
906 |
Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk.Int J Cancer. 2008 Dec 1;123(11):2644-50. doi: 10.1002/ijc.23826.
|
907 |
CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.Clin Cancer Res. 2007 Dec 1;13(23):6947-58. doi: 10.1158/1078-0432.CCR-07-0842.
|
908 |
Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carc... Am J Pathol. 2003 Aug;163(2):543-52.
|
909 |
Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer.J Biol Chem. 2010 Sep 24;285(39):30233-46. doi: 10.1074/jbc.M110.122226. Epub 2010 Mar 30.
|
910 |
Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.Cancer Lett. 2017 Jul 1;397:103-110. doi: 10.1016/j.canlet.2017.03.034. Epub 2017 Mar 31.
|
911 |
Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness.J Transl Med. 2019 Sep 9;17(1):307. doi: 10.1186/s12967-019-2053-6.
|
912 |
Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.Cancer Immunol Res. 2017 Aug;5(8):676-684. doi: 10.1158/2326-6066.CIR-17-0049. Epub 2017 Jul 3.
|
913 |
Mutation of androgen receptor N-terminal phosphorylation site Tyr-267 leads to inhibition of nuclear translocation and DNA binding.PLoS One. 2015 May 7;10(5):e0126270. doi: 10.1371/journal.pone.0126270. eCollection 2015.
|
914 |
Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation.Cancer Lett. 2019 Feb 28;443:80-90. doi: 10.1016/j.canlet.2018.11.013. Epub 2018 Nov 22.
|
915 |
Np63 Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.PLoS One. 2016 Jan 19;11(1):e0147542. doi: 10.1371/journal.pone.0147542. eCollection 2016.
|
916 |
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapy.Nucleic Acids Res. 2020 Feb 20;48(3):1314-1326. doi: 10.1093/nar/gkz1139.
|
917 |
Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.Theranostics. 2019 Feb 7;9(5):1247-1263. doi: 10.7150/thno.29884. eCollection 2019.
|
918 |
TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression.Nat Commun. 2018 Nov 27;9(1):5007. doi: 10.1038/s41467-018-07475-5.
|
919 |
REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells.Oncogene. 2003 May 15;22(19):2920-5. doi: 10.1038/sj.onc.1206397.
|
920 |
Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.PLoS One. 2009 Aug 5;4(8):e6523. doi: 10.1371/journal.pone.0006523.
|
921 |
Transient Receptor Potential Channel Expression Signatures in Tumor-Derived Endothelial Cells: Functional Roles in Prostate Cancer Angiogenesis.Cancers (Basel). 2019 Jul 8;11(7):956. doi: 10.3390/cancers11070956.
|
922 |
Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.J Physiol. 2003 May 1;548(Pt 3):823-36. doi: 10.1113/jphysiol.2002.036772.
|
923 |
TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer.J Cancer Res Clin Oncol. 2019 May;145(5):1297-1311. doi: 10.1007/s00432-019-02898-z. Epub 2019 Mar 19.
|
924 |
TGF-induced epithelial-to-mesenchymal transition in prostate cancer cells is mediated via TRPM7 expression.Mol Carcinog. 2018 Jun;57(6):752-761. doi: 10.1002/mc.22797. Epub 2018 Mar 15.
|
925 |
ADP-Ribose and oxidative stress activate TRPM8 channel in prostate cancer and kidney cells.Sci Rep. 2019 Mar 11;9(1):4100. doi: 10.1038/s41598-018-37552-0.
|
926 |
Natural product-drug conjugates for modulation of TRPV1-expressing tumors.Bioorg Med Chem. 2019 Jun 15;27(12):2531-2536. doi: 10.1016/j.bmc.2019.03.025. Epub 2019 Mar 13.
|
927 |
Structure-Based Discovery of a Subtype-Selective Inhibitor Targeting a Transient Receptor Potential Vanilloid Channel.J Med Chem. 2019 Feb 14;62(3):1373-1384. doi: 10.1021/acs.jmedchem.8b01496. Epub 2019 Jan 16.
|
928 |
Reduction of TSG101 protein has a negative impact on tumor cell growth.Int J Cancer. 2004 Apr 20;109(4):541-7. doi: 10.1002/ijc.20014.
|
929 |
Silencing TTK expression inhibits the proliferation and progression of prostate cancer.Exp Cell Res. 2019 Dec 1;385(1):111669. doi: 10.1016/j.yexcr.2019.111669. Epub 2019 Oct 9.
|
930 |
Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.Prostate. 2019 May;79(6):647-656. doi: 10.1002/pros.23772. Epub 2019 Feb 3.
|
931 |
The Role of Genetic Variants in the Association between Dietary Acrylamide and Advanced Prostate Cancer in the Netherlands Cohort Study on Diet and Cancer.Nutr Cancer. 2018 May-Jun;70(4):620-631. doi: 10.1080/01635581.2018.1460682. Epub 2018 Apr 26.
|
932 |
c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer.Biochem Biophys Res Commun. 2018 Oct 2;504(2):415-421. doi: 10.1016/j.bbrc.2018.08.069. Epub 2018 Aug 10.
|
933 |
Isolation, characterization, and bioactivities of compounds from Fuscoporia torulosa mushroom.J Food Biochem. 2019 Dec;43(12):e13074. doi: 10.1111/jfbc.13074. Epub 2019 Oct 10.
|
934 |
GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.PLoS One. 2013 Apr 24;8(4):e61873. doi: 10.1371/journal.pone.0061873. Print 2013.
|
935 |
N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.Int J Biochem Cell Biol. 2010 Dec;42(12):2037-46. doi: 10.1016/j.biocel.2010.09.008. Epub 2010 Sep 18.
|
936 |
Targeting the signalling pathways regulated by deubiquitinases for prostate cancer therapeutics.Cell Biochem Funct. 2019 Jul;37(5):304-319. doi: 10.1002/cbf.3401. Epub 2019 May 6.
|
937 |
Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.Oncol Res. 2016;24(5):361-369. doi: 10.3727/096504016X14685034103310.
|
938 |
Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.Mol Cell Proteomics. 2018 Jun;17(6):1170-1183. doi: 10.1074/mcp.RA117.000504. Epub 2018 Feb 20.
|
939 |
Polymorphisms of Estrogen Metabolism-Related Genes and Prostate Cancer Risk in Two Populations of African Ancestry.PLoS One. 2016 Apr 13;11(4):e0153609. doi: 10.1371/journal.pone.0153609. eCollection 2016.
|
940 |
Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression.Autophagy. 2017 Mar 4;13(3):506-521. doi: 10.1080/15548627.2016.1268300. Epub 2016 Dec 15.
|
941 |
Association of USP10 with G3BP2 Inhibits p53 Signaling and Contributes to Poor Outcome in Prostate Cancer.Mol Cancer Res. 2018 May;16(5):846-856. doi: 10.1158/1541-7786.MCR-17-0471. Epub 2018 Jan 29.
|
942 |
Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide.J Exp Clin Cancer Res. 2019 May 24;38(1):220. doi: 10.1186/s13046-019-1227-7.
|
943 |
USP44 Promotes the Tumorigenesis of Prostate Cancer Cells through EZH2 Protein Stabilization.Mol Cells. 2019 Jan 31;42(1):17-27. doi: 10.14348/molcells.2018.0329. Epub 2019 Jan 2.
|
944 |
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells.Oncotarget. 2017 May 9;8(19):31815-31829. doi: 10.18632/oncotarget.16463.
|
945 |
Androgen-induced expression of DRP1 regulates mitochondrial metabolic reprogramming in prostate cancer.Cancer Lett. 2020 Feb 28;471:72-87. doi: 10.1016/j.canlet.2019.12.017. Epub 2019 Dec 12.
|
946 |
Urotensin II receptor expression in prostate cancer patients: A new possible marker.Prostate. 2019 Feb;79(3):288-294. doi: 10.1002/pros.23734. Epub 2018 Nov 8.
|
947 |
Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-B/DNMT1 signaling pathway.Prostate. 2018 Jun;78(9):682-690. doi: 10.1002/pros.23512. Epub 2018 Mar 30.
|
948 |
VIP induces NF-B1-nuclear localisation through different signalling pathways in human tumour and non-tumour prostate cells.Cell Signal. 2015 Feb;27(2):236-44. doi: 10.1016/j.cellsig.2014.11.005. Epub 2014 Nov 15.
|
949 |
Overexpression of vasoactive intestinal peptide receptors and cyclooxygenase-2 in human prostate cancer. Analysis of potential prognostic relevance.Histol Histopathol. 2012 Aug;27(8):1093-101. doi: 10.14670/HH-27.1093.
|
950 |
Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.Oncol Rep. 2018 Aug;40(2):1174-1184. doi: 10.3892/or.2018.6503. Epub 2018 Jun 18.
|
951 |
WEE1 epigenetically modulates 5-hmC levels by pY37-H2B dependent regulation of IDH2 gene expression.Oncotarget. 2017 Nov 10;8(63):106352-106368. doi: 10.18632/oncotarget.22374. eCollection 2017 Dec 5.
|
952 |
Validation of the prognostic value of NF-B p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network.PLoS Med. 2019 Jul 2;16(7):e1002847. doi: 10.1371/journal.pmed.1002847. eCollection 2019 Jul.
|
953 |
Wnt5a induces and maintains prostate cancer cells dormancy in bone.J Exp Med. 2019 Feb 4;216(2):428-449. doi: 10.1084/jem.20180661. Epub 2018 Dec 28.
|
954 |
6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage.Oncol Lett. 2019 Dec;18(6):6917-6925. doi: 10.3892/ol.2019.11015. Epub 2019 Oct 29.
|
955 |
Targeting the deubiquitinase STAMBPL1 triggers apoptosis in prostate cancer cells by promoting XIAP degradation.Cancer Lett. 2019 Aug 1;456:49-58. doi: 10.1016/j.canlet.2019.04.020. Epub 2019 Apr 17.
|
956 |
XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.Sci Rep. 2019 Jul 11;9(1):10078. doi: 10.1038/s41598-019-45245-5.
|
957 |
Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.Prostate. 2019 Jun;79(9):1032-1042. doi: 10.1002/pros.23813. Epub 2019 Apr 24.
|
958 |
YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.Pathol Oncol Res. 2020 Apr;26(2):867-876. doi: 10.1007/s12253-019-00634-z. Epub 2019 Mar 11.
|
959 |
MicroRNA-140 inhibit prostate cancer cell invasion and migration by targeting YES proto-oncogene 1.J Cell Biochem. 2020 Jan;121(1):482-488. doi: 10.1002/jcb.29231. Epub 2019 Jul 16.
|
960 |
Early Response Monitoring Following Radiation Therapy by Using [(18)F]FDG and [(11)C]Acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration.Molecules. 2017 Nov 10;22(11):1946. doi: 10.3390/molecules22111946.
|
961 |
Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.Cancer Res. 2016 Apr 1;76(7):1869-81. doi: 10.1158/0008-5472.CAN-15-1911. Epub 2016 Feb 15.
|
962 |
Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.Oncol Rep. 2016 Oct;36(4):2349-56. doi: 10.3892/or.2016.5018. Epub 2016 Aug 11.
|
963 |
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.Oncotarget. 2016 Sep 13;7(37):59589-59603. doi: 10.18632/oncotarget.10729.
|
964 |
Transcriptional regulatory networks in human lung adenocarcinoma.Mol Med Rep. 2012 Nov;6(5):961-6. doi: 10.3892/mmr.2012.1034. Epub 2012 Aug 14.
|
965 |
miRNA-30a functions as a tumor suppressor by downregulating cyclin E2 expression in castration-resistant prostate cancer.Mol Med Rep. 2016 Sep;14(3):2077-84. doi: 10.3892/mmr.2016.5469. Epub 2016 Jul 6.
|
966 |
Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.Oncotarget. 2014 Feb 15;5(3):667-78. doi: 10.18632/oncotarget.1574.
|
967 |
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression.BMC Cancer. 2014 Mar 5;14:154. doi: 10.1186/1471-2407-14-154.
|
968 |
[DTPA-(PABn)-Leu5]-des-acyl ghrelin(1-5) as a new carrier of radionuclides and potential precursor of radiopharmaceuticals.Nucl Med Commun. 2018 Feb;39(2):140-146. doi: 10.1097/MNM.0000000000000790.
|
969 |
Circadian clock genes and risk of fatal prostate cancer.Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12.
|
970 |
Increased diacylglycerol kinase expression in human metastatic colon cancer cells augments Rho GTPase activity and contributes to enhanced invasion.BMC Cancer. 2014 Mar 19;14:208. doi: 10.1186/1471-2407-14-208.
|
971 |
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.Prostate. 2016 Feb 15;76(3):259-72. doi: 10.1002/pros.23120. Epub 2015 Nov 2.
|
972 |
miR-1207-3p regulates the androgen receptor in prostate cancer via FNDC1/fibronectin.Exp Cell Res. 2016 Nov 1;348(2):190-200. doi: 10.1016/j.yexcr.2016.09.021. Epub 2016 Sep 29.
|
973 |
MicroRNA-613 represses prostate cancer cell proliferation and invasion through targeting Frizzled7.Biochem Biophys Res Commun. 2016 Jan 15;469(3):633-8. doi: 10.1016/j.bbrc.2015.12.054. Epub 2015 Dec 15.
|
974 |
Knockdown of GPR137,G Protein-coupled receptor 137, Inhibits the Proliferation and Migration of Human Prostate Cancer Cells.Chem Biol Drug Des. 2016 May;87(5):704-13. doi: 10.1111/cbdd.12704. Epub 2016 Jan 17.
|
975 |
12-HETER1/GPR31, a high-affinity 12(S)-hydroxyeicosatetraenoic acid receptor, is significantly up-regulated in prostate cancer and plays a critical role in prostate cancer progression.FASEB J. 2016 Jun;30(6):2360-9. doi: 10.1096/fj.201500076. Epub 2016 Mar 10.
|
976 |
Lack of expression of preproorexin and orexin receptors genes in human normal and prostate cancer cell lines.Folia Histochem Cytobiol. 2015;53(4):333-41. doi: 10.5603/fhc.a2015.0035.
|
977 |
Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.Int J Cancer. 2015 May 15;136(10):2316-27. doi: 10.1002/ijc.29276. Epub 2014 Nov 8.
|
978 |
Expression of hepatocyte growth factor activator inhibitor-1 (HAI-1) gene in prostate cancer: clinical and biological significance.J BUON. 2014 Jan-Mar;19(1):215-20.
|
979 |
Ultrasound targeted microbubble destruction for novel dual targeting of HSP72 and HSC70 in prostate cancer.Asian Pac J Cancer Prev. 2014;15(3):1285-90. doi: 10.7314/apjcp.2014.15.3.1285.
|
980 |
Regulation of the ITGA2 gene by epigenetic mechanisms in prostate cancer.Prostate. 2015 May;75(7):723-34. doi: 10.1002/pros.22954. Epub 2015 Feb 7.
|
981 |
DNA damage signalling barrier, oxidative stress and treatment-relevant DNA repair factor alterations during progression of human prostate cancer.Mol Oncol. 2016 Jun;10(6):879-94. doi: 10.1016/j.molonc.2016.02.005. Epub 2016 Mar 3.
|
982 |
SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.Oncotarget. 2015 Jan 20;6(2):771-88. doi: 10.18632/oncotarget.2718.
|
983 |
Prostate cancer cell phenotypes based on AGR2 and CD10 expression.Mod Pathol. 2013 Jun;26(6):849-59. doi: 10.1038/modpathol.2012.238. Epub 2013 Jan 25.
|
984 |
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.Oncotarget. 2016 Aug 9;7(32):51284-51300. doi: 10.18632/oncotarget.9992.
|
985 |
Targeting epithelial to mesenchymal transition in prostate cancer by a novel compound, plectranthoic acid, isolated from Ficus microcarpa.Mol Carcinog. 2018 May;57(5):653-663. doi: 10.1002/mc.22790. Epub 2018 Feb 27.
|
986 |
Polymorphisms in NFKB1 and NFKBIA Genes Modulate the Risk of Developing Prostate Cancer among Han Chinese.Med Sci Monit. 2015 Jun 12;21:1707-15. doi: 10.12659/MSM.893471.
|
987 |
Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer.Nat Commun. 2016 Mar 15;7:10982. doi: 10.1038/ncomms10982.
|
988 |
PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.Int Braz J Urol. 2013 Sep-Oct;39(5):649-56. doi: 10.1590/S1677-5538.IBJU.2013.05.06.
|
989 |
Pim-3 is a Critical Risk Factor in Development and Prognosis of Prostate Cancer.Med Sci Monit. 2016 Nov 9;22:4254-4260. doi: 10.12659/msm.898223.
|
990 |
HES6 promotes prostate cancer aggressiveness independently of Notch signalling.J Cell Mol Med. 2015 Jul;19(7):1624-36. doi: 10.1111/jcmm.12537. Epub 2015 Apr 12.
|
991 |
Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.Hum Pathol. 2016 Jan;47(1):109-14. doi: 10.1016/j.humpath.2015.08.021. Epub 2015 Sep 28.
|
992 |
A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone.J Bone Miner Res. 2020 Jan;35(1):155-166. doi: 10.1002/jbmr.3869. Epub 2019 Oct 31.
|
993 |
Uric acid: a modulator of prostate cells and activin sensitivity.Mol Cell Biochem. 2016 Mar;414(1-2):187-99. doi: 10.1007/s11010-016-2671-8. Epub 2016 Feb 24.
|
994 |
Evaluation of PSF1 as a prognostic biomarker for prostate cancer.Prostate Cancer Prostatic Dis. 2015 Mar;18(1):56-62. doi: 10.1038/pcan.2014.46. Epub 2014 Nov 18.
|
995 |
(68)Ga-PSMA I&T PET/CT for primary staging of prostate cancer.Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):168-177. doi: 10.1007/s00259-019-04524-z. Epub 2019 Sep 16.
|
996 |
Expression of the TP and TP isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.Oncotarget. 2016 Nov 8;7(45):73171-73187. doi: 10.18632/oncotarget.12256.
|
997 |
Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.Medicine (Baltimore). 2016 Jul;95(29):e4326. doi: 10.1097/MD.0000000000004326.
|
998 |
AR-regulated TWEAK-FN14 pathway promotes prostate cancer bone metastasis.Cancer Res. 2014 Aug 15;74(16):4306-17. doi: 10.1158/0008-5472.CAN-13-3233. Epub 2014 Jun 26.
|
999 |
Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2 expression to TMPRSS2-ERG fusion status in prostate cancer.Neoplasma. 2014;61(1):9-16.
|
1000 |
Effects of TRPC6 on invasibility of low-differentiated prostate cancer cells.Asian Pac J Trop Med. 2014 Jan;7(1):44-7. doi: 10.1016/S1995-7645(13)60190-X.
|
1001 |
Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.Prostate. 2016 Apr;76(5):479-90. doi: 10.1002/pros.23139. Epub 2015 Dec 28.
|
1002 |
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.Oncotarget. 2015 Aug 28;6(25):21675-84. doi: 10.18632/oncotarget.4328.
|
1003 |
Effects of antisense RNA targeting of ODC and AdoMetDC on the synthesis of polyamine synthesis and cell growth in prostate cancer cells using a prostatic androgen-dependent promoter in adenovirus.Prostate. 2008 Sep 1;68(12):1354-61. doi: 10.1002/pros.20800.
|
1004 |
Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.Urology. 2011 Oct;78(4):971.e1-9. doi: 10.1016/j.urology.2011.04.055. Epub 2011 Jul 29.
|
1005 |
The role of p21 3'UTR gene polymorphism in the risk of prostate cancer: a pilot study.Mol Med Rep. 2013 Mar;7(3):986-90. doi: 10.3892/mmr.2012.1242. Epub 2012 Dec 18.
|
1006 |
Expression of the non-gastric H+/K+ ATPase ATP12A in normal and pathological human prostate tissue.Cell Physiol Biochem. 2011;28(6):1287-94. doi: 10.1159/000335860. Epub 2011 Dec 16.
|
1007 |
Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue.J Cell Biochem. 2012 Feb;113(2):553-62. doi: 10.1002/jcb.23379.
|
1008 |
EGF-activated PI3K/Akt signalling coordinates leucine uptake by regulating LAT3 expression in prostate cancer.Cell Commun Signal. 2019 Jul 25;17(1):83. doi: 10.1186/s12964-019-0400-0.
|
1009 |
Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus.Biochim Biophys Acta. 2004 Apr 16;1678(1):22-32. doi: 10.1016/j.bbaexp.2004.01.007.
|
1010 |
E2F site in the essential promoter region does not confer S phase-specific transcription of the ABCC10 gene in human prostate cancer cells.Acta Biochim Pol. 2017;64(2):371-374. doi: 10.18388/abp.2017_1521. Epub 2017 Jun 13.
|
1011 |
Loss of miR-516a-3p mediates upregulation of ABCC5 in prostate cancer and drives its progression.Onco Targets Ther. 2018 Jul 6;11:3853-3867. doi: 10.2147/OTT.S167463. eCollection 2018.
|
1012 |
Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer.J Formos Med Assoc. 2000 Dec;99(12):885-94.
|
1013 |
Succinate Accumulation Is Associated with a Shift of Mitochondrial Respiratory Control and HIF-1 Upregulation in PTEN Negative Prostate Cancer Cells.Int J Mol Sci. 2018 Jul 21;19(7):2129. doi: 10.3390/ijms19072129.
|
1014 |
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.Prostate. 2005 Jun 15;64(1):29-39. doi: 10.1002/pros.20236.
|
1015 |
Glutamine Transporters Are Targets of Multiple Oncogenic Signaling Pathways in Prostate Cancer.Mol Cancer Res. 2017 Aug;15(8):1017-1028. doi: 10.1158/1541-7786.MCR-16-0480. Epub 2017 May 15.
|
1016 |
Unbiased data mining identifies cell cycle transcripts that predict non-indolent Gleason score 7 prostate cancer.BMC Urol. 2019 Jan 7;19(1):4. doi: 10.1186/s12894-018-0433-5.
|
1017 |
Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.Oncogene. 2017 Oct 26;36(43):6030-6040. doi: 10.1038/onc.2017.216. Epub 2017 Jul 3.
|
1018 |
Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer.Gene. 2018 Jul 30;665:26-34. doi: 10.1016/j.gene.2018.04.086. Epub 2018 Apr 30.
|
1019 |
Regulation of metallothionein and zinc transporter expression in human prostate cancer cells and tissues.Cancer Lett. 2003 Oct 28;200(2):187-95. doi: 10.1016/s0304-3835(03)00441-5.
|
1020 |
Expression of the zinc transporter ZnT4 is decreased in the progression from early prostate disease to invasive prostate cancer.Oncogene. 2003 Sep 4;22(38):6005-12. doi: 10.1038/sj.onc.1206797.
|
1021 |
Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer.J Nucl Med. 2014 Apr;55(4):622-8. doi: 10.2967/jnumed.113.126979. Epub 2014 Mar 17.
|
1022 |
A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer.J Cell Mol Med. 2018 Jul;22(7):3661-3670. doi: 10.1111/jcmm.13649. Epub 2018 Apr 23.
|
1023 |
Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11091-E11100. doi: 10.1073/pnas.1813956115. Epub 2018 Nov 5.
|
1024 |
The role of zinc transporter ZIP4 in prostate carcinoma.Urol Oncol. 2012 Nov-Dec;30(6):906-11. doi: 10.1016/j.urolonc.2010.11.010. Epub 2011 Jul 30.
|
1025 |
Novel mechanism of endocrine disruption by fungicides through binding to the membrane androgen receptor, ZIP9 (SLC39A9), and antagonizing rapid testosterone induction of the intrinsic apoptotic pathway. Steroids. 2019 Sep;149:108415. doi: 10.1016/j.steroids.2019.05.007. Epub 2019 May 30.
|
1026 |
Extramammary Paget Disease of the Scrotum: A Contemporary Clinicopathologic Analysis of 20 Cases in the United States.Appl Immunohistochem Mol Morphol. 2020 Aug;28(7):524-531. doi: 10.1097/PAI.0000000000000789.
|
1027 |
Cross-Kingdom Gene regulation via miRNAs of Hypericum perforatum (St. John's wort) flower dietetically absorbed: An in silico approach to define potential biomarkers for prostate cancer.Comput Biol Chem. 2019 Jun;80:16-22. doi: 10.1016/j.compbiolchem.2019.02.010. Epub 2019 Feb 28.
|
1028 |
Delivery of a TNF--derived peptide by nanoparticles enhances its antitumor activity by inducing cell-cycle arrest and caspase-dependent apoptosis.FASEB J. 2018 Aug 30:fj201800377R. doi: 10.1096/fj.201800377R. Online ahead of print.
|
1029 |
12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.Nat Commun. 2019 Sep 27;10(1):4422. doi: 10.1038/s41467-019-12267-6.
|
1030 |
Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation.Br J Cancer. 2004 Aug 31;91(5):985-94. doi: 10.1038/sj.bjc.6602030.
|
1031 |
Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer.Oncotarget. 2015 Jul 30;6(21):18460-8. doi: 10.18632/oncotarget.3782.
|
1032 |
Genetic markers in carcinoma of the prostate.Eur Urol. 1984;10(5):315-6. doi: 10.1159/000463818.
|
1033 |
Analysis of Zinc-Exporters Expression in Prostate Cancer.Sci Rep. 2016 Nov 11;6:36772. doi: 10.1038/srep36772.
|
1034 |
The UGT1 locus is a determinant of prostate cancer recurrence after prostatectomy.Endocr Relat Cancer. 2015 Feb;22(1):77-85. doi: 10.1530/ERC-14-0423. Epub 2014 Dec 1.
|
1035 |
Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Cancer. 2015 Jun 15;121(12):1949-56. doi: 10.1002/cncr.29320. Epub 2015 Mar 2.
|
1036 |
Searching for candidate genes in familial BRCAX mutation carriers with prostate cancer.Urol Oncol. 2016 Mar;34(3):120.e9-16. doi: 10.1016/j.urolonc.2015.10.009. Epub 2015 Nov 14.
|
1037 |
Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.Prostate. 2007 Sep 15;67(13):1439-46. doi: 10.1002/pros.20630.
|
1038 |
The engineered thymidylate kinase (TMPK)/AZT enzyme-prodrug axis offers efficient bystander cell killing for suicide gene therapy of cancer.PLoS One. 2013 Oct 23;8(10):e78711. doi: 10.1371/journal.pone.0078711. eCollection 2013.
|
1039 |
Xenobiotic-metabolizing gene variants, pesticide use, and the risk of prostate cancer.Pharmacogenet Genomics. 2011 Oct;21(10):615-23. doi: 10.1097/FPC.0b013e3283493a57.
|
1040 |
MicroRNA-135b regulates ER, AR and HIF1AN and affects breast and prostate cancer cell growth.Mol Oncol. 2015 Aug;9(7):1287-300. doi: 10.1016/j.molonc.2015.03.001. Epub 2015 Mar 21.
|
1041 |
A- and D-Ring Structural Modifications of an Androsterone Derivative Inhibiting 17-Hydroxysteroid Dehydrogenase Type 3: Chemical Synthesis and Structure-Activity Relationships.J Med Chem. 2019 Aug 8;62(15):7070-7088. doi: 10.1021/acs.jmedchem.9b00624. Epub 2019 Jul 19.
|
1042 |
Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.J Genet Couns. 2014 Jun;23(3):371-6. doi: 10.1007/s10897-013-9672-5. Epub 2013 Dec 7.
|
1043 |
Differences in urinary proteins related to surgical margin status after radical prostatectomy.Oncol Rep. 2015 Dec;34(6):3247-55. doi: 10.3892/or.2015.4322.
|
1044 |
Circadian genes and risk of prostate cancer: Findings from the EPICAP study.Int J Cancer. 2019 Oct 1;145(7):1745-1753. doi: 10.1002/ijc.32149. Epub 2019 Feb 12.
|
1045 |
SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1.Mol Endocrinol. 2014 Jun;28(6):935-48. doi: 10.1210/me.2013-1339. Epub 2014 Apr 16.
|
1046 |
Lack of association of CYP1A1 polymorphism with prostate cancer susceptibility of Tunisian men.Genet Test Mol Biomarkers. 2012 Jul;16(7):661-6. doi: 10.1089/gtmb.2011.0212. Epub 2012 Feb 3.
|
1047 |
Knockdown of prostaglandin reductase 1 (PTGR1) suppresses prostate cancer cell proliferation by inducing cell cycle arrest and apoptosis.Biosci Trends. 2016 May 23;10(2):133-9. doi: 10.5582/bst.2016.01045. Epub 2016 Apr 30.
|
1048 |
Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models.Prostate. 2012 Oct 1;72(14):1542-9. doi: 10.1002/pros.22509. Epub 2012 Mar 13.
|
1049 |
The Diagnostic Significance of Serum Alcohol Dehydrogenase Isoenzymes and Aldehyde Dehydrogenase Activity in Prostate Cancer Patients.Anticancer Res. 2017 Sep;37(9):4961-4965. doi: 10.21873/anticanres.11906.
|
1050 |
Aberrant promoter CpG methylation is a mechanism for impaired PHD3 expression in a diverse set of malignant cells.PLoS One. 2011 Jan 28;6(1):e14617. doi: 10.1371/journal.pone.0014617.
|
1051 |
Transcriptional regulation of type 11 17beta-hydroxysteroid dehydrogenase expression in prostate cancer cells. Mol Cell Endocrinol. 2011 Jun 6;339(1-2):45-53.
|
1052 |
The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy.Eur Urol. 2012 Jul;62(1):88-96. doi: 10.1016/j.eururo.2011.12.021. Epub 2011 Dec 21.
|
1053 |
The impact of amyloid precursor protein signalling and histone deacetylase inhibition on neprilysin expression in human prostate cells.Int J Cancer. 2012 Feb 15;130(4):775-86. doi: 10.1002/ijc.26028. Epub 2011 Jun 18.
|
1054 |
Improved detection of prostate cancer using a magneto-nanosensor assay for serum circulating autoantibodies.PLoS One. 2019 Aug 12;14(8):e0221051. doi: 10.1371/journal.pone.0221051. eCollection 2019.
|
1055 |
Association of common variations of 8q24 with the risk of prostate cancer in Koreans and a review of the Asian population.BJU Int. 2012 Sep;110(6 Pt B):E318-25. doi: 10.1111/j.1464-410X.2012.11211.x. Epub 2012 May 15.
|
1056 |
A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.Int J Cancer. 2012 Aug 1;131(3):662-72. doi: 10.1002/ijc.26414. Epub 2012 Jan 24.
|
1057 |
Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer.Cancer Res. 2011 Feb 15;71(4):1486-96. doi: 10.1158/0008-5472.CAN-10-1343. Epub 2011 Feb 8.
|
1058 |
Activation of -catenin signaling in androgen receptor-negative prostate cancer cells.Clin Cancer Res. 2012 Feb 1;18(3):726-36. doi: 10.1158/1078-0432.CCR-11-2521.
|
1059 |
Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis.Genomics. 2001 Jun 15;74(3):385-95. doi: 10.1006/geno.2001.6556.
|
1060 |
Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study.Urol Oncol. 2017 Jun;35(6):425-431. doi: 10.1016/j.urolonc.2017.01.005. Epub 2017 Feb 9.
|
1061 |
Involvement of heparin affin regulatory peptide in human prostate cancer.Prostate. 1999 Feb 1;38(2):126-36. doi: 10.1002/(sici)1097-0045(19990201)38:2<126::aid-pros6>3.0.co;2-c.
|
1062 |
ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.Transl Res. 2019 Jan;203:49-56. doi: 10.1016/j.trsl.2018.08.007. Epub 2018 Sep 12.
|
1063 |
Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.Int J Cancer. 2017 Jan 1;140(1):75-85. doi: 10.1002/ijc.30436. Epub 2016 Oct 8.
|
1064 |
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.
|
1065 |
Single Nucleotide Polymorphisms in -Carotene Oxygenase 1 are Associated with Plasma Lycopene Responses to a Tomato-Soy Juice Intervention in Men with Prostate Cancer.J Nutr. 2019 Mar 1;149(3):381-397. doi: 10.1093/jn/nxy304.
|
1066 |
Effective targeting of RNA polymerase I in treatment-resistant prostate cancer.Prostate. 2019 Dec;79(16):1837-1851. doi: 10.1002/pros.23909. Epub 2019 Sep 16.
|
1067 |
Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.Cancer Lett. 1999 Oct 18;145(1-2):93-9. doi: 10.1016/s0304-3835(99)00236-0.
|
1068 |
Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.BMC Cancer. 2009 Feb 26;9:69. doi: 10.1186/1471-2407-9-69.
|
1069 |
Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2019 Jun;28(6):1052-1058. doi: 10.1158/1055-9965.EPI-18-1083. Epub 2019 Mar 13.
|
1070 |
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide.Cancer Treat Rev. 2017 Apr;55:71-82. doi: 10.1016/j.ctrv.2017.03.001. Epub 2017 Mar 9.
|
1071 |
Ligand-binding properties and catalytic activity of the purified human 24-hydroxycholesterol 7-hydroxylase, CYP39A1.J Steroid Biochem Mol Biol. 2019 Oct;193:105416. doi: 10.1016/j.jsbmb.2019.105416. Epub 2019 Jun 24.
|
1072 |
Dicarbonyl/L-xylulose reductase: a potential biomarker identified by laser-capture microdissection-micro serial analysis of gene expression of human prostate adenocarcinoma.Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2615-22. doi: 10.1158/1055-9965.EPI-07-0684.
|
1073 |
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).Angiogenesis. 2018 Feb;21(1):79-94. doi: 10.1007/s10456-017-9587-0. Epub 2017 Nov 17.
|
1074 |
DHRS7 (SDR34C1) - A new player in the regulation of androgen receptor function by inactivation of 5-dihydrotestosterone?.J Steroid Biochem Mol Biol. 2017 Jul;171:288-295. doi: 10.1016/j.jsbmb.2017.04.013. Epub 2017 Apr 27.
|
1075 |
Gossypol inhibits 5-reductase 1 and 3-hydroxysteroid dehydrogenase: Its possible use for the treatment of prostate cancer.Fitoterapia. 2019 Mar;133:102-108. doi: 10.1016/j.fitote.2018.12.024. Epub 2018 Dec 31.
|
1076 |
miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer.Clin Cancer Res. 2014 Dec 15;20(24):6559-69. doi: 10.1158/1078-0432.CCR-14-1784. Epub 2014 Oct 16.
|
1077 |
Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.PLoS One. 2010 Aug 19;5(8):e12275. doi: 10.1371/journal.pone.0012275.
|
1078 |
Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer.Biosci Rep. 2019 Jun 25;39(6):BSR20181826. doi: 10.1042/BSR20181826. Print 2019 Jun 28.
|
1079 |
Glyoxalase 2 Is Involved in Human Prostate Cancer Progression as Part of a Mechanism Driven By PTEN/PI3K/AKT/mTOR Signaling With Involvement of PKM2 and ER.Prostate. 2017 Feb;77(2):196-210. doi: 10.1002/pros.23261. Epub 2016 Oct 3.
|
1080 |
Characterization of prostate cancer cell progression in zebrafish xenograft model.Int J Oncol. 2018 Jan;52(1):252-260. doi: 10.3892/ijo.2017.4189. Epub 2017 Nov 6.
|
1081 |
HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond.Endocrinology. 2019 Sep 1;160(9):2180-2188. doi: 10.1210/en.2019-00366.
|
1082 |
Effect of metallothionein 2A gene polymorphism on allele-specific gene expression and metal content in prostate cancer.Toxicol Appl Pharmacol. 2013 May 1;268(3):278-85. doi: 10.1016/j.taap.2013.02.013. Epub 2013 Mar 4.
|
1083 |
Nicotinamide N-methyltransferase enhances the progression of prostate cancer by stabilizing sirtuin 1.Oncol Lett. 2018 Jun;15(6):9195-9201. doi: 10.3892/ol.2018.8474. Epub 2018 Apr 12.
|
1084 |
A novel gene signature for molecular diagnosis of human prostate cancer by RT-qPCR.PLoS One. 2008;3(10):e3617. doi: 10.1371/journal.pone.0003617. Epub 2008 Oct 31.
|
1085 |
Inherited Variants in SULT1E1 and Response to Abiraterone Acetate by Men with Metastatic Castration Refractory Prostate Cancer.J Urol. 2016 Oct;196(4):1112-6. doi: 10.1016/j.juro.2016.04.079. Epub 2016 May 3.
|
1086 |
JAB1/COPS5 is a putative oncogene that controls critical oncoproteins deregulated in prostate cancer.Biochem Biophys Res Commun. 2019 Oct 15;518(2):374-380. doi: 10.1016/j.bbrc.2019.08.066. Epub 2019 Aug 18.
|
1087 |
Inhibiting Glycine Decarboxylase Suppresses Pyruvate-to-Lactate Metabolism in Lung Cancer Cells.Front Oncol. 2018 Jun 1;8:196. doi: 10.3389/fonc.2018.00196. eCollection 2018.
|
1088 |
Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.Am J Med Sci. 2013 Dec;346(6):447-54. doi: 10.1097/MAJ.0b013e3182882578.
|
1089 |
Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5.BMC Cancer. 2017 Sep 6;17(1):631. doi: 10.1186/s12885-017-3589-6.
|
1090 |
Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.PLoS One. 2015 Aug 3;10(8):e0133449. doi: 10.1371/journal.pone.0133449. eCollection 2015.
|
1091 |
ARP2, a novel pro-apoptotic protein expressed in epithelial prostate cancer LNCaP cells and epithelial ovary CHO transformed cells.PLoS One. 2014 Jan 22;9(1):e86089. doi: 10.1371/journal.pone.0086089. eCollection 2014.
|
1092 |
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.Nat Genet. 2014 Oct;46(10):1103-9. doi: 10.1038/ng.3094. Epub 2014 Sep 14.
|
1093 |
SP1 and RAR regulate AGAP2 expression in cancer.Sci Rep. 2019 Jan 23;9(1):390. doi: 10.1038/s41598-018-36888-x.
|
1094 |
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis.Br J Cancer. 2014 May 13;110(10):2593-603. doi: 10.1038/bjc.2014.201. Epub 2014 Apr 24.
|
1095 |
Tumor-suppressive functions of 15-Lipoxygenase-2 and RB1CC1 in prostate cancer.Cell Cycle. 2014;13(11):1798-810. doi: 10.4161/cc.28757. Epub 2014 Apr 14.
|
1096 |
Mllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers.Gynecol Oncol. 2008 Jan;108(1):141-8. doi: 10.1016/j.ygyno.2007.09.010. Epub 2007 Nov 7.
|
1097 |
D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1.Carcinogenesis. 2007 Jan;28(1):151-62. doi: 10.1093/carcin/bgl144. Epub 2006 Aug 18.
|
1098 |
Genetic variants reflecting higher vitamin e status in men are associated with reduced risk of prostate cancer.J Nutr. 2014 May;144(5):729-33. doi: 10.3945/jn.113.189928. Epub 2014 Mar 12.
|
1099 |
Expression of DNA cytosine deaminase APOBEC3 proteins, a potential source for producing mutations, in gastric, colorectal and prostate cancers.Tumori. 2014 Jul-Aug;100(4):112e-7e. doi: 10.1700/1636.17922.
|
1100 |
BMCC1 is an AP-2 associated endosomal protein in prostate cancer cells.PLoS One. 2013 Sep 6;8(9):e73880. doi: 10.1371/journal.pone.0073880. eCollection 2013.
|
1101 |
RhoGDI downregulates androgen receptor signaling in prostate cancer cells.Prostate. 2013 Nov;73(15):1614-22. doi: 10.1002/pros.22615. Epub 2013 Aug 6.
|
1102 |
Aromatic Hydrocarbon Receptor Suppresses Prostate Cancer Bone Metastasis Cells-Induced Vasculogenesis of Endothelial Progenitor Cells under Hypoxia.Cell Physiol Biochem. 2016;39(2):709-20. doi: 10.1159/000445662. Epub 2016 Jul 25.
|
1103 |
ASEQ: fast allele-specific studies from next-generation sequencing data.BMC Med Genomics. 2015 Mar 1;8:9. doi: 10.1186/s12920-015-0084-2.
|
1104 |
Increased acid ceramidase expression depends on upregulation of androgen-dependent deubiquitinases, USP2, in a human prostate cancer cell line, LNCaP.J Biochem. 2015 Oct;158(4):309-19. doi: 10.1093/jb/mvv039. Epub 2015 Apr 17.
|
1105 |
Tumor necrosis factor-related apoptosis-inducing ligand-mediated activation of mitochondria-associated nuclear factor-kappaB in prostatic carcinoma cell lines.Mol Cancer Res. 2004 Oct;2(10):574-84.
|
1106 |
ATPase family AAA domain containing 3A is an anti-apoptotic factor and a secretion regulator of PSA in prostate cancer.Int J Mol Med. 2011 Jul;28(1):9-15. doi: 10.3892/ijmm.2011.670. Epub 2011 Apr 6.
|
1107 |
Genetic variants in ATP6 and ND3 mitochondrial genes are not associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity.Aging Male. 2016 Sep;19(3):187-191. doi: 10.1080/13685538.2016.1185409. Epub 2016 May 17.
|
1108 |
Silencing of vacuolar ATPase csubunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.Oncol Rep. 2018 Jan;39(1):298-306. doi: 10.3892/or.2017.6092. Epub 2017 Nov 10.
|
1109 |
A novel approach to identify driver genes involved in androgen-independent prostate cancer.Mol Cancer. 2014 May 23;13:120. doi: 10.1186/1476-4598-13-120.
|
1110 |
HIF1 Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.Mol Cancer Res. 2015 Mar;13(3):556-64. doi: 10.1158/1541-7786.MCR-14-0153-T. Epub 2014 Oct 27.
|
1111 |
Revisiting quantitative multi-parametric MRI of benign prostatic hyperplasia and its differentiation from transition zone cancer.Abdom Radiol (NY). 2019 Jun;44(6):2233-2243. doi: 10.1007/s00261-019-01936-1.
|
1112 |
BAG-1 inhibits PPARgamma-induced cell death, but not PPARgamma-induced transcription, cell cycle arrest or differentiation in breast cancer cells.Oncol Rep. 2008 Mar;19(3):689-96.
|
1113 |
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate cancer and inhibits ER-stress induced apoptosis.BMC Cancer. 2013 Mar 1;13:96. doi: 10.1186/1471-2407-13-96.
|
1114 |
BCAS2 promotes prostate cancer cells proliferation by enhancing AR mRNA transcription and protein stability.Br J Cancer. 2015 Jan 20;112(2):391-402. doi: 10.1038/bjc.2014.603. Epub 2014 Dec 2.
|
1115 |
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.Oncogene. 2013 Mar 21;32(12):1601-8. doi: 10.1038/onc.2012.175. Epub 2012 May 14.
|
1116 |
Copy number alterations in prostate tumors and disease aggressiveness.Genes Chromosomes Cancer. 2012 Jan;51(1):66-76. doi: 10.1002/gcc.20932. Epub 2011 Oct 2.
|
1117 |
Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer.Biomed Res Int. 2013;2013:624632. doi: 10.1155/2013/624632. Epub 2013 Jan 31.
|
1118 |
DNA methylation regulates the expression of Y chromosome specific genes in prostate cancer.J Urol. 2002 Jan;167(1):335-8.
|
1119 |
Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.Cancer Res. 2014 Jun 15;74(12):3228-37. doi: 10.1158/0008-5472.CAN-13-2699. Epub 2014 Apr 8.
|
1120 |
Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis.Oncogene. 2012 Jul 5;31(27):3287-97. doi: 10.1038/onc.2011.491. Epub 2011 Oct 24.
|
1121 |
Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score.Med Oncol. 2013 Jun;30(2):526. doi: 10.1007/s12032-013-0526-7. Epub 2013 Mar 9.
|
1122 |
Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer.Prostate. 1999 Sep 15;41(1):31-8. doi: 10.1002/(sici)1097-0045(19990915)41:1<31::aid-pros5>3.0.co;2-p.
|
1123 |
The serine/threonine protein kinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation.Cancer Res. 2005 Apr 15;65(8):3108-16. doi: 10.1158/0008-5472.CAN-04-3151.
|
1124 |
Capping Protein Regulator and Myosin 1 Linker 3 Is Required for Tumor Metastasis.Mol Cancer Res. 2020 Feb;18(2):240-252. doi: 10.1158/1541-7786.MCR-19-0722. Epub 2019 Nov 6.
|
1125 |
Human heterochromatin protein 1 isoforms regulate androgen receptor signaling in prostate cancer.J Mol Endocrinol. 2013 Apr 23;50(3):401-9. doi: 10.1530/JME-13-0024. Print 2013 Jun.
|
1126 |
Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.Prostate. 2019 May;79(6):592-603. doi: 10.1002/pros.23764. Epub 2019 Jan 24.
|
1127 |
Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42-PAK1 axis.J Pathol. 2017 Oct;243(2):208-219. doi: 10.1002/path.4940. Epub 2017 Aug 29.
|
1128 |
CDC6 mRNA Expression Is Associated with the Aggressiveness of Prostate Cancer.J Korean Med Sci. 2018 Nov 2;33(47):e303. doi: 10.3346/jkms.2018.33.e303. eCollection 2018 Nov 19.
|
1129 |
Downregulation of CENPF Remodels Prostate Cancer Cells and Alters Cellular Metabolism.Proteomics. 2019 Jun;19(11):e1900038. doi: 10.1002/pmic.201900038. Epub 2019 May 8.
|
1130 |
FGF-2 disrupts mitotic stability in prostate cancer through the intracellular trafficking protein CEP57.Cancer Res. 2013 Feb 15;73(4):1400-10. doi: 10.1158/0008-5472.CAN-12-1857. Epub 2012 Dec 12.
|
1131 |
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.Oncotarget. 2017 Apr 21;8(34):56051-56065. doi: 10.18632/oncotarget.17359. eCollection 2017 Aug 22.
|
1132 |
Ciz1 promotes tumorigenicity of prostate carcinoma cells.Front Biosci (Landmark Ed). 2015 Jan 1;20(4):705-15. doi: 10.2741/4331.
|
1133 |
Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells.PLoS One. 2014 Jan 31;9(1):e86238. doi: 10.1371/journal.pone.0086238. eCollection 2014.
|
1134 |
PSMA SPECT/CT with (99m)Tc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels.Ann Nucl Med. 2019 Dec;33(12):891-898. doi: 10.1007/s12149-019-01400-6. Epub 2019 Sep 9.
|
1135 |
CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.Clin Transl Oncol. 2015 Aug;17(8):632-9. doi: 10.1007/s12094-015-1288-9. Epub 2015 May 20.
|
1136 |
Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma.Oncotarget. 2017 May 9;8(34):56428-56442. doi: 10.18632/oncotarget.17701. eCollection 2017 Aug 22.
|
1137 |
Reactive stroma component COL6A1 is upregulated in castration-resistant prostate cancer and promotes tumor growth.Oncotarget. 2015 Jun 10;6(16):14488-96. doi: 10.18632/oncotarget.3697.
|
1138 |
Association of primary open-angle glaucoma with mitochondrial variants and haplogroups common in African Americans.Mol Vis. 2016 May 16;22:454-71. eCollection 2016.
|
1139 |
Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.Prostate. 2014 May;74(7):732-42. doi: 10.1002/pros.22793. Epub 2014 Feb 24.
|
1140 |
The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.Oncogene. 2015 Jan 8;34(2):226-36. doi: 10.1038/onc.2013.538. Epub 2014 Jan 20.
|
1141 |
SOST Inhibits Prostate Cancer Invasion.PLoS One. 2015 Nov 6;10(11):e0142058. doi: 10.1371/journal.pone.0142058. eCollection 2015.
|
1142 |
Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.Anticancer Res. 2015 May;35(5):2565-70.
|
1143 |
Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates.BMC Syst Biol. 2008 Dec 5;2:106. doi: 10.1186/1752-0509-2-106.
|
1144 |
Inhibition of cortactin and SIRT1 expression attenuates migration and invasion of prostate cancer DU145 cells.Int J Urol. 2012 Jan;19(1):71-9. doi: 10.1111/j.1442-2042.2011.02888.x. Epub 2011 Nov 3.
|
1145 |
CUL4B promotes prostate cancer progression by forming positive feedback loop with SOX4.Oncogenesis. 2019 Mar 14;8(3):23. doi: 10.1038/s41389-019-0131-5.
|
1146 |
CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and v3 integrin clustering.Oncotarget. 2016 Feb 9;7(6):7343-53. doi: 10.18632/oncotarget.6944.
|
1147 |
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.Prostate Cancer Prostatic Dis. 2013 Dec;16(4):292-300. doi: 10.1038/pcan.2013.21. Epub 2013 Jul 30.
|
1148 |
Transcriptional Repressor DAXX Promotes Prostate Cancer Tumorigenicity via Suppression of Autophagy.J Biol Chem. 2015 Jun 19;290(25):15406-15420. doi: 10.1074/jbc.M115.658765. Epub 2015 Apr 22.
|
1149 |
Construction of a lncRNA-PCG bipartite network and identification of cancer-related lncRNAs: a case study in prostate cancer.Mol Biosyst. 2015 Feb;11(2):384-93. doi: 10.1039/c4mb00439f. Epub 2014 Nov 11.
|
1150 |
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?.Int J Biol Sci. 2014 Jun 1;10(6):576-87. doi: 10.7150/ijbs.8479. eCollection 2014.
|
1151 |
Genome-wide association study of prostate cancer-specific survival.Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1796-800. doi: 10.1158/1055-9965.EPI-15-0543. Epub 2015 Aug 25.
|
1152 |
DLEC1, a 3p tumor suppressor, represses NF-B signaling and is methylated in prostate cancer.J Mol Med (Berl). 2015 Jun;93(6):691-701. doi: 10.1007/s00109-015-1255-5. Epub 2015 Feb 5.
|
1153 |
Loss of Dlg5 expression promotes the migration and invasion of prostate cancer cells via Girdin phosphorylation.Oncogene. 2015 Feb 26;34(9):1141-9. doi: 10.1038/onc.2014.31. Epub 2014 Mar 24.
|
1154 |
Loss of DMBT1 expression in human prostate cancer and its correlation with clinical progressive features.Urology. 2011 Feb;77(2):509.e9-13. doi: 10.1016/j.urology.2010.09.023. Epub 2010 Dec 16.
|
1155 |
Effect of radical prostatectomy on levels of cancer related epitopes in circulating macrophages of patients with clinically localized prostate cancer.Prostate. 2017 Sep;77(12):1251-1258. doi: 10.1002/pros.23384. Epub 2017 Jul 20.
|
1156 |
Exposure to bisphenol A: current levels from food intake are toxic to human cells.Mol Biol Rep. 2019 Apr;46(2):2555-2559. doi: 10.1007/s11033-019-04666-1. Epub 2019 Feb 7.
|
1157 |
Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells.Mol Med Rep. 2014 Dec;10(6):3052-8. doi: 10.3892/mmr.2014.2575. Epub 2014 Sep 18.
|
1158 |
Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration.Clin Cancer Res. 2018 Nov 15;24(22):5622-5634. doi: 10.1158/1078-0432.CCR-18-0420. Epub 2018 Jul 16.
|
1159 |
E2F4 regulates a stable G2 arrest response to genotoxic stress in prostate carcinoma.Oncogene. 2007 Mar 22;26(13):1897-909. doi: 10.1038/sj.onc.1209998. Epub 2006 Oct 9.
|
1160 |
Conditional Deletion of Eaf1 Induces Murine Prostatic Intraepithelial Neoplasia in Mice.Neoplasia. 2019 Aug;21(8):752-764. doi: 10.1016/j.neo.2019.05.005. Epub 2019 Jun 21.
|
1161 |
Decreased expression of EFS is correlated with the advanced prostate cancer.Tumour Biol. 2015 Feb;36(2):799-805. doi: 10.1007/s13277-014-2703-5. Epub 2014 Oct 9.
|
1162 |
Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2 phosphorylation in prostate cancer.Cell Signal. 2015 Apr;27(4):789-97. doi: 10.1016/j.cellsig.2014.12.020. Epub 2015 Jan 7.
|
1163 |
The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer.Med Oncol. 2015 Jul;32(7):518. doi: 10.1007/s12032-015-0518-x. Epub 2015 Jun 3.
|
1164 |
The ternary complex factor protein ELK1 is an independent prognosticator of disease recurrence in prostate cancer.Prostate. 2020 Feb;80(2):198-208. doi: 10.1002/pros.23932. Epub 2019 Dec 3.
|
1165 |
A 12-gene expression signature is associated with aggressive histological in prostate cancer: SEC14L1 and TCEB1 genes are potential markers of progression.Am J Pathol. 2012 Nov;181(5):1585-94. doi: 10.1016/j.ajpath.2012.08.005.
|
1166 |
Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression.J Biol Chem. 2006 Aug 18;281(33):23652-7. doi: 10.1074/jbc.M602930200. Epub 2006 Jun 8.
|
1167 |
The role of serum neuron-specific enolase in patients with prostate cancer: a systematic review of the recent literature.Int J Biol Markers. 2018 Jan;33(1):10-21. doi: 10.5301/ijbm.5000286.
|
1168 |
Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res. 2009 Mar 1;69(5):1877-84. doi: 10.1158/0008-5472.CAN-08-2447. Epub 2009 Feb 17.
|
1169 |
Strong cytoplasmic ETV1 expression has a negative impact on prostate cancer outcome.Virchows Arch. 2019 Oct;475(4):457-466. doi: 10.1007/s00428-019-02573-1. Epub 2019 Apr 23.
|
1170 |
Exonuclease 1 expression is associated with clinical progression, metastasis, and survival prognosis of prostate cancer.J Cell Biochem. 2019 Jul;120(7):11383-11389. doi: 10.1002/jcb.28415. Epub 2019 Feb 18.
|
1171 |
Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients.Arch Toxicol. 2014 Apr;88(4):901-11. doi: 10.1007/s00204-014-1196-8. Epub 2014 Jan 22.
|
1172 |
Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer.Histol Histopathol. 2006 Apr;21(4):415-22. doi: 10.14670/HH-21.415.
|
1173 |
Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain.BMC Cancer. 2014 Nov 20;14:852. doi: 10.1186/1471-2407-14-852.
|
1174 |
Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.Prostate. 2011 Jul;71(10):1115-21. doi: 10.1002/pros.21325. Epub 2011 Jan 12.
|
1175 |
Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer.Sci Rep. 2017 Jul 11;7(1):5124. doi: 10.1038/s41598-017-05209-z.
|
1176 |
Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11miRNA-541androgen receptor (AR)MMP9 signaling.Mol Oncol. 2015 Jan;9(1):44-57. doi: 10.1016/j.molonc.2014.07.013. Epub 2014 Jul 29.
|
1177 |
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.J Clin Invest. 2008 Aug;118(8):2697-710. doi: 10.1172/JCI33093.
|
1178 |
CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.J Urol. 2013 Jan;189(1):329-35. doi: 10.1016/j.juro.2012.08.188. Epub 2012 Nov 20.
|
1179 |
Strong expression of the neuronal transcription factor FOXP2 is linked to an increased risk of early PSA recurrence in ERG fusion-negative cancers.J Clin Pathol. 2013 Jul;66(7):563-8. doi: 10.1136/jclinpath-2012-201335. Epub 2013 Apr 4.
|
1180 |
Human fucosyltransferase 6 enables prostate cancer metastasis to bone.Br J Cancer. 2013 Dec 10;109(12):3014-22. doi: 10.1038/bjc.2013.690. Epub 2013 Oct 31.
|
1181 |
Chromium(VI) promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.Toxicol Lett. 2019 Jan;300:10-17. doi: 10.1016/j.toxlet.2018.10.012. Epub 2018 Oct 10.
|
1182 |
Mechanism of androgen receptor corepression by CKBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.Mol Cell Endocrinol. 2014 Jan 25;382(1):302-313. doi: 10.1016/j.mce.2013.09.036. Epub 2013 Oct 5.
|
1183 |
microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.J Cell Physiol. 2019 Aug;234(8):13182-13190. doi: 10.1002/jcp.27989. Epub 2018 Dec 10.
|
1184 |
GDF-9 promotes the growth of prostate cancer cells by protecting them from apoptosis.J Cell Physiol. 2010 Nov;225(2):529-36. doi: 10.1002/jcp.22235.
|
1185 |
RET Signaling in Prostate Cancer.Clin Cancer Res. 2017 Aug 15;23(16):4885-4896. doi: 10.1158/1078-0432.CCR-17-0528. Epub 2017 May 10.
|
1186 |
Type I gonadotropin-releasing hormone receptor mediates the antiproliferative effects of GnRH-II on prostate cancer cells.J Clin Endocrinol Metab. 2009 May;94(5):1761-7. doi: 10.1210/jc.2008-1741. Epub 2009 Feb 3.
|
1187 |
GOLPH2, a gene downstream of ras signaling, promotes the progression of pancreatic ductal adenocarcinoma.Mol Med Rep. 2018 Mar;17(3):4187-4194. doi: 10.3892/mmr.2018.8430. Epub 2018 Jan 15.
|
1188 |
Expression and functional role of orphan receptor GPR158 in prostate cancer growth and progression.PLoS One. 2015 Feb 18;10(2):e0117758. doi: 10.1371/journal.pone.0117758. eCollection 2015.
|
1189 |
GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.Int J Cancer. 2020 Mar 1;146(5):1369-1382. doi: 10.1002/ijc.32554. Epub 2019 Jul 22.
|
1190 |
Troglitazone inhibits the migration and invasion of PC-3 human prostate cancer cells by upregulating E-cadherin and glutathione peroxidase 3.Oncol Lett. 2018 Oct;16(4):5482-5488. doi: 10.3892/ol.2018.9278. Epub 2018 Aug 8.
|
1191 |
Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation.BMC Cancer. 2016 Aug 2;16:567. doi: 10.1186/s12885-016-2632-3.
|
1192 |
Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells.J Control Release. 2019 Feb 10;295:102-117. doi: 10.1016/j.jconrel.2018.12.034. Epub 2018 Dec 21.
|
1193 |
A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.PLoS Genet. 2014 Nov 20;10(11):e1004809. doi: 10.1371/journal.pgen.1004809. eCollection 2014 Nov.
|
1194 |
HES5 silencing is an early and recurrent change in prostate tumourigenesis.Endocr Relat Cancer. 2015 Apr;22(2):131-44. doi: 10.1530/ERC-14-0454. Epub 2015 Jan 5.
|
1195 |
Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer.Cancer Res. 2005 May 15;65(10):4126-33. doi: 10.1158/0008-5472.CAN-04-4658.
|
1196 |
microRNA-183-3p Inhibits Progression of Human Prostate Cancer by Downregulating High-Mobility Group Nucleosome Binding Domain 5.DNA Cell Biol. 2019 Aug;38(8):840-848. doi: 10.1089/dna.2019.4642. Epub 2019 Jul 17.
|
1197 |
High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer.PLoS One. 2015 Jul 31;10(7):e0134614. doi: 10.1371/journal.pone.0134614. eCollection 2015.
|
1198 |
HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.Oncol Rep. 2015 Sep;34(3):1203-10. doi: 10.3892/or.2015.4085. Epub 2015 Jun 26.
|
1199 |
HOXA10 expression profiling in prostate cancer.Prostate. 2019 Apr;79(5):554-563. doi: 10.1002/pros.23761. Epub 2019 Jan 6.
|
1200 |
Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.Mol Carcinog. 1999 Mar;24(3):160-8. doi: 10.1002/(sici)1098-2744(199903)24:3<160::aid-mc2>3.0.co;2-m.
|
1201 |
Heat-shock factor 2 is a suppressor of prostate cancer invasion.Oncogene. 2016 Apr 7;35(14):1770-84. doi: 10.1038/onc.2015.241. Epub 2015 Jun 29.
|
1202 |
Synergistic effect and VEGF/HSP70-hom haplotype analysis: relationship to prostate cancer risk and clinical outcome.Hum Immunol. 2010 Apr;71(4):377-82. doi: 10.1016/j.humimm.2010.01.017. Epub 2010 Feb 4.
|
1203 |
Androgen receptor-interacting protein HSPBAP1 facilitates growth of prostate cancer cells in androgen-deficient conditions.Int J Cancer. 2015 Jun 1;136(11):2535-45. doi: 10.1002/ijc.29303. Epub 2014 Nov 20.
|
1204 |
Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52.Mol Oncol. 2017 Apr;11(4):337-357. doi: 10.1002/1878-0261.12028. Epub 2017 Mar 2.
|
1205 |
IFI16 in human prostate cancer.Mol Cancer Res. 2007 Mar;5(3):251-9. doi: 10.1158/1541-7786.MCR-06-0269. Epub 2007 Mar 5.
|
1206 |
Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells.Oncotarget. 2015 May 30;6(15):13088-104. doi: 10.18632/oncotarget.3743.
|
1207 |
Differential expression of IL-17RC isoforms in androgen-dependent and androgen-independent prostate cancers.Neoplasia. 2007 Jun;9(6):464-70. doi: 10.1593/neo.07109.
|
1208 |
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.Br J Cancer. 2009 Dec 1;101(11):1891-9. doi: 10.1038/sj.bjc.6605379. Epub 2009 Nov 3.
|
1209 |
Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.Mol Cell Biochem. 2020 Jan;464(1-2):153-167. doi: 10.1007/s11010-019-03657-x. Epub 2019 Nov 27.
|
1210 |
Elevated level of inhibin-alpha subunit is pro-tumourigenic and pro-metastatic and associated with extracapsular spread in advanced prostate cancer.Br J Cancer. 2009 Jun 2;100(11):1784-93. doi: 10.1038/sj.bjc.6605089. Epub 2009 May 12.
|
1211 |
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.Cancer Res. 2014 May 1;74(9):2591-603. doi: 10.1158/0008-5472.CAN-13-1606. Epub 2014 Mar 7.
|
1212 |
IL6 sensitizes prostate cancer to the antiproliferative effect of IFN2 through IRF9.Endocr Relat Cancer. 2013 Aug 23;20(5):677-89. doi: 10.1530/ERC-13-0222. Print 2013 Oct.
|
1213 |
Long noncoding RNA DANCR contributes to docetaxel resistance in prostate cancer through targeting the miR-34a-5p/JAG1 pathway.Onco Targets Ther. 2019 Jul 9;12:5485-5497. doi: 10.2147/OTT.S197009. eCollection 2019.
|
1214 |
Patients with prostate cancer and androgen deprivation therapy have increased risk of fractures-a study from the fractures and fall injuries in the elderly cohort (FRAILCO).Osteoporos Int. 2019 Jan;30(1):115-125. doi: 10.1007/s00198-018-4722-3. Epub 2018 Oct 15.
|
1215 |
Mutational landscape of candidate genes in familial prostate cancer.Prostate. 2014 Oct;74(14):1371-8. doi: 10.1002/pros.22849. Epub 2014 Aug 11.
|
1216 |
KIF3a promotes proliferation and invasion via Wnt signaling in advanced prostate cancer.Mol Cancer Res. 2014 Apr;12(4):491-503. doi: 10.1158/1541-7786.MCR-13-0418. Epub 2014 Jan 10.
|
1217 |
Krppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.Acta Pharmacol Sin. 2013 Feb;34(2):282-8. doi: 10.1038/aps.2012.130. Epub 2012 Oct 1.
|
1218 |
Knockdown of KLK12 inhibits viability and inducesapoptosis in human colorectal cancer HT-29 cell line.Int J Mol Med. 2019 Nov;44(5):1667-1676. doi: 10.3892/ijmm.2019.4327. Epub 2019 Aug 30.
|
1219 |
Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.Urol Oncol. 2013 Jul;31(5):635-43. doi: 10.1016/j.urolonc.2011.05.011. Epub 2011 Jul 8.
|
1220 |
Biochemical characterization of human tissue kallikrein 15 and examination of its potential role in cancer.Clin Biochem. 2018 Aug;58:108-115. doi: 10.1016/j.clinbiochem.2018.06.007. Epub 2018 Jun 18.
|
1221 |
Transcription factor KLLN inhibits tumor growth by AR suppression, induces apoptosis by TP53/TP73 stimulation in prostate carcinomas, and correlates with cellular differentiation.J Clin Endocrinol Metab. 2013 Mar;98(3):E586-94. doi: 10.1210/jc.2012-3490. Epub 2013 Feb 5.
|
1222 |
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.PLoS One. 2015 Jul 13;10(7):e0131307. doi: 10.1371/journal.pone.0131307. eCollection 2015.
|
1223 |
High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.Mol Oncol. 2013 Dec;7(6):1001-11. doi: 10.1016/j.molonc.2013.07.009. Epub 2013 Jul 19.
|
1224 |
A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.EBioMedicine. 2015 Oct 31;2(12):1957-64. doi: 10.1016/j.ebiom.2015.10.028. eCollection 2015 Dec.
|
1225 |
Prostate cancer in Germany among migrants from the Former Soviet Union.Glob Health Action. 2012;5:9135. doi: 10.3402/gha.v5i0.9135. Epub 2012 Jan 2.
|
1226 |
-Mannosidase 2C1 attenuates PTEN function in prostate cancer cells.Nat Commun. 2011;2:307. doi: 10.1038/ncomms1309.
|
1227 |
Genistein treatment duration effects biomarkers of cell motility in human prostate.PLoS One. 2019 Mar 27;14(3):e0214078. doi: 10.1371/journal.pone.0214078. eCollection 2019.
|
1228 |
Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.Int J Oncol. 2000 Dec;17(6):1077-86. doi: 10.3892/ijo.17.6.1077.
|
1229 |
Heme oxygenase-1 in macrophages controls prostate cancer progression.Oncotarget. 2015 Oct 20;6(32):33675-88. doi: 10.18632/oncotarget.5284.
|
1230 |
The Distinct Gene Regulatory Network of Myoglobin in Prostate and Breast Cancer.PLoS One. 2015 Nov 11;10(11):e0142662. doi: 10.1371/journal.pone.0142662. eCollection 2015.
|
1231 |
Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.Biosci Rep. 2008 Dec;28(6):319-26. doi: 10.1042/BSR20080032.
|
1232 |
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.Cancer Res. 2010 Apr 1;70(7):2809-18. doi: 10.1158/0008-5472.CAN-09-4176. Epub 2010 Mar 23.
|
1233 |
MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.Nucleic Acids Res. 2015 May 26;43(10):4893-908. doi: 10.1093/nar/gkv394. Epub 2015 Apr 30.
|
1234 |
Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression.Oncotarget. 2017 Apr 25;8(17):27966-27975. doi: 10.18632/oncotarget.15854.
|
1235 |
MED15 overexpression in prostate cancer arises during androgen deprivation therapy via PI3K/mTOR signaling.Oncotarget. 2017 Jan 31;8(5):7964-7976. doi: 10.18632/oncotarget.13860.
|
1236 |
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.Prostate. 2019 Mar;79(4):414-424. doi: 10.1002/pros.23747. Epub 2018 Dec 17.
|
1237 |
A genetic screen in Drosophila for regulators of human prostate cancer progression.Biochem Biophys Res Commun. 2014 Sep 5;451(4):548-55. doi: 10.1016/j.bbrc.2014.08.015. Epub 2014 Aug 10.
|
1238 |
Mitofusin 1 degradation is induced by a disruptor of mitochondrial calcium homeostasis, CGP37157: a role in apoptosis in prostate cancer cells.Int J Oncol. 2014 May;44(5):1767-73. doi: 10.3892/ijo.2014.2343. Epub 2014 Mar 13.
|
1239 |
Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.Cell Res. 2006 Sep;16(9):750-8. doi: 10.1038/sj.cr.7310089.
|
1240 |
Polymorphisms of DNA repair-related genes with susceptibility and prognosis of prostate cancer.Genet Mol Res. 2014 Jan 24;13(2):4419-24. doi: 10.4238/2014.January.24.20.
|
1241 |
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer.J Urol. 2013 Jul;190(1):102-8. doi: 10.1016/j.juro.2013.01.096. Epub 2013 Feb 1.
|
1242 |
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer.BMC Cancer. 2016 Nov 16;16(1):894. doi: 10.1186/s12885-016-2941-6.
|
1243 |
Association between mismatch repair gene MSH3 codons 1036 and 222 polymorphisms and sporadic prostate cancer in the Iranian population.Asian Pac J Cancer Prev. 2012;13(12):6055-7. doi: 10.7314/apjcp.2012.13.12.6055.
|
1244 |
MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.Clin Exp Metastasis. 2005;22(7):565-73. doi: 10.1007/s10585-005-5376-z. Epub 2006 Feb 11.
|
1245 |
Knockdown of myosin VI by lentivirus-mediated short hairpin RNA suppresses proliferation of melanoma.Mol Med Rep. 2015 Nov;12(5):6801-6. doi: 10.3892/mmr.2015.4261. Epub 2015 Aug 28.
|
1246 |
Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer.Med Oncol. 2014 Jan;31(1):820. doi: 10.1007/s12032-013-0820-4. Epub 2013 Dec 14.
|
1247 |
Two susceptibility loci identified for prostate cancer aggressiveness.Nat Commun. 2015 May 5;6:6889. doi: 10.1038/ncomms7889.
|
1248 |
Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy.Eur Urol. 2007 Mar;51(3):665-74; discussion 674. doi: 10.1016/j.eururo.2006.08.008. Epub 2006 Aug 23.
|
1249 |
Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55.Oncogene. 2008 Nov 20;27(54):6791-805. doi: 10.1038/onc.2008.291. Epub 2008 Sep 1.
|
1250 |
The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.Pathobiology. 2013;80(2):60-9. doi: 10.1159/000341396. Epub 2012 Aug 29.
|
1251 |
Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.Biochem Biophys Res Commun. 2012 Jul 6;423(3):564-70. doi: 10.1016/j.bbrc.2012.06.005. Epub 2012 Jun 10.
|
1252 |
The mitotic regulator Hec1 is a critical modulator of prostate cancer through the long non-coding RNA BX647187 invitro.Biosci Rep. 2015 Nov 26;35(6):e00273. doi: 10.1042/BSR20150003. Print 2015.
|
1253 |
A transductionally retargeted adenoviral vector for virotherapy of Her2/neu-expressing prostate cancer.Hum Gene Ther. 2012 Jan;23(1):70-82. doi: 10.1089/hum.2011.016. Epub 2011 Oct 12.
|
1254 |
Plasma membrane-associated sialidase (NEU3) regulates progression of prostate cancer to androgen-independent growth through modulation of androgen receptor signaling.Cell Death Differ. 2012 Jan;19(1):170-9. doi: 10.1038/cdd.2011.83. Epub 2011 Jun 17.
|
1255 |
Impact of cancer service centralisation on the radical treatment of men with high-risk and locally advanced prostate cancer: A national cross-sectional analysis in England.Int J Cancer. 2019 Jul 1;145(1):40-48. doi: 10.1002/ijc.32068. Epub 2019 Jan 17.
|
1256 |
Androgen-Induced TMPRSS2 Activates Matriptase and Promotes Extracellular Matrix Degradation, Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis.Cancer Res. 2015 Jul 15;75(14):2949-60. doi: 10.1158/0008-5472.CAN-14-3297. Epub 2015 May 27.
|
1257 |
NADPH oxidase 5 (NOX5)-induced reactive oxygen signaling modulates normoxic HIF-1 and p27(Kip1) expression in malignant melanoma and other human tumors.Mol Carcinog. 2017 Dec;56(12):2643-2662. doi: 10.1002/mc.22708. Epub 2017 Aug 30.
|
1258 |
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.Br J Cancer. 2004 Jan 26;90(2):510-4. doi: 10.1038/sj.bjc.6601417.
|
1259 |
Com-1/p8 acts as a putative tumour suppressor in prostate cancer.Int J Mol Med. 2006 Nov;18(5):981-6.
|
1260 |
The NLR-related protein NWD1 is associated with prostate cancer and modulates androgen receptor signaling.Oncotarget. 2014 Mar 30;5(6):1666-82. doi: 10.18632/oncotarget.1850.
|
1261 |
Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.PLoS One. 2012;7(12):e51680. doi: 10.1371/journal.pone.0051680. Epub 2012 Dec 14.
|
1262 |
Overexpression of oxidored-nitro domain containing protein 1 induces growth inhibition and apoptosis in human prostate cancer PC3 cells.Oncol Rep. 2014 Nov;32(5):1939-46. doi: 10.3892/or.2014.3407. Epub 2014 Aug 14.
|
1263 |
Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors.Neoplasia. 2015 Dec;17(12):871-881. doi: 10.1016/j.neo.2015.11.007.
|
1264 |
Surface functionalized folate targeted oleuropein nano-liposomes for prostate tumor targeting: Invitro and invivo activity.Life Sci. 2019 Mar 1;220:136-146. doi: 10.1016/j.lfs.2019.01.053. Epub 2019 Jan 31.
|
1265 |
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.Cancer Res. 2000 Oct 1;60(19):5522-8.
|
1266 |
Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.J Biol Chem. 2019 Mar 22;294(12):4572-4582. doi: 10.1074/jbc.RA118.006057. Epub 2019 Feb 4.
|
1267 |
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer.Mol Cancer. 2011 May 6;10:50. doi: 10.1186/1476-4598-10-50.
|
1268 |
Aberrant methylation of protocadherin 17 and its clinical significance in patients with prostate cancer after radical prostatectomy.Med Sci Monit. 2014 Aug 5;20:1376-82. doi: 10.12659/MSM.891247.
|
1269 |
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):278-289. doi: 10.1080/21691401.2018.1553783.
|
1270 |
Cisplatin in combination with programmed cell death protein5 increases antitumor activity in prostate cancer cells by promoting apoptosis.Mol Med Rep. 2015 Jun;11(6):4561-6. doi: 10.3892/mmr.2015.3252. Epub 2015 Jan 26.
|
1271 |
NF-kappaB activation stimulates transcription and replication of retrovirus XMRV in human B-lineage and prostate carcinoma cells.J Virol. 2011 Apr;85(7):3179-86. doi: 10.1128/JVI.02333-10. Epub 2011 Jan 26.
|
1272 |
Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells.J Pineal Res. 2010 Aug;49(1):60-8. doi: 10.1111/j.1600-079X.2010.00767.x. Epub 2010 May 27.
|
1273 |
Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.Cancer Discov. 2012 Apr;2(4):328-43. doi: 10.1158/2159-8290.CD-11-0234. Epub 2012 Mar 22.
|
1274 |
Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis.Cancer Chemother Pharmacol. 2017 May;79(5):985-994. doi: 10.1007/s00280-017-3301-1. Epub 2017 Apr 8.
|
1275 |
PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt/-catenin signaling pathway.J Exp Clin Cancer Res. 2017 Jun 23;36(1):85. doi: 10.1186/s13046-017-0560-y.
|
1276 |
A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1599-610. doi: 10.1158/1055-9965.EPI-11-0312. Epub 2011 Jun 29.
|
1277 |
CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor.Oncogene. 2014 Jan 23;33(4):504-13. doi: 10.1038/onc.2012.602. Epub 2013 Jan 14.
|
1278 |
Systematic enrichment analysis of potentially functional regions for 103 prostate cancer risk-associated loci.Prostate. 2015 Sep;75(12):1264-76. doi: 10.1002/pros.23008. Epub 2015 May 25.
|
1279 |
TGF- cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy.J Cell Mol Med. 2014 Apr;18(4):555-67. doi: 10.1111/jcmm.12266. Epub 2014 Mar 15.
|
1280 |
Pathway specific gene expression profiling reveals oxidative stress genes potentially regulated by transcription co-activator LEDGF/p75 in prostate cancer cells.Prostate. 2012 May 1;72(6):597-611. doi: 10.1002/pros.21463. Epub 2011 Jul 27.
|
1281 |
Protein kinase A type II- regulatory subunit regulates the response of prostate cancer cells to taxane treatment.Cell Cycle. 2014;13(20):3292-301. doi: 10.4161/15384101.2014.949501.
|
1282 |
Prosaposin is an AR-target gene and its neurotrophic domain upregulates AR expression and activity in prostate stromal cells.J Cell Biochem. 2008 Aug 15;104(6):2272-85. doi: 10.1002/jcb.21786.
|
1283 |
Inhibition on Proteasome 1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.PLoS One. 2015 Oct 29;10(10):e0141681. doi: 10.1371/journal.pone.0141681. eCollection 2015.
|
1284 |
The role of prostate tumor overexpressed 1 in cancer progression.Oncotarget. 2017 Feb 14;8(7):12451-12471. doi: 10.18632/oncotarget.14104.
|
1285 |
Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins.Prostate. 2011 Dec;71(16):1810-7. doi: 10.1002/pros.21398. Epub 2011 Apr 7.
|
1286 |
Receptor-like protein tyrosine phosphatase negatively regulates the apoptosis of prostate cancer cells via the JNK pathway.Int J Oncol. 2013 Nov;43(5):1560-8. doi: 10.3892/ijo.2013.2082. Epub 2013 Aug 29.
|
1287 |
The tumor suppressing effects of QKI-5 in prostate cancer: a novel diagnostic and prognostic protein.Cancer Biol Ther. 2014 Jan;15(1):108-18. doi: 10.4161/cbt.26722. Epub 2013 Oct 23.
|
1288 |
RAB27A, RAB27B and VPS36 are downregulated in advanced prostate cancer and show functional relevance in prostate cancer cells.Int J Oncol. 2017 Mar;50(3):920-932. doi: 10.3892/ijo.2017.3872. Epub 2017 Feb 10.
|
1289 |
Intracellular oxygen determined by respiration regulates localization of Ras and prenylated proteins.Cell Death Dis. 2015 Jul 16;6(7):e1825. doi: 10.1038/cddis.2015.64.
|
1290 |
TCEB1 promotes invasion of prostate cancer cells.Int J Cancer. 2009 Jan 1;124(1):95-102. doi: 10.1002/ijc.23916.
|
1291 |
Multiple roles of RARRES1 in prostate cancer: Autophagy induction and angiogenesis inhibition.PLoS One. 2017 Jul 5;12(7):e0180344. doi: 10.1371/journal.pone.0180344. eCollection 2017.
|
1292 |
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.BMC Cancer. 2016 Feb 29;16:170. doi: 10.1186/s12885-016-2209-1.
|
1293 |
Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays.Genet Test Mol Biomarkers. 2013 Nov;17(11):807-13. doi: 10.1089/gtmb.2013.0226. Epub 2013 Aug 28.
|
1294 |
EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.Int J Cancer. 2005 Feb 10;113(4):561-7. doi: 10.1002/ijc.20612.
|
1295 |
Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth.Mol Endocrinol. 2007 Feb;21(2):343-58. doi: 10.1210/me.2006-0104. Epub 2006 Nov 2.
|
1296 |
Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.Mol Cancer Res. 2011 Jan;9(1):36-50. doi: 10.1158/1541-7786.MCR-10-0158. Epub 2010 Dec 8.
|
1297 |
miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.Clin Cancer Res. 2015 Nov 1;21(21):4922-34. doi: 10.1158/1078-0432.CCR-15-0217. Epub 2015 Jun 16.
|
1298 |
How to make clinical decisions to avoid unnecessary prostate screening in biopsy-nave men with PI-RADs v2 score??.Int J Clin Oncol. 2020 Jan;25(1):175-186. doi: 10.1007/s10147-019-01524-9. Epub 2019 Aug 31.
|
1299 |
Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2.Oncogene. 2014 Jun 19;33(25):3235-45. doi: 10.1038/onc.2013.294. Epub 2013 Jul 29.
|
1300 |
Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Prostate. 2014 May;74(5):547-60. doi: 10.1002/pros.22777. Epub 2014 Jan 16.
|
1301 |
Evaluation of pharmacokinetics/pharmacodynamics and efficacy of one-month depots of TAK-448 and TAK-683, investigational kisspeptin analogs, in male rats and an androgen-dependent prostate cancer model.Eur J Pharmacol. 2018 Mar 5;822:138-146. doi: 10.1016/j.ejphar.2018.01.012.
|
1302 |
Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.Int J Cancer. 2011 May 15;128(10):2284-95. doi: 10.1002/ijc.25580.
|
1303 |
Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.Prostate. 2019 Apr;79(5):462-467. doi: 10.1002/pros.23752. Epub 2018 Dec 23.
|
1304 |
Steroidogenic factor 1 promotes aggressive growth of castration-resistant prostate cancer cells by stimulating steroid synthesis and cell proliferation.Endocrinology. 2014 Feb;155(2):358-69. doi: 10.1210/en.2013-1583. Epub 2013 Nov 21.
|
1305 |
Semaphorin 3C as a Therapeutic Target in Prostate and Other Cancers.Int J Mol Sci. 2019 Feb 12;20(3):774. doi: 10.3390/ijms20030774.
|
1306 |
Substitution at carbon 2 of 19-nor-1,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells.J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):269-75. doi: 10.1016/j.jsbmb.2011.08.010. Epub 2011 Sep 3.
|
1307 |
Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2.Cancer Biol Ther. 2007 Mar;6(3):419-25. doi: 10.4161/cbt.6.3.3757. Epub 2007 Mar 28.
|
1308 |
Quantitative proteomic study of human prostate cancer cells with different metastatic potentials.Int J Oncol. 2016 Apr;48(4):1437-46. doi: 10.3892/ijo.2016.3378. Epub 2016 Feb 4.
|
1309 |
Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels.Biofactors. 2015 Jan-Feb;41(1):52-7. doi: 10.1002/biof.1200.
|
1310 |
Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer.J Investig Med. 2019 Aug;67(6):1009-1017. doi: 10.1136/jim-2018-000849. Epub 2019 Feb 20.
|
1311 |
GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes.Clin Exp Metastasis. 2015 Dec;32(8):769-82. doi: 10.1007/s10585-015-9745-y. Epub 2015 Oct 1.
|
1312 |
Differential role of Sloan-Kettering Institute (Ski) protein in Nodal and transforming growth factor-beta (TGF-)-induced Smad signaling in prostate cancer cells.Carcinogenesis. 2012 Nov;33(11):2054-64. doi: 10.1093/carcin/bgs252. Epub 2012 Jul 27.
|
1313 |
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.Oncotarget. 2015 Mar 20;6(8):6235-50. doi: 10.18632/oncotarget.3359.
|
1314 |
Differential 18F-FDG and 18F-Fluciclovine Uptake Pattern in a Patient With Poorly Differentiated Adenocarcinoma of the Lung and Prostate Cancer Biochemical Recurrence.Clin Nucl Med. 2020 Jan;45(1):e63-e64. doi: 10.1097/RLU.0000000000002781.
|
1315 |
Bortezomib prevents oncogenesis and bone metastasis of prostate cancer by inhibiting WWP1, Smurf1 and Smurf2.Int J Oncol. 2014 Oct;45(4):1469-78. doi: 10.3892/ijo.2014.2545. Epub 2014 Jul 17.
|
1316 |
Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.Am J Pathol. 2019 Jun;189(6):1180-1189. doi: 10.1016/j.ajpath.2019.02.009. Epub 2019 May 9.
|
1317 |
ErbB-2 signaling in advanced prostate cancer progression and potential therapy.Endocr Relat Cancer. 2019 Apr 1;26(4):R195-R209. doi: 10.1530/ERC-19-0009.
|
1318 |
Hepcidin regulation in prostate and its disruption in prostate cancer.Cancer Res. 2015 Jun 1;75(11):2254-63. doi: 10.1158/0008-5472.CAN-14-2465. Epub 2015 Apr 9.
|
1319 |
miR-539 inhibits prostate cancer progression by directly targeting SPAG5.J Exp Clin Cancer Res. 2016 Apr 1;35:60. doi: 10.1186/s13046-016-0337-8.
|
1320 |
Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.Br J Cancer. 2013 Feb 19;108(3):597-601. doi: 10.1038/bjc.2012.507. Epub 2012 Nov 20.
|
1321 |
Dysregulation of miR-212 Promotes Castration Resistance through hnRNPH1-Mediated Regulation of AR and AR-V7: Implications for Racial Disparity of Prostate Cancer.Clin Cancer Res. 2016 Apr 1;22(7):1744-56. doi: 10.1158/1078-0432.CCR-15-1606. Epub 2015 Nov 9.
|
1322 |
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90 and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth.J Cell Biochem. 2020 Jan;121(1):407-417. doi: 10.1002/jcb.29195. Epub 2019 Jun 21.
|
1323 |
STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization.J Biol Chem. 2017 Nov 24;292(47):19392-19399. doi: 10.1074/jbc.M117.802884. Epub 2017 Oct 6.
|
1324 |
Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.Prostate. 2009 Feb 15;69(3):234-48. doi: 10.1002/pros.20867.
|
1325 |
Important role of SUMOylation of Spliceosome factors in prostate cancer cells.J Proteome Res. 2014 Aug 1;13(8):3571-82. doi: 10.1021/pr4012848. Epub 2014 Jul 24.
|
1326 |
Synaptopodin-2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration.Oncotarget. 2015 May 10;6(13):11162-74. doi: 10.18632/oncotarget.3578.
|
1327 |
A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1.Nat Genet. 2014 Aug;46(8):891-4. doi: 10.1038/ng.3020. Epub 2014 Jun 29.
|
1328 |
Expression and purification of TAT-NDRG2 recombinant protein and evaluation of its anti-proliferative effect on LNCaP cell line.Protein Expr Purif. 2017 Oct;138:25-33. doi: 10.1016/j.pep.2017.07.004. Epub 2017 Jul 13.
|
1329 |
Tectonic? contributes to the growth and migration of prostate cancer cells invitro.Int J Mol Med. 2015 Oct;36(4):931-8. doi: 10.3892/ijmm.2015.2313. Epub 2015 Aug 14.
|
1330 |
TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer.Gene. 2014 Mar 10;537(2):253-9. doi: 10.1016/j.gene.2013.12.051. Epub 2014 Jan 7.
|
1331 |
Multi-omics Biomarker Pipeline Reveals Elevated Levels of Protein-glutamine Gamma-glutamyltransferase 4 in Seminal Plasma of Prostate Cancer Patients.Mol Cell Proteomics. 2019 Sep;18(9):1807-1823. doi: 10.1074/mcp.RA119.001612. Epub 2019 Jun 27.
|
1332 |
PKCalpha activation downregulates ATM and radio-sensitizes androgen-sensitive human prostate cancer cells in vitro and in vivo.Cancer Biol Ther. 2009 Jan;8(1):54-63. doi: 10.4161/cbt.8.1.7119. Epub 2009 Jan 4.
|
1333 |
Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer.Oncotarget. 2019 Oct 22;10(58):6234-6244. doi: 10.18632/oncotarget.27263. eCollection 2019 Oct 22.
|
1334 |
The mouse thymosin beta15 gene family displays unique complexity and encodes a functional thymosin repeat.J Mol Biol. 2009 Apr 10;387(4):809-25. doi: 10.1016/j.jmb.2009.02.026. Epub 2009 Feb 20.
|
1335 |
Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.Cell Death Dis. 2018 Feb 21;9(3):301. doi: 10.1038/s41419-018-0293-7.
|
1336 |
Identification of a candidate prognostic gene signature by transcriptome analysis of matched pre- and post-treatment prostatic biopsies from patients with advanced prostate cancer.BMC Cancer. 2014 Dec 18;14:977. doi: 10.1186/1471-2407-14-977.
|
1337 |
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.Oncogene. 2012 Nov 15;31(46):4878-87. doi: 10.1038/onc.2011.641. Epub 2012 Feb 13.
|
1338 |
The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo.Oncotarget. 2016 May 24;7(21):31037-52. doi: 10.18632/oncotarget.8832.
|
1339 |
GCPII modulates oxidative stress and prostate cancer susceptibility through changes in methylation of RASSF1, BNIP3, GSTP1 and Ec-SOD.Mol Biol Rep. 2013 Oct;40(10):5541-50. doi: 10.1007/s11033-013-2655-7. Epub 2013 Aug 24.
|
1340 |
BAP18 coactivates androgen receptor action and promotes prostate cancer progression.Nucleic Acids Res. 2016 Sep 30;44(17):8112-28. doi: 10.1093/nar/gkw472. Epub 2016 May 25.
|
1341 |
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.Oncotarget. 2016 Jul 26;7(30):48011-48026. doi: 10.18632/oncotarget.10333.
|
1342 |
NADPH Oxidases NOXs and DUOXs as putative targets for cancer therapy.Anticancer Agents Med Chem. 2013 Mar;13(3):502-14.
|
1343 |
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer.Cancer Lett. 2016 Sep 28;380(1):39-46. doi: 10.1016/j.canlet.2016.06.013. Epub 2016 Jun 17.
|
1344 |
Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.Exp Cell Res. 2016 Nov 15;349(1):77-84. doi: 10.1016/j.yexcr.2016.09.023. Epub 2016 Oct 12.
|
1345 |
Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.Oncotarget. 2016 Aug 23;7(34):54616-54626. doi: 10.18632/oncotarget.10520.
|
1346 |
Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.Oncotarget. 2016 Jun 21;7(25):37846-37856. doi: 10.18632/oncotarget.9344.
|
1347 |
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.Eur Urol. 2019 Dec;76(6):831-842. doi: 10.1016/j.eururo.2019.08.019. Epub 2019 Sep 16.
|
1348 |
A novel crosstalk between the tumor suppressors ING1 and ING2 regulates androgen receptor signaling.J Mol Med (Berl). 2016 Oct;94(10):1167-1179. doi: 10.1007/s00109-016-1440-1. Epub 2016 Jun 16.
|
1349 |
Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.J Cell Physiol. 2019 Aug;234(8):12727-12744. doi: 10.1002/jcp.27893. Epub 2019 Jan 5.
|
1350 |
Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6997-7002. doi: 10.1073/pnas.1304502110. Epub 2013 Apr 4.
|
1351 |
Microbubble-assisted p53, RB, and p130 gene transfer in combination with radiation therapy in prostate cancer.Curr Gene Ther. 2013 Jun 1;13(3):163-74. doi: 10.2174/1566523211313030001.
|
1352 |
PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK/JNK/ERK pathway.J Exp Clin Cancer Res. 2019 Jan 18;38(1):24. doi: 10.1186/s13046-019-1032-3.
|
1353 |
PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.Biomed Pharmacother. 2016 Jul;81:1-6. doi: 10.1016/j.biopha.2016.03.030. Epub 2016 Apr 6.
|
1354 |
miR?9a?p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.Mol Med Rep. 2016 May;13(5):4030-8. doi: 10.3892/mmr.2016.5033. Epub 2016 Mar 21.
|
1355 |
TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression.Oncogene. 2020 Jan;39(2):356-367. doi: 10.1038/s41388-019-0991-3. Epub 2019 Sep 2.
|
1356 |
Histone methyltransferase PRMT6 plays an oncogenic role of in prostate cancer.Oncotarget. 2016 Aug 16;7(33):53018-53028. doi: 10.18632/oncotarget.10061.
|
1357 |
RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.Am J Pathol. 2013 Sep;183(3):951-63. doi: 10.1016/j.ajpath.2013.05.021. Epub 2013 Jul 16.
|
1358 |
S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.Tumour Biol. 2016 Sep;37(9):12241-12250. doi: 10.1007/s13277-016-5096-9. Epub 2016 May 30.
|
1359 |
Effects of siRNA-mediated silencing of Sal-like 4 expression on proliferation and apoptosis of prostate cancer C4-2 cells.Genet Mol Res. 2016 May 13;15(2). doi: 10.4238/gmr.15027885.
|
1360 |
Variation in selenoenzyme genes and prostate cancer risk and survival.Prostate. 2013 May;73(7):734-42. doi: 10.1002/pros.22617. Epub 2012 Nov 9.
|
1361 |
Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.Tumour Biol. 2016 Sep;37(9):12843-12854. doi: 10.1007/s13277-016-5158-z. Epub 2016 Jul 23.
|
1362 |
SFMBT2 (Scm-like with four mbt domains 2) negatively regulates cell migration and invasion in prostate cancer cells.Oncotarget. 2016 Jul 26;7(30):48250-48264. doi: 10.18632/oncotarget.10198.
|
1363 |
Folate and B12 in prostate cancer.Adv Clin Chem. 2013;60:1-63. doi: 10.1016/b978-0-12-407681-5.00001-5.
|
1364 |
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex.Nat Genet. 2013 Nov;45(11):1392-8. doi: 10.1038/ng.2771. Epub 2013 Sep 29.
|
1365 |
Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1.Oncol Lett. 2019 Feb;17(2):2257-2265. doi: 10.3892/ol.2018.9822. Epub 2018 Dec 11.
|
1366 |
Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells.BJU Int. 2019 May;123 Suppl 5:27-35. doi: 10.1111/bju.14695.
|
1367 |
Reciprocal regulation of long noncoding RNAs THBS4?03 and THBS4 control migration and invasion in prostate cancer cell lines.Mol Med Rep. 2016 Aug;14(2):1451-8. doi: 10.3892/mmr.2016.5443. Epub 2016 Jun 23.
|
1368 |
High NRBP1 expression in prostate cancer is linked with poor clinical outcomes and increased cancer cell growth.Prostate. 2012 Nov;72(15):1678-87. doi: 10.1002/pros.22521. Epub 2012 Apr 2.
|
1369 |
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate Cancers.Neoplasia. 2017 Apr;19(4):279-287. doi: 10.1016/j.neo.2017.01.005. Epub 2017 Mar 8.
|
1370 |
LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6.
|
1371 |
Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer.Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2618-27. doi: 10.1158/1055-9965.EPI-11-0434. Epub 2011 Sep 29.
|
1372 |
AIM2, an IFN-inducible cytosolic DNA sensor, in the development of benign prostate hyperplasia and prostate cancer.Mol Cancer Res. 2013 Oct;11(10):1193-202. doi: 10.1158/1541-7786.MCR-13-0145. Epub 2013 Jul 17.
|
1373 |
ALDH1A3 correlates with luminal phenotype in prostate cancer.Tumour Biol. 2017 Apr;39(4):1010428317703652. doi: 10.1177/1010428317703652.
|
1374 |
Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.PLoS One. 2017 Aug 2;12(8):e0180541. doi: 10.1371/journal.pone.0180541. eCollection 2017.
|
1375 |
gp78 is specifically expressed in human prostate cancer rather than normal prostate tissue.J Mol Histol. 2013 Dec;44(6):653-9. doi: 10.1007/s10735-013-9512-9. Epub 2013 May 12.
|
1376 |
Self-Normalized Detection of ANXA3 from Untreated Urine of Prostate Cancer Patients without Digital Rectal Examination.Adv Healthc Mater. 2017 Sep;6(17). doi: 10.1002/adhm.201700449. Epub 2017 Jul 13.
|
1377 |
Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1928-36. doi: 10.1158/1055-9965.EPI-11-0236. Epub 2011 Aug 16.
|
1378 |
Deprivation of arginine by recombinant human arginase in prostate cancer cells.J Hematol Oncol. 2012 Apr 30;5:17. doi: 10.1186/1756-8722-5-17.
|
1379 |
Functional and cancer genomics of ASXL family members.Br J Cancer. 2013 Jul 23;109(2):299-306. doi: 10.1038/bjc.2013.281. Epub 2013 Jun 4.
|
1380 |
SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.J Exp Clin Cancer Res. 2018 Jul 11;37(1):145. doi: 10.1186/s13046-018-0809-0.
|
1381 |
Prediction nomogram for (68)Ga-PSMA-11 PET/CT in different clinical settings of PSA failure after radical treatment for prostate cancer.Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):136-146. doi: 10.1007/s00259-019-04505-2. Epub 2019 Sep 6.
|
1382 |
Correlation between DEC1/DEC2 and epithelialmesenchymal transition in human prostate cancer PC? cells.Mol Med Rep. 2018 Oct;18(4):3859-3865. doi: 10.3892/mmr.2018.9367. Epub 2018 Aug 9.
|
1383 |
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.Genes Chromosomes Cancer. 2012 Feb;51(2):149-60. doi: 10.1002/gcc.20939. Epub 2011 Nov 1.
|
1384 |
Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer.J Cancer. 2019 Oct 15;10(24):5915-5925. doi: 10.7150/jca.34564. eCollection 2019.
|
1385 |
High Dimensional Variable Selection with Error Control.Biomed Res Int. 2016;2016:8209453. doi: 10.1155/2016/8209453. Epub 2016 Aug 15.
|
1386 |
LSD1 Activates PI3K/AKT Signaling Through Regulating p85 Expression in Prostate Cancer Cells.Front Oncol. 2019 Aug 2;9:721. doi: 10.3389/fonc.2019.00721. eCollection 2019.
|
1387 |
A regulatory circuit HP1/miR-451a/c-Myc promotes prostate cancer progression.Oncogene. 2018 Jan 25;37(4):415-426. doi: 10.1038/onc.2017.332. Epub 2017 Oct 2.
|
1388 |
Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies.Mol Oncol. 2018 Apr;12(4):545-560. doi: 10.1002/1878-0261.12183. Epub 2018 Mar 13.
|
1389 |
CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.Am J Pathol. 2019 Jul;189(7):1451-1461. doi: 10.1016/j.ajpath.2019.04.006. Epub 2019 Jun 12.
|
1390 |
Identification of transmembrane protein in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of CDON is involved in tumor cell growth and invasion.Pathobiology. 2011;78(5):277-84. doi: 10.1159/000329588. Epub 2011 Aug 17.
|
1391 |
Copy number polymorphisms in new HapMap III and Singapore populations.J Hum Genet. 2011 Aug;56(8):552-60. doi: 10.1038/jhg.2011.54. Epub 2011 Jun 16.
|
1392 |
Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer.World J Urol. 2020 Sep;38(9):2185-2196. doi: 10.1007/s00345-019-03017-w. Epub 2019 Nov 19.
|
1393 |
Mesenchymal stem cells modified to express lentivirus TNF- Tumstatin(45-132) inhibit the growth of prostate cancer.J Cell Mol Med. 2011 Feb;15(2):433-44. doi: 10.1111/j.1582-4934.2009.00920.x.
|
1394 |
Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis.Genet Test Mol Biomarkers. 2013 Jul;17(7):562-6. doi: 10.1089/gtmb.2012.0524. Epub 2013 Apr 27.
|
1395 |
COX-2 mediates pro-tumorigenic effects of PKC in prostate cancer.Oncogene. 2018 Aug;37(34):4735-4749. doi: 10.1038/s41388-018-0318-9. Epub 2018 May 16.
|
1396 |
Expression of leukemia/lymphoma related factor (LRF/Pokemon) in human benign prostate hyperplasia and prostate cancer.Exp Mol Pathol. 2011 Apr;90(2):226-30. doi: 10.1016/j.yexmp.2011.01.003. Epub 2011 Jan 18.
|
1397 |
CTBP1 depletion on prostate tumors deregulates miRNA/mRNA expression and impairs cancer progression in metabolic syndrome mice.Cell Death Dis. 2019 Apr 1;10(4):299. doi: 10.1038/s41419-019-1535-z.
|
1398 |
Antimony enhances c-Myc stability in prostate cancer via activating CtBP2-ROCK1 signaling pathway.Ecotoxicol Environ Saf. 2018 Nov 30;164:61-68. doi: 10.1016/j.ecoenv.2018.07.070. Epub 2018 Aug 8.
|
1399 |
Expression of CCCTC-binding factor (CTCF) is linked to poor prognosis in prostate cancer.Mol Oncol. 2020 Jan;14(1):129-138. doi: 10.1002/1878-0261.12597. Epub 2019 Nov 29.
|
1400 |
Potential use of chymotrypsin-like proteasomal activity as a biomarker for prostate cancer.Oncol Lett. 2018 Apr;15(4):5149-5154. doi: 10.3892/ol.2018.7936. Epub 2018 Feb 2.
|
1401 |
NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.Oncotarget. 2017 Mar 28;8(13):21501-21515. doi: 10.18632/oncotarget.15308.
|
1402 |
Inhibition of cytohesin-1 by siRNA leads to reduced IGFR signaling in prostate cancer.Braz J Med Biol Res. 2011 Jul;44(7):642-6. doi: 10.1590/s0100-879x2011007500072. Epub 2011 Jun 10.
|
1403 |
Insulin resistance in prostate cancer patients and predisposing them to acute ischemic heart disease.Biosci Rep. 2019 Jul 29;39(7):BSR20182313. doi: 10.1042/BSR20182313. Print 2019 Jul 31.
|
1404 |
Diaphanous-related formin-3 overexpression inhibits the migration and invasion of triple-negative breast cancer by inhibiting RhoA-GTP expression.Biomed Pharmacother. 2017 Oct;94:439-445. doi: 10.1016/j.biopha.2017.07.119. Epub 2017 Aug 2.
|
1405 |
Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy.J Urol. 2019 Aug;202(2):256-263. doi: 10.1097/JU.0000000000000293. Epub 2019 Jul 8.
|
1406 |
Combined analysis of CRMP4 methylation levels and CAPRA-S score predicts metastasis and outcomes in prostate cancer patients.Asian J Androl. 2018 Jan-Feb;20(1):56-61. doi: 10.4103/aja.aja_3_17.
|
1407 |
Association of DSC3 mRNA down-regulation in prostate cancer with promoter hypermethylation and poor prognosis.PLoS One. 2014 Mar 24;9(3):e92815. doi: 10.1371/journal.pone.0092815. eCollection 2014.
|
1408 |
Dishevelled-2 silencing reduces androgen-dependent prostate tumor cell proliferation and migration and expression of Wnt-3a and matrix metalloproteinases.Mol Biol Rep. 2013 Jul;40(7):4241-50. doi: 10.1007/s11033-013-2506-6. Epub 2013 May 8.
|
1409 |
Geraniol suppresses prostate cancer growth through down-regulation of E2F8. Cancer Med. 2016 Oct;5(10):2899-2908.
|
1410 |
Electrochemical detection of methylated DNA on a microfluidic chip with nanoelectrokinetic pre-concentration.Biosens Bioelectron. 2018 Jun 1;107:103-110. doi: 10.1016/j.bios.2018.01.067. Epub 2018 Feb 1.
|
1411 |
ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-B and drives prostate cancer progression.Cancer Res. 2013 Jul 15;73(14):4533-47. doi: 10.1158/0008-5472.CAN-12-4537. Epub 2013 May 16.
|
1412 |
Linkage between prostate cancer occurrence and Y-chromosomal DYS loci in Malaysian subjects.Asian Pac J Cancer Prev. 2011;12(5):1265-8.
|
1413 |
Epithelial membrane protein 1 promotes tumor metastasis by enhancing cell migration via copine-III and Rac1.Oncogene. 2018 Oct;37(40):5416-5434. doi: 10.1038/s41388-018-0286-0. Epub 2018 Jun 4.
|
1414 |
Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer.Prostate. 2012 May 15;72(7):789-802. doi: 10.1002/pros.21487. Epub 2011 Sep 14.
|
1415 |
Low concentrations of alendronate increase the local invasive potential of osteoblastic sarcoma cell lines via connexin 43 activation.Pathol Res Pract. 2011 Jul 15;207(7):417-22. doi: 10.1016/j.prp.2011.04.007. Epub 2011 Jun 12.
|
1416 |
Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.Oncogene. 2012 Apr 26;31(17):2153-63. doi: 10.1038/onc.2011.401. Epub 2011 Sep 12.
|
1417 |
Inflammation-associated DNA methylation patterns in epithelium of ulcerative colitis.Epigenetics. 2017 Aug;12(8):591-606. doi: 10.1080/15592294.2017.1334023. Epub 2017 May 30.
|
1418 |
Role and expression of FRS2 and FRS3 in prostate cancer.BMC Cancer. 2011 Nov 11;11:484. doi: 10.1186/1471-2407-11-484.
|
1419 |
Role of WNT5A receptors FZD5 and RYK in prostate cancer cells.Oncotarget. 2018 Jun 5;9(43):27293-27304. doi: 10.18632/oncotarget.25551. eCollection 2018 Jun 5.
|
1420 |
Frizzled-8 integrates Wnt-11 and transforming growth factor- signaling in prostate cancer.Nat Commun. 2018 May 1;9(1):1747. doi: 10.1038/s41467-018-04042-w.
|
1421 |
Genetic variants in the microRNA machinery gene GEMIN4 are associated with risk of prostate cancer: a case-control study of the Chinese Han population.DNA Cell Biol. 2012 Jul;31(7):1296-302. doi: 10.1089/dna.2011.1600. Epub 2012 Apr 16.
|
1422 |
G-13 induces CXC motif chemokine ligand 5 expression in prostate cancer cells by transactivating NF-B.J Biol Chem. 2019 Nov 29;294(48):18192-18206. doi: 10.1074/jbc.RA119.010018. Epub 2019 Oct 21.
|
1423 |
G Protein 3 subunit gene C825T polymorphism and its association with the presence and clinicopathological characteristics of prostate cancer.J Urol. 2012 Jul;188(1):287-93. doi: 10.1016/j.juro.2012.02.2557. Epub 2012 May 16.
|
1424 |
Gene polymorphisms in antioxidant enzymes correlate with the efficacy of androgen-deprivation therapy for prostate cancer with implications of oxidative stress.Ann Oncol. 2017 Mar 1;28(3):569-575. doi: 10.1093/annonc/mdw646.
|
1425 |
Prostate Cancer Patients with Late Radiation Toxicity Exhibit Reduced Expression of Genes Involved in DNA Double-Strand Break Repair and Homologous Recombination.Cancer Res. 2017 Mar 15;77(6):1485-1491. doi: 10.1158/0008-5472.CAN-16-1966. Epub 2017 Jan 20.
|
1426 |
Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.J Biol Chem. 2011 May 20;286(20):17796-808. doi: 10.1074/jbc.M110.198655. Epub 2011 Mar 17.
|
1427 |
LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.PLoS One. 2016 Jan 15;11(1):e0146549. doi: 10.1371/journal.pone.0146549. eCollection 2016.
|
1428 |
Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B.Cancer Med. 2012 Oct;1(2):187-97. doi: 10.1002/cam4.19. Epub 2012 Aug 28.
|
1429 |
Inositol polyphosphate 4-phosphatase type II regulation of androgen receptor activity.Oncogene. 2019 Feb;38(7):1121-1135. doi: 10.1038/s41388-018-0498-3. Epub 2018 Sep 18.
|
1430 |
Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis.Transl Oncol. 2019 Feb;12(2):236-244. doi: 10.1016/j.tranon.2018.10.009. Epub 2018 Nov 11.
|
1431 |
SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells.Oncotarget. 2017 Jun 21;8(32):53518-53530. doi: 10.18632/oncotarget.18591. eCollection 2017 Aug 8.
|
1432 |
HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population.Gene. 2017 May 20;613:20-24. doi: 10.1016/j.gene.2017.02.031. Epub 2017 Mar 1.
|
1433 |
High Expression of KIF22/Kinesin-Like DNA Binding Protein (Kid) as a Poor Prognostic Factor in Prostate Cancer Patients.Med Sci Monit. 2018 Nov 14;24:8190-8197. doi: 10.12659/MSM.912643.
|
1434 |
Transcription factor KLF13 inhibits AKT activation and suppresses the growth of prostate carcinoma cells.Cancer Biomark. 2018;22(3):533-541. doi: 10.3233/CBM-181196.
|
1435 |
Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.Prostate. 2011 May 15;71(7):682-9. doi: 10.1002/pros.21284. Epub 2010 Oct 13.
|
1436 |
Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells.Oncotarget. 2016 Dec 20;7(51):84645-84657. doi: 10.18632/oncotarget.13175.
|
1437 |
Up-Regulation of LAT1 during Antiandrogen Therapy Contributes to Progression in Prostate Cancer Cells.J Urol. 2016 May;195(5):1588-1597. doi: 10.1016/j.juro.2015.11.071. Epub 2015 Dec 9.
|
1438 |
Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.J Biol Chem. 2011 Oct 28;286(43):37108-17. doi: 10.1074/jbc.M111.292771. Epub 2011 Aug 19.
|
1439 |
Genomic analysis of DNA repair genes and androgen signaling in prostate cancer.BMC Cancer. 2018 Oct 10;18(1):960. doi: 10.1186/s12885-018-4848-x.
|
1440 |
LILRA3 is associated with benign prostatic hyperplasia risk in a Chinese Population.Int J Mol Sci. 2013 Apr 24;14(5):8832-40. doi: 10.3390/ijms14058832.
|
1441 |
An exome-wide rare variant analysis of Korean men identifies three novel genes predisposing to prostate cancer.Sci Rep. 2019 Nov 20;9(1):17173. doi: 10.1038/s41598-019-53445-2.
|
1442 |
Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genes.Cancer Biol Ther. 2013 Sep;14(9):840-52. doi: 10.4161/cbt.25329. Epub 2013 Jul 26.
|
1443 |
CAPC negatively regulates NF-B activation and suppresses tumor growth and metastasis.Oncogene. 2012 Mar 29;31(13):1673-82. doi: 10.1038/onc.2011.355. Epub 2011 Aug 8.
|
1444 |
LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.Biochimie. 2012 May;94(5):1151-7. doi: 10.1016/j.biochi.2012.01.019. Epub 2012 Feb 2.
|
1445 |
ORCA-010, a novel potency-enhanced oncolytic adenovirus, exerts strong antitumor activity in preclinical models.Hum Gene Ther. 2014 Oct;25(10):897-904. doi: 10.1089/hum.2013.229. Epub 2014 Sep 17.
|
1446 |
LZTS2 and PTEN collaboratively regulate -catenin in prostatic tumorigenesis.PLoS One. 2017 Mar 21;12(3):e0174357. doi: 10.1371/journal.pone.0174357. eCollection 2017.
|
1447 |
Transforming Growth Factor TGF Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas.PLoS One. 2015 Nov 16;10(11):e0143150. doi: 10.1371/journal.pone.0143150. eCollection 2015.
|
1448 |
Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.PLoS One. 2011;6(8):e23144. doi: 10.1371/journal.pone.0023144. Epub 2011 Aug 4.
|
1449 |
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6686-91. doi: 10.1073/pnas.1117405109. Epub 2012 Apr 10.
|
1450 |
p53-induced gene 3 mediates cell death induced by glutathione peroxidase 3.J Biol Chem. 2012 May 11;287(20):16890-902. doi: 10.1074/jbc.M111.322636. Epub 2012 Mar 29.
|
1451 |
CNPY2 inhibits MYLIP-mediated AR protein degradation in prostate cancer cells.Oncotarget. 2018 Apr 3;9(25):17645-17655. doi: 10.18632/oncotarget.24824. eCollection 2018 Apr 3.
|
1452 |
MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.Oncol Rep. 2016 Sep;36(3):1285-92. doi: 10.3892/or.2016.4910. Epub 2016 Jun 29.
|
1453 |
Characterization of OCT3/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer.Int J Biochem Cell Biol. 2019 Mar;108:21-28. doi: 10.1016/j.biocel.2019.01.002. Epub 2019 Jan 8.
|
1454 |
Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.Clin Cancer Res. 2016 Aug 1;22(15):3937-49. doi: 10.1158/1078-0432.CCR-15-1983. Epub 2016 Mar 11.
|
1455 |
Human cytosolic sialidase NEU2-low general tissue expression but involvement in PC-3 prostate cancer cell survival.Biochem Biophys Res Commun. 2012 Nov 9;428(1):142-9. doi: 10.1016/j.bbrc.2012.10.028. Epub 2012 Oct 12.
|
1456 |
Inducible expression of antizyme 1 in prostate cancer cell lines after lentivirus mediated gene transfer.Amino Acids. 2012 Feb;42(2-3):559-64. doi: 10.1007/s00726-011-1033-9. Epub 2011 Jul 29.
|
1457 |
Epigenetic markers of prostate cancer in plasma circulating DNA.Hum Mol Genet. 2012 Aug 15;21(16):3619-31. doi: 10.1093/hmg/dds192. Epub 2012 May 22.
|
1458 |
PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.Prostate. 2018 May;78(7):547-559. doi: 10.1002/pros.23499. Epub 2018 Mar 9.
|
1459 |
The RNA-Binding Protein PCBP1 Functions as a Tumor Suppressor in Prostate Cancer by Inhibiting Mitogen Activated Protein Kinase 1.Cell Physiol Biochem. 2018;48(4):1747-1754. doi: 10.1159/000492315. Epub 2018 Aug 3.
|
1460 |
Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.Nat Genet. 2018 Feb;50(2):219-228. doi: 10.1038/s41588-017-0026-3. Epub 2018 Jan 15.
|
1461 |
FAM84B promotes prostate tumorigenesis through a network alteration.Ther Adv Med Oncol. 2019 May 13;11:1758835919846372. doi: 10.1177/1758835919846372. eCollection 2019.
|
1462 |
Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin.Int J Oncol. 2013 Aug;43(2):365-74. doi: 10.3892/ijo.2013.1954. Epub 2013 May 24.
|
1463 |
SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1.EMBO Mol Med. 2018 Feb;10(2):219-238. doi: 10.15252/emmm.201707689.
|
1464 |
PGC1 Suppresses Prostate Cancer Cell Invasion through ERR Transcriptional Control.Cancer Res. 2019 Dec 15;79(24):6153-6165. doi: 10.1158/0008-5472.CAN-19-1231. Epub 2019 Oct 8.
|
1465 |
Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-B and CHOP expression.Cell Signal. 2011 May;23(5):857-65. doi: 10.1016/j.cellsig.2011.01.010. Epub 2011 Jan 27.
|
1466 |
Coordinated regulation of polycomb group complexes through microRNAs in cancer.Cancer Cell. 2011 Aug 16;20(2):187-99. doi: 10.1016/j.ccr.2011.06.016.
|
1467 |
PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-B- and HDAC1-mediated expression and activation of uPA.J Cell Sci. 2012 Oct 15;125(Pt 20):4800-11. doi: 10.1242/jcs.106542. Epub 2012 Jul 13.
|
1468 |
Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells.Free Radic Biol Med. 2011 Jul 1;51(1):78-87. doi: 10.1016/j.freeradbiomed.2011.04.001. Epub 2011 Apr 14.
|
1469 |
PRSS3/mesotrypsin is a therapeutic target for metastatic prostate cancer.Mol Cancer Res. 2012 Dec;10(12):1555-66. doi: 10.1158/1541-7786.MCR-12-0314.
|
1470 |
Identification of kinases regulating prostate cancer cell growth using an RNAi phenotypic screen.PLoS One. 2012;7(6):e38950. doi: 10.1371/journal.pone.0038950. Epub 2012 Jun 27.
|
1471 |
The bispecific anti-CD3anti-CD155 antibody mediates T cell immunotherapy for human prostate cancer.Invest New Drugs. 2019 Oct;37(5):810-817. doi: 10.1007/s10637-018-0683-9. Epub 2018 Oct 29.
|
1472 |
Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.Mol Cell Biol. 2012 Jan;32(2):399-414. doi: 10.1128/MCB.05958-11. Epub 2011 Nov 14.
|
1473 |
RAD9A promotes metastatic phenotypes through transcriptional regulation of anterior gradient 2 (AGR2).Carcinogenesis. 2019 Mar 12;40(1):164-172. doi: 10.1093/carcin/bgy131.
|
1474 |
A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.J Transl Med. 2011 Oct 28;9:185. doi: 10.1186/1479-5876-9-185.
|
1475 |
HNF1b is involved in prostate cancer risk via modulating androgenic hormone effects and coordination with other genes.Genet Mol Res. 2013 Apr 25;12(2):1327-35. doi: 10.4238/2013.April.25.4.
|
1476 |
Long noncoding RNA AFAP1-AS1 accelerates the proliferation and metastasis of prostate cancer via inhibiting RBM5 expression.Eur Rev Med Pharmacol Sci. 2019 Apr;23(8):3284-3290. doi: 10.26355/eurrev_201904_17690.
|
1477 |
AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.Prostate. 2012 Jul 1;72(10):1133-9. doi: 10.1002/pros.22461. Epub 2011 Nov 29.
|
1478 |
Histone H2B ubiquitin ligases RNF20 and RNF40 in androgen signaling and prostate cancer cell growth.Mol Cell Endocrinol. 2012 Mar 5;350(1):87-98. doi: 10.1016/j.mce.2011.11.025. Epub 2011 Dec 2.
|
1479 |
Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.Int J Cancer. 2019 Jul 1;145(1):49-57. doi: 10.1002/ijc.32073. Epub 2019 Jan 5.
|
1480 |
Short hairpin RNA library-based functional screening identified ribosomal protein L31 that modulates prostate cancer cell growth via p53 pathway.PLoS One. 2014 Oct 6;9(10):e108743. doi: 10.1371/journal.pone.0108743. eCollection 2014.
|
1481 |
The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.Cancer Res. 2003 Oct 15;63(20):6583-94.
|
1482 |
SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.J Clin Invest. 2011 Nov;121(11):4257-67. doi: 10.1172/JCI58509. Epub 2011 Oct 3.
|
1483 |
SEL1L expression in non-small cell lung cancer.Hum Pathol. 2006 May;37(5):505-12. doi: 10.1016/j.humpath.2005.12.012. Epub 2006 Mar 20.
|
1484 |
A role for class 3 semaphorins in prostate cancer.Prostate. 2011 May;71(6):649-58. doi: 10.1002/pros.21281. Epub 2010 Oct 14.
|
1485 |
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial.Radiother Oncol. 2019 Oct;139:83-86. doi: 10.1016/j.radonc.2019.07.018. Epub 2019 Aug 17.
|
1486 |
ETS1 induces transforming growth factor signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.J Cell Biochem. 2019 Jan;120(1):848-860. doi: 10.1002/jcb.27446. Epub 2018 Aug 30.
|
1487 |
SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway.Am J Transl Res. 2019 Aug 15;11(8):5249-5260. eCollection 2019.
|
1488 |
Mutational analysis of SPANX genes in families with X-linked prostate cancer.Prostate. 2007 Jun 1;67(8):820-8. doi: 10.1002/pros.20561.
|
1489 |
Cancer/testis antigen SPATA19 is frequently expressed in benign prostatic hyperplasia and prostate cancer.APMIS. 2017 Dec;125(12):1092-1101. doi: 10.1111/apm.12775. Epub 2017 Oct 3.
|
1490 |
Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomics.J Transl Med. 2017 Aug 15;15(1):175. doi: 10.1186/s12967-017-1276-7.
|
1491 |
SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.Prostate. 2011 Oct 1;71(14):1559-67. doi: 10.1002/pros.21372. Epub 2011 Feb 25.
|
1492 |
TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.Mol Endocrinol. 2012 May;26(5):748-61. doi: 10.1210/me.2011-1242. Epub 2012 Mar 28.
|
1493 |
Reliable housekeeping gene combination for quantitative PCR of lymph nodes in patients with prostate cancer.Anticancer Res. 2013 Dec;33(12):5243-8.
|
1494 |
Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis.Prostate. 2012 May 1;72(6):626-37. doi: 10.1002/pros.21466. Epub 2011 Aug 1.
|
1495 |
Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression.J Hematol Oncol. 2017 Jan 25;10(1):33. doi: 10.1186/s13045-017-0390-6.
|
1496 |
The expression of Tousled kinases in CaP cell lines and its relation to radiation response and DSB repair.Prostate. 2011 Sep 15;71(13):1367-73. doi: 10.1002/pros.21358. Epub 2011 Feb 14.
|
1497 |
TM4SF1, a novel primary androgen receptor target gene over-expressed in human prostate cancer and involved in cell migration.Prostate. 2011 Aug 1;71(11):1239-50. doi: 10.1002/pros.21340. Epub 2011 Jan 12.
|
1498 |
Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression.Cancer Lett. 2012 Feb 1;315(1):38-47. doi: 10.1016/j.canlet.2011.10.003. Epub 2011 Oct 12.
|
1499 |
High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.PLoS One. 2012;7(6):e39801. doi: 10.1371/journal.pone.0039801. Epub 2012 Jun 28.
|
1500 |
TRAF2 is a Valuable Prognostic Biomarker in Patients with Prostate Cancer.Med Sci Monit. 2017 Aug 31;23:4192-4204. doi: 10.12659/msm.903500.
|
1501 |
Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development.J Biol Chem. 2016 Nov 25;291(48):25247-25254. doi: 10.1074/jbc.M116.745950. Epub 2016 Oct 17.
|
1502 |
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.Cell Death Dis. 2018 Feb 5;9(2):155. doi: 10.1038/s41419-017-0197-y.
|
1503 |
PSA-alpha-2-macroglobulin complex is enzymatically active in the serum of patients with advanced prostate cancer and can degrade circulating peptide hormones.Prostate. 2018 Aug;78(11):819-829. doi: 10.1002/pros.23539. Epub 2018 Apr 16.
|
1504 |
Doxorubicin induces prostate cancer drug resistance by upregulation of ABCG4 through GSH depletion and CREB activation: Relevance of statins in chemosensitization.Mol Carcinog. 2019 Jul;58(7):1118-1133. doi: 10.1002/mc.22996. Epub 2019 Mar 4.
|
1505 |
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.Cell Commun Signal. 2019 Sep 18;17(1):120. doi: 10.1186/s12964-019-0410-y.
|
1506 |
A hnRNP KAR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.Int J Mol Sci. 2018 Jun 30;19(7):1920. doi: 10.3390/ijms19071920.
|
1507 |
Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.Prostate. 2005 Jun 1;63(4):316-23. doi: 10.1002/pros.20177.
|
1508 |
ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.Cancer Sci. 2017 Oct;108(10):2011-2021. doi: 10.1111/cas.13339. Epub 2017 Sep 10.
|
1509 |
Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.Biochem Pharmacol. 2019 Jan;159:52-63. doi: 10.1016/j.bcp.2018.11.005. Epub 2018 Nov 9.
|
1510 |
Actin alpha cardiac muscle 1 gene expression is upregulated in the skeletal muscle of men undergoing androgen deprivation therapy for prostate cancer.J Steroid Biochem Mol Biol. 2017 Nov;174:56-64. doi: 10.1016/j.jsbmb.2017.07.029. Epub 2017 Jul 27.
|
1511 |
BAF53A regulates androgen receptor-mediated gene expression and proliferation in LNCaP cells.Biochem Biophys Res Commun. 2018 Oct 28;505(2):618-623. doi: 10.1016/j.bbrc.2018.09.149. Epub 2018 Sep 29.
|
1512 |
Novel biomarkers for prostate cancer including noncoding transcripts.Am J Pathol. 2009 Dec;175(6):2264-76. doi: 10.2353/ajpath.2009.080868. Epub 2009 Nov 5.
|
1513 |
Overexpression and knock-down studies highlight that a disintegrin and metalloproteinase 28 controls proliferation and migration in human prostate cancer.Medicine (Baltimore). 2016 Oct;95(40):e5085. doi: 10.1097/MD.0000000000005085.
|
1514 |
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis.Acta Neuropathol. 2017 Dec;134(6):905-922. doi: 10.1007/s00401-017-1774-y. Epub 2017 Oct 13.
|
1515 |
The methionine salvage pathway-involving ADI1 inhibits hepatoma growth by epigenetically altering genes expression via elevating S-adenosylmethionine.Cell Death Dis. 2019 Mar 11;10(3):240. doi: 10.1038/s41419-019-1486-4.
|
1516 |
C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance.Med Sci Monit. 2017 Oct 30;23:5176-5183. doi: 10.12659/msm.906680.
|
1517 |
The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial.J Cancer. 2019 Oct 16;10(25):6217-6224. doi: 10.7150/jca.35510. eCollection 2019.
|
1518 |
AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.J Clin Invest. 2007 Oct;117(10):2962-73. doi: 10.1172/JCI30710.
|
1519 |
Stroma-induced Jagged1 expression drives PC3 prostate cancer cell migration; disparate effects of RIP-generated proteolytic fragments on cell behaviour and Notch signaling.Biochem Biophys Res Commun. 2016 Mar 25;472(1):255-61. doi: 10.1016/j.bbrc.2016.02.101. Epub 2016 Feb 26.
|
1520 |
Targeting Nucleoporin POM121-Importin Axis in Prostate Cancer.Cell Chem Biol. 2018 Sep 20;25(9):1056-1058. doi: 10.1016/j.chembiol.2018.09.003.
|
1521 |
Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2.Int J Oncol. 2014 Jul;45(1):362-72. doi: 10.3892/ijo.2014.2413. Epub 2014 Apr 30.
|
1522 |
Phenotype-specific CpG island methylation events in a murine model of prostate cancer.Cancer Res. 2008 Jun 1;68(11):4173-82. doi: 10.1158/0008-5472.CAN-07-6715.
|
1523 |
AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.Oncogenesis. 2018 May 25;7(5):43. doi: 10.1038/s41389-018-0053-7.
|
1524 |
Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.Prostate. 2017 Jun;77(9):1000-1011. doi: 10.1002/pros.23356. Epub 2017 Apr 19.
|
1525 |
ALKBH7 Variant Related to Prostate Cancer Exhibits Altered Substrate Binding.PLoS Comput Biol. 2017 Feb 23;13(2):e1005345. doi: 10.1371/journal.pcbi.1005345. eCollection 2017 Feb.
|
1526 |
Fluorescence Monitoring of the Oxidative Repair of DNA Alkylation Damage by ALKBH3, a Prostate Cancer Marker.J Am Chem Soc. 2016 Mar 23;138(11):3647-50. doi: 10.1021/jacs.6b00986. Epub 2016 Mar 15.
|
1527 |
The associations of DNA methylation alterations in oxidative stress-related genes with cancer incidence and mortality outcomes: a population-based cohort study.Clin Epigenetics. 2019 Jan 24;11(1):14. doi: 10.1186/s13148-018-0604-y.
|
1528 |
Ambra1 induces autophagy and desensitizes human prostate cancer cells to cisplatin.Biosci Rep. 2019 Aug 23;39(8):BSR20170770. doi: 10.1042/BSR20170770. Print 2019 Aug 30.
|
1529 |
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors. Oncotarget. 2015 Jul 30;6(21):18693-706.
|
1530 |
Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway.Oncogene. 2019 Apr;38(14):2516-2532. doi: 10.1038/s41388-018-0602-8. Epub 2018 Dec 7.
|
1531 |
Antigen-specific IgG elicited in subjects with prostate cancer treated with flt3 ligand.J Immunother. 2005 May-Jun;28(3):268-75. doi: 10.1097/01.cji.0000158853.15664.0c.
|
1532 |
ANKRD22 is involved in the progression of prostate cancer.Oncol Lett. 2019 Oct;18(4):4106-4113. doi: 10.3892/ol.2019.10738. Epub 2019 Aug 9.
|
1533 |
Tumor suppression and potentiation by manipulation of pp32 expression.Oncogene. 2001 Apr 19;20(17):2153-60. doi: 10.1038/sj.onc.1204294.
|
1534 |
Modulation of oncogenic potential by alternative gene use in human prostate cancer.Nat Med. 1999 Mar;5(3):275-9. doi: 10.1038/6488.
|
1535 |
Rap1-GTP-interacting adaptor molecule (RIAM) protein controls invasion and growth of melanoma cells.J Biol Chem. 2011 May 27;286(21):18492-504. doi: 10.1074/jbc.M110.189811. Epub 2011 Mar 26.
|
1536 |
Cholesterol Induces Epithelial-to-Mesenchymal Transition of Prostate Cancer Cells by Suppressing Degradation of EGFR through APMAP.Cancer Res. 2019 Jun 15;79(12):3063-3075. doi: 10.1158/0008-5472.CAN-18-3295. Epub 2019 Apr 15.
|
1537 |
APOBEC3A/B deletion polymorphism and cancer risk.Carcinogenesis. 2018 Feb 9;39(2):118-124. doi: 10.1093/carcin/bgx131.
|
1538 |
Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro.J Biochem Mol Toxicol. 2018 May 2;32(7):e22158. doi: 10.1002/jbt.22158. Online ahead of print.
|
1539 |
Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.Prostate. 2004 Feb 1;58(2):103-8. doi: 10.1002/pros.10343.
|
1540 |
The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer.Oncotarget. 2017 May 9;8(19):31215-31226. doi: 10.18632/oncotarget.16107.
|
1541 |
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence.Hum Pathol. 2016 Feb;48:102-10. doi: 10.1016/j.humpath.2015.09.026. Epub 2015 Oct 22.
|
1542 |
AQP8 inhibits colorectal cancer growth and metastasis by down-regulating PI3K/AKT signaling and PCDH7 expression.Am J Cancer Res. 2018 Feb 1;8(2):266-279. eCollection 2018.
|
1543 |
Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.Mol Carcinog. 2016 Nov;55(11):1761-1771. doi: 10.1002/mc.22425. Epub 2015 Oct 29.
|
1544 |
ARHGAP21 is a RhoGAP for RhoA and RhoC with a role in proliferation and migration of prostate adenocarcinoma cells.Biochim Biophys Acta. 2013 Feb;1832(2):365-74. doi: 10.1016/j.bbadis.2012.11.010. Epub 2012 Nov 28.
|
1545 |
Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells.Oncotarget. 2017 May 9;8(19):30992-31002. doi: 10.18632/oncotarget.16047.
|
1546 |
Phospholipase C gamma 1 regulates the Rap GEF1-Rap1 signalling axis in the control of human prostate carcinoma cell adhesion.Oncogene. 2008 May 1;27(20):2823-32. doi: 10.1038/sj.onc.1210954. Epub 2007 Nov 26.
|
1547 |
The role of katanin p60 in breast cancer bone metastasis.Oncol Lett. 2018 Apr;15(4):4963-4969. doi: 10.3892/ol.2018.7942. Epub 2018 Feb 2.
|
1548 |
Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.J Cell Biochem. 2018 Sep;119(9):7245-7255. doi: 10.1002/jcb.26913. Epub 2018 May 24.
|
1549 |
Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer.Nat Commun. 2019 Sep 24;10(1):4332. doi: 10.1038/s41467-019-12184-8.
|
1550 |
AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells.Prostate. 2018 Dec;78(16):1238-1247. doi: 10.1002/pros.23699. Epub 2018 Jul 19.
|
1551 |
ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITG4 Pathway.Curr Mol Med. 2017;17(3):221-229. doi: 10.2174/1566524017666170807144711.
|
1552 |
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis.Cancer Res. 2008 Jun 1;68(11):4352-9. doi: 10.1158/0008-5472.CAN-07-5237.
|
1553 |
Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.Clin Epigenetics. 2019 Mar 27;11(1):54. doi: 10.1186/s13148-019-0651-z.
|
1554 |
hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen.Sci Rep. 2019 Dec 13;9(1):19076. doi: 10.1038/s41598-019-55665-y.
|
1555 |
Knockdown of anti-silencing function 1B histone chaperone induces cell apoptosis via repressing PI3K/Akt pathway in prostate cancer.Int J Oncol. 2018 Nov;53(5):2056-2066. doi: 10.3892/ijo.2018.4526. Epub 2018 Aug 16.
|
1556 |
Correction: ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3--catenin signaling.Oncogene. 2019 Feb;38(8):1354. doi: 10.1038/s41388-018-0561-0.
|
1557 |
Reduced Arginyltransferase 1 is a driver and a potential prognostic indicator of prostate cancer metastasis.Oncogene. 2019 Feb;38(6):838-851. doi: 10.1038/s41388-018-0462-2. Epub 2018 Sep 3.
|
1558 |
Activation of UPR Signaling Pathway is Associated With the Malignant Progression and Poor Prognosis in Prostate Cancer.Prostate. 2017 Feb;77(3):274-281. doi: 10.1002/pros.23264. Epub 2016 Oct 8.
|
1559 |
Dynamics of Atg5-Atg12-Atg16L1 Aggregation and Deaggregation.Methods Enzymol. 2017;587:247-255. doi: 10.1016/bs.mie.2016.09.059. Epub 2016 Dec 3.
|
1560 |
Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.Oncol Rep. 2016 Jan;35(1):64-72. doi: 10.3892/or.2015.4331. Epub 2015 Oct 16.
|
1561 |
In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer.Cancer Control. 2019 Jan-Dec;26(1):1073274819846590. doi: 10.1177/1073274819846590.
|
1562 |
Salinomycin triggers endoplasmic reticulum stress through ATP2A3 upregulation in PC-3 cells.BMC Cancer. 2019 Apr 25;19(1):381. doi: 10.1186/s12885-019-5590-8.
|
1563 |
Reduced Levels of ATP Synthase Subunit ATP5F1A Correlate with Earlier-Onset Prostate Cancer.Oxid Med Cell Longev. 2018 Nov 14;2018:1347174. doi: 10.1155/2018/1347174. eCollection 2018.
|
1564 |
Ectopic expression of the ATP synthase subunit on the membrane of PC-3M cells supports its potential role in prostate cancer metastasis.Int J Oncol. 2017 Apr;50(4):1312-1320. doi: 10.3892/ijo.2017.3878. Epub 2017 Feb 16.
|
1565 |
V-ATPase-associated prorenin receptor is upregulated in prostate cancer after PTEN loss.Oncotarget. 2019 Aug 13;10(48):4923-4936. doi: 10.18632/oncotarget.27075. eCollection 2019 Aug 13.
|
1566 |
Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells.Int J Oncol. 2004 Jan;24(1):97-105.
|
1567 |
Mutations in the AXIN1 gene in advanced prostate cancer.Eur Urol. 2009 Sep;56(3):486-94. doi: 10.1016/j.eururo.2008.05.029. Epub 2008 May 23.
|
1568 |
The association between three AXIN2 variants and cancer risk.J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30.
|
1569 |
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel.J Exp Clin Cancer Res. 2017 Dec 8;36(1):178. doi: 10.1186/s13046-017-0649-3.
|
1570 |
Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.Cell Death Dis. 2017 Jun 1;8(6):e2844. doi: 10.1038/cddis.2017.226.
|
1571 |
Regulation of bombesin-stimulated cyclooxygenase-2 expression in prostate cancer cells.BMC Mol Biol. 2011 Jul 11;12:29. doi: 10.1186/1471-2199-12-29.
|
1572 |
High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.BMC Cancer. 2018 Jan 5;18(1):37. doi: 10.1186/s12885-017-3956-3.
|
1573 |
Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.Cancer Res. 2008 Apr 15;68(8):2927-33. doi: 10.1158/0008-5472.CAN-07-5759.
|
1574 |
Bcl-B expression in human epithelial and nonepithelial malignancies.Clin Cancer Res. 2008 May 15;14(10):3011-21. doi: 10.1158/1078-0432.CCR-07-1955.
|
1575 |
Expression mapping at 12p12-13 in advanced prostate carcinoma.Int J Cancer. 2004 May 1;109(5):668-72. doi: 10.1002/ijc.20060.
|
1576 |
-Carotene 9',10' Oxygenase Modulates the Anticancer Activity of Dietary Tomato or Lycopene on Prostate Carcinogenesis in the TRAMP Model.Cancer Prev Res (Phila). 2017 Feb;10(2):161-169. doi: 10.1158/1940-6207.CAPR-15-0402. Epub 2016 Nov 2.
|
1577 |
Bone mineral density, structure, distribution and strength in men with prostate cancer treated with androgen deprivation therapy.Bone. 2019 Oct;127:367-375. doi: 10.1016/j.bone.2019.06.005. Epub 2019 Jun 9.
|
1578 |
CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.J Exp Clin Cancer Res. 2017 Jun 28;36(1):90. doi: 10.1186/s13046-017-0561-x.
|
1579 |
III-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.Am J Pathol. 2014 Mar;184(3):609-17. doi: 10.1016/j.ajpath.2013.11.007. Epub 2013 Dec 28.
|
1580 |
High levels of glioma tumor suppressor candidate region gene 1 predicts a poor prognosis for prostate cancer.Oncol Lett. 2018 Nov;16(5):6749-6755. doi: 10.3892/ol.2018.9490. Epub 2018 Sep 24.
|
1581 |
Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.Oncogene. 2001 Sep 20;20(42):6073-83. doi: 10.1038/sj.onc.1204736.
|
1582 |
KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.Cell Commun Signal. 2018 Sep 3;16(1):53. doi: 10.1186/s12964-018-0270-x.
|
1583 |
Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.Int J Cancer. 2000 Apr 15;86(2):155-61. doi: 10.1002/(sici)1097-0215(20000415)86:2<155::aid-ijc2>3.0.co;2-m.
|
1584 |
Germline BLM mutations and metastatic prostate cancer.Prostate. 2020 Feb;80(2):235-237. doi: 10.1002/pros.23924. Epub 2019 Nov 5.
|
1585 |
Sequence and expression of bone morphogenetic protein 3 mRNA in prolonged cultures of fetal rat calvarial osteoblasts and in rat prostate adenocarcinoma PA III cells.DNA Cell Biol. 1995 Mar;14(3):235-9. doi: 10.1089/dna.1995.14.235.
|
1586 |
A miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in China.Mol Biol Rep. 2012 Jan;39(1):369-73. doi: 10.1007/s11033-011-0747-9. Epub 2011 May 10.
|
1587 |
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.Oncogene. 2020 Feb;39(8):1797-1806. doi: 10.1038/s41388-019-1106-x. Epub 2019 Nov 18.
|
1588 |
Breast cancer metastasis suppressor 1 (BRMS1) suppresses prostate cancer progression by inducing apoptosis and regulating invasion.Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):68-75.
|
1589 |
Multi-lectin Affinity Chromatography and Quantitative Proteomic Analysis Reveal Differential Glycoform Levels between Prostate Cancer and Benign Prostatic Hyperplasia Sera.Sci Rep. 2018 Apr 25;8(1):6509. doi: 10.1038/s41598-018-24270-w.
|
1590 |
BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.J Exp Clin Cancer Res. 2019 May 28;38(1):227. doi: 10.1186/s13046-019-1222-z.
|
1591 |
New Insights into the Binding Mechanism of Co-regulator BUD31 to AR AF2 Site: Structural Determination and Analysis of the Mutation Effect.Curr Comput Aided Drug Des. 2020;16(1):45-53. doi: 10.2174/1573409915666190502153307.
|
1592 |
O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer.FASEB J. 2018 Jun 15:fj201800687. doi: 10.1096/fj.201800687. Online ahead of print.
|
1593 |
Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.BMC Cancer. 2017 Jun 26;17(1):447. doi: 10.1186/s12885-017-3413-3.
|
1594 |
Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.J Pathol. 2007 Aug;212(4):395-401. doi: 10.1002/path.2186.
|
1595 |
RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.EBioMedicine. 2018 Jun;32:234-244. doi: 10.1016/j.ebiom.2018.05.010. Epub 2018 Jun 1.
|
1596 |
Clinical significance of SCCRO (DCUN1D1) in prostate cancer and its proliferation-inhibiting effect on Lncap cells.Eur Rev Med Pharmacol Sci. 2017 Oct;21(19):4283-4291.
|
1597 |
Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.Jpn J Cancer Res. 2002 Jun;93(6):605-9. doi: 10.1111/j.1349-7006.2002.tb01297.x.
|
1598 |
Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.Clin Cancer Res. 2010 Nov 15;16(22):5390-401. doi: 10.1158/1078-0432.CCR-10-1461. Epub 2010 Nov 9.
|
1599 |
Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.Semin Oncol. 1999 Apr;26(2):227-33.
|
1600 |
Repeatability of radiomics and machine learning for DWI: Short-term repeatability study of 112 patients with prostate cancer.Magn Reson Med. 2020 Jun;83(6):2293-2309. doi: 10.1002/mrm.28058. Epub 2019 Nov 8.
|
1601 |
NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy.J Clin Med. 2019 Mar 31;8(4):442. doi: 10.3390/jcm8040442.
|
1602 |
Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/-catenin signaling.Biomed Pharmacother. 2018 Dec;108:467-475. doi: 10.1016/j.biopha.2018.09.019. Epub 2018 Sep 18.
|
1603 |
Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.Mol Cancer. 2019 Nov 26;18(1):170. doi: 10.1186/s12943-019-1096-x.
|
1604 |
The complex genetic epidemiology of prostate cancer.Hum Mol Genet. 2004 Apr 1;13 Spec No 1:R103-21. doi: 10.1093/hmg/ddh072. Epub 2004 Jan 28.
|
1605 |
Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy?.J Urol. 2018 Jun;199(6):1502-1509. doi: 10.1016/j.juro.2017.12.056. Epub 2018 Jan 4.
|
1606 |
Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.PLoS One. 2015 May 5;10(5):e0126056. doi: 10.1371/journal.pone.0126056. eCollection 2015.
|
1607 |
The migration and invasion of human prostate cancer cell lines involves CD151 expression.Oncol Rep. 2010 Dec;24(6):1593-7. doi: 10.3892/or_00001022.
|
1608 |
Heterochromatin Protein 1 Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer.Cancer Res. 2018 May 15;78(10):2691-2704. doi: 10.1158/0008-5472.CAN-17-3677. Epub 2018 Feb 27.
|
1609 |
Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity.J Biol Chem. 2009 Mar 13;284(11):6832-40. doi: 10.1074/jbc.M808988200. Epub 2009 Jan 5.
|
1610 |
Modifier locus mapping of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans.BMC Genomics. 2018 Jun 11;19(1):450. doi: 10.1186/s12864-018-4827-2.
|
1611 |
Expression and functional role of CCR9 in prostate cancer cell migration and invasion.Clin Cancer Res. 2004 Dec 15;10(24):8743-50. doi: 10.1158/1078-0432.CCR-04-0266.
|
1612 |
Circ_KATNAL1 regulates prostate cancer cell growth and invasiveness through the miR-145-3p/WISP1 pathway.Biochem Cell Biol. 2020 Jun;98(3):396-404. doi: 10.1139/bcb-2019-0211. Epub 2019 Dec 4.
|
1613 |
Cyclin A1 and P450 Aromatase Promote Metastatic Homing and Growth of Stem-like Prostate Cancer Cells in the Bone Marrow.Cancer Res. 2016 Apr 15;76(8):2453-64. doi: 10.1158/0008-5472.CAN-15-2340. Epub 2016 Feb 26.
|
1614 |
MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.Tumour Biol. 2018 Nov;40(11):1010428318803011. doi: 10.1177/1010428318803011.
|
1615 |
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancer.Int J Cancer. 2017 Oct 15;141(8):1643-1653. doi: 10.1002/ijc.30864. Epub 2017 Jul 12.
|
1616 |
Randomised Phase II Feasibility Trial of Image-guided External Beam Radiotherapy With or Without High Dose Rate Brachytherapy Boost in Men with Intermediate-risk Prostate Cancer (CCTG PR15/ NCT01982786).Clin Oncol (R Coll Radiol). 2018 Sep;30(9):527-533. doi: 10.1016/j.clon.2018.05.007. Epub 2018 Jun 11.
|
1617 |
Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.Eur J Med Chem. 2017 Aug 18;136:212-222. doi: 10.1016/j.ejmech.2017.05.017. Epub 2017 May 5.
|
1618 |
Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells.Oncol Rep. 2010 Jun;23(6):1501-16. doi: 10.3892/or_00000789.
|
1619 |
Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.Prostate. 2006 Feb 1;66(2):135-45. doi: 10.1002/pros.20310.
|
1620 |
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression.Cell Rep. 2018 Mar 13;22(11):3006-3020. doi: 10.1016/j.celrep.2018.02.058.
|
1621 |
Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.Clin Cancer Res. 2006 Mar 1;12(5):1412-9. doi: 10.1158/1078-0432.CCR-05-1906.
|
1622 |
A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.Nucleic Acids Res. 2003 May 1;31(9):2272-8. doi: 10.1093/nar/gkg337.
|
1623 |
Androgen regulation of the human pseudoautosomal gene MIC2, a potential marker for prostate cancer.Mol Carcinog. 1998 Sep;23(1):13-9.
|
1624 |
Oncogenic Properties of NEAT1 in Prostate Cancer Cells Depend on the CDC5L-AGRN Transcriptional Regulation Circuit.Cancer Res. 2018 Aug 1;78(15):4138-4149. doi: 10.1158/0008-5472.CAN-18-0688. Epub 2018 Jun 5.
|
1625 |
R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.Mol Cancer Res. 2018 Dec;16(12):1940-1951. doi: 10.1158/1541-7786.MCR-16-0346. Epub 2018 Jul 24.
|
1626 |
Regulation of inside-out 1-integrin activation by CDCP1.Oncogene. 2018 May;37(21):2817-2836. doi: 10.1038/s41388-018-0142-2. Epub 2018 Mar 7.
|
1627 |
Gene panel model predictive of outcome in men at high-risk of systemic progression and death from prostate cancer after radical retropubic prostatectomy.J Clin Oncol. 2008 Aug 20;26(24):3930-6. doi: 10.1200/JCO.2007.15.6752.
|
1628 |
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.J Exp Clin Cancer Res. 2018 Sep 5;37(1):219. doi: 10.1186/s13046-018-0895-z.
|
1629 |
Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.Prostate. 2009 Oct 1;69(14):1586-97. doi: 10.1002/pros.21007.
|
1630 |
Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):558-65. doi: 10.1158/1055-9965.EPI-09-0902.
|
1631 |
Cyclin-dependent kinase inhibitor 3 (CDKN3) plays a critical role in prostate cancer via regulating cell cycle and DNA replication signaling.Biomed Pharmacother. 2017 Dec;96:1109-1118. doi: 10.1016/j.biopha.2017.11.112. Epub 2017 Nov 28.
|
1632 |
Challenges in optimizing a prostate carcinoma binding peptide, identified through the phage display technology.Molecules. 2011 Feb 14;16(2):1559-78. doi: 10.3390/molecules16021559.
|
1633 |
Long noncoding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR?656 to modulate CEMIP expression.Oncol Rep. 2020 Jan;43(1):328-336. doi: 10.3892/or.2019.7404. Epub 2019 Nov 8.
|
1634 |
Mapping Complex Traits in a Diversity Outbred F1 Mouse Population Identifies Germline Modifiers of Metastasis in Human Prostate Cancer.Cell Syst. 2017 Jan 25;4(1):31-45.e6. doi: 10.1016/j.cels.2016.10.018. Epub 2016 Dec 1.
|
1635 |
MicroRNA-144-3p inhibits cell proliferation and induces cell apoptosis in prostate cancer by targeting CEP55.Am J Transl Res. 2018 Aug 15;10(8):2457-2468. eCollection 2018.
|
1636 |
Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation.Mol Cancer Ther. 2018 Sep;17(9):1927-1940. doi: 10.1158/1535-7163.MCT-17-1138. Epub 2018 Jun 11.
|
1637 |
DNA methylation and immunohistochemical analysis of the S100A4 calcium binding protein in human prostate cancer.Prostate. 2007 Mar 1;67(4):341-7. doi: 10.1002/pros.20401.
|
1638 |
DC-SCRIPT: AR and VDR regulator lost upon transformation of prostate epithelial cells.Prostate. 2012 Dec 1;72(16):1708-17. doi: 10.1002/pros.22522. Epub 2012 Apr 2.
|
1639 |
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.Bioorg Chem. 2019 Dec;93:103317. doi: 10.1016/j.bioorg.2019.103317. Epub 2019 Sep 26.
|
1640 |
Ursolic acid activates the apoptosis of prostate cancer via ROCK/PTEN mediated mitochondrial translocation of cofilin-1.Oncol Lett. 2018 Mar;15(3):3202-3206. doi: 10.3892/ol.2017.7689. Epub 2017 Dec 27.
|
1641 |
Long noncoding RNA SOX2-OT facilitates prostate cancer cell proliferation and migration via miR-369-3p/CFL2 axis.Biochem Biophys Res Commun. 2019 Dec 10;520(3):586-593. doi: 10.1016/j.bbrc.2019.09.108. Epub 2019 Oct 14.
|
1642 |
Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes.Oncotarget. 2017 Jan 3;8(1):1495-1507. doi: 10.18632/oncotarget.13646.
|
1643 |
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.Cancer Cell. 2019 Apr 15;35(4):603-617.e8. doi: 10.1016/j.ccell.2019.03.001. Epub 2019 Mar 28.
|
1644 |
Frequent disruption of chromodomain helicase DNA-binding protein 8 (CHD8) and functionally associated chromatin regulators in prostate cancer. Neoplasia. 2014 Dec;16(12):1018-27. doi: 10.1016/j.neo.2014.10.003.
|
1645 |
Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer.Sci Rep. 2017 Feb 17;7:42961. doi: 10.1038/srep42961.
|
1646 |
Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer.Int J Oncol. 2018 Sep;53(3):1279-1288. doi: 10.3892/ijo.2018.4464. Epub 2018 Jun 29.
|
1647 |
Down-regulating cold shock protein genes impairs cancer cell survival and enhances chemosensitivity.J Cell Biochem. 2009 May 1;107(1):179-88. doi: 10.1002/jcb.22114.
|
1648 |
p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.Oncogene. 2017 Jan 5;36(1):60-70. doi: 10.1038/onc.2016.175. Epub 2016 May 16.
|
1649 |
CLCA2 epigenetic regulation by CTBP1, HDACs, ZEB1, EP300 and miR-196b-5p impacts prostate cancer cell adhesion and EMT in metabolic syndrome disease.Int J Cancer. 2018 Aug 15;143(4):897-906. doi: 10.1002/ijc.31379. Epub 2018 Mar 30.
|
1650 |
CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration.Cancer Sci. 2017 Jul;108(7):1386-1393. doi: 10.1111/cas.13269. Epub 2017 Jun 2.
|
1651 |
Disruption by SaCas9 Endonuclease of HERV-Kenv, a Retroviral Gene with Oncogenic and Neuropathogenic Potential, Inhibits Molecules Involved in Cancer and Amyotrophic Lateral Sclerosis.Viruses. 2018 Aug 7;10(8):412. doi: 10.3390/v10080412.
|
1652 |
Heritable methylation marks associated with breast and prostate cancer risk.Prostate. 2018 Sep;78(13):962-969. doi: 10.1002/pros.23654. Epub 2018 May 29.
|
1653 |
Age-related DNA methylation changes in normal human prostate tissues.Clin Cancer Res. 2007 Jul 1;13(13):3796-802. doi: 10.1158/1078-0432.CCR-07-0085.
|
1654 |
Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.J Nanosci Nanotechnol. 2019 Apr 1;19(4):1942-1950. doi: 10.1166/jnn.2019.16404.
|
1655 |
COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.Proc Natl Acad Sci U S A. 2018 May 8;115(19):4975-4980. doi: 10.1073/pnas.1721957115. Epub 2018 Apr 23.
|
1656 |
Screening and identification of key biomarkers in prostate cancer using bioinformatics.Mol Med Rep. 2020 Jan;21(1):311-319. doi: 10.3892/mmr.2019.10799. Epub 2019 Nov 6.
|
1657 |
Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.Mol Cancer Res. 2010 Jan;8(1):119-30. doi: 10.1158/1541-7786.MCR-09-0277. Epub 2010 Jan 12.
|
1658 |
COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer.Mol Cancer Ther. 2019 Nov;18(11):2111-2123. doi: 10.1158/1535-7163.MCT-19-0150. Epub 2019 Aug 29.
|
1659 |
Cartilage oligomeric matrix protein in patients with osteoarthritis is independently associated with metastatic disease in prostate cancer.Oncotarget. 2019 Jul 30;10(46):4776-4785. doi: 10.18632/oncotarget.27113. eCollection 2019 Jul 30.
|
1660 |
Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.Biochem Biophys Res Commun. 2018 Jan 1;495(1):473-480. doi: 10.1016/j.bbrc.2017.11.040. Epub 2017 Nov 10.
|
1661 |
Silencing of MALAT1 inhibits migration and invasion by sponging miR??p in prostate cancer cells.Mol Med Rep. 2019 Oct;20(4):3499-3508. doi: 10.3892/mmr.2019.10602. Epub 2019 Aug 22.
|
1662 |
Identification of PCAG1 as a novel prostate cancer-associated gene.Mol Med Rep. 2013 Mar;7(3):755-60. doi: 10.3892/mmr.2012.1249. Epub 2012 Dec 24.
|
1663 |
CPNE1 Is a Useful Prognostic Marker and Is Associated with TNF Receptor-Associated Factor 2 (TRAF2) Expression in Prostate Cancer.Med Sci Monit. 2017 Nov 19;23:5504-5514. doi: 10.12659/msm.904720.
|
1664 |
Cellular retinoic acid-binding protein 2 is down-regulated in prostate cancer.Int J Oncol. 2005 Nov;27(5):1273-82.
|
1665 |
The role of CREB3L4 in the proliferation of prostate cancer cells.Sci Rep. 2017 Mar 24;7:45300. doi: 10.1038/srep45300.
|
1666 |
CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer.Cell Rep. 2019 Nov 19;29(8):2355-2370.e6. doi: 10.1016/j.celrep.2019.10.068.
|
1667 |
The expression of inducible cAMP early repressor (ICER) is altered in prostate cancer cells and reverses the transformed phenotype of the LNCaP prostate tumor cell line.Cancer Res. 2001 Aug 15;61(16):6055-9.
|
1668 |
Androgen receptor mediated epigenetic regulation of CRISP3 promoter in prostate cancer cells.J Steroid Biochem Mol Biol. 2018 Jul;181:20-27. doi: 10.1016/j.jsbmb.2018.02.012. Epub 2018 Feb 22.
|
1669 |
Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer.Cell Signal. 2010 Dec;22(12):1874-81. doi: 10.1016/j.cellsig.2010.07.015. Epub 2010 Aug 2.
|
1670 |
Peptide T7-modified polypeptide with disulfide bonds for targeted delivery of plasmid DNA for gene therapy of prostate cancer.Int J Nanomedicine. 2018 Oct 30;13:6913-6927. doi: 10.2147/IJN.S180957. eCollection 2018.
|
1671 |
Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer. Oncogene. 2009 Aug 6;28(31):2829-38. doi: 10.1038/onc.2009.134. Epub 2009 Jun 8.
|
1672 |
CTHRC1 and PD?/PDL1 expression predicts tumor recurrence in prostate cancer.Mol Med Rep. 2019 Nov;20(5):4244-4252. doi: 10.3892/mmr.2019.10690. Epub 2019 Sep 19.
|
1673 |
Links between Fer tyrosine kinase expression levels and prostate cell proliferation.Mol Cell Endocrinol. 2000 Jan 25;159(1-2):63-77. doi: 10.1016/s0303-7207(99)00205-1.
|
1674 |
Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.Proteomics. 2019 Nov;19(21-22):e1900174. doi: 10.1002/pmic.201900174. Epub 2019 Oct 20.
|
1675 |
The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.Int J Mol Sci. 2019 May 21;20(10):2496. doi: 10.3390/ijms20102496.
|
1676 |
Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties.J Cell Physiol. 2018 Dec;233(12):9247-9260. doi: 10.1002/jcp.27029. Epub 2018 Aug 4.
|
1677 |
Chemokine CXCL3 mediates prostate cancer cells proliferation, migration and gene expression changes in an autocrine/paracrine fashion.Int Urol Nephrol. 2018 May;50(5):861-868. doi: 10.1007/s11255-018-1818-9. Epub 2018 Mar 9.
|
1678 |
Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.J Clin Invest. 2018 Jan 2;128(1):248-266. doi: 10.1172/JCI92466. Epub 2017 Nov 27.
|
1679 |
Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.Eur Urol. 2020 Jan;77(1):78-94. doi: 10.1016/j.eururo.2019.06.023. Epub 2019 Jul 18.
|
1680 |
MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression.Int J Biol Macromol. 2019 Mar 15;125:557-565. doi: 10.1016/j.ijbiomac.2018.12.088. Epub 2018 Dec 10.
|
1681 |
A potential clinical significance of DAB2IP and SPRY2 transcript variants in prostate cancer.Pathol Res Pract. 2018 Dec;214(12):2018-2024. doi: 10.1016/j.prp.2018.09.019. Epub 2018 Sep 29.
|
1682 |
The cell fate determination factor dachshund inhibits androgen receptor signaling and prostate cancer cellular growth.Cancer Res. 2009 Apr 15;69(8):3347-55. doi: 10.1158/0008-5472.CAN-08-3821. Epub 2009 Apr 7.
|
1683 |
Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer.J Cancer. 2019 Apr 20;10(7):1755-1763. doi: 10.7150/jca.28577. eCollection 2019.
|
1684 |
The drebrin/EB3 pathway drives invasive activity in prostate cancer.Oncogene. 2017 Jul 20;36(29):4111-4123. doi: 10.1038/onc.2017.45. Epub 2017 Mar 20.
|
1685 |
Novel centrosome protein, TCC52, is a cancer-testis antigen.Cancer Sci. 2008 Nov;99(11):2274-9. doi: 10.1111/j.1349-7006.2008.00937.x. Epub 2008 Oct 14.
|
1686 |
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.Adv Exp Med Biol. 1997;407:41-53. doi: 10.1007/978-1-4899-1813-0_7.
|
1687 |
Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools.Anticancer Agents Med Chem. 2019;19(10):1262-1275. doi: 10.2174/1871520619666190318152726.
|
1688 |
Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes.Cancer Res. 2003 May 15;63(10):2470-6.
|
1689 |
Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.Hum Mutat. 2014 Sep;35(9):1142-51. doi: 10.1002/humu.22614. Epub 2014 Jul 23.
|
1690 |
High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-B pathway.Int J Mol Med. 2016 Jun;37(6):1551-7. doi: 10.3892/ijmm.2016.2575. Epub 2016 Apr 25.
|
1691 |
The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.Biochem Biophys Res Commun. 2017 Jan 29;483(1):271-276. doi: 10.1016/j.bbrc.2016.12.153. Epub 2016 Dec 23.
|
1692 |
Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.Am J Pathol. 2019 Jun;189(6):1256-1267. doi: 10.1016/j.ajpath.2019.02.011. Epub 2019 Mar 27.
|
1693 |
Hyaluronan stimulates transformation of androgen-independent prostate cancer.Carcinogenesis. 2007 Feb;28(2):310-20. doi: 10.1093/carcin/bgl134. Epub 2006 Jul 24.
|
1694 |
p68/DdX5 supports -catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.PLoS One. 2013;8(1):e54150. doi: 10.1371/journal.pone.0054150. Epub 2013 Jan 17.
|
1695 |
DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells.PLoS One. 2016 Nov 11;11(11):e0166664. doi: 10.1371/journal.pone.0166664. eCollection 2016.
|
1696 |
Genetic variants of the copy number polymorphic beta-defensin locus are associated with sporadic prostate cancer.Tumour Biol. 2008;29(2):83-92. doi: 10.1159/000135688. Epub 2008 Jun 2.
|
1697 |
High levels of DEPDC1B predict shorter biochemical recurrence-free survival of patients with prostate cancer.Oncol Lett. 2017 Dec;14(6):6801-6808. doi: 10.3892/ol.2017.7027. Epub 2017 Sep 22.
|
1698 |
Reliable identification of prostate cancer using mass spectrometry metabolomic imaging in needle core biopsies.Lab Invest. 2019 Oct;99(10):1561-1571. doi: 10.1038/s41374-019-0265-2. Epub 2019 Jun 3.
|
1699 |
Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene.Nat Biotechnol. 2017 Jun;35(6):543-550. doi: 10.1038/nbt.3843. Epub 2017 May 1.
|
1700 |
Long noncoding RNA TUG1 promotes progression via upregulating DGCR8 in prostate cancer.Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2391-2398. doi: 10.26355/eurrev_201903_17385.
|
1701 |
Lymphadenectomy in Gleason 7 prostate cancer: Adherence to guidelines and effect on clinical outcomes.Urol Oncol. 2018 Jan;36(1):13.e11-13.e18. doi: 10.1016/j.urolonc.2017.08.023. Epub 2017 Sep 14.
|
1702 |
DHX15 is up-regulated in castration-resistant prostate cancer and required for androgen receptor sensitivity to low DHT concentrations.Prostate. 2019 May;79(6):657-666. doi: 10.1002/pros.23773. Epub 2019 Feb 3.
|
1703 |
Identification of TWIST-interacting genes in prostate cancer.Sci China Life Sci. 2017 Apr;60(4):386-396. doi: 10.1007/s11427-016-0262-6. Epub 2017 Jan 22.
|
1704 |
The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance.Oncogene. 2019 May;38(22):4412-4424. doi: 10.1038/s41388-019-0712-y. Epub 2019 Feb 11.
|
1705 |
MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.Cancer Prev Res (Phila). 2011 Jan;4(1):76-86. doi: 10.1158/1940-6207.CAPR-10-0167. Epub 2010 Nov 11.
|
1706 |
Increased DKC1 expression in glioma and its significance in tumor cell proliferation, migration and invasion.Invest New Drugs. 2019 Dec;37(6):1177-1186. doi: 10.1007/s10637-019-00748-w. Epub 2019 Mar 7.
|
1707 |
DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion.Oncogene. 2014 Feb 6;33(6):724-33. doi: 10.1038/onc.2013.7. Epub 2013 Feb 4.
|
1708 |
Identification of new octamer transcription factor 1-target genes upregulated in castration-resistant prostate cancer.Cancer Sci. 2019 Nov;110(11):3476-3485. doi: 10.1111/cas.14183. Epub 2019 Sep 16.
|
1709 |
Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function.Mol Endocrinol. 2005 Sep;19(9):2273-82. doi: 10.1210/me.2005-0134. Epub 2005 May 26.
|
1710 |
Loss of heterozygosity on 8p in prostate cancer implicates a role for dematin in tumor progression.Cancer Genet Cytogenet. 1999 Nov;115(1):65-9. doi: 10.1016/s0165-4608(99)00081-3.
|
1711 |
High Norwegian prostate cancer mortality: evidence of over-reporting.Scand J Urol. 2018 Apr;52(2):122-128. doi: 10.1080/21681805.2017.1421260. Epub 2018 Jan 11.
|
1712 |
The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.Cancer Res. 2005 Nov 1;65(21):9906-13. doi: 10.1158/0008-5472.CAN-05-1481.
|
1713 |
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079.
|
1714 |
miR-214-5p inhibits human prostate cancer proliferation and migration through regulating CRMP5.Cancer Biomark. 2019;26(2):193-202. doi: 10.3233/CBM-190128.
|
1715 |
Differentiation-related gene-1 decreases Bim stability by proteasome-mediated degradation.Cancer Res. 2009 Aug 1;69(15):6115-21. doi: 10.1158/0008-5472.CAN-08-3024. Epub 2009 Jul 21.
|
1716 |
Generation and characterization of a specific single-chain antibody against DSPP as a prostate cancer biomarker: Involvement of bioinformatics-based design of novel epitopes.Int Immunopharmacol. 2019 Apr;69:217-224. doi: 10.1016/j.intimp.2019.01.016. Epub 2019 Feb 6.
|
1717 |
DUSP22 suppresses prostate cancer proliferation by targeting the EGFR-AR axis.FASEB J. 2019 Dec;33(12):14653-14667. doi: 10.1096/fj.201802558RR. Epub 2019 Nov 5.
|
1718 |
Upregulation and overexpression of DVL1, the human counterpart of the Drosophila dishevelled gene, in prostate cancer.Tumori. 2005 Nov-Dec;91(6):546-51. doi: 10.1177/030089160509100616.
|
1719 |
Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.Int J Mol Med. 2018 Apr;41(4):2429-2433. doi: 10.3892/ijmm.2018.3421. Epub 2018 Jan 23.
|
1720 |
Extracellular vesicle-mediated EBAG9 transfer from cancer cells to tumor microenvironment promotes immune escape and tumor progression.Oncogenesis. 2018 Jan 24;7(1):7. doi: 10.1038/s41389-017-0022-6.
|
1721 |
HNF1B expression regulates ECI2 gene expression, potentially serving a role in prostate cancer progression.Oncol Lett. 2019 Jan;17(1):1094-1100. doi: 10.3892/ol.2018.9677. Epub 2018 Nov 8.
|
1722 |
Protective effect of stromal Dickkopf-3 in prostate cancer: opposing roles for TGFBI and ECM-1.Oncogene. 2018 Sep;37(39):5305-5324. doi: 10.1038/s41388-018-0294-0. Epub 2018 Jun 1.
|
1723 |
Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer.Med Oncol. 2017 Jan;34(1):13. doi: 10.1007/s12032-016-0872-3. Epub 2016 Dec 23.
|
1724 |
Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.EBioMedicine. 2016 Jun;8:103-116. doi: 10.1016/j.ebiom.2016.04.018. Epub 2016 Apr 20.
|
1725 |
Dissecting the expression of EEF1A1/2 genes in human prostate cancer cells: the potential of EEF1A2 as a hallmark for prostate transformation and progression.Br J Cancer. 2012 Jan 3;106(1):166-73. doi: 10.1038/bjc.2011.500. Epub 2011 Nov 17.
|
1726 |
The EEF1A2 gene expression as risk predictor in localized prostate cancer.BMC Urol. 2017 Sep 18;17(1):86. doi: 10.1186/s12894-017-0278-3.
|
1727 |
Eukaryotic Elongation Factor 2 (eEF2) is a Potential Biomarker of Prostate Cancer.Pathol Oncol Res. 2018 Oct;24(4):885-890. doi: 10.1007/s12253-017-0302-7. Epub 2017 Sep 14.
|
1728 |
Chronic hypoxia-induced slug promotes invasive behavior of prostate cancer cells by activating expression of ephrin-B1.Cancer Sci. 2018 Oct;109(10):3159-3170. doi: 10.1111/cas.13754. Epub 2018 Aug 29.
|
1729 |
Overexpressing miR?35 inhibits DU145 cell proliferation by targeting early growth response 3 in prostate cancer.Int J Oncol. 2019 Jun;54(6):1981-1994. doi: 10.3892/ijo.2019.4778. Epub 2019 Apr 9.
|
1730 |
Increased expression of EHF contributes to thyroid tumorigenesis through transcriptionally regulating HER2 and HER3.Oncotarget. 2016 Sep 6;7(36):57978-57990. doi: 10.18632/oncotarget.11154.
|
1731 |
Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells.Bone Joint Res. 2017 Mar;6(3):186-193. doi: 10.1302/2046-3758.63.BJR-2016-0151.R2.
|
1732 |
Androgen upregulates the palmitoylation of eIF3L in human prostate LNCaP cells.Onco Targets Ther. 2019 Jun 5;12:4451-4459. doi: 10.2147/OTT.S193480. eCollection 2019.
|
1733 |
Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.J Biol Chem. 2018 Nov 30;293(48):18624-18635. doi: 10.1074/jbc.RA118.003352. Epub 2018 Oct 12.
|
1734 |
ELF5-Mediated AR Activation Regulates Prostate Cancer Progression.Sci Rep. 2017 Mar 13;7:42759. doi: 10.1038/srep42759.
|
1735 |
Development of a reactive stroma associated with prostatic intraepithelial neoplasia in EAF2 deficient mice.PLoS One. 2013 Nov 18;8(11):e79542. doi: 10.1371/journal.pone.0079542. eCollection 2013.
|
1736 |
ELL2 regulates DNA non-homologous end joining (NHEJ) repair in prostate cancer cells.Cancer Lett. 2018 Feb 28;415:198-207. doi: 10.1016/j.canlet.2017.11.028. Epub 2017 Nov 26.
|
1737 |
The chromatin remodeling protein BRG1 links ELOVL3 trans-activation to prostate cancer metastasis.Biochim Biophys Acta Gene Regul Mech. 2019 Aug;1862(8):834-845. doi: 10.1016/j.bbagrm.2019.05.005. Epub 2019 May 30.
|
1738 |
Maximizing RNA Loading for Gene Silencing Using Porous Silicon Nanoparticles.ACS Appl Mater Interfaces. 2019 Jul 3;11(26):22993-23005. doi: 10.1021/acsami.9b05577. Epub 2019 Jun 24.
|
1739 |
Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism.Cancer Res. 2009 Oct 15;69(20):8133-40. doi: 10.1158/0008-5472.CAN-09-0775. Epub 2009 Oct 13.
|
1740 |
Emerin Deregulation Links Nuclear Shape Instability to Metastatic Potential.Cancer Res. 2018 Nov 1;78(21):6086-6097. doi: 10.1158/0008-5472.CAN-18-0608. Epub 2018 Aug 28.
|
1741 |
Is Engrailed-2 (EN2) a truly promising biomarker in prostate cancer detection?.Biomarkers. 2020 Feb;25(1):34-39. doi: 10.1080/1354750X.2019.1690047. Epub 2019 Nov 14.
|
1742 |
Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation.Cancer Lett. 2008 Oct 18;270(1):132-43. doi: 10.1016/j.canlet.2008.04.053. Epub 2008 Jun 18.
|
1743 |
PCPH/ENTPD5 expression confers to prostate cancer cells resistance against cisplatin-induced apoptosis through protein kinase Calpha-mediated Bcl-2 stabilization.Cancer Res. 2009 Jan 1;69(1):102-10. doi: 10.1158/0008-5472.CAN-08-2922.
|
1744 |
Factor interaction analysis for chromosome 8 and DNA methylation alterations highlights innate immune response suppression and cytoskeletal changes in prostate cancer.Mol Cancer. 2007 Feb 5;6:14. doi: 10.1186/1476-4598-6-14.
|
1745 |
Clinical implications of the influence of Ehm2 on the aggressiveness of breast cancer cells through regulation of matrix metalloproteinase-9 expression.Mol Cancer Res. 2010 Nov;8(11):1501-12. doi: 10.1158/1541-7786.MCR-10-0186. Epub 2010 Oct 5.
|
1746 |
Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.J Urol. 2007 May;177(5):1753-8. doi: 10.1016/j.juro.2007.01.010.
|
1747 |
Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer.BMC Cancer. 2017 Jul 26;17(1):504. doi: 10.1186/s12885-017-3489-9.
|
1748 |
From androgen receptor to the general transcription factor TFIIH. Identification of cdk activating kinase (CAK) as an androgen receptor NH(2)-terminal associated coactivator.J Biol Chem. 2000 Mar 31;275(13):9308-13. doi: 10.1074/jbc.275.13.9308.
|
1749 |
PTX1(ERGIC2)-VP22 fusion protein upregulates interferon-beta in prostate cancer cell line PC-3.DNA Cell Biol. 2006 Sep;25(9):523-9. doi: 10.1089/dna.2006.25.523.
|
1750 |
Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes.Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3030-5. doi: 10.1158/1055-9965.EPI-09-0772. Epub 2009 Oct 27.
|
1751 |
Loss of endothelial cell-specific molecule 1 promotes the tumorigenicity and metastasis of prostate cancer cells through regulation of the TIMP-1/MMP-9 expression.Oncotarget. 2017 Feb 21;8(8):13886-13897. doi: 10.18632/oncotarget.14684.
|
1752 |
Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.Bioorg Med Chem. 2018 Sep 1;26(16):4751-4760. doi: 10.1016/j.bmc.2018.08.018. Epub 2018 Aug 13.
|
1753 |
Cooperation between ETS variant 2 and Jumonji domaincontaining 2 histone demethylases.Mol Med Rep. 2018 Apr;17(4):5518-5527. doi: 10.3892/mmr.2018.8507. Epub 2018 Jan 26.
|
1754 |
Meta-analysis of metabolic syndrome and prostate cancer.Prostate Cancer Prostatic Dis. 2017 Jun;20(2):146-155. doi: 10.1038/pcan.2017.1. Epub 2017 Feb 21.
|
1755 |
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.Prostate. 2020 Jan;80(1):38-50. doi: 10.1002/pros.23914. Epub 2019 Oct 4.
|
1756 |
Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis.Oncogene. 2020 Feb;39(6):1246-1259. doi: 10.1038/s41388-019-1061-6. Epub 2019 Oct 15.
|
1757 |
Family with sequence similarity 13C (FAM13C) overexpression is an independent prognostic marker in prostate cancer.Oncotarget. 2017 May 9;8(19):31494-31508. doi: 10.18632/oncotarget.16357.
|
1758 |
FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.J Cell Mol Med. 2019 Feb;23(2):1375-1385. doi: 10.1111/jcmm.14040. Epub 2018 Dec 18.
|
1759 |
The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).IUBMB Life. 2017 Jan;69(1):16-21. doi: 10.1002/iub.1585. Epub 2016 Nov 10.
|
1760 |
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.Hum Mol Genet. 2013 Jan 15;22(2):408-15. doi: 10.1093/hmg/dds425. Epub 2012 Oct 12.
|
1761 |
Identification of Fibulin-1 as a Human Bone Marrow Stromal (HS-5) Cell-Derived Factor That Induces Human Prostate Cancer Cell Death.Prostate. 2017 May;77(7):729-742. doi: 10.1002/pros.23303. Epub 2017 Feb 7.
|
1762 |
The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.Cell Cycle. 2019 Oct;18(19):2432-2446. doi: 10.1080/15384101.2019.1648956. Epub 2019 Aug 25.
|
1763 |
Downregulation of IgG Fc binding protein (Fc gammaBP) in prostate cancer.Cancer Biol Ther. 2008 Jan;7(1):70-5. doi: 10.4161/cbt.7.1.5131. Epub 2007 Oct 8.
|
1764 |
Expression of FGD4 positively correlates with the aggressive phenotype of prostate cancer.BMC Cancer. 2018 Dec 17;18(1):1257. doi: 10.1186/s12885-018-5096-9.
|
1765 |
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer.Urol Oncol. 2018 Aug;36(8):365.e15-365.e26. doi: 10.1016/j.urolonc.2018.05.020. Epub 2018 Jun 7.
|
1766 |
FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.Prostate. 2004 Jun 15;60(1):18-24. doi: 10.1002/pros.20026.
|
1767 |
Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.Differentiation. 2007 Nov;75(9):831-42. doi: 10.1111/j.1432-0436.2007.00210.x. Epub 2007 Aug 14.
|
1768 |
Alternol eliminates excessive ATP production by disturbing Krebs cycle in prostate cancer.Prostate. 2019 May;79(6):628-639. doi: 10.1002/pros.23767. Epub 2019 Jan 20.
|
1769 |
The FHL2 regulation in the transcriptional circuitry of human cancers.Gene. 2015 Nov 1;572(1):1-7. doi: 10.1016/j.gene.2015.07.043. Epub 2015 Jul 26.
|
1770 |
Increasing of FKBP9 can predict poor prognosis in patients with prostate cancer.Pathol Res Pract. 2020 Jan;216(1):152732. doi: 10.1016/j.prp.2019.152732. Epub 2019 Nov 11.
|
1771 |
Locus-specific gene repositioning in prostate cancer.Mol Biol Cell. 2016 Jan 15;27(2):236-46. doi: 10.1091/mbc.E15-05-0280. Epub 2015 Nov 12.
|
1772 |
Flightless I Homolog Represses Prostate Cancer Progression through Targeting Androgen Receptor Signaling.Clin Cancer Res. 2016 Mar 15;22(6):1531-44. doi: 10.1158/1078-0432.CCR-15-1632. Epub 2015 Nov 2.
|
1773 |
Vinculin and filamin-C are two potential prognostic biomarkers and therapeutic targets for prostate cancer cell migration.Oncotarget. 2017 Jul 19;8(47):82430-82436. doi: 10.18632/oncotarget.19397. eCollection 2017 Oct 10.
|
1774 |
microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer.Biosci Rep. 2017 Mar 15;37(2):BSR20160521. doi: 10.1042/BSR20160521. Print 2017 Apr 30.
|
1775 |
The small leucine rich proteoglycan fibromodulin is overexpressed in human prostate epithelial cancer cell lines in culture and human prostate cancer tissue.Cancer Biomark. 2016;16(1):191-202. doi: 10.3233/CBM-150555.
|
1776 |
Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion.Prostate. 2003 Sep 15;57(1):39-50. doi: 10.1002/pros.10272.
|
1777 |
Clinical relevance of gene expression in localized and metastatic prostate cancer exemplified by FABP5.World J Urol. 2020 Mar;38(3):637-645. doi: 10.1007/s00345-019-02651-8. Epub 2019 Jan 30.
|
1778 |
Wnt activator FOXB2 drives the neuroendocrine differentiation of prostate cancer.Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22189-22195. doi: 10.1073/pnas.1906484116. Epub 2019 Oct 14.
|
1779 |
Gene expression of forkhead transcription factors in the normal and diseased human prostate.BJU Int. 2009 Jun;103(11):1574-80. doi: 10.1111/j.1464-410X.2009.08351.x. Epub 2009 Feb 11.
|
1780 |
Significance of the detection of TIM-3 and FOXJ1 in prostate cancer.J BUON. 2017 Jul-Aug;22(4):1017-1021.
|
1781 |
Knockdown of FOXK1 Suppresses Proliferation, Migration, and Invasion in Prostate Cancer Cells.Oncol Res. 2017 Sep 21;25(8):1261-1267. doi: 10.3727/096504017X14871164924588. Epub 2017 Mar 2.
|
1782 |
Circular RNA circFOXO3 promotes prostate cancer progression through sponging miR-29a-3p.J Cell Mol Med. 2020 Jan;24(1):799-813. doi: 10.1111/jcmm.14791. Epub 2019 Nov 16.
|
1783 |
Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.Cancer Res. 2017 Dec 1;77(23):6524-6537. doi: 10.1158/0008-5472.CAN-17-0686. Epub 2017 Oct 6.
|
1784 |
Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.BMC Cancer. 2019 Apr 11;19(1):346. doi: 10.1186/s12885-019-5509-4.
|
1785 |
MicroRNA?98 suppresses prostate tumorigenesis by targeting MIB1.Oncol Rep. 2019 Sep;42(3):1047-1056. doi: 10.3892/or.2019.7234. Epub 2019 Jul 15.
|
1786 |
A spliced form of CD44 expresses the unique glycan that is recognized by the prostate cancer specific antibody F77.Oncotarget. 2017 Dec 16;9(3):3631-3640. doi: 10.18632/oncotarget.23341. eCollection 2018 Jan 9.
|
1787 |
Overexpression of (1,6) fucosyltransferase in the development of castration-resistant prostate cancer cells.Prostate Cancer Prostatic Dis. 2018 Apr;21(1):137-146. doi: 10.1038/s41391-017-0016-7. Epub 2018 Jan 16.
|
1788 |
Wnt receptor Frizzled 8 is a target of ERG in prostate cancer.Prostate. 2018 Dec;78(16):1311-1320. doi: 10.1002/pros.23704. Epub 2018 Jul 26.
|
1789 |
A novel non-canonical Wnt signature for prostate cancer aggressiveness.Oncotarget. 2017 Feb 7;8(6):9572-9586. doi: 10.18632/oncotarget.14161.
|
1790 |
Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.Sci Rep. 2018 Jun 4;8(1):8537. doi: 10.1038/s41598-018-26761-2.
|
1791 |
E-cadherin gene 3'-UTR C/T polymorphism is associated with prostate cancer.Urol Int. 2005;75(4):350-3. doi: 10.1159/000089173.
|
1792 |
beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.Cancer Res. 2005 Aug 1;65(15):6692-700. doi: 10.1158/0008-5472.CAN-04-4315.
|
1793 |
GABARAPL1 Promotes AR+ Prostate Cancer Growth by Increasing FL-AR/AR-V Transcription Activity and Nuclear Translocation.Front Oncol. 2019 Nov 15;9:1254. doi: 10.3389/fonc.2019.01254. eCollection 2019.
|
1794 |
GABA promotes gastrin-releasing peptide secretion in NE/NE-like cells: Contribution to prostate cancer progression.Sci Rep. 2018 Jul 6;8(1):10272. doi: 10.1038/s41598-018-28538-z.
|
1795 |
Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease.Br J Cancer. 2015 Jul 28;113(3):460-8. doi: 10.1038/bjc.2015.240. Epub 2015 Jul 14.
|
1796 |
Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens.J Biol Chem. 1998 Jul 10;273(28):17618-25. doi: 10.1074/jbc.273.28.17618.
|
1797 |
Use of multiple biomarkers for a molecular diagnosis of prostate cancer.Int J Cancer. 2005 May 10;114(6):950-6. doi: 10.1002/ijc.20760.
|
1798 |
MiR-506-3p acts as a novel tumor suppressor in prostate cancer through targeting GALNT4.Eur Rev Med Pharmacol Sci. 2019 Jun;23(12):5133-5138. doi: 10.26355/eurrev_201906_18177.
|
1799 |
The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer.Mol Cancer Res. 2019 Jun;17(6):1264-1278. doi: 10.1158/1541-7786.MCR-18-1231. Epub 2019 Mar 4.
|
1800 |
Interferon-alpha counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer.Carcinogenesis. 2009 May;30(5):851-60. doi: 10.1093/carcin/bgp052. Epub 2009 Feb 23.
|
1801 |
Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.Cancer Res. 1998 Apr 1;58(7):1391-4.
|
1802 |
Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/-catenin signaling pathway.Cancer Biomark. 2018;23(3):405-418. doi: 10.3233/CBM-181466.
|
1803 |
GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.Front Biosci. 1999 Jul 15;4:D596-600. doi: 10.2741/reichardt.
|
1804 |
Growth Factor-Independent 1 Is a Tumor Suppressor Gene in Colorectal Cancer.Mol Cancer Res. 2019 Mar;17(3):697-708. doi: 10.1158/1541-7786.MCR-18-0666. Epub 2019 Jan 3.
|
1805 |
Effects of gametogenetin-binding protein 2 on proliferation, invasion and migration of prostate cancer PC-3 cells.Andrologia. 2020 Mar;52(2):e13488. doi: 10.1111/and.13488. Epub 2019 Dec 3.
|
1806 |
Targeting protein geranylgeranylation slows tumor development in a murine model of prostate cancer metastasis.Cancer Biol Ther. 2017 Nov 2;18(11):872-882. doi: 10.1080/15384047.2016.1219817. Epub 2016 Sep 13.
|
1807 |
Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonists.Invest New Drugs. 2020 Jun;38(3):746-754. doi: 10.1007/s10637-019-00831-2. Epub 2019 Jul 17.
|
1808 |
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer.Cancer Sci. 2019 Jan;110(1):245-255. doi: 10.1111/cas.13869. Epub 2018 Dec 12.
|
1809 |
Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells.Mol Nutr Food Res. 2009 Jul;53(7):878-86. doi: 10.1002/mnfr.200800253.
|
1810 |
Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.Prostate. 2019 Oct;79(14):1629-1639. doi: 10.1002/pros.23887. Epub 2019 Aug 2.
|
1811 |
c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.Molecules. 2017 Apr 10;22(4):612. doi: 10.3390/molecules22040612.
|
1812 |
The mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2.J Biol Chem. 2002 Apr 12;277(15):12622-31. doi: 10.1074/jbc.M110568200. Epub 2002 Jan 25.
|
1813 |
Genetic polymorphisms of the glycine N-methyltransferase and prostate cancer risk in the health professionals follow-up study.PLoS One. 2014 May 6;9(5):e94683. doi: 10.1371/journal.pone.0094683. eCollection 2014.
|
1814 |
Paradoxical Role of Glypican-1 in Prostate Cancer Cell and Tumor Growth.Sci Rep. 2019 Aug 7;9(1):11478. doi: 10.1038/s41598-019-47874-2.
|
1815 |
Overexpression of Glypican 5 (GPC5) Inhibits Prostate Cancer Cell Proliferation and Invasion via Suppressing Sp1-Mediated EMT and Activation of Wnt/-Catenin Signaling.Oncol Res. 2018 May 7;26(4):565-572. doi: 10.3727/096504017X15044461944385. Epub 2017 Sep 6.
|
1816 |
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes.Cancer Lett. 2018 Jun 1;423:28-35. doi: 10.1016/j.canlet.2018.03.006. Epub 2018 Mar 8.
|
1817 |
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor.Mol Cancer Ther. 2003 Nov;2(11):1139-47.
|
1818 |
Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.J Natl Cancer Inst. 2007 Sep 5;99(17):1313-27. doi: 10.1093/jnci/djm107. Epub 2007 Aug 28.
|
1819 |
Activator of G protein signaling 3 modulates prostate tumor development and progression.Carcinogenesis. 2019 Dec 31;40(12):1504-1513. doi: 10.1093/carcin/bgz076.
|
1820 |
Proproliferative function of adaptor protein GRB10 in prostate carcinoma.FASEB J. 2019 Mar;33(3):3198-3211. doi: 10.1096/fj.201800265RR. Epub 2018 Oct 31.
|
1821 |
Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers.Int J Mol Sci. 2018 Aug 28;19(9):2543. doi: 10.3390/ijms19092543.
|
1822 |
Physiological (68)Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements.Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):115-122. doi: 10.1007/s00259-019-04503-4. Epub 2019 Sep 2.
|
1823 |
A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy.Urol Int. 2016;97(1):16-25. doi: 10.1159/000446446. Epub 2016 May 25.
|
1824 |
Bioinformatics Analysis of Stromal Molecular Signatures Associated with Breast and Prostate Cancer.J Comput Biol. 2019 Oct;26(10):1130-1139. doi: 10.1089/cmb.2019.0045. Epub 2019 Jun 11.
|
1825 |
KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.Oncogene. 2005 Jan 20;24(4):637-49. doi: 10.1038/sj.onc.1208216.
|
1826 |
Germline genetic variants in men with prostate cancer and one or more additional cancers.Cancer. 2017 Oct 15;123(20):3925-3932. doi: 10.1002/cncr.30817. Epub 2017 Jun 28.
|
1827 |
Metformin alters H2A.Z dynamics and regulates androgen dependent prostate cancer progression.Oncotarget. 2018 Dec 11;9(97):37054-37068. doi: 10.18632/oncotarget.26457. eCollection 2018 Dec 11.
|
1828 |
Regulation of protein kinase C-related kinase (PRK) signalling by the TP and TP isoforms of the human thromboxane A(2) receptor: Implications for thromboxane- and androgen- dependent neoplastic and epigenetic responses in prostate cancer.Biochim Biophys Acta Mol Basis Dis. 2017 Apr;1863(4):838-856. doi: 10.1016/j.bbadis.2017.01.011. Epub 2017 Jan 18.
|
1829 |
Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.Cancer Res. 2001 Jul 1;61(13):5207-14.
|
1830 |
Transcription Factor HBP1 Enhances Radiosensitivity by Inducing Apoptosis in Prostate Cancer Cell Lines.Anal Cell Pathol (Amst). 2016;2016:7015659. doi: 10.1155/2016/7015659. Epub 2016 Jan 28.
|
1831 |
Traditional Chinese Medicine CFF-1 induced cell growth inhibition, autophagy, and apoptosis via inhibiting EGFR-related pathways in prostate cancer.Cancer Med. 2018 Apr;7(4):1546-1559. doi: 10.1002/cam4.1419. Epub 2018 Mar 13.
|
1832 |
HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain.Mol Med Rep. 2019 Mar;19(3):2115-2124. doi: 10.3892/mmr.2019.9841. Epub 2019 Jan 10.
|
1833 |
Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.Oncogene. 2002 Dec 12;21(57):8749-58. doi: 10.1038/sj.onc.1205992.
|
1834 |
CK2 abrogates the inhibitory effects of PRH/HHEX on prostate cancer cell migration and invasion and acts through PRH to control cell proliferation.Oncogenesis. 2017 Jan 30;6(1):e293. doi: 10.1038/oncsis.2016.82.
|
1835 |
HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.J Pathol. 2017 Aug;242(4):409-420. doi: 10.1002/path.4913. Epub 2017 Jun 13.
|
1836 |
Upregulation of Holliday junction recognition protein predicts poor prognosis and biochemical recurrence in patients with prostate cancer.Oncol Lett. 2019 Dec;18(6):6697-6703. doi: 10.3892/ol.2019.11061. Epub 2019 Nov 5.
|
1837 |
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.J Hum Genet. 2018 Feb;63(2):195-205. doi: 10.1038/s10038-017-0371-1. Epub 2017 Dec 1.
|
1838 |
RB Loss Promotes Prostate Cancer Metastasis.Cancer Res. 2017 Feb 15;77(4):982-995. doi: 10.1158/0008-5472.CAN-16-1589. Epub 2016 Dec 6.
|
1839 |
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.Cell. 2018 Jul 26;174(3):564-575.e18. doi: 10.1016/j.cell.2018.06.014. Epub 2018 Jul 19.
|
1840 |
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.Mol Cancer. 2019 Jun 20;18(1):109. doi: 10.1186/s12943-019-1037-8.
|
1841 |
HnRNP-L promotes prostate cancer progression by enhancing cell cycling and inhibiting apoptosis.Oncotarget. 2017 Mar 21;8(12):19342-19353. doi: 10.18632/oncotarget.14258.
|
1842 |
hnRNPM, a potential mediator of YY1 in promotingthe epithelial-mesenchymal transition of prostate cancer cells.Prostate. 2019 Aug;79(11):1199-1210. doi: 10.1002/pros.23790.
|
1843 |
TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis.Cancer Res. 2017 Jun 15;77(12):3181-3193. doi: 10.1158/0008-5472.CAN-16-2797. Epub 2017 May 8.
|
1844 |
The relationship between homeobox B7 expression and the clinical characteristics of patient with prostate cancer.J Cell Biochem. 2019 Apr;120(4):6395-6401. doi: 10.1002/jcb.27926. Epub 2018 Oct 14.
|
1845 |
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.
|
1846 |
Decreased HoxD10 Expression Promotes a Proliferative and Aggressive Phenotype in Prostate Cancer.Curr Mol Med. 2017;17(1):70-78. doi: 10.2174/1566524017666170220104920.
|
1847 |
A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.Clin Epigenetics. 2018 Nov 23;10(1):147. doi: 10.1186/s13148-018-0575-z.
|
1848 |
HRK inactivation associated with promoter methylation and LOH in prostate cancer.Prostate. 2008 Jan 1;68(1):105-13. doi: 10.1002/pros.20600.
|
1849 |
A novel human hydroxysteroid dehydrogenase like 1 gene (HSDL1) is highly expressed in reproductive tissues.Mol Biol Rep. 2001;28(4):185-91. doi: 10.1023/a:1015726217890.
|
1850 |
The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer.Cancers (Basel). 2019 Aug 16;11(8):1194. doi: 10.3390/cancers11081194.
|
1851 |
Mutation detection in the human HSP7OB' gene by denaturing high-performance liquid chromatography.Cell Stress Chaperones. 2000 Nov;5(5):415-24. doi: 10.1379/1466-1268(2000)005<0415:mdithh>2.0.co;2.
|
1852 |
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer.World J Surg Oncol. 2018 Jun 11;16(1):107. doi: 10.1186/s12957-018-1395-5.
|
1853 |
Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.APMIS. 2006 Dec;114(12):893-8. doi: 10.1111/j.1600-0463.2006.apm_271.x.
|
1854 |
Meta-analysis of gene expression alterations and clinical significance of the HECT domain-containing ubiquitin ligase HUWE1 in cancer.Oncol Lett. 2019 Sep;18(3):2292-2303. doi: 10.3892/ol.2019.10579. Epub 2019 Jul 5.
|
1855 |
Prostate tumor cell exosomes containing hyaluronidase Hyal1 stimulate prostate stromal cell motility by engagement of FAK-mediated integrin signaling.Matrix Biol. 2019 May;78-79:165-179. doi: 10.1016/j.matbio.2018.05.002. Epub 2018 May 10.
|
1856 |
Antitumor effect of reduction of 150-kDa oxygen-regulated protein expression on human prostate cancer cells.Int J Urol. 2002 Oct;9(10):577-85. doi: 10.1046/j.1442-2042.2002.00519.x.
|
1857 |
ICAM gene cluster SNPs and prostate cancer risk in African Americans.Hum Genet. 2006 Aug;120(1):69-76. doi: 10.1007/s00439-006-0184-3. Epub 2006 May 30.
|
1858 |
Tumor-suppressive lipoxygenases inhibit the expression of c-myc mRNA coding region determinant-binding protein/insulin-like growth factor II mRNA-binding protein 1 in human prostate carcinoma PC-3 cells.Biosci Biotechnol Biochem. 2009 Aug;73(8):1811-7. doi: 10.1271/bbb.90185. Epub 2009 Aug 7.
|
1859 |
Biology of insulin-like growth factor binding protein-4 and its role in cancer (review).Int J Oncol. 2006 Jun;28(6):1317-25.
|
1860 |
TET2 binds the androgen receptor and loss is associated with prostate cancer.Oncogene. 2017 Apr;36(15):2172-2183. doi: 10.1038/onc.2016.376. Epub 2016 Nov 7.
|
1861 |
Repurposing antitubercular agent isoniazid for treatment of prostate cancer.Biomater Sci. 2018 Dec 18;7(1):296-306. doi: 10.1039/c8bm01189c.
|
1862 |
Identification of prognostic biomarkers of prostate cancer with long non-coding RNA-mediated competitive endogenous RNA network.Exp Ther Med. 2019 Apr;17(4):3035-3040. doi: 10.3892/etm.2019.7277. Epub 2019 Feb 14.
|
1863 |
Complex-I Alteration and Enhanced Mitochondrial Fusion Are Associated With Prostate Cancer Progression.J Cell Physiol. 2016 Jun;231(6):1364-74. doi: 10.1002/jcp.25240. Epub 2015 Nov 24.
|
1864 |
Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.PLoS Genet. 2017 Apr 27;13(4):e1006748. doi: 10.1371/journal.pgen.1006748. eCollection 2017 Apr.
|
1865 |
The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.J Mol Cell Biol. 2016 Jun;8(3):207-20. doi: 10.1093/jmcb/mjw007. Epub 2016 Mar 18.
|
1866 |
Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein.Br J Cancer. 2018 Mar 6;118(5):713-726. doi: 10.1038/bjc.2017.447. Epub 2018 Jan 30.
|
1867 |
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer.Cell Biol Int. 2020 Jan;44(1):242-252. doi: 10.1002/cbin.11227. Epub 2019 Sep 10.
|
1868 |
PAPA-1 Is a nuclear binding partner of IGFBP-2 and modulates its growth-promoting actions.Mol Endocrinol. 2009 Feb;23(2):169-75. doi: 10.1210/me.2008-0168. Epub 2008 Dec 18.
|
1869 |
INSL3 in the benign hyperplastic and neoplastic human prostate gland. Int J Oncol. 2005 Aug;27(2):307-15.
|
1870 |
Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.Hum Pathol. 2018 Sep;79:151-159. doi: 10.1016/j.humpath.2018.05.014. Epub 2018 Jun 6.
|
1871 |
Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study.Cancer Causes Control. 2017 Jul;28(7):767-777. doi: 10.1007/s10552-017-0896-9. Epub 2017 Apr 27.
|
1872 |
Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth.Oncotarget. 2017 Jul 17;8(47):82231-82243. doi: 10.18632/oncotarget.19288. eCollection 2017 Oct 10.
|
1873 |
Overexpression of Interferon Regulatory Factor 7 (IRF7) Reduces Bone Metastasis of Prostate Cancer Cells in Mice.Oncol Res. 2017 Apr 14;25(4):511-522. doi: 10.3727/096504016X14756226781802. Epub 2016 Oct 11.
|
1874 |
The iroquois homeobox gene 5 is regulated by 1,25-dihydroxyvitamin D3 in human prostate cancer and regulates apoptosis and the cell cycle in LNCaP prostate cancer cells.Clin Cancer Res. 2008 Jun 1;14(11):3562-70. doi: 10.1158/1078-0432.CCR-07-4649.
|
1875 |
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer.J Gene Med. 2010 Sep;12(9):755-65. doi: 10.1002/jgm.1495.
|
1876 |
Tenascin-C and Integrin 9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment.Cancer Res. 2017 Nov 1;77(21):5977-5988. doi: 10.1158/0008-5472.CAN-17-0064. Epub 2017 Sep 15.
|
1877 |
ITGBL1 promotes EMT, invasion and migration by activating NF-B signaling pathway in prostate cancer.Onco Targets Ther. 2019 May 16;12:3753-3763. doi: 10.2147/OTT.S200082. eCollection 2019.
|
1878 |
Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl.Oncogenesis. 2019 Feb 19;8(3):14. doi: 10.1038/s41389-019-0122-6.
|
1879 |
Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice.Prostate. 2001 Nov 1;49(3):200-7. doi: 10.1002/pros.1135.
|
1880 |
GCN5 inhibition prevents IL-6-induced prostate cancer metastases through PI3K/PTEN/Akt signaling by inactivating Egr-1.Biosci Rep. 2018 Nov 30;38(6):BSR20180816. doi: 10.1042/BSR20180816. Print 2018 Dec 21.
|
1881 |
GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells.Regul Pept. 2002 Nov 15;109(1-3):141-8. doi: 10.1016/s0167-0115(02)00197-0.
|
1882 |
KCTD11 tumor suppressor gene expression is reduced in prostate adenocarcinoma.Biomed Res Int. 2014;2014:380398. doi: 10.1155/2014/380398. Epub 2014 Jun 19.
|
1883 |
Upregulated KDM4B promotes prostate cancer cell proliferation by activating autophagy.J Cell Physiol. 2020 Mar;235(3):2129-2138. doi: 10.1002/jcp.29117. Epub 2019 Aug 29.
|
1884 |
ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.J Clin Invest. 2018 Jul 2;128(7):2979-2995. doi: 10.1172/JCI96769. Epub 2018 Jun 4.
|
1885 |
The histone demethylase UTX/KDM6A in cancer: Progress and puzzles.Int J Cancer. 2019 Aug 1;145(3):614-620. doi: 10.1002/ijc.32116. Epub 2019 Jan 28.
|
1886 |
SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis.Int J Biochem Cell Biol. 2018 Sep;102:138-150. doi: 10.1016/j.biocel.2018.07.009. Epub 2018 Jul 24.
|
1887 |
Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.Oncotarget. 2017 Jul 11;8(28):45459-45469. doi: 10.18632/oncotarget.17564.
|
1888 |
Expression of KIF18A Is Associated with Increased Tumor Stage and Cell Proliferation in Prostate Cancer.Med Sci Monit. 2019 Aug 27;25:6418-6428. doi: 10.12659/MSM.917352.
|
1889 |
Effects of KIF2A on the prognosis of nasopharyngeal carcinoma and nasopharyngeal carcinoma cells.Oncol Lett. 2019 Sep;18(3):2718-2723. doi: 10.3892/ol.2019.10597. Epub 2019 Jul 9.
|
1890 |
Targeting the KIF4A/AR Axis to Reverse Endocrine Therapy Resistance in Castration-resistant Prostate Cancer.Clin Cancer Res. 2020 Mar 15;26(6):1516-1528. doi: 10.1158/1078-0432.CCR-19-0396. Epub 2019 Dec 3.
|
1891 |
KIF7 attenuates prostate tumor growth through LKB1-mediated AKT inhibition.Oncotarget. 2017 Apr 26;8(33):54558-54571. doi: 10.18632/oncotarget.17421. eCollection 2017 Aug 15.
|
1892 |
KIFC1 Inhibitor CW069 Induces Apoptosis and Reverses Resistance to Docetaxel in Prostate Cancer.J Clin Med. 2019 Feb 9;8(2):225. doi: 10.3390/jcm8020225.
|
1893 |
Defining a common region of deletion at 13q21 in human cancers.Genes Chromosomes Cancer. 2001 Aug;31(4):333-44. doi: 10.1002/gcc.1152.
|
1894 |
Upregulation of MicroRNA-21 promotes tumorigenesis of prostate cancer cells by targeting KLF5.Cancer Biol Ther. 2019;20(8):1149-1161. doi: 10.1080/15384047.2019.1599659. Epub 2019 Apr 19.
|
1895 |
MiR-141-3p promotes prostate cancer cell proliferation through inhibiting kruppel-like factor-9 expression.Biochem Biophys Res Commun. 2017 Jan 22;482(4):1381-1386. doi: 10.1016/j.bbrc.2016.12.045. Epub 2016 Dec 9.
|
1896 |
NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.Sci Rep. 2015 Nov 30;5:17426. doi: 10.1038/srep17426.
|
1897 |
Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer.Med Oncol. 2010 Mar;27(1):145-51. doi: 10.1007/s12032-009-9185-0. Epub 2009 Feb 26.
|
1898 |
Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.Epigenetics. 2019 Dec;14(12):1194-1208. doi: 10.1080/15592294.2019.1634985. Epub 2019 Jun 28.
|
1899 |
Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-7 to drive hypoxia-inducible factor (HIF)-1 nuclear translocation.Cytoskeleton (Hoboken). 2019 Jan;76(1):123-130. doi: 10.1002/cm.21450. Epub 2018 Aug 24.
|
1900 |
KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy.Clin Cancer Res. 2011 Mar 1;17(5):1111-21. doi: 10.1158/1078-0432.CCR-10-0081. Epub 2011 Jan 10.
|
1901 |
Inhibition of KPNA4 attenuates prostate cancer metastasis.Oncogene. 2017 May 18;36(20):2868-2878. doi: 10.1038/onc.2016.440. Epub 2016 Dec 12.
|
1902 |
Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells. Mol Cancer Res. 2018 Sep;16(9):1430-1440.
|
1903 |
EMT Markers in Locally-Advanced Prostate Cancer: Predicting Recurrence?.Front Oncol. 2019 Mar 11;9:131. doi: 10.3389/fonc.2019.00131. eCollection 2019.
|
1904 |
The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.Cancer Biol Ther. 2015;16(1):125-36. doi: 10.4161/15384047.2014.987078.
|
1905 |
MicroRNA?06b functions as an oncogene and regulates tumor viability and metastasis by targeting LARP4B in prostate cancer.Mol Med Rep. 2019 Aug;20(2):951-958. doi: 10.3892/mmr.2019.10343. Epub 2019 Jun 5.
|
1906 |
The study of PSA gene expression on urogenital cell lines.Int J Urol. 1999 Oct;6(10):526-31. doi: 10.1046/j.1442-2042.1999.00104.x.
|
1907 |
Limb-bud and Heart Overexpression Inhibits the Proliferation and Migration of PC3M Cells.J Cancer. 2018 Jan 1;9(2):424-432. doi: 10.7150/jca.21375. eCollection 2018.
|
1908 |
Loss of LDAH associated with prostate cancer and hearing loss.Hum Mol Genet. 2018 Dec 15;27(24):4194-4203. doi: 10.1093/hmg/ddy310.
|
1909 |
Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.Cancer Res. 2018 Aug 15;78(16):4459-4470. doi: 10.1158/0008-5472.CAN-17-3226. Epub 2018 Jun 11.
|
1910 |
Expression of two testis-specific genes, SPATA19 and LEMD1, in prostate cancer.Arch Med Res. 2010 Apr;41(3):195-200. doi: 10.1016/j.arcmed.2010.04.003.
|
1911 |
Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.Oncotarget. 2017 Jul 4;8(27):44654-44668. doi: 10.18632/oncotarget.17963.
|
1912 |
Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis.Int J Cancer. 2018 Nov 15;143(10):2537-2550. doi: 10.1002/ijc.31786. Epub 2018 Sep 19.
|
1913 |
Role of BioResponse 3,3'-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience.Med Princ Pract. 2016;25 Suppl 2(Suppl 2):11-7. doi: 10.1159/000439307. Epub 2015 Oct 27.
|
1914 |
LITAF Enhances Radiosensitivity of Human Glioma Cells via the FoxO1 Pathway.Cell Mol Neurobiol. 2019 Aug;39(6):871-882. doi: 10.1007/s10571-019-00686-4. Epub 2019 May 16.
|
1915 |
Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.Oncotarget. 2015 May 30;6(15):13591-606. doi: 10.18632/oncotarget.3792.
|
1916 |
LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer.Nat Commun. 2019 Dec 2;10(1):5494. doi: 10.1038/s41467-019-13532-4.
|
1917 |
Overexpressed LRIG3 gene ameliorates prostate cancer through suppression of cell invasion and migration.Int J Biol Macromol. 2019 Mar 1;124:1-9. doi: 10.1016/j.ijbiomac.2018.11.028. Epub 2018 Nov 7.
|
1918 |
Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.Am J Pathol. 2001 Jan;158(1):25-32. doi: 10.1016/S0002-9440(10)63940-5.
|
1919 |
Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.Tumour Biol. 2015 Aug;36(8):6383-90. doi: 10.1007/s13277-015-3326-1. Epub 2015 Apr 2.
|
1920 |
Bone Microenvironment Changes in Latexin Expression Promote Chemoresistance.Mol Cancer Res. 2017 Apr;15(4):457-466. doi: 10.1158/1541-7786.MCR-16-0392. Epub 2017 Jan 13.
|
1921 |
Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):401-6. doi: 10.1073/pnas.012574899. Epub 2001 Dec 18.
|
1922 |
Hypermethylation of the tumor necrosis factor receptor superfamily 6 (APT1, Fas, CD95/Apo-1) gene promoter at rel/nuclear factor kappaB sites in prostatic carcinoma.Mol Carcinog. 2001 Sep;32(1):36-43. doi: 10.1002/mc.1062.
|
1923 |
Novel fusion transcripts associate with progressive prostate cancer.Am J Pathol. 2014 Oct;184(10):2840-9. doi: 10.1016/j.ajpath.2014.06.025.
|
1924 |
Histone variant MacroH2A1 is downregulated in prostate cancer and influences malignant cell phenotype.Cancer Cell Int. 2019 Apr 29;19:112. doi: 10.1186/s12935-019-0835-9. eCollection 2019.
|
1925 |
Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.Int Urol Nephrol. 2017 May;49(5):811-816. doi: 10.1007/s11255-017-1546-6. Epub 2017 Feb 17.
|
1926 |
Genomic Validation of 3-Tiered Clinical Subclassification of High-Risk Prostate Cancer.Int J Radiat Oncol Biol Phys. 2019 Nov 1;105(3):621-627. doi: 10.1016/j.ijrobp.2019.06.2510. Epub 2019 Jul 2.
|
1927 |
MAGI2 is an independent predictor of biochemical recurrence in prostate cancer.Prostate. 2018 Jun;78(8):616-622. doi: 10.1002/pros.23506. Epub 2018 Mar 14.
|
1928 |
USP14 regulates DNA damage repair by targeting RNF168-dependent ubiquitination.Autophagy. 2018;14(11):1976-1990. doi: 10.1080/15548627.2018.1496877. Epub 2018 Aug 10.
|
1929 |
Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection.World J Urol. 2020 Feb;38(2):361-369. doi: 10.1007/s00345-019-02695-w. Epub 2019 Apr 24.
|
1930 |
The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study.Urology. 2018 Jan;111:122-128. doi: 10.1016/j.urology.2017.08.039. Epub 2017 Sep 6.
|
1931 |
Consulting prostate cancer cohort data uncovers transcriptional control: Regulation of the MARCH6 gene.Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov;1864(11):1656-1668. doi: 10.1016/j.bbalip.2019.08.006. Epub 2019 Aug 15.
|
1932 |
A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells.Oncogene. 2009 Jul 16;28(28):2556-68. doi: 10.1038/onc.2009.118. Epub 2009 May 18.
|
1933 |
Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.Cancer Res. 2003 Nov 15;63(22):7936-41.
|
1934 |
Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.Tumori. 2018 Jun;104(3):172-178. doi: 10.5301/tj.5000646. Epub 2018 May 9.
|
1935 |
AKT Inhibition Modulates H3K4 Demethylase Levels in PTEN-Null Prostate Cancer.Mol Cancer Ther. 2019 Feb;18(2):356-363. doi: 10.1158/1535-7163.MCT-18-0141. Epub 2018 Nov 16.
|
1936 |
Overexpression of malignant brain tumor domain containing protein 1 predicts a poor prognosis of prostate cancer.Oncol Lett. 2019 May;17(5):4640-4646. doi: 10.3892/ol.2019.10109. Epub 2019 Mar 5.
|
1937 |
Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study).Environ Health Perspect. 2018 Apr 23;126(4):047011. doi: 10.1289/EHP1837.
|
1938 |
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer.Prostate. 2018 Dec;78(16):1299-1310. doi: 10.1002/pros.23703. Epub 2018 Aug 10.
|
1939 |
Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.Oncotarget. 2017 Jun 13;8(24):39209-39217. doi: 10.18632/oncotarget.16835.
|
1940 |
Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments.J Natl Cancer Inst. 2002 Jul 17;94(14):1071-9. doi: 10.1093/jnci/94.14.1071.
|
1941 |
Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignancies.Oncogene. 2017 Jun 22;36(25):3629-3639. doi: 10.1038/onc.2017.123. Epub 2017 May 8.
|
1942 |
MicroRNA-1291 mediates cell proliferation and tumorigenesis by downregulating MED1 in prostate cancer.Oncol Lett. 2019 Mar;17(3):3253-3260. doi: 10.3892/ol.2019.9980. Epub 2019 Jan 28.
|
1943 |
Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms.Prostate. 2016 Jan;76(1):22-31. doi: 10.1002/pros.23092. Epub 2015 Sep 18.
|
1944 |
Knockdown of Mediator Complex Subunit 19 Suppresses the Growth and Invasion of Prostate Cancer Cells.PLoS One. 2017 Jan 26;12(1):e0171134. doi: 10.1371/journal.pone.0171134. eCollection 2017.
|
1945 |
The novel gene EG-1 stimulates cellular proliferation.Cancer Res. 2005 Jul 15;65(14):6159-66. doi: 10.1158/0008-5472.CAN-04-4016.
|
1946 |
ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.J Mol Biol. 2017 Oct 13;429(20):2975-2995. doi: 10.1016/j.jmb.2017.06.024. Epub 2017 Jul 17.
|
1947 |
Epigenetic silencing of MEIS2 in prostate cancer recurrence.Clin Epigenetics. 2019 Oct 22;11(1):147. doi: 10.1186/s13148-019-0742-x.
|
1948 |
Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.Cancer Biother Radiopharm. 2019 Mar;34(2):91-102. doi: 10.1089/cbr.2018.2545. Epub 2018 Dec 12.
|
1949 |
RNA m(6)A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway.Onco Targets Ther. 2019 Nov 5;12:9143-9152. doi: 10.2147/OTT.S226796. eCollection 2019.
|
1950 |
Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis.Anticancer Res. 2008 Jul-Aug;28(4A):1993-9.
|
1951 |
Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.Exp Mol Pathol. 2019 Jun;108:173-182. doi: 10.1016/j.yexmp.2019.04.010. Epub 2019 Apr 17.
|
1952 |
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression.Clin Cancer Res. 2006 May 1;12(9):2767-73. doi: 10.1158/1078-0432.CCR-05-1995.
|
1953 |
A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling.Mol Cancer. 2014 Jun 9;13:146. doi: 10.1186/1476-4598-13-146.
|
1954 |
Correction to: MIIP inhibits the growth of prostate cancer via interaction with PP1 and negative modulation of AKT signaling.Cell Commun Signal. 2019 Oct 21;17(1):130. doi: 10.1186/s12964-019-0441-4.
|
1955 |
Volumetric modulated arc therapy with dynamic collimator rotation for improved multileaf collimator tracking of the prostate.Radiother Oncol. 2017 Jan;122(1):109-115. doi: 10.1016/j.radonc.2016.11.004. Epub 2016 Nov 28.
|
1956 |
TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.Prostate. 2017 Sep;77(12):1271-1278. doi: 10.1002/pros.23387. Epub 2017 Jul 21.
|
1957 |
Methylation and MicroRNA Profiling to Understand Racial Disparities of Prostate Cancer.Methods Mol Biol. 2018;1856:255-267. doi: 10.1007/978-1-4939-8751-1_15.
|
1958 |
Thioredoxin-interacting protein: an oxidative stress-related gene is upregulated by glucose in human prostate carcinoma cells.J Mol Endocrinol. 2009 Mar;42(3):205-14. doi: 10.1677/JME-08-0033. Epub 2008 Dec 3.
|
1959 |
Abituzumab Targeting of V-Class Integrins Inhibits Prostate Cancer Progression.Mol Cancer Res. 2017 Jul;15(7):875-883. doi: 10.1158/1541-7786.MCR-16-0447. Epub 2017 Mar 17.
|
1960 |
Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.Oncol Rep. 2018 Mar;39(3):1276-1282. doi: 10.3892/or.2017.6172. Epub 2017 Dec 20.
|
1961 |
Elevated MRE11 expression associated with progression and poor outcome in prostate cancer.J Cancer. 2019 Jul 10;10(18):4333-4340. doi: 10.7150/jca.31454. eCollection 2019.
|
1962 |
Texture analysis of T1-w and T2-w MR images allows a quantitative evaluation of radiation-induced changes of internal obturator muscles after radiotherapy for prostate cancer.Med Phys. 2018 Apr;45(4):1518-1528. doi: 10.1002/mp.12798. Epub 2018 Feb 26.
|
1963 |
Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423. Bioorg Med Chem Lett. 2010 Jan 15;20(2):665-72.
|
1964 |
Elevated Expression Levels of PC3-Secreted Microprotein (PSMP) in Prostate Cancer Associated With Increased Xenograft Growth and Modification of Immune-Related Microenvironment.Front Oncol. 2019 Aug 28;9:724. doi: 10.3389/fonc.2019.00724. eCollection 2019.
|
1965 |
The role of the intravascular microenvironment in spontaneous metastasis development.Int J Cancer. 2010 Jun 1;126(11):2534-41. doi: 10.1002/ijc.24979.
|
1966 |
Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer.J Clin Lab Anal. 2020 Mar;34(3):e23086. doi: 10.1002/jcla.23086. Epub 2019 Nov 11.
|
1967 |
Cell membrane-anchored MUC4 promotes tumorigenicity in epithelial carcinomas.Oncotarget. 2017 Feb 21;8(8):14147-14157. doi: 10.18632/oncotarget.13122.
|
1968 |
Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft.Br J Cancer. 2004 Feb 9;90(3):720-7. doi: 10.1038/sj.bjc.6601570.
|
1969 |
Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.Prostate Cancer Prostatic Dis. 2016 Mar;19(1):28-34. doi: 10.1038/pcan.2015.63. Epub 2016 Jan 12.
|
1970 |
Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.Genes Chromosomes Cancer. 1998 Aug;22(4):295-304.
|
1971 |
Somatic mutation analysis of MYH11 in breast and prostate cancer.BMC Cancer. 2008 Sep 17;8:263. doi: 10.1186/1471-2407-8-263.
|
1972 |
Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.Gynecol Oncol. 2018 Apr;149(1):188-197. doi: 10.1016/j.ygyno.2018.01.024. Epub 2018 Feb 1.
|
1973 |
Selective expression of myosin IC Isoform A in mouse and human cell lines and mouse prostate cancer tissues.PLoS One. 2014 Sep 26;9(9):e108609. doi: 10.1371/journal.pone.0108609. eCollection 2014.
|
1974 |
Myosin Va plays essential roles in maintaining normal mitosis, enhancing tumor cell motility and viability.Oncotarget. 2017 May 17;8(33):54654-54671. doi: 10.18632/oncotarget.17920. eCollection 2017 Aug 15.
|
1975 |
The ultrasound characteristics of regions identified as suspicious by magnetic resonance imaging (MRI) predict the likelihood of clinically significant cancer on MRI-ultrasound fusion-targeted biopsy.BJU Int. 2019 Mar;123(3):439-446. doi: 10.1111/bju.14615. Epub 2018 Nov 30.
|
1976 |
MYSM1-AR complex-mediated repression of Akt/c-Raf/GSK-3 signaling impedes castration-resistant prostate cancer growth.Aging (Albany NY). 2019 Nov 24;11(22):10644-10663. doi: 10.18632/aging.102482. Epub 2019 Nov 24.
|
1977 |
ARD1/NAA10 acetylation in prostate cancer.Exp Mol Med. 2018 Jul 27;50(7):1-8. doi: 10.1038/s12276-018-0107-0.
|
1978 |
Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer.Cancer Lett. 2010 Jun 28;292(2):176-85. doi: 10.1016/j.canlet.2009.11.023. Epub 2009 Dec 30.
|
1979 |
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational Cohort.Urology. 2017 Sep;107:67-75. doi: 10.1016/j.urology.2017.02.052. Epub 2017 Apr 25.
|
1980 |
Inherited NBN Mutations and Prostate Cancer Risk and Survival.Cancer Res Treat. 2019 Jul;51(3):1180-1187. doi: 10.4143/crt.2018.532. Epub 2018 Dec 13.
|
1981 |
hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature.Am J Surg Pathol. 2008 Feb;32(2):205-9. doi: 10.1097/PAS.0b013e318124a865.
|
1982 |
Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer.Oncol Lett. 2019 Jun;17(6):5768-5776. doi: 10.3892/ol.2019.10260. Epub 2019 Apr 17.
|
1983 |
Heredity and prostate cancer: a study of World War II veteran twins.Prostate. 1997 Dec 1;33(4):240-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<240::aid-pros3>3.0.co;2-l.
|
1984 |
Somatic mutations throughout the entire mitochondrial genome are associated with elevated PSA levels in prostate cancer patients.Am J Hum Genet. 2010 Dec 10;87(6):802-12. doi: 10.1016/j.ajhg.2010.11.001.
|
1985 |
Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/-catenin signaling.Biomed Pharmacother. 2018 Jan;97:120-127. doi: 10.1016/j.biopha.2017.10.115. Epub 2017 Nov 6.
|
1986 |
NDRG3 lowers the metastatic potential in prostate cancer as a feedback controller of hypoxia-inducible factors.Exp Mol Med. 2018 May 14;50(5):1-13. doi: 10.1038/s12276-018-0089-y.
|
1987 |
Is there any association between nek3 and cancers with frequent 13q14 deletion?.Cancer Invest. 2006 Nov;24(7):682-8. doi: 10.1080/07357900600981364.
|
1988 |
BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.Int J Mol Sci. 2018 Jul 20;19(7):2104. doi: 10.3390/ijms19072104.
|
1989 |
Decreased gene expression of steroid 5 alpha-reductase 2 in human prostate cancer: implications for finasteride therapy of prostate carcinoma.Prostate. 2003 Oct 1;57(2):134-9. doi: 10.1002/pros.10284.
|
1990 |
NeuroD1 expression in human prostate cancer: can it contribute to neuroendocrine differentiation comprehension?.Eur Urol. 2007 Nov;52(5):1365-73. doi: 10.1016/j.eururo.2006.11.030. Epub 2006 Nov 20.
|
1991 |
Down-Regulation of Nfatc1 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Prostate Cancer Cells.Med Sci Monit. 2019 Feb 28;25:1572-1581. doi: 10.12659/MSM.910998.
|
1992 |
Incidental Finding of Intrathyroid Metastases of Prostatic Cancer on 18F-Choline PET/CT.Clin Nucl Med. 2019 Feb;44(2):e101-e103. doi: 10.1097/RLU.0000000000002374.
|
1993 |
Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.Clin Cancer Res. 2010 Jul 15;16(14):3539-47. doi: 10.1158/1078-0432.CCR-09-3342. Epub 2010 Jul 6.
|
1994 |
Expression analysis of inflammasome sensors and implication of NLRP12 inflammasome in prostate cancer.Sci Rep. 2017 Jun 29;7(1):4378. doi: 10.1038/s41598-017-04286-4.
|
1995 |
The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression.Int J Cancer. 2014 Sep 15;135(6):1399-407. doi: 10.1002/ijc.28778. Epub 2014 Feb 26.
|
1996 |
MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.Int J Mol Med. 2016 Feb;37(2):485-92. doi: 10.3892/ijmm.2016.2449. Epub 2016 Jan 5.
|
1997 |
An ALP-activatable and mitochondria-targeted probe for prostate cancer-specific bimodal imaging and aggregation-enhanced photothermal therapy.Nanoscale. 2019 Mar 28;11(13):6307-6314. doi: 10.1039/c9nr00913b.
|
1998 |
The BMP antagonist Noggin is produced by osteoblasts in response to the presence of prostate cancer cells.Biotechnol Appl Biochem. 2018 May;65(3):407-418. doi: 10.1002/bab.1619. Epub 2017 Nov 2.
|
1999 |
Reproducibility of FCM-DNA ploidy analysis in prostatic cancer: comparison between needle biopsy and surgical specimens.Anal Cell Pathol. 1993 Jan;5(1):17-21.
|
2000 |
NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells.Chem Biol Interact. 2018 Oct 1;294:40-47. doi: 10.1016/j.cbi.2018.08.019. Epub 2018 Aug 18.
|
2001 |
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression.Cancer Cell Int. 2019 Apr 5;19:87. doi: 10.1186/s12935-019-0811-4. eCollection 2019.
|
2002 |
NPRL2 enhances autophagy and the resistance to Everolimus in castration-resistant prostate cancer.Prostate. 2019 Jan;79(1):44-53. doi: 10.1002/pros.23709. Epub 2018 Sep 3.
|
2003 |
TR2 orphan receptor functions as negative modulator for androgen receptor in prostate cancer cells PC-3.Prostate. 2003 Oct 1;57(2):129-33. doi: 10.1002/pros.10282.
|
2004 |
MPC1, a key gene in cancer metabolism, is regulated by COUPTFII in human prostate cancer.Oncotarget. 2016 Mar 22;7(12):14673-83. doi: 10.18632/oncotarget.7405.
|
2005 |
Positive expression of NR6A1/CT150 as a predictor of biochemical recurrence-free survival in prostate cancer patients.Oncotarget. 2016 Aug 31;8(38):64427-64439. doi: 10.18632/oncotarget.11749. eCollection 2017 Sep 8.
|
2006 |
NSD2 is a conserved driver of metastatic prostate cancer progression.Nat Commun. 2018 Dec 5;9(1):5201.
|
2007 |
Germline mutations in the p73 gene do not predispose to familial prostate-brain cancer.Prostate. 2001 Sep 15;48(4):292-6. doi: 10.1002/pros.1109.
|
2008 |
High expression of nucleobindin 2 is associated with poor prognosis in gastric cancer.Tumour Biol. 2017 Jul;39(7):1010428317703817. doi: 10.1177/1010428317703817.
|
2009 |
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia.Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7492-7. doi: 10.1073/pnas.131590998.
|
2010 |
Numb(-/low) Enriches a Castration-Resistant Prostate Cancer Cell Subpopulation Associated with Enhanced Notch and Hedgehog Signaling.Clin Cancer Res. 2017 Nov 1;23(21):6744-6756. doi: 10.1158/1078-0432.CCR-17-0913. Epub 2017 Jul 27.
|
2011 |
Nucleoporin 153 regulates estrogen-dependent nuclear translocation of endothelial nitric oxide synthase and estrogen receptor beta in prostate cancer.Oncotarget. 2018 Jun 15;9(46):27985-27997. doi: 10.18632/oncotarget.25462. eCollection 2018 Jun 15.
|
2012 |
SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone.J Proteomics. 2019 Feb 20;193:217-229. doi: 10.1016/j.jprot.2018.10.012. Epub 2018 Oct 25.
|
2013 |
Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320-Mediated Suppression of the Androgen Receptor.Cancer Res. 2016 Jul 15;76(14):4192-204. doi: 10.1158/0008-5472.CAN-15-3339. Epub 2016 May 23.
|
2014 |
Expression of splice variants of cancer-testis genes ODF3 and ODF4 in the testis of a prostate cancer patient.Genet Mol Res. 2012 Oct 4;11(4):3642-8. doi: 10.4238/2012.October.4.11.
|
2015 |
Targeted Notch1 inhibition with a Notch1 antibody, OMP-A2G1, decreases tumor growth in two murine models of prostate cancer in association with differing patterns of DNA damage response gene expression.J Cell Biochem. 2019 Oct;120(10):16946-16955. doi: 10.1002/jcb.28954. Epub 2019 May 17.
|
2016 |
ONECUT2 is a driver of neuroendocrine prostate cancer.Nat Commun. 2019 Jan 17;10(1):278. doi: 10.1038/s41467-018-08133-6.
|
2017 |
The activation of OR51E1 causes growth suppression of human prostate cancer cells.Oncotarget. 2016 Jul 26;7(30):48231-48249. doi: 10.18632/oncotarget.10197.
|
2018 |
Overexpression of certain transient receptor potential and Orai channels in prostate cancer is associated with decreased risk of systemic recurrence after radical prostatectomy.Prostate. 2019 Dec;79(16):1793-1804. doi: 10.1002/pros.23904. Epub 2019 Sep 2.
|
2019 |
Ovol2 induces mesenchymal-epithelial transition via targeting ZEB1 in osteosarcoma.Onco Targets Ther. 2018 May 22;11:2963-2973. doi: 10.2147/OTT.S157119. eCollection 2018.
|
2020 |
Identification of nucleolar protein No55 as a tumour-associated autoantigen in patients with prostate cancer.Br J Cancer. 2000 Sep;83(6):743-9. doi: 10.1054/bjoc.2000.1365.
|
2021 |
The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.Mol Cell Biochem. 2014 Nov;396(1-2):175-85. doi: 10.1007/s11010-014-2153-9. Epub 2014 Aug 1.
|
2022 |
HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer.Oncotarget. 2017 Dec 8;9(1):512-523. doi: 10.18632/oncotarget.23070. eCollection 2018 Jan 2.
|
2023 |
PADI2-Mediated Citrullination Promotes Prostate Cancer Progression.Cancer Res. 2017 Nov 1;77(21):5755-5768. doi: 10.1158/0008-5472.CAN-17-0150. Epub 2017 Aug 17.
|
2024 |
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159).BMC Cancer. 2019 Sep 10;19(1):903. doi: 10.1186/s12885-019-6117-z.
|
2025 |
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.Cancer Res. 1993 Sep 1;53(17):3869-73.
|
2026 |
Human PARM-1 is a novel mucin-like, androgen-regulated gene exhibiting proliferative effects in prostate cancer cells.Int J Cancer. 2008 Mar 15;122(6):1229-35. doi: 10.1002/ijc.23185.
|
2027 |
PARP9 is overexpressed in human breast cancer and promotes cancer cell migration.Oncol Lett. 2018 Sep;16(3):4073-4077. doi: 10.3892/ol.2018.9124. Epub 2018 Jul 11.
|
2028 |
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach.Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3058-63. doi: 10.1073/pnas.052713699.
|
2029 |
Protocadherin 7 is overexpressed in castration resistant prostate cancer and promotes aberrant MEK and AKT signaling.Prostate. 2019 Nov;79(15):1739-1751. doi: 10.1002/pros.23898. Epub 2019 Aug 26.
|
2030 |
Aberrant Promoter Methylation of Protocadherin8 (PCDH8) in Serum is a Potential Prognostic Marker for Low Gleason Score Prostate Cancer.Med Sci Monit. 2017 Oct 13;23:4895-4900. doi: 10.12659/msm.904366.
|
2031 |
Whole-genome and Transcriptome Sequencing of Prostate Cancer Identify New Genetic Alterations Driving Disease Progression.Eur Urol. 2018 Mar;73(3):322-339. doi: 10.1016/j.eururo.2017.08.027. Epub 2017 Sep 18.
|
2032 |
Protocadherin B9 promotes resistance to bicalutamide and is associated with the survival of prostate cancer patients.Prostate. 2019 Feb;79(2):234-242. doi: 10.1002/pros.23728. Epub 2018 Oct 16.
|
2033 |
Analysis of Mel-18 expression in prostate cancer tissues and correlation with clinicopathologic features.Urol Oncol. 2011 May-Jun;29(3):244-51. doi: 10.1016/j.urolonc.2009.02.004. Epub 2009 Apr 22.
|
2034 |
Glycolytic reprogramming through PCK2 regulates tumor initiation of prostate cancer cells.Oncotarget. 2017 Jun 28;8(48):83602-83618. doi: 10.18632/oncotarget.18787. eCollection 2017 Oct 13.
|
2035 |
Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression.Cancer Res. 2001 Mar 1;61(5):2212-9.
|
2036 |
PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.Mol Cancer Res. 2019 Feb;17(2):618-627. doi: 10.1158/1541-7786.MCR-18-0837. Epub 2018 Dec 5.
|
2037 |
PRLTS gene alterations in human prostate cancer.Jpn J Cancer Res. 1997 Apr;88(4):389-93. doi: 10.1111/j.1349-7006.1997.tb00394.x.
|
2038 |
CX4945 suppresses the growth of castration-resistant prostate cancer cells by reducing AR-V7 expression.World J Urol. 2017 Aug;35(8):1213-1221. doi: 10.1007/s00345-016-1996-y. Epub 2017 Jan 19.
|
2039 |
AMPK/GSK3/-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.FASEB J. 2018 Jul;32(7):3924-3935. doi: 10.1096/fj.201701078R. Epub 2018 Mar 5.
|
2040 |
PDLIM4, an actin binding protein, suppresses prostate cancer cell growth.Cancer Invest. 2009 Mar;27(3):264-72. doi: 10.1080/07357900802406319.
|
2041 |
Correlation of genomic and expression alterations of AS3 with esophageal squamous cell carcinoma.J Genet Genomics. 2008 May;35(5):267-71. doi: 10.1016/S1673-8527(08)60038-7.
|
2042 |
Pre-clinical and clinical evaluation of estramustine, docetaxel and thalidomide combination in androgen-independent prostate cancer.BJU Int. 2007 May;99(5):1047-55. doi: 10.1111/j.1464-410X.2007.06763.x.
|
2043 |
PEG10 is associated with treatment-induced neuroendocrine prostate cancer.J Mol Endocrinol. 2019 Jul 1;63(1):39-49. doi: 10.1530/JME-18-0226.
|
2044 |
Overexpression of PER3 reverses paclitaxel resistance of prostate cancer cells by inhibiting the Notch pathway.Eur Rev Med Pharmacol Sci. 2018 May;22(9):2572-2579. doi: 10.26355/eurrev_201805_14950.
|
2045 |
Downregulation of serum CXCL4L1 predicts progression and poor prognosis in prostate cancer patients treated by radical prostatectomy.Asian J Androl. 2019 Jul-Aug;21(4):387-392. doi: 10.4103/aja.aja_117_18.
|
2046 |
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.Asian J Androl. 2018 Mar-Apr;20(2):178-183. doi: 10.4103/aja.aja_57_17.
|
2047 |
RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.Eur Urol. 2019 Aug;76(2):157-166. doi: 10.1016/j.eururo.2019.03.011. Epub 2019 Mar 23.
|
2048 |
Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.Mol Cancer. 2016 Dec 12;15(1):81. doi: 10.1186/s12943-016-0567-6.
|
2049 |
The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.J Cell Biol. 2019 Jun 3;218(6):1943-1957. doi: 10.1083/jcb.201902048. Epub 2019 May 15.
|
2050 |
Identification, purification and characterization of a novel human blood protein with binding affinity for prostate secretory protein of 94 amino acids.Biochem J. 2005 Jan 1;385(Pt 1):105-14. doi: 10.1042/BJ20040290.
|
2051 |
PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target.PLoS One. 2019 Oct 22;14(10):e0224085. doi: 10.1371/journal.pone.0224085. eCollection 2019.
|
2052 |
The TGF- signalling negative regulator PICK1 represses prostate cancer metastasis to bone.Br J Cancer. 2017 Aug 22;117(5):685-694. doi: 10.1038/bjc.2017.212. Epub 2017 Jul 11.
|
2053 |
Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt/mTOR pathway and acceleration of cell cycle.Int J Oncol. 2019 Sep;55(3):629-644. doi: 10.3892/ijo.2019.4839. Epub 2019 Jul 15.
|
2054 |
Dermcidin expression confers a survival advantage in prostate cancer cells subjected to oxidative stress or hypoxia.Prostate. 2007 Sep 1;67(12):1308-17. doi: 10.1002/pros.20618.
|
2055 |
Novel roles for class II Phosphoinositide 3-Kinase C2 in signalling pathways involved in prostate cancer cell invasion.Sci Rep. 2016 Mar 17;6:23277. doi: 10.1038/srep23277.
|
2056 |
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.Cancer Res. 2010 Mar 15;70(6):2389-96. doi: 10.1158/0008-5472.CAN-09-3575. Epub 2010 Mar 2.
|
2057 |
PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.Medicine (Baltimore). 2019 Jan;98(1):e13820. doi: 10.1097/MD.0000000000013820.
|
2058 |
Protein kinase D1 regulates subcellular localisation and metastatic function of metastasis-associated protein 1.Br J Cancer. 2018 Feb 20;118(4):587-599. doi: 10.1038/bjc.2017.431. Epub 2018 Feb 20.
|
2059 |
Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.APMIS. 2009 Mar;117(3):151-61. doi: 10.1111/j.1600-0463.2008.00002.x.
|
2060 |
Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection.PLoS One. 2019 Jun 24;14(6):e0218950. doi: 10.1371/journal.pone.0218950. eCollection 2019.
|
2061 |
Combination of phospholipase C knockdown with GANT61 sensitizes castrationresistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway.Oncol Rep. 2019 May;41(5):2689-2702. doi: 10.3892/or.2019.7054. Epub 2019 Mar 7.
|
2062 |
Use of the probasin promoter ARR2PB to express Bax in androgen receptor-positive prostate cancer cells.J Natl Cancer Inst. 2001 Sep 5;93(17):1314-24. doi: 10.1093/jnci/93.17.1314.
|
2063 |
Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer.Cancer Manag Res. 2019 Feb 14;11:1517-1524. doi: 10.2147/CMAR.S176762. eCollection 2019.
|
2064 |
Loss of ABHD5 promotes the aggressiveness of prostate cancer cells.Sci Rep. 2017 Oct 12;7(1):13021. doi: 10.1038/s41598-017-13398-w.
|
2065 |
Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.Anticancer Res. 2018 Nov;38(11):6361-6366. doi: 10.21873/anticanres.12994.
|
2066 |
Hypothesis driven single nucleotide polymorphism search (HyDn-SNP-S).DNA Repair (Amst). 2013 Sep;12(9):733-40. doi: 10.1016/j.dnarep.2013.06.001. Epub 2013 Jul 5.
|
2067 |
The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.Pathol Res Pract. 2019 May;215(5):1061-1065. doi: 10.1016/j.prp.2019.02.015. Epub 2019 Feb 27.
|
2068 |
Effects on prostate cancer cells of targeting RNA polymerase III.Nucleic Acids Res. 2019 May 7;47(8):3937-3956. doi: 10.1093/nar/gkz128.
|
2069 |
POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16975-80. doi: 10.1073/pnas.262655399. Epub 2002 Dec 10.
|
2070 |
Clinical and molecular features of treatment-related neuroendocrine prostate cancer.Int J Urol. 2018 Apr;25(4):345-351. doi: 10.1111/iju.13526. Epub 2018 Feb 3.
|
2071 |
Long noncoding RNA POU3F3 promotes cancer cell proliferation in prostate carcinoma by upregulating rho-associated protein kinase 1.J Cell Biochem. 2019 May;120(5):8195-8200. doi: 10.1002/jcb.28101. Epub 2018 Nov 26.
|
2072 |
Brn-3a neuronal transcription factor functional expression in human prostate cancer.Prostate Cancer Prostatic Dis. 2006;9(1):83-91. doi: 10.1038/sj.pcan.4500837.
|
2073 |
Elimination of SOX2/OCT4-Associated Prostate Cancer Stem Cells Blocks Tumor Development and Enhances Therapeutic Response.Cancers (Basel). 2019 Sep 8;11(9):1331. doi: 10.3390/cancers11091331.
|
2074 |
Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.Int J Mol Med. 2002 Aug;10(2):173-6.
|
2075 |
CYP 1A1 polymorphism and organochlorine pesticides levels in the etiology of prostate cancer.Chemosphere. 2010 Sep;81(4):464-8. doi: 10.1016/j.chemosphere.2010.07.067.
|
2076 |
Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms.Nat Commun. 2019 Jul 15;10(1):3107. doi: 10.1038/s41467-019-10808-7.
|
2077 |
PPP2R2A prostate cancer haploinsufficiency is associated with worse prognosis and a high vulnerability to B55/PP2A reconstitution that triggers centrosome destabilization.Oncogenesis. 2019 Dec 10;8(12):72. doi: 10.1038/s41389-019-0180-9.
|
2078 |
miR-1301 promotes prostate cancer proliferation through directly targeting PPP2R2C.Biomed Pharmacother. 2016 Jul;81:25-30. doi: 10.1016/j.biopha.2016.03.043. Epub 2016 Apr 8.
|
2079 |
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.World J Urol. 2020 Oct;38(10):2501-2511. doi: 10.1007/s00345-019-03038-5. Epub 2019 Dec 4.
|
2080 |
Anticancer activity of the PR domain of tumor suppressor RIZ1.Int J Med Sci. 2011 Feb 21;8(2):161-7. doi: 10.7150/ijms.8.161.
|
2081 |
Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis.Oncogene. 2009 Apr 23;28(16):1853-63. doi: 10.1038/onc.2009.30. Epub 2009 Mar 23.
|
2082 |
The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer.Gene. 2019 Feb 20;686:220-227. doi: 10.1016/j.gene.2018.11.048. Epub 2018 Nov 16.
|
2083 |
The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.Oncotarget. 2017 Jul 11;8(28):45994-46005. doi: 10.18632/oncotarget.17522.
|
2084 |
Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.Oncotarget. 2015 Sep 22;6(28):26437-56. doi: 10.18632/oncotarget.4664.
|
2085 |
Identification and characterization of a novel testosterone-regulated prominin-like gene in the rat ventral prostate.Endocrinology. 2002 Dec;143(12):4788-96. doi: 10.1210/en.2002-220522.
|
2086 |
Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer.Biosci Rep. 2018 Oct 31;38(5):BSR20171571. doi: 10.1042/BSR20171571. Print 2018 Oct 31.
|
2087 |
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8403-8. doi: 10.1073/pnas.1507882112. Epub 2015 Jun 15.
|
2088 |
Predictive value of the UICC and AJCC 8th edition tumor-nodes-metastasis (TNM) classification for patients treated with radical prostatectomy.Cancer Epidemiol. 2018 Oct;56:126-132. doi: 10.1016/j.canep.2018.08.007. Epub 2018 Aug 31.
|
2089 |
PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance.Anticancer Drugs. 2019 Aug;30(7):e0773. doi: 10.1097/CAD.0000000000000773.
|
2090 |
Targeting POH1 inhibits prostate cancer cell growth and enhances the suppressive efficacy of androgen deprivation and docetaxel.Prostate. 2019 Aug;79(11):1304-1315. doi: 10.1002/pros.23838. Epub 2019 Jun 18.
|
2091 |
Knockdown of REG inhibits proliferation by inducing apoptosis and cell cycle arrest in prostate cancer.Am J Transl Res. 2017 Aug 15;9(8):3787-3795. eCollection 2017.
|
2092 |
Elevated expression of PTCD3 correlates with tumor progression and predicts poor prognosis in patients with prostate cancer.Mol Med Rep. 2018 Oct;18(4):3914-3922. doi: 10.3892/mmr.2018.9402. Epub 2018 Aug 20.
|
2093 |
Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1292-300. doi: 10.1016/j.ijrobp.2010.07.036.
|
2094 |
Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of -catenin activation of the DKK1 promoter in prostate cancer.Oncogene. 2014 May 8;33(19):2464-77. doi: 10.1038/onc.2013.203. Epub 2013 Jun 10.
|
2095 |
Quantitative proteomic analysis of prostate tissue specimens identifies deregulated protein complexes in primary prostate cancer.Clin Proteomics. 2019 Apr 13;16:15. doi: 10.1186/s12014-019-9236-2. eCollection 2019.
|
2096 |
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancer.BMC Cancer. 2019 Oct 12;19(1):944. doi: 10.1186/s12885-019-6182-3.
|
2097 |
Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells.Sci Rep. 2019 Jun 20;9(1):8838. doi: 10.1038/s41598-019-44991-w.
|
2098 |
Loss of receptor protein tyrosine phosphatase / (RPTP/) promotes prostate cancer metastasis.J Biol Chem. 2012 Nov 23;287(48):40339-49. doi: 10.1074/jbc.M112.405852. Epub 2012 Oct 11.
|
2099 |
Proteomics-Metabolomics Combined Approach Identifies Peroxidasin as a Protector against Metabolic and Oxidative Stress in Prostate Cancer.Int J Mol Sci. 2019 Jun 21;20(12):3046. doi: 10.3390/ijms20123046.
|
2100 |
PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model.Oncogene. 2004 Jan 8;23(1):250-9. doi: 10.1038/sj.onc.1207076.
|
2101 |
Paxillin regulated genomic networks in prostate cancer.Steroids. 2019 Nov;151:108463. doi: 10.1016/j.steroids.2019.108463. Epub 2019 Jul 22.
|
2102 |
Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer.Oncol Lett. 2018 Jan;15(1):731-740. doi: 10.3892/ol.2017.7400. Epub 2017 Nov 14.
|
2103 |
PYGOPUS2 expression in prostatic adenocarcinoma is a potential risk stratification marker for PSA progression following radical prostatectomy.J Clin Pathol. 2018 May;71(5):402-411. doi: 10.1136/jclinpath-2017-204718. Epub 2017 Sep 18.
|
2104 |
Involvement of the glutamine RFamide peptide and its cognate receptor GPR103 in prostate cancer.Oncol Rep. 2019 Feb;41(2):1140-1150. doi: 10.3892/or.2018.6893. Epub 2018 Nov 27.
|
2105 |
A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes.Oncogene. 2009 Oct 29;28(43):3847-56. doi: 10.1038/onc.2009.243. Epub 2009 Aug 17.
|
2106 |
Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.Mol Cancer Res. 2018 Aug;16(8):1319-1331. doi: 10.1158/1541-7786.MCR-17-0589. Epub 2018 May 14.
|
2107 |
miR-338-3p targets RAB23 and suppresses tumorigenicity of prostate cancer cells.Am J Cancer Res. 2018 Dec 1;8(12):2564-2574. eCollection 2018.
|
2108 |
High expression of Rab25 contributes to malignant phenotypes and biochemical recurrence in patients with prostate cancer after radical prostatectomy.Cancer Cell Int. 2017 Apr 11;17:45. doi: 10.1186/s12935-017-0411-0. eCollection 2017.
|
2109 |
Interactive effects of 9-cis-retinoic acid and androgen on proliferation, differentiation, and apoptosis of LNCaP prostate cancer cells.Eur J Cancer Prev. 2017 Jan;26(1):71-77. doi: 10.1097/CEJ.0000000000000230.
|
2110 |
PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer.Cancer Res. 2002 Oct 1;62(19):5420-4.
|
2111 |
Tissue ACE phenotyping in prostate cancer.Oncotarget. 2019 Oct 29;10(59):6349-6361. doi: 10.18632/oncotarget.27276. eCollection 2019 Oct 29.
|
2112 |
CD44 collaborates with ERBB2 mediate radiation resistance via p38 phosphorylation and DNA homologous recombination pathway in prostate cancer.Exp Cell Res. 2018 Sep 1;370(1):58-67. doi: 10.1016/j.yexcr.2018.06.006. Epub 2018 Jun 15.
|
2113 |
No effect of unacylated ghrelin administration on subcutaneous PC3 xenograft growth or metabolic parameters in a Rag1-/- mouse model of metabolic dysfunction.PLoS One. 2018 Nov 20;13(11):e0198495. doi: 10.1371/journal.pone.0198495. eCollection 2018.
|
2114 |
DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.Acta Biomater. 2019 Sep 15;96:480-490. doi: 10.1016/j.actbio.2019.07.003. Epub 2019 Jul 9.
|
2115 |
Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population.Anticancer Res. 2003 May-Jun;23(3C):2897-902.
|
2116 |
SmgGDS is up-regulated in prostate carcinoma and promotes tumour phenotypes in prostate cancer cells.J Pathol. 2009 Feb;217(3):389-97. doi: 10.1002/path.2456.
|
2117 |
Serum concentrations of adipokines in men with prostate cancer and benign prostate hyperplasia.Endokrynol Pol. 2018;69(2):120-127. doi: 10.5603/EP.a2018.0006. Epub 2018 Feb 21.
|
2118 |
Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming.J Clin Invest. 2018 Oct 1;128(10):4472-4484. doi: 10.1172/JCI99397. Epub 2018 Jul 26.
|
2119 |
Evaluation of an Epigenetic Assay for Predicting Repeat Prostate Biopsy Outcome in African American Men.Urology. 2019 Jun;128:62-65. doi: 10.1016/j.urology.2018.04.001. Epub 2018 Apr 13.
|
2120 |
Epigenetic down regulation of RASSF10 and its possible clinical implication in prostate carcinoma.Prostate. 2012 Oct 1;72(14):1550-8. doi: 10.1002/pros.22510. Epub 2012 Mar 13.
|
2121 |
Impact of RNAbinding motif 3 expression on the whole transcriptome of prostate cancer cells: An RNA sequencing study.Oncol Rep. 2018 Oct;40(4):2307-2315. doi: 10.3892/or.2018.6618. Epub 2018 Aug 1.
|
2122 |
CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma.BMC Cancer. 2018 May 2;18(1):514. doi: 10.1186/s12885-018-4249-1.
|
2123 |
Association of ring box-1 protein overexpression with clinicopathologic prognostic parameters in prostate carcinoma.Urol Oncol. 2016 Aug;34(8):336.e7-336.e12. doi: 10.1016/j.urolonc.2016.03.008. Epub 2016 Apr 13.
|
2124 |
CHC1-L, a candidate gene for prostate carcinogenesis at 13q14.2, is frequently affected by loss of heterozygosity and underexpressed in human prostate cancer.Int J Cancer. 2002 Jun 10;99(5):689-96. doi: 10.1002/ijc.10393.
|
2125 |
Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.Mol Cell Biol. 2006 Sep;26(17):6502-10. doi: 10.1128/MCB.00147-06.
|
2126 |
Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells.Cancer Sci. 2018 Apr;109(4):1147-1157. doi: 10.1111/cas.13541. Epub 2018 Mar 31.
|
2127 |
Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.PLoS Genet. 2018 Apr 16;14(4):e1007355. doi: 10.1371/journal.pgen.1007355. eCollection 2018 Apr.
|
2128 |
Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF- signaling.Cell Death Dis. 2018 Jul 13;9(7):779. doi: 10.1038/s41419-018-0807-3.
|
2129 |
Suppressed glycolytic metabolism in the prostate of transgenic rats overexpressing calcium-binding protein regucalcin underpins reduced cell proliferation.Transgenic Res. 2016 Apr;25(2):139-48. doi: 10.1007/s11248-015-9918-0. Epub 2015 Nov 9.
|
2130 |
MiR-203 inhibits the malignant behavior of prostate cancer cells by targeting RGS17.Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5667-5674. doi: 10.26355/eurrev_201907_18303.
|
2131 |
Predictive factors for prolonged hospital stay after retropubic radical prostatectomy in a high-volume teaching center.Int Braz J Urol. 2018 Nov-Dec;44(6):1089-1105. doi: 10.1590/S1677-5538.IBJU.2017.0339.
|
2132 |
Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.Prostate. 2010 Jun 1;70(8):866-74. doi: 10.1002/pros.21120.
|
2133 |
RhoBTB1 interacts with ROCKs and inhibits invasion.Biochem J. 2019 Sep 13;476(17):2499-2514. doi: 10.1042/BCJ20190203.
|
2134 |
Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.J Exp Clin Cancer Res. 2019 Dec 17;38(1):495. doi: 10.1186/s13046-019-1488-1.
|
2135 |
Upregulated expression of polycomb protein Ring1 contributes to poor prognosis and accelerated proliferation in human hepatocellular carcinoma.Tumour Biol. 2015 Dec;36(12):9579-88. doi: 10.1007/s13277-015-3721-7. Epub 2015 Jul 4.
|
2136 |
Potential benefits of combining cytosine deaminase/5-fluorocytosine gene therapy and irradiation for prostate cancer: experimental study.Int J Urol. 2002 Oct;9(10):567-76. doi: 10.1046/j.1442-2042.2002.00513.x.
|
2137 |
Interaction between angiotensin II and relaxin 2 in the progress of growth and spread of prostate cancer cells.Int J Oncol. 2016 Jun;48(6):2619-28. doi: 10.3892/ijo.2016.3458. Epub 2016 Mar 24.
|
2138 |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation.Sci Rep. 2017 Dec 4;7(1):16824. doi: 10.1038/s41598-017-17207-2.
|
2139 |
PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.Prostate. 2009 Dec 1;69(16):1751-62. doi: 10.1002/pros.21025.
|
2140 |
Identification of novel alternative transcripts of the human Ribonuclease (RNASEK) gene using 3' RACE and high-throughput sequencing approaches.Genomics. 2020 Jan;112(1):943-951. doi: 10.1016/j.ygeno.2019.06.010. Epub 2019 Jun 11.
|
2141 |
Knockdown of RNF2 induces cell cycle arrest and apoptosis in prostate cancer cells through the upregulation of TXNIP.Oncotarget. 2017 Jan 17;8(3):5323-5338. doi: 10.18632/oncotarget.14142.
|
2142 |
Role of RNF20 in cancer development and progression - a comprehensive review.Biosci Rep. 2018 Jul 12;38(4):BSR20171287. doi: 10.1042/BSR20171287. Print 2018 Aug 31.
|
2143 |
Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.Oncotarget. 2017 Jul 18;8(29):47110-47120. doi: 10.18632/oncotarget.16943.
|
2144 |
Differentially expressed genes in hormone refractory prostate cancer: association with chromosomal regions involved with genetic aberrations.Am J Pathol. 1999 May;154(5):1335-43. doi: 10.1016/S0002-9440(10)65387-4.
|
2145 |
siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.PLoS One. 2011;6(7):e22672. doi: 10.1371/journal.pone.0022672. Epub 2011 Jul 22.
|
2146 |
Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.Med Oncol. 2019 May 14;36(6):56. doi: 10.1007/s12032-019-1283-z.
|
2147 |
Expression of ribosomal proteins in normal and cancerous human prostate tissue.PLoS One. 2017 Oct 10;12(10):e0186047. doi: 10.1371/journal.pone.0186047. eCollection 2017.
|
2148 |
RPS7 promotes cell migration through targeting epithelial-mesenchymal transition in prostate cancer.Urol Oncol. 2019 May;37(5):297.e1-297.e7. doi: 10.1016/j.urolonc.2019.01.011. Epub 2019 Feb 6.
|
2149 |
hZIP1 zinc transporter down-regulation in prostate cancer involves the overexpression of ras responsive element binding protein-1 (RREB-1).Prostate. 2011 Oct 1;71(14):1518-24. doi: 10.1002/pros.21368. Epub 2011 Feb 25.
|
2150 |
RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.Oncogene. 2004 Apr 15;23(17):3080-8. doi: 10.1038/sj.onc.1207435.
|
2151 |
P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage.Cell Cycle. 2018;17(17):2175-2186. doi: 10.1080/15384101.2018.1520565. Epub 2018 Sep 22.
|
2152 |
Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.Hum Pathol. 2004 Nov;35(11):1385-91. doi: 10.1016/j.humpath.2004.07.015.
|
2153 |
Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells.Urol Oncol. 2013 Nov;31(8):1576-83. doi: 10.1016/j.urolonc.2012.05.006. Epub 2012 Jun 12.
|
2154 |
Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment.Int J Cancer. 2017 Jan 15;140(2):358-369. doi: 10.1002/ijc.30450. Epub 2016 Oct 20.
|
2155 |
miR-4286 promotes prostate cancer progression by targeting the expression of SALL1.J Gene Med. 2023 Jul;25(7):e3127. doi: 10.1002/jgm.3127. Epub 2023 May 30.
|
2156 |
SAMD5 mRNA was overexpressed in prostate cancer and can predict biochemical recurrence after radical prostatectomy.Int Urol Nephrol. 2019 Mar;51(3):443-451. doi: 10.1007/s11255-019-02096-3. Epub 2019 Feb 9.
|
2157 |
Long non-coding RNA SAP30L-AS1 promotes prostate cancer growth through repressing SAP30L.Gene. 2019 Mar 30;690:120-128. doi: 10.1016/j.gene.2018.12.047. Epub 2018 Dec 29.
|
2158 |
HOX genes: Major actors in resistance to selective endocrine response modifiers.Biochim Biophys Acta. 2016 Apr;1865(2):105-10. doi: 10.1016/j.bbcan.2016.01.003. Epub 2016 Jan 22.
|
2159 |
Silver nanoparticles deposited on graphene oxide for ultrasensitive surface-enhanced Raman scattering immunoassay of cancer biomarker.Nanoscale. 2018 Jul 5;10(25):11942-11947. doi: 10.1039/c8nr02820f.
|
2160 |
Capability of SART3(109-118) peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles.Int J Oncol. 2009 Feb;34(2):529-36.
|
2161 |
Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.Br J Cancer. 2001 Jul 20;85(2):190-8. doi: 10.1054/bjoc.2001.1885.
|
2162 |
CSR1 suppresses tumor growth and metastasis of human hepatocellular carcinoma via inhibition of HPIP.Eur Rev Med Pharmacol Sci. 2017 Oct;21(17):3813-3820.
|
2163 |
Proteogenomic Characterization of Patient-Derived Xenografts Highlights the Role of REST in Neuroendocrine Differentiation of Castration-Resistant Prostate Cancer.Clin Cancer Res. 2019 Jan 15;25(2):595-608. doi: 10.1158/1078-0432.CCR-18-0729. Epub 2018 Oct 1.
|
2164 |
Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells.FEBS Open Bio. 2018 Apr 10;8(5):743-750. doi: 10.1002/2211-5463.12412. eCollection 2018 May.
|
2165 |
Epigenetic deregulation across chromosome 2q14.2 differentiates normal from prostate cancer and provides a regional panel of novel DNA methylation cancer biomarkers.Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):148-59. doi: 10.1158/1055-9965.EPI-10-0719. Epub 2010 Nov 23.
|
2166 |
Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.Mol Cancer Ther. 2019 Nov;18(11):1997-2007. doi: 10.1158/1535-7163.MCT-18-1019. Epub 2019 Jul 25.
|
2167 |
In vivo imaging of retinoic acid receptor beta2 transcriptional activation by the histone deacetylase inhibitor MS-275 in retinoid-resistant prostate cancer cells.Prostate. 2005 Jun 15;64(1):20-8. doi: 10.1002/pros.20209.
|
2168 |
Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter.Acta Biochim Biophys Sin (Shanghai). 2004 Jan;36(1):64-7. doi: 10.1093/abbs/36.1.64.
|
2169 |
miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Mol Cancer. 2016 Nov 10;15(1):70. doi: 10.1186/s12943-016-0556-9.
|
2170 |
Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.J Urol. 2009 Oct;182(4):1614-20. doi: 10.1016/j.juro.2009.06.016. Epub 2009 Aug 15.
|
2171 |
SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F.Biochem Biophys Res Commun. 2017 Sep 2;490(4):1394-1398. doi: 10.1016/j.bbrc.2017.07.043. Epub 2017 Jul 8.
|
2172 |
Semaphorin 4F as a critical regulator of neuroepithelial interactions and a biomarker of aggressive prostate cancer.Clin Cancer Res. 2013 Nov 15;19(22):6101-11. doi: 10.1158/1078-0432.CCR-12-3669. Epub 2013 Oct 4.
|
2173 |
Targeting the androgen receptor and overcoming resistance in prostate cancer.Curr Opin Oncol. 2019 May;31(3):175-182. doi: 10.1097/CCO.0000000000000520.
|
2174 |
The interaction between androgen receptor and semenogelin I: a synthetic LxxLL peptide antagonist inhibits the growth of prostate cancer cells.Br J Cancer. 2018 Feb 6;118(3):416-420. doi: 10.1038/bjc.2017.404. Epub 2017 Nov 14.
|
2175 |
Silk scaffolds connected with different naturally occurring biomaterials for prostate cancer cell cultivation in 3D.Biopolymers. 2017 Feb;107(2):70-79. doi: 10.1002/bip.22993.
|
2176 |
Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.Prostate. 2009 Nov 1;69(15):1694-703. doi: 10.1002/pros.21020.
|
2177 |
Identification of CpG Sites of SERPINA5 Promoter with Opposite Methylation Patterns in Benign and Malignant Prostate Cells.Anticancer Res. 2017 Dec;37(12):6609-6618. doi: 10.21873/anticanres.12118.
|
2178 |
Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.Mol Cancer Res. 2019 Apr;17(4):845-859. doi: 10.1158/1541-7786.MCR-18-0638. Epub 2019 Jan 4.
|
2179 |
Neuroserpin (PI-12) is upregulated in high-grade prostate cancer and is associated with survival.Int J Cancer. 2005 Jul 20;115(6):911-6. doi: 10.1002/ijc.20967.
|
2180 |
Sertad1 promotes prostate cancer progression through binding androgen receptor ligand binding domain.Int J Cancer. 2019 Feb 1;144(3):558-568. doi: 10.1002/ijc.31877. Epub 2018 Oct 31.
|
2181 |
Transcriptional regulation of FoxM1 by HIF? mediates hypoxiainduced EMT in prostate cancer.Oncol Rep. 2019 Oct;42(4):1307-1318. doi: 10.3892/or.2019.7248. Epub 2019 Jul 25.
|
2182 |
PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer.Tumour Biol. 2015 Aug;36(8):5753-5. doi: 10.1007/s13277-015-3849-5. Epub 2015 Aug 4.
|
2183 |
SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.Cancer Res. 2019 Oct 15;79(20):5204-5217. doi: 10.1158/0008-5472.CAN-18-3965. Epub 2019 Aug 20.
|
2184 |
miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3.Biomed Pharmacother. 2018 Mar;99:369-374. doi: 10.1016/j.biopha.2018.01.086.
|
2185 |
Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.Oncogene. 2003 Feb 27;22(8):1247-52. doi: 10.1038/sj.onc.1206247.
|
2186 |
Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels.J Clin Endocrinol Metab. 2007 Dec;92(12):4820-6. doi: 10.1210/jc.2007-0887. Epub 2007 Oct 2.
|
2187 |
Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.Prostate. 2005 Sep 15;65(1):58-65. doi: 10.1002/pros.20230.
|
2188 |
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer.Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1376-1383. doi: 10.1158/1055-9965.EPI-18-0369. Epub 2018 Aug 14.
|
2189 |
Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.EBioMedicine. 2018 May;31:267-275. doi: 10.1016/j.ebiom.2018.05.002. Epub 2018 May 16.
|
2190 |
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3509-14. doi: 10.1073/pnas.0712269105. Epub 2008 Feb 26.
|
2191 |
Elevation of SHARPIN Protein Levels in Prostate Adenocarcinomas Promotes Metastasis and Impairs Patient Survivals.Prostate. 2017 May;77(7):718-728. doi: 10.1002/pros.23302. Epub 2017 Feb 23.
|
2192 |
Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men.Cancer Causes Control. 2018 Jan;29(1):157-166. doi: 10.1007/s10552-017-0985-9. Epub 2017 Nov 24.
|
2193 |
Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.Oncogene. 2005 Nov 3;24(48):7203-12. doi: 10.1038/sj.onc.1208852.
|
2194 |
DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.Oncogene. 2018 Feb 1;37(5):638-650. doi: 10.1038/onc.2017.371. Epub 2017 Oct 9.
|
2195 |
Reduced number of CD169(+) macrophages in pre-metastatic regional lymph nodes is associated with subsequent metastatic disease in an animal model and with poor outcome in prostate cancer patients.Prostate. 2017 Nov;77(15):1468-1477. doi: 10.1002/pros.23407. Epub 2017 Sep 7.
|
2196 |
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.PLoS One. 2017 Sep 14;12(9):e0184094. doi: 10.1371/journal.pone.0184094. eCollection 2017.
|
2197 |
Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence.Cancer Res. 2017 Oct 1;77(19):5339-5348. doi: 10.1158/0008-5472.CAN-16-3410. Epub 2017 Aug 14.
|
2198 |
Sirtuin 7: a new marker of aggressiveness in prostate cancer.Oncotarget. 2017 Aug 24;8(44):77309-77316. doi: 10.18632/oncotarget.20468. eCollection 2017 Sep 29.
|
2199 |
New sparse implantation technique of I-125 low-dose-rate brachytherapy using concomitant short-term hormonal treatment for low and intermediate-risk prostate cancer: An initial study of therapeutic feasibility.Sci Rep. 2019 Dec 10;9(1):18674. doi: 10.1038/s41598-019-55317-1.
|
2200 |
MicroRNA-30a functions as tumor suppressor and inhibits the proliferation and invasion of prostate cancer cells by down-regulation of SIX1.Hum Cell. 2017 Oct;30(4):290-299. doi: 10.1007/s13577-017-0170-1. Epub 2017 Jun 1.
|
2201 |
Overexpression of spindle and kinetochore-associated protein 1 contributes to the progression of prostate cancer.Tumour Biol. 2017 Jun;39(6):1010428317701918. doi: 10.1177/1010428317701918.
|
2202 |
Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity.Mol Endocrinol. 2006 May;20(5):1061-72. doi: 10.1210/me.2005-0346. Epub 2005 Dec 29.
|
2203 |
miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF- Signaling.Mol Ther Nucleic Acids. 2019 Jun 7;16:91-104. doi: 10.1016/j.omtn.2019.01.004. Epub 2019 Jan 15.
|
2204 |
Androgen-responsive circular RNA circSMARCA5 is up-regulated and promotes cell proliferation in prostate cancer.Biochem Biophys Res Commun. 2017 Nov 25;493(3):1217-1223. doi: 10.1016/j.bbrc.2017.07.162. Epub 2017 Jul 29.
|
2205 |
Aberrant BAF57 signaling facilitates prometastatic phenotypes.Clin Cancer Res. 2013 May 15;19(10):2657-67. doi: 10.1158/1078-0432.CCR-12-3049. Epub 2013 Mar 14.
|
2206 |
SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.Mol Carcinog. 2019 Jan;58(1):113-125. doi: 10.1002/mc.22913. Epub 2018 Oct 5.
|
2207 |
Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. Oncol Rep. 2008 Jul;20(1):151-4.
|
2208 |
Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy.Clin Cancer Res. 2006 Nov 1;12(21):6452-8. doi: 10.1158/1078-0432.CCR-06-1485.
|
2209 |
SNW1 is a prognostic biomarker in prostate cancer.Diagn Pathol. 2019 May 1;14(1):33. doi: 10.1186/s13000-019-0810-8.
|
2210 |
MiR-492 exerts tumor-promoting function in prostate cancer through repressing SOCS2 expression.Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):992-1001. doi: 10.26355/eurrev_201902_16986.
|
2211 |
SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.Curr Cancer Drug Targets. 2018;18(9):894-904. doi: 10.2174/1568009618666180102101442.
|
2212 |
SOD3 acts as a tumor suppressor in PC-3 prostate cancer cells via hydrogen peroxide accumulation.Anticancer Res. 2014 Jun;34(6):2821-31.
|
2213 |
Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.Mol Endocrinol. 2012 Dec;26(12):1967-79. doi: 10.1210/me.2012-1165. Epub 2012 Sep 28.
|
2214 |
Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.Int J Exp Pathol. 2017 Dec;98(6):341-346. doi: 10.1111/iep.12257. Epub 2018 Jan 8.
|
2215 |
PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers.Gigascience. 2019 May 1;8(5):giz046. doi: 10.1093/gigascience/giz046.
|
2216 |
MicroRNA-140 inhibits proliferation and promotes apoptosis and cell cycle arrest of prostate cancer via degrading SOX4.J BUON. 2019 Jan-Feb;24(1):249-255.
|
2217 |
miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6.Eur J Pharmacol. 2018 Mar 15;823:65-71. doi: 10.1016/j.ejphar.2018.01.016. Epub 2018 Jan 31.
|
2218 |
Interplay Between SOX9, Wnt/-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer.Int J Mol Sci. 2019 Apr 26;20(9):2066. doi: 10.3390/ijms20092066.
|
2219 |
Entering an era of radiogenomics in prostate cancer risk stratification.Transl Androl Urol. 2018 Sep;7(Suppl 4):S443-S452. doi: 10.21037/tau.2018.07.04.
|
2220 |
Hyaluronidase gene profiling and role of hyal-1 overexpression in an orthotopic model of prostate cancer.Int J Cancer. 2002 Feb 1;97(4):416-24. doi: 10.1002/ijc.1638.
|
2221 |
Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.Cancer Res. 2015 Oct 15;75(20):4322-34. doi: 10.1158/0008-5472.CAN-15-0024. Epub 2015 Aug 20.
|
2222 |
The Immune Checkpoint Regulator PDL1 is an Independent Prognostic Biomarker for Biochemical Recurrence in Prostate Cancer Patients Following Adjuvant Hormonal Therapy.J Cancer. 2019 Jun 2;10(14):3102-3111. doi: 10.7150/jca.30384. eCollection 2019.
|
2223 |
Knockdown of spindle pole body component 25 homolog inhibits cell proliferation and cycle progression in prostate cancer.Oncol Lett. 2018 Apr;15(4):5712-5720. doi: 10.3892/ol.2018.8003. Epub 2018 Feb 8.
|
2224 |
SHARP hypofractionated stereotactic radiotherapy for localized prostate cancer: a biochemical response to treatment.J BUON. 2019 Sep-Oct;24(5):2099-2106.
|
2225 |
Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.Cancer Res. 2019 Sep 15;79(18):4592-4598. doi: 10.1158/0008-5472.CAN-18-3997. Epub 2019 Jul 23.
|
2226 |
Serum BSP, PSADT, and Spondin-2 levels in prostate cancer and the diagnostic significance of their ROC curves in bone metastasis.Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):61-67.
|
2227 |
Long non-coding RNA CASC2 regulates Sprouty2 via functioning as a competing endogenous RNA for miR-183 to modulate the sensitivity of prostate cancer cells to docetaxel.Arch Biochem Biophys. 2019 Apr 15;665:69-78. doi: 10.1016/j.abb.2018.01.013. Epub 2018 Jan 31.
|
2228 |
The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells.J Cell Physiol. 2010 Aug;224(2):369-75. doi: 10.1002/jcp.22132.
|
2229 |
Knockdown of SRPX2 inhibits the proliferation, migration, and invasion of prostate cancer cells through the PI3K/Akt/mTOR signaling pathway.J Biochem Mol Toxicol. 2018 Dec 9:e22237. doi: 10.1002/jbt.22237. Online ahead of print.
|
2230 |
SRRM4 gene expression correlates with neuroendocrine prostate cancer.Prostate. 2019 Jan;79(1):96-104. doi: 10.1002/pros.23715. Epub 2018 Aug 28.
|
2231 |
A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.Cancer Res. 2005 Feb 15;65(4):1213-22. doi: 10.1158/0008-5472.CAN-04-4249.
|
2232 |
ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer.Clin Cancer Res. 2008 Jun 15;14(12):3754-60. doi: 10.1158/1078-0432.CCR-07-4763.
|
2233 |
Inducible expression of cancer-testis antigens in human prostate cancer.Oncotarget. 2016 Dec 20;7(51):84359-84374. doi: 10.18632/oncotarget.12711.
|
2234 |
Gene structure and transcriptional regulation of human Gal beta1,4(3) GlcNAc alpha2,3-sialyltransferase VI (hST3Gal VI) gene in prostate cancer cell line.Biochem Biophys Res Commun. 2001 Oct 12;287(5):1148-56. doi: 10.1006/bbrc.2001.5709.
|
2235 |
Sialyltransferase-Based Chemoenzymatic Histology for the Detection of N- and O-Glycans.Bioconjug Chem. 2018 Apr 18;29(4):1231-1239. doi: 10.1021/acs.bioconjchem.8b00021. Epub 2018 Mar 23.
|
2236 |
Prostate--specific G protein couple receptor genes and STAG1/PMEPA1 in peripheral blood from patients with prostatic cancer.Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):871-8. doi: 10.1177/039463200601900416.
|
2237 |
Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13.Cell Mol Biol Lett. 2019 Mar 8;24:20. doi: 10.1186/s11658-019-0145-1. eCollection 2019.
|
2238 |
Increased metastatic lymph node 64 and CYP17 expression are associated with high stage prostate cancer.J Endocrinol. 2007 Jul;194(1):55-61. doi: 10.1677/JOE-07-0131.
|
2239 |
Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth.Oncogene. 2007 Jul 5;26(31):4580-9. doi: 10.1038/sj.onc.1210244. Epub 2007 Feb 5.
|
2240 |
Direct Targeting Options for STAT3 and STAT5 in Cancer.Cancers (Basel). 2019 Dec 3;11(12):1930. doi: 10.3390/cancers11121930.
|
2241 |
Utilisation of the STEAP protein family in a diagnostic setting may provide a more comprehensive prognosis of prostate cancer.PLoS One. 2019 Aug 8;14(8):e0220456. doi: 10.1371/journal.pone.0220456. eCollection 2019.
|
2242 |
Suppression of STIM1 inhibits the migration and invasion of human prostate cancer cells and is associated with PI3K/Akt signaling inactivation.Oncol Rep. 2017 Nov;38(5):2629-2636. doi: 10.3892/or.2017.5961. Epub 2017 Sep 18.
|
2243 |
The Ste20 kinase MST4 plays a role in prostate cancer progression.Cancer Res. 2003 Jun 15;63(12):3356-63.
|
2244 |
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer.Nat Commun. 2018 Nov 16;9(1):4700. doi: 10.1038/s41467-018-07178-x.
|
2245 |
Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers.Cancer Genet Cytogenet. 2000 Oct 1;122(1):43-8. doi: 10.1016/s0165-4608(00)00276-4.
|
2246 |
Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer.Mol Carcinog. 2020 Jan;59(1):62-72. doi: 10.1002/mc.23129. Epub 2019 Nov 1.
|
2247 |
High sulfite oxidase expression could predict postoperative biochemical recurrence in patients with prostate cancer.Med Mol Morphol. 2019 Sep;52(3):164-172. doi: 10.1007/s00795-018-00214-1. Epub 2019 Jan 10.
|
2248 |
Molecular characterization of prostatic small-cell neuroendocrine carcinoma.Prostate. 2003 Apr 1;55(1):55-64. doi: 10.1002/pros.10217.
|
2249 |
Using prognosis to guide inclusion criteria, define standardised endpoints and stratify follow-up in active surveillance for prostate cancer.BJU Int. 2019 Nov;124(5):758-767. doi: 10.1111/bju.14800. Epub 2019 Jun 2.
|
2250 |
A bioinformatics-to-clinic sequential approach to analysis of prostate cancer biomarkers using TCGA datasets and clinical samples: a new method for precision oncology?.Oncotarget. 2017 Aug 24;8(59):99601-99611. doi: 10.18632/oncotarget.20448. eCollection 2017 Nov 21.
|
2251 |
Downregulation of SYT7 inhibits glioblastoma growth by promoting cellular apoptosis.Mol Med Rep. 2017 Dec;16(6):9017-9022. doi: 10.3892/mmr.2017.7723. Epub 2017 Oct 4.
|
2252 |
Assessment of the Utility of Gene Positioning Biomarkers in the Stratification of Prostate Cancers.Front Genet. 2019 Oct 17;10:1029. doi: 10.3389/fgene.2019.01029. eCollection 2019.
|
2253 |
Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity.World J Urol. 2015 Oct;33(10):1481-6. doi: 10.1007/s00345-014-1469-0. Epub 2014 Dec 28.
|
2254 |
NF-B Mediates the Expression of TBX15 in Cancer Cells.PLoS One. 2016 Jun 21;11(6):e0157761. doi: 10.1371/journal.pone.0157761. eCollection 2016.
|
2255 |
Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.Cancer Res. 2017 Mar 15;77(6):1331-1344. doi: 10.1158/0008-5472.CAN-16-0497. Epub 2017 Jan 20.
|
2256 |
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancer.Tumour Biol. 2017 Jun;39(6):1010428317703924. doi: 10.1177/1010428317703924.
|
2257 |
TCF21 and PCDH17 methylation: An innovative panel of biomarkers for a simultaneous detection of urological cancers.Epigenetics. 2011 Sep 1;6(9):1120-30. doi: 10.4161/epi.6.9.16376. Epub 2011 Sep 1.
|
2258 |
TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.Prostate Cancer Prostatic Dis. 2017 Jun;20(2):172-178. doi: 10.1038/pcan.2017.2. Epub 2017 Feb 21.
|
2259 |
Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2833-8. doi: 10.1158/1055-9965.EPI-10-0582. Epub 2010 Sep 17.
|
2260 |
FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of -catenin.Exp Mol Med. 2018 Dec 10;50(12):1-12. doi: 10.1038/s12276-018-0184-0.
|
2261 |
Association of testis derived transcript gene variants and prostate cancer risk.J Urol. 2007 Mar;177(3):894-8. doi: 10.1016/j.juro.2006.10.057.
|
2262 |
Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men.Urol Oncol. 2017 Mar;35(3):111.e9-111.e14. doi: 10.1016/j.urolonc.2016.10.011. Epub 2016 Nov 11.
|
2263 |
Development of Bispecific NT-PSMA Heterodimer for Prostate Cancer Imaging: A Potential Approach to Address Tumor Heterogeneity.Bioconjug Chem. 2019 May 15;30(5):1314-1322. doi: 10.1021/acs.bioconjchem.9b00252. Epub 2019 May 7.
|
2264 |
TGFBR3 loss and consequences in prostate cancer.Prostate. 2007 Feb 15;67(3):301-11. doi: 10.1002/pros.20526.
|
2265 |
Association of TGIFLX/Y mRNA expression with prostate cancer.Med Oncol. 2009;26(1):73-7. doi: 10.1007/s12032-008-9086-7. Epub 2008 Jul 29.
|
2266 |
Tumor-infiltrating mesenchymal stem cells: Drivers of the immunosuppressive tumor microenvironment in prostate cancer?.Prostate. 2019 Feb;79(3):320-330. doi: 10.1002/pros.23738. Epub 2018 Nov 28.
|
2267 |
TIMP4 expression is regulated by miR-200b-3p in prostate cancer cells.APMIS. 2017 Feb;125(2):101-105. doi: 10.1111/apm.12638. Epub 2016 Dec 28.
|
2268 |
Splice variants of TLE family genes and up-regulation of a TLE3 isoform in prostate tumors.Biochem Biophys Res Commun. 2007 Dec 28;364(4):918-23. doi: 10.1016/j.bbrc.2007.10.097. Epub 2007 Oct 26.
|
2269 |
Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.Cancer Sci. 2017 Apr;108(4):744-752. doi: 10.1111/cas.13187. Epub 2017 Apr 12.
|
2270 |
Transmembrane Channel-Like 5 (TMC5) promotes prostate cancer cell proliferation through cell cycle regulation.Biochimie. 2019 Oct;165:115-122. doi: 10.1016/j.biochi.2019.07.017. Epub 2019 Jul 26.
|
2271 |
TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.Neoplasma. 2018 Sep 19;65(5):815-821. doi: 10.4149/neo_2018_170822N551. Epub 2018 Sep 4.
|
2272 |
In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen-dependent prostate cancer cell line.J Formos Med Assoc. 2005 Sep;104(9):652-8.
|
2273 |
TMPRSS4 Upregulates TWIST1 Expression through STAT3 Activation to Induce Prostate Cancer Cell Migration.Pathol Oncol Res. 2018 Apr;24(2):251-257. doi: 10.1007/s12253-017-0237-z. Epub 2017 May 2.
|
2274 |
Oncogenic Role of Tumor Necrosis Factor -Induced Protein 8 (TNFAIP8).Cells. 2018 Dec 24;8(1):9. doi: 10.3390/cells8010009.
|
2275 |
Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.Prostate. 2009 Feb 15;69(3):327-35. doi: 10.1002/pros.20882.
|
2276 |
Differential gene methylation patterns in cancerous and noncancerous cells.Oncol Rep. 2019 Jul;42(1):43-54. doi: 10.3892/or.2019.7159. Epub 2019 May 15.
|
2277 |
4-1BBL has a Possible Role in Mediating Castration-Resistant Conversion of Prostate Cancer via Up-Regulation of Androgen Receptor.J Cancer. 2019 Jun 2;10(11):2464-2471. doi: 10.7150/jca.29648. eCollection 2019.
|
2278 |
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-B signaling pathway.Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.
|
2279 |
Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1.J Biol Chem. 2008 Feb 22;283(8):4834-40. doi: 10.1074/jbc.M708630200. Epub 2007 Dec 12.
|
2280 |
Vasitis nodosa and related lesions: a modern immunohistochemical staining profile with special emphasis on novel diagnostic dilemmas.Hum Pathol. 2018 Mar;73:164-170. doi: 10.1016/j.humpath.2017.12.001. Epub 2017 Dec 11.
|
2281 |
Tumor protein D52 (isoform 3) interacts with and promotes peroxidase activity of Peroxiredoxin 1 in prostate cancer cells implicated in cell growth and migration.Biochim Biophys Acta Mol Cell Res. 2019 Aug;1866(8):1298-1309. doi: 10.1016/j.bbamcr.2019.04.007. Epub 2019 Apr 11.
|
2282 |
Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.Oncol Lett. 2017 Dec;14(6):7739-7744. doi: 10.3892/ol.2017.7214. Epub 2017 Oct 18.
|
2283 |
A novel splice variant of the beta-tropomyosin (TPM2) gene in prostate cancer.Mol Carcinog. 2010 Jun;49(6):525-31. doi: 10.1002/mc.20626.
|
2284 |
MicroRNA-1180 is associated with growth and apoptosis in prostate cancer via TNF receptor associated factor 1 expression regulation and nuclear factor-B signaling pathway activation.Oncol Lett. 2018 Apr;15(4):4775-4780. doi: 10.3892/ol.2018.7914. Epub 2018 Jan 31.
|
2285 |
Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1.J Clin Med. 2019 Mar 12;8(3):348. doi: 10.3390/jcm8030348.
|
2286 |
Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.J Urol. 2004 Sep;172(3):1145-50. doi: 10.1097/01.ju.0000135117.40086.fa.
|
2287 |
Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193.Med Sci Monit. 2019 Jan 4;25:98-106. doi: 10.12659/MSM.911818.
|
2288 |
TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.Int J Mol Med. 2016 Dec;38(6):1734-1742. doi: 10.3892/ijmm.2016.2774. Epub 2016 Oct 17.
|
2289 |
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.Oncogene. 2018 Apr;37(16):2165-2180. doi: 10.1038/s41388-017-0095-x. Epub 2018 Jan 30.
|
2290 |
Up-regulation of TIF1 by valproic acid inhibits the epithelial mesenchymal transition in prostate carcinoma through TGF-/Smad signaling pathway.Eur J Pharmacol. 2019 Oct 5;860:172551. doi: 10.1016/j.ejphar.2019.172551. Epub 2019 Jul 16.
|
2291 |
Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.Oncol Res. 2017 Sep 21;25(8):1253-1259. doi: 10.3727/096504017X14854310794561. Epub 2017 Feb 3.
|
2292 |
Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion.Epigenetics. 2012 Aug;7(8):940-9. doi: 10.4161/epi.21236. Epub 2012 Jul 18.
|
2293 |
TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer.Int J Biol Macromol. 2019 Jan;121:200-206. doi: 10.1016/j.ijbiomac.2018.09.168. Epub 2018 Sep 26.
|
2294 |
TROAP regulates prostate cancer progression via the WNT3/survivin signalling pathways.Oncol Rep. 2019 Feb;41(2):1169-1179. doi: 10.3892/or.2018.6854. Epub 2018 Nov 9.
|
2295 |
Quantitative immunohistochemical analysis and prognostic significance of TRPS-1, a new GATA transcription factor family member, in breast cancer.Horm Cancer. 2010 Feb;1(1):21-33. doi: 10.1007/s12672-010-0008-8. Epub 2010 Feb 13.
|
2296 |
Rare and frequent promoter methylation, respectively, of TSHZ2 and 3 genes that are both downregulated in expression in breast and prostate cancers.PLoS One. 2011 Mar 14;6(3):e17149. doi: 10.1371/journal.pone.0017149.
|
2297 |
The cancer-associated cell migration protein TSPAN1 is under control of androgens and its upregulation increases prostate cancer cell migration.Sci Rep. 2017 Jul 12;7(1):5249. doi: 10.1038/s41598-017-05489-5.
|
2298 |
Localization of candidate genes in a region of high frequency of microvariant alleles for prostate cancer susceptibility: the chromosome region Yp11.2 genetic variation.DNA Cell Biol. 2010 Jan;29(1):3-7. doi: 10.1089/dna.2009.0905.
|
2299 |
Testis specific Y-like 5: gene expression, methylation and implications for drug sensitivity in prostate carcinoma.BMC Cancer. 2017 Feb 24;17(1):158. doi: 10.1186/s12885-017-3134-7.
|
2300 |
Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.Int J Cancer. 2010 Dec 1;127(11):2542-53. doi: 10.1002/ijc.25261.
|
2301 |
Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.Eur J Cancer. 2016 Apr;57:39-49. doi: 10.1016/j.ejca.2016.01.002. Epub 2016 Feb 6.
|
2302 |
Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer.BMC Cancer. 2016 Feb 24;16:151. doi: 10.1186/s12885-016-2178-4.
|
2303 |
XB130 is overexpressed in prostate cancer and involved in cell growth and invasion.Oncotarget. 2016 Sep 13;7(37):59377-59387. doi: 10.18632/oncotarget.11074.
|
2304 |
SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.Cancer Lett. 2018 Mar 1;416:11-23. doi: 10.1016/j.canlet.2017.12.008. Epub 2017 Dec 13.
|
2305 |
Impact of prostate-specific antigen on a baseline prostate cancer risk assessment including genetic risk.Urology. 2015 Jan;85(1):165-70. doi: 10.1016/j.urology.2014.07.081.
|
2306 |
miR?0c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.Mol Med Rep. 2017 Sep;16(3):2431-2438. doi: 10.3892/mmr.2017.6910. Epub 2017 Jul 4.
|
2307 |
Copper chaperone ATOX1 is required for MAPK signaling and growth in BRAF mutation-positive melanoma.Metallomics. 2019 Aug 1;11(8):1430-1440. doi: 10.1039/c9mt00042a. Epub 2019 Jul 18.
|
2308 |
MiR-185 attenuates androgen receptor function in prostate cancer indirectly by targeting bromodomain containing 8 isoform 2, an androgen receptor co-activator.Mol Cell Endocrinol. 2016 May 15;427:13-20. doi: 10.1016/j.mce.2016.02.023. Epub 2016 Mar 3.
|
2309 |
Analysis of the Expression and Single-Nucleotide Variant Frequencies of the Butyrophilin-like 2 Gene in Patients With Uveal Melanoma.JAMA Ophthalmol. 2016 Oct 1;134(10):1125-1133. doi: 10.1001/jamaophthalmol.2016.2691.
|
2310 |
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20.
|
2311 |
Identification of the epigenetic reader CBX2 as a potential drug target in advanced prostate cancer.Clin Epigenetics. 2016 Feb 12;8:16. doi: 10.1186/s13148-016-0182-9. eCollection 2016.
|
2312 |
Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer.Cytokine. 2016 Oct;86:110-118. doi: 10.1016/j.cyto.2016.07.006. Epub 2016 Aug 5.
|
2313 |
The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.Tumour Biol. 2015 Jan;36(1):329-35. doi: 10.1007/s13277-014-2642-1. Epub 2014 Sep 26.
|
2314 |
CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients.Epigenetics. 2016 Dec;11(12):871-880. doi: 10.1080/15592294.2016.1241931. Epub 2016 Sep 30.
|
2315 |
The combination of the prodrugs perforin-CEBPD and perforin-granzyme B efficiently enhances the activation of caspase signaling and kills prostate cancer.Cell Death Dis. 2014 May 8;5(5):e1220. doi: 10.1038/cddis.2014.106.
|
2316 |
Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.Oncotarget. 2016 Oct 18;7(42):68650-68661. doi: 10.18632/oncotarget.11896.
|
2317 |
Inhibition of DIXDC1 by microRNA-1271 suppresses the proliferation and invasion of prostate cancer cells.Biochem Biophys Res Commun. 2017 Mar 18;484(4):794-800. doi: 10.1016/j.bbrc.2017.01.169. Epub 2017 Jan 31.
|
2318 |
Identifying cancer origin using circulating tumor cells.Cancer Biol Ther. 2016 Apr 2;17(4):430-8. doi: 10.1080/15384047.2016.1141839.
|
2319 |
Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclinD2 pathway.Oncol Rep. 2016 Nov;36(5):3058-3064. doi: 10.3892/or.2016.5073. Epub 2016 Sep 7.
|
2320 |
PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer.Cancer Med. 2015 Aug;4(8):1258-71. doi: 10.1002/cam4.463. Epub 2015 May 29.
|
2321 |
Syndecan-1 up-regulates microRNA-331-3p and mediates epithelial-to-mesenchymal transition in prostate cancer.Mol Carcinog. 2016 Sep;55(9):1378-86. doi: 10.1002/mc.22381. Epub 2015 Aug 10.
|
2322 |
Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer.Tumour Biol. 2016 Apr;37(4):5365-74. doi: 10.1007/s13277-015-4398-7. Epub 2015 Nov 11.
|
2323 |
The increased expression of fatty acid-binding protein 9 in prostate cancer and its prognostic significance.Oncotarget. 2016 Dec 13;7(50):82783-82797. doi: 10.18632/oncotarget.12635.
|
2324 |
Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer.Epigenetics. 2016 Apr 2;11(4):247-58. doi: 10.1080/15592294.2016.1148867. Epub 2016 Feb 18.
|
2325 |
Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.BMC Genomics. 2008 Jul 16;9:337. doi: 10.1186/1471-2164-9-337.
|
2326 |
Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.Prostate. 2014 Jul;74(10):1059-67. doi: 10.1002/pros.22826. Epub 2014 May 22.
|
2327 |
D-glucuronyl C5-epimerase cell type specifically affects angiogenesis pathway in different prostate cancer cells.Tumour Biol. 2014 Apr;35(4):3237-45. doi: 10.1007/s13277-013-1423-6. Epub 2013 Nov 22.
|
2328 |
PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.Oncotarget. 2016 Aug 16;7(33):53837-53852. doi: 10.18632/oncotarget.10782.
|
2329 |
GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.Carcinogenesis. 2014 Sep;35(9):1962-7. doi: 10.1093/carcin/bgu048. Epub 2014 Feb 22.
|
2330 |
Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1037-46. doi: 10.1158/1055-9965.EPI-13-0670. Epub 2014 Apr 7.
|
2331 |
Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.Mol Cancer. 2014 Mar 31;13:74. doi: 10.1186/1476-4598-13-74.
|
2332 |
The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related.Oncogene. 2016 Sep 8;35(36):4752-61. doi: 10.1038/onc.2016.6. Epub 2016 Feb 22.
|
2333 |
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer.Mol Cancer Ther. 2014 Dec;13(12):2827-39. doi: 10.1158/1535-7163.MCT-13-0842. Epub 2014 Sep 29.
|
2334 |
Genetic Variants of DICE1/INTS6 in German Prostate Cancer Families with Linkage to 13q14.Urol Int. 2015;95(4):386-9. doi: 10.1159/000366229. Epub 2015 Jan 31.
|
2335 |
Variants at IRX4 as prostate cancer expression quantitative trait loci.Eur J Hum Genet. 2014 Apr;22(4):558-63. doi: 10.1038/ejhg.2013.195. Epub 2013 Sep 11.
|
2336 |
miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.Mol Endocrinol. 2015 Jul;29(7):1037-54. doi: 10.1210/me.2014-1358. Epub 2015 Jun 8.
|
2337 |
An NKX3.1 binding site polymorphism in the l-plastin promoter leads to differential gene expression in human prostate cancer.Int J Cancer. 2016 Jan 1;138(1):74-86. doi: 10.1002/ijc.29677. Epub 2015 Jul 17.
|
2338 |
A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors.Oncotarget. 2016 Nov 1;7(44):71833-71840. doi: 10.18632/oncotarget.12377.
|
2339 |
Single-nucleotide polymorphism rs13426236 contributes to an increased prostate cancer risk via regulating MLPH splicing variant 4.Mol Carcinog. 2020 Jan;59(1):45-55. doi: 10.1002/mc.23127. Epub 2019 Oct 29.
|
2340 |
mLST8 Promotes mTOR-Mediated Tumor Progression.PLoS One. 2015 Apr 23;10(4):e0119015. doi: 10.1371/journal.pone.0119015. eCollection 2015.
|
2341 |
BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts.Int J Oncol. 2015 Aug;47(2):719-27. doi: 10.3892/ijo.2015.3060. Epub 2015 Jun 22.
|
2342 |
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.Br J Cancer. 2016 Apr 12;114(8):945-52. doi: 10.1038/bjc.2016.50.
|
2343 |
Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.Prostate. 2015 Feb 15;75(3):266-79. doi: 10.1002/pros.22912. Epub 2014 Oct 18.
|
2344 |
NKAIN2 functions as a novel tumor suppressor in prostate cancer.Oncotarget. 2016 Sep 27;7(39):63793-63803. doi: 10.18632/oncotarget.11690.
|
2345 |
Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression.Oncotarget. 2016 Oct 18;7(42):68688-68707. doi: 10.18632/oncotarget.11925.
|
2346 |
Aberrant methylation of PCDH10 predicts worse biochemical recurrence-free survival in patients with prostate cancer after radical prostatectomy.Med Sci Monit. 2014 Aug 3;20:1363-8. doi: 10.12659/MSM.891241.
|
2347 |
MicroRNA-103 suppresses tumor cell proliferation by targeting PDCD10 in prostate cancer.Prostate. 2016 May;76(6):543-51. doi: 10.1002/pros.23143. Epub 2016 Jan 15.
|
2348 |
PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.Prostate. 2016 Feb 15;76(3):273-85. doi: 10.1002/pros.23118. Epub 2015 Oct 26.
|
2349 |
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.Prostate. 2014 Sep;74(12):1171-82. doi: 10.1002/pros.22833. Epub 2014 Jun 24.
|
2350 |
Strong cis-acting expression quantitative trait loci for the genes encoding SNHG5 and PEX6.Medicine (Baltimore). 2016 Dec;95(52):e5793. doi: 10.1097/MD.0000000000005793.
|
2351 |
Cathepsin X Cleaves Profilin 1 C-Terminal Tyr139 and Influences Clathrin-Mediated Endocytosis.PLoS One. 2015 Sep 1;10(9):e0137217. doi: 10.1371/journal.pone.0137217. eCollection 2015.
|
2352 |
Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.Tumour Biol. 2015 Dec;36(12):9567-77. doi: 10.1007/s13277-015-3628-3. Epub 2015 Jul 4.
|
2353 |
MicroRNA124 regulate cell growth of prostate cancer cells by targeting iASPP.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2283-90. eCollection 2014.
|
2354 |
Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancer.Biomed Pharmacother. 2016 Mar;78:116-120. doi: 10.1016/j.biopha.2016.01.004. Epub 2016 Jan 24.
|
2355 |
Silencing of CD24 Enhances the PRIMA-1-Induced Restoration of Mutant p53 in Prostate Cancer Cells.Clin Cancer Res. 2016 May 15;22(10):2545-54. doi: 10.1158/1078-0432.CCR-15-1927. Epub 2015 Dec 28.
|
2356 |
DAB2IP regulates EMT and metastasis of prostate cancer through targeting PROX1 transcription and destabilizing HIF1 protein.Cell Signal. 2016 Nov;28(11):1623-30. doi: 10.1016/j.cellsig.2016.07.011. Epub 2016 Jul 27.
|
2357 |
Expression of RABEX-5 and its clinical significance in prostate cancer.J Exp Clin Cancer Res. 2014 Apr 9;33(1):31. doi: 10.1186/1756-9966-33-31.
|
2358 |
Upregulation of RASGRP3 expression in prostate cancer correlates with aggressive capabilities and predicts biochemical recurrence after radical prostatectomy.Prostate Cancer Prostatic Dis. 2014 Jun;17(2):119-25. doi: 10.1038/pcan.2013.51. Epub 2014 Jan 14.
|
2359 |
Role of RbBP5 and H3K4me3 in the vicinity of Snail transcription start site during epithelial-mesenchymal transition in prostate cancer cell.Oncotarget. 2016 Oct 4;7(40):65553-65567. doi: 10.18632/oncotarget.11549.
|
2360 |
miR-888 is an expressed prostatic secretions-derived microRNA that promotes prostate cell growth and migration.Cell Cycle. 2014;13(2):227-39. doi: 10.4161/cc.26984. Epub 2013 Nov 7.
|
2361 |
Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.Mol Cell Endocrinol. 2016 Jan 15;420:159-68. doi: 10.1016/j.mce.2015.10.011. Epub 2015 Oct 21.
|
2362 |
Clinical significance of RKIP mRNA expression in non-small cell lung cancer.Tumour Biol. 2014 May;35(5):4377-80. doi: 10.1007/s13277-013-1575-4. Epub 2014 Jan 14.
|
2363 |
Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer.Endocr Relat Cancer. 2015 Jun;22(3):369-86. doi: 10.1530/ERC-15-0021. Epub 2015 Mar 10.
|
2364 |
Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.Vet J. 2015 Nov;206(2):143-8. doi: 10.1016/j.tvjl.2015.08.002. Epub 2015 Aug 7.
|
2365 |
SHISA2 enhances the aggressive phenotype in prostate cancer through the regulation of WNT5A expression.Oncol Lett. 2017 Dec;14(6):6650-6658. doi: 10.3892/ol.2017.7099. Epub 2017 Sep 28.
|
2366 |
Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.Prostate. 2015 May;75(6):561-72. doi: 10.1002/pros.22935. Epub 2015 Jan 28.
|
2367 |
The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells.Oncogene. 2014 Jul 17;33(29):3794-802. doi: 10.1038/onc.2013.360. Epub 2013 Sep 2.
|
2368 |
TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer.PLoS One. 2019 Sep 19;14(9):e0213488. doi: 10.1371/journal.pone.0213488. eCollection 2019.
|
2369 |
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.Oncotarget. 2016 Apr 26;7(17):24326-38. doi: 10.18632/oncotarget.8220.
|
2370 |
Gelsolin-like actin-capping proteinis associated with patient prognosis, cellular apoptosis and proliferation in prostate cancer.Biomark Med. 2016 Dec;10(12):1251-1260. doi: 10.2217/bmm-2016-0186. Epub 2016 Dec 7.
|
2371 |
TIPE2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Prostate Cancer Cells by Inhibiting PI3K/Akt Signaling Pathway.Oncol Res. 2016;24(5):305-313. doi: 10.3727/096504016X14666990347437.
|
2372 |
Truncating mutations of TP53AIP1 gene predispose to cutaneous melanoma.Genes Chromosomes Cancer. 2018 Jun;57(6):294-303. doi: 10.1002/gcc.22528. Epub 2018 Feb 21.
|
2373 |
MiR-205 suppresses autophagy and enhances radiosensitivity of prostate cancer cells by targeting TP53INP1.Eur Rev Med Pharmacol Sci. 2016;20(1):92-100.
|
2374 |
Steroid Receptor-Associated Immunophilins: Candidates for Diverse Drug-Targeting Approaches in Disease.Curr Mol Pharmacol. 2015;9(1):66-95. doi: 10.2174/1874467208666150519113639.
|
2375 |
TRIM29 as a novel prostate basal cell marker for diagnosis of prostate cancer.Acta Histochem. 2014 Jun;116(5):708-12. doi: 10.1016/j.acthis.2013.12.009. Epub 2014 Jan 30.
|
2376 |
Germline Variants of Prostate Cancer in Japanese Families.PLoS One. 2016 Oct 4;11(10):e0164233. doi: 10.1371/journal.pone.0164233. eCollection 2016.
|
2377 |
Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer.J Korean Med Sci. 2015 Dec;30(12):1784-92. doi: 10.3346/jkms.2015.30.12.1784. Epub 2015 Nov 30.
|
2378 |
TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.Mol Endocrinol. 2016 Jan;30(1):13-25. doi: 10.1210/me.2015-1075. Epub 2015 Dec 9.
|
|
|
|
|
|
|